Sentence,class,file
"Two days later, Fah-ex- pressing hepatocytes were stimulated to undergo selec-tive repopulation by removing the drug NTBC, which prevents toxin formation in Fah-deficient hepatocytes by inhibiting an upstream enzymatic step (Grompe 2001).Mouse livers were harvested at predetermined time points after removal of NTBC, DNA was extracted, and high- [Keywords : liver; regeneration; repopulation; injury; Foxa3; TNFR1] Corresponding author: kaestner@mail.med.upenn.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.258855.",Non-OADS,/arxiv_data1/oa_pdf/61/95/904.PMC4421979.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri- bution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/61/95/904.PMC4421979.pdf
The unique barcode sequences were generated using Barcode Generator free software (http://comailab.genomecenter.ucdavis.edu/index.php/Barcode_generator).,OADS,/arxiv_data1/oa_pdf/61/95/904.PMC4421979.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.260174.115.© 2015 Rasmussen et al.,OADS,/arxiv_data1/oa_pdf/1e/99/910.PMC4421980.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/1e/99/910.PMC4421980.pdf
Corresponding author: cedar@mail.huji.ac.ilArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.259309.115.© 2015 Reizel et al.,Non-OADS,/arxiv_data1/oa_pdf/06/78/923.PMC4421981.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/06/78/923.PMC4421981.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/06/78/923.PMC4421981.pdf
Transcription factor-binding sites and their promoter associa- tion were analyzed using Genomatix (http://www.genomatix.de).,OADS,/arxiv_data1/oa_pdf/06/78/923.PMC4421981.pdf
"Corresponding authors: aziz_sancar@med.unc.edu, jdlieb@uchicago.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.261271.115.© 2015 Hu et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/d1/948.PMC4421983.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f1/d1/948.PMC4421983.pdf
"Aftersix months, it is available under a Creative Commons License (Attribu-tion-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f1/d1/948.PMC4421983.pdf
"For comparison of the DNA repair signal, we normalized all of the count data by the sequencing depth, and data are available for viewing on the University of Cali-fornia at Santa Cruz (UCSC) genome browser by pasting the link http://trackhubs.its.unc.edu/sancarlb/XRseq/hub.txt as the track hub URL in “My hubs.",OADS,/arxiv_data1/oa_pdf/f1/d1/948.PMC4421983.pdf
"” ENCODE data NHDF long total stranded RNA-seq (ENCODE DCC acces- sion ENCSR00CUH), H3K27ac (accession ENCSR000APN), H3K9me3 (accession ENCSR000ARX), and DNase-seq (accession ENCSR000EMP) fastq, aligned reads .bam files, and peak files as well as the NHLF chromHMM chromatin state segmentation(UCSC accession wgEncodeEH000792) were downloaded from the ENCODE portal (http://genome.ucsc.edu/ENCODE) or viewed on the UCSC browser.",OADS,/arxiv_data1/oa_pdf/f1/d1/948.PMC4421983.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.257568.114.© 2015 Guiley et al.,Non-OADS,/arxiv_data1/oa_pdf/5b/bd/961.PMC4421984.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5b/bd/961.PMC4421984.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5b/bd/961.PMC4421984.pdf
"The F-box containing blue-light receptor FKF1 per- ceives light information and, together with GIGANTEA(GI), mediates the degradation of the CYCLING DOFFACTOR (CDF) proteins in a blue-light-dependent Corresponding author: hongma@fudan.edu.cn Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.251520.114.",OADS,/arxiv_data1/oa_pdf/17/c9/975.PMC4421985.pdf
"This article, published in Genes & Development ,i s available under a Creative Commons License (Attribution-NonCom-mercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/17/c9/975.PMC4421985.pdf
Vitamin D supplementation in PCOS1–9 4:108 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS2–9 4:109 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS3–9 4:110 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS4–9 4:111 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS5–9 4:112 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS6–9 4:113 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS7–9 4:114 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS8–9 4:115 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
Vitamin D supplementation in PCOS9–9 4:116 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0001/C2092015 The author Published by Bioscientiﬁca Ltd This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .,Non-OADS,/arxiv_data1/oa_pdf/94/59/ec-04-108.PMC4422012.pdf
"Classification analysis using machine learning  methods    Analyses were performed using BRB-ArrayTools  version 4.2.1 Stable Release developed by Dr.  Richard Simon and BRB-ArrayTools Development  Team (http://linus.nci.nih.gov/BRB-ArrayTools.html)   (Simon et al., 2007).",OADS,/arxiv_data1/oa_pdf/7e/49/nrs-13-002.PMC4422105.pdf
“All samples used in the training and  testing sets were first log2 normalized using RMA i n  the RMAExpress software environment  (http://rmaexpress.bmbolstad.com/).,OADS,/arxiv_data1/oa_pdf/7e/49/nrs-13-002.PMC4422105.pdf
"To comprehensively assess whether the genes  in the CAR signature were previously identified as  being regulated by CAR activators, we used the  Comparative Toxicogenomics Database (CTD;  http://ctdbase.org/) to find published relationship s  between chemicals and the signature genes in mice.",OADS,/arxiv_data1/oa_pdf/7e/49/nrs-13-002.PMC4422105.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Journal of Visualized Experiments April 2015 |  98  | e52503 | Page 1 of 12Video Article Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders Balakrishnan S. Moorthy*1, Lavanya K. Iyer*1, Elizabeth M. Topp1 1Department of Industrial and Physical Pharmacy, Purdue University *These authors contributed equally Correspondence to: Elizabeth M. Topp at topp@purdue.edu URL: http://www.jove.com/video/52503 DOI: doi:10.3791/52503 Keywords: Chemistry, Issue 98, Amide hydrogen/deuterium exchange, photolytic labeling, mass spectrometry, lyophilized formulations, photo- leucine, solid-state, protein structure, protein conformation, protein dynamics, secondary structure, protein stability, excipients Date Published: 4/14/2015 Citation: Moorthy, B.S., Iyer, L.K., Topp, E.M. Mass Spectrometric Approaches to Study Protein Structure and Interactions in Lyophilized Powders.",Non-OADS,/arxiv_data1/oa_pdf/c9/b7/jove-98-52503.PMC4422116.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52503/ Introduction Protein drugs are the fastest growing sector of the biopharmaceutical industry and offer promising new treatments for previously intractable diseases, including hormonal disorders, cancers and autoimmune diseases1.",Non-OADS,/arxiv_data1/oa_pdf/c9/b7/jove-98-52503.PMC4422116.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/63/opth-9-733.PMC4422283.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 733–744Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  733Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4943 7Current and emerging treatment options  for myopic choroidal neovascularization Leila el Matri Ahmed Chebil Fedra Kort Department B of Ophthalmology,   Hedi Rais institute of Ophthalmology,   Faculty of Medicine of T unis,   University of el Manar, T unis, T unisiaAbstract:  Choroidal neovascularization (CNV) is the main cause of visual impairment in  highly myopic patients younger than 50 years of age.",Non-OADS,/arxiv_data1/oa_pdf/69/63/opth-9-733.PMC4422283.pdf
"The aim of this article is to provide a review of the literature related to mCNV and  highlight the current and emerging treatment options.Correspondence: Leila el Matri Boulevard 9 Avril, 1006 Bab Saadoun,  Tunis, Tunisia   Tel +216 71 57 36 04 Fax +216 71 57 59 56 email leila.elmatri@planet.t n Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: El Matri et al Running head recto: Treatment options for myopic choroidal neovascularization DOI: http://dx.doi.org/10.2147/OPTH.S49437",Non-OADS,/arxiv_data1/oa_pdf/69/63/opth-9-733.PMC4422283.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/69/63/opth-9-733.PMC4422283.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/63/opth-9-733.PMC4422283.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/cb/opth-9-745.PMC4422284.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 745–749Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  745Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7500 0Virtual glaucoma clinics: patient acceptance   and quality of patient education compared   to standard clinics Jennifer h Court1 Michael W austin1,2 1Department of Ophthalmology,   singleton hospital, swansea, Wales,   UK; 2Department of Ophthalmology,   neath Port Talbot hospital, swansea,   Wales, UKPurpose:  Virtual glaucoma clinics allow rapid, reliable patient assessment but the service  should be acceptable to patients and concordance with treatment needs to be maintained with  adequate patient education.",Non-OADS,/arxiv_data1/oa_pdf/ff/cb/opth-9-745.PMC4422284.pdf
"The  purpose of this study is to investigate non-inferiority of a new virtual clinic format  by comparing experiences of patients managed via this pathway with a control group  reviewed via the “standard” clinic, and to compare patients’ understanding of their  condition and management.Correspondence: Jennifer h Court Department of Ophthalmology, singleton hospital, sketty lane, swansea sa2 8Qa, Wales Tel +44 1792 285 036 Fax +44 1792 285 839 email j ennifer.court@wales.nhs.u k Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Court and Austin Running head recto: Virtual glaucoma clinics: patient acceptance and education DOI: http://dx.doi.org/10.2147/OPTH.S75000",Non-OADS,/arxiv_data1/oa_pdf/ff/cb/opth-9-745.PMC4422284.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ff/cb/opth-9-745.PMC4422284.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/cb/opth-9-745.PMC4422284.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 125–136HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  125ReVIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S5002 5Pre-exposure prophylaxis for sexually-acquired  HIV risk management: a review James wilton1 Heather Senn2 Malika Sharma3 Darrell HS Tan4,5 1Canadian AIDS Treatment  Information exchange (CATI e),  2Department of Family and  Community Medicine, University  of Toronto, 3wilson Centre for  Research in education, University  Health Network, University of  Toronto, 4Division of Infectious  Diseases, St Michael’s Hospital,  5Department of Medicine, University  of Toronto, Toronto, ON, Canada Correspondence: Darrell HS Tan   Division of Infectious Diseases, St  Michael’s Hospital, 30 Bond St,   4CC – Room 4-179, Toronto, ON,   M5B 1w8 Canada   Tel +1 416 864 5568   Fax +1 416 864 5310   email darrell.tan@gmail.co mAbstract:  Despite significant efforts, the rate of new HIV infections worldwide remains  unacceptably high, highlighting the need for new HIV prevention strategies.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Data from http://www.clinicaltrials.go v, http://vicprep.csrh.or g105 and http://depts.washington.edu/uwicrc .104 Abbreviations:  TDF, tenofovir; FTC, emtricitabine; MSM, men who have sex with men; n, number; Pr eP, pre-exposure prophylaxis; STD, sexually transmitted disease;   PeP, postexposure prophylaxis; CPP, customized prevention package; iTAB, individual Texting for Adherence Building; IDU, intravenous drug users; ART, antiretroviral therapy.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Available from: http://www.unaids.org/sites/default/files/media_asset/ UNAIDS_Gap_report_en.pd f. Accessed December 23, 2014.",OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
Available from: http://www.cdc.gov/hiv/pdf/prepguidelines2014.,Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Available from: http://www.huffingtonpost.com/david-duran/truvada- whores_b_2113588.htm l. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Available from: http://www.proud.mrc.ac.uk/PDF/PROUD%20 Statement%20161014.pd f. Accessed December 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Available  from: http://depts.washington.edu/uwicrc/research/studies/demo.htm l.  Accessed December 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
"Available from: http://vicprep.csrh.org/index.ph p.  Accessed December 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4f/b9/hiv-7-125.PMC4422285.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2367–2374Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2367Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DDDT .S6525 5Changing the face of hepatitis C management –  the design and development of sofosbuvir Bennett C Noell* Siddesh v Besur* Andrew S deLemos Department of Medicine, Center for  Liver Diseases and Transplantation,   Carolinas Medical Center, Charlotte,   NC, USA *These authors contributed equally  to this workAbstract:  The availability of direct-acting antiviral (DAA) therapy has launched a new era in  the management of chronic hepatitis C. Sofosbuvir, a uridine nucleotide analog that inhibits the  hepatitis C RNA-dependent RNA polymerase, is the backbone of chronic hepatitis C therapy.",Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
"Patients no longer require treatment with pegylated inter - feron (Peg-IFN), which caused innumerable side effects resulting in poor adherence Correspondence: Andrew S deLemos Department of Medicine, Center for  Liver Diseases and Transplantation,  Carolinas Medical Center, 1025  Morehead Medical Drive, Suite 600,  Charlotte, NC 28204, USA Tel +1 704 446 4849 Fax +1 704 446 4877 email andrew.deLemos@carolinas.or g Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Noell et al Running head recto: Sofosbuvir for chronic hepatitis C DOI: http://dx.doi.org/ 10.2147/DDDT.S65255",Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
"While this combination remains a viable option  for interferon-eligible patients, 24 weeks of sofosbuvir and  RBV or 12-weeks of Harvoni® is probably a better alternative  (http://www.hcvguideline.or g) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
"However, ledipasvir increases  tenofovir levels and should be avoided in patients with a crea - tinine clearance below 60 mL/min ( http://www.hcvguideline.",Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
"Recommenda - tions for testing, managing, and treating hepatitis C. Available from:  http://www.hcvguidelines.org.",Non-OADS,/arxiv_data1/oa_pdf/49/2e/dddt-9-2367.PMC4422286.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/d9/dddt-9-2395.PMC4422287.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2395–2398Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2395CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6868 2Development of acquired factor V inhibitor  after treatment with ceftazidime: a case report  and review of the literature Qing-ya Cui1 Hong-shi Shen1 Tian-qin Wu1 Hai-fei Chen1  Zi-qiang Yu2 Zhao-yue Wang2 1Department of Hematology,   PLA 100th Hospital, 2Jiangsu Institute  of Hematology, The First Affiliated  Hospital of Soochow University,   Suzhou, People’s Republic of ChinaAbstract:  We report the case of a 59-year-old Chinese man who showed an asymptomatic  coagulation factor V deficiency pattern after second intravenous treatment with ceftazidime.",Non-OADS,/arxiv_data1/oa_pdf/c0/d9/dddt-9-2395.PMC4422287.pdf
"Correspondence: Hong-shi Shen Department of Hematology,   PLA 100th Hospital,   53 Wuqueqiao Street, Suzhou 215006,  People’s Republic of China Tel +86 512 6506 3541 Fax +86 512 6506 3541 Email shs10@163.co m  Zhao-yue Wang Jiangsu Institute of Hematology, The First  Affiliated Hospital of Soochow University,  188 Shizi Street, Suzhou 215006,   People’s Republic of China Tel +86 512 6778 0872 Fax +86 512 6511 3556 Email zwang11@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: CASE REPORT Y ear: 2015 Volume: 9 Running head verso: Cui et al Running head recto: Acquired factor V deficiency DOI: http://dx.doi.org/10.2147/DDDT.S68682",Non-OADS,/arxiv_data1/oa_pdf/c0/d9/dddt-9-2395.PMC4422287.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c0/d9/dddt-9-2395.PMC4422287.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/d9/dddt-9-2395.PMC4422287.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/ce/dddt-9-2375.PMC4422289.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2375–2382Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2375Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7849 6apolipoprotein M regulates the orphan nuclear  receptor lrh-1 gene expression through binding  to its promoter region in hepg2 cells Yi Pan1,2,* hou-gang Zhou1,* hui Zhou3 Min hu1 li-jun Tang2 1clinical laboratory, The second  Xiangya hospital of central south  University, changsha, hunan, People’s  republic of china; 2Molecular Biology  research center, school of life  sciences, central south University,   changsha, hunan, People’s republic  of china; 3Tumor hospital of  Xiangya school of Medicine, central  south University, changsha, hunan,   People’s  republic of china *These authors contributed equally  to this workAbstract:  Apolipoprotein M (ApoM) is predominantly located in the high-density lipoprotein  in human plasma.",Non-OADS,/arxiv_data1/oa_pdf/38/ce/dddt-9-2375.PMC4422289.pdf
"As two important members of the nuclear receptor superfamily, liver receptor  homolog-1 (LRH-1) and farnesoid X receptor (FXR) play a pivotal role in the bile  acid metabolism.9 To date, LRH-1 still remains an orphan member of the nuclear receptor super - family, whose physiological ligands have not yet been identified, while FXR can be correspondence: Min hu clinical laboratory, The second Xiangya  hospital of central south University 139  renmin Middle road, changsha 410011,  hunan, People’s republic of china Tel +86 731 8529 2142 email min_hucsu@163.co m li-jun Tang Molecular Biology research center,  school of life sciences, central south  University, 88 Xiangya road, changsha  410078, hunan, People’s republic  of china Tel +86 731 8480 5449 email tljxie@csu.edu.c nJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Pan et al Running head recto: Apolipoprotein M in HepG2 cells DOI: http://dx.doi.org/10.2147/DDDT.S78496",Non-OADS,/arxiv_data1/oa_pdf/38/ce/dddt-9-2375.PMC4422289.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/38/ce/dddt-9-2375.PMC4422289.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/ce/dddt-9-2375.PMC4422289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/d4/ijn-10-3231.PMC4422291.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3231–3244International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3231OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8175 4gold nanoparticle-based beacon to detect STAT5b   mrNa expression in living cells: a case optimized  by bioinformatics screen Dawei Deng* Yang li* Jianpeng Xue Jie Wang guanhua ai Xin li Yueqing gu Department of Biomedical  engineering, china Pharmaceutical  University, Nanjing, People’s republic  of china *These authors contributed equally  to this workAbstract:  Messenger RNA (mRNA), a single-strand ribonucleic acid with functional gene  information is usually abnormally expressed in cancer cells and has become a promising bio - marker for the study of tumor progress.",Non-OADS,/arxiv_data1/oa_pdf/04/d4/ijn-10-3231.PMC4422291.pdf
"Primary patient samples of leukemic model systems have  provided evidence that STAT5b plays an important role in the process of malignant  transformation in acute leukemia.4,5 Activation of STAT5b increases the activity of  casein promoter, which causes malignant transformation of lymphocytes.5 In addition,  overexpression and constitutive activation of STAT5b have been detected in primary  acute myeloid leukemia blast cells.6 Therefore, overexpression and activation of correspondence: Yueqing gu Department of Biomedical engineering,  china Pharmaceutical University,  24 Tongjia lane, Nanjing 210009,  People’s republic of china Tel +86 25 8327 1080 Fax +86 25 8327 1046 email guyueqingsubmission@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Deng et al Running head recto: Hairpin DNA AuNP beacon to detect STAT5b  mRNA expression DOI: http://dx.doi.org/10.2147/IJN.S81754",Non-OADS,/arxiv_data1/oa_pdf/04/d4/ijn-10-3231.PMC4422291.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/04/d4/ijn-10-3231.PMC4422291.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/d4/ijn-10-3231.PMC4422291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/38/dddt-9-2383.PMC4422293.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2383–2394Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2383Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7950 4structure–activity exploration of a small-molecule  lipid ii inhibitor steven Fletcher1 Wenbo Yu1,2 Jing huang1,2 steven M Kwasny3 Jay chauhan1 Timothy J Opperman3 alexander D MacKerell Jr1,2 erik P h de leeuw4 1Department of Pharmaceutical  sciences, 2computer- aided Drug  Design center, University of Maryland,   school of Pharmacy, Baltimore,   MD, 3Microbiotix, inc., Worcester,   Ma, 4institute of human Virology  and Department of Biochemistry  and Molecular Biology, University  of Maryland, school of Medicine,   Baltimore, MD, UsaAbstract:  We have recently identified low-molecular weight compounds that act as inhibitors of  Lipid II, an essential precursor of bacterial cell wall biosynthesis.",Non-OADS,/arxiv_data1/oa_pdf/86/38/dddt-9-2383.PMC4422293.pdf
"Based on the interaction between  Lipid II and human neutrophil peptide-1, we identified low-molecular weight synthetic correspondence: erik Ph de leeuw institute of human Virology and  Department of Biochemistry and  Molecular Biology, University  of Maryland, school of Medicine,  725 West lombard street,  Baltimore, MD 21201, Usa Tel +1 410 706 1970 Fax +1 410 706 7583 email edeleeuw@som.umaryland.ed uJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Fletcher et al Running head recto: Structure-activity exploration of Lipid II inhibitor DOI: http://dx.doi.org/10.2147/DDDT.S79504",Non-OADS,/arxiv_data1/oa_pdf/86/38/dddt-9-2383.PMC4422293.pdf
The accompanying poster abstract can be found  at http://www.icaaconline.com/php/icaac2014abstracts/data/ papers/2014/F-978.ht m. A full copy of the poster can be  provided upon request.,Non-OADS,/arxiv_data1/oa_pdf/86/38/dddt-9-2383.PMC4422293.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/86/38/dddt-9-2383.PMC4422293.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/38/dddt-9-2383.PMC4422293.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2359–2365Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2359Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7865 8comparative fasting bioavailability of two  clopidogrel formulations in healthy Mediterranean  volunteers: an in vitro–in vivo correlation abdel naser Zaid1 rowa’ al ramahi1 rana Bustami2 ayman Mousa3 sewar Khasawneh2 1Department of Pharmacy, Faculty  of Medicine and health sciences,   an-n ajah national University,   nablus, Palestine; 2Pharmaceutical  research Unit, amman, Jordan;   3r&D Department, Middle east  Pharmaceutical industries co ltd,   riyadh, saudi arabiaObjective:  The aim of this study was to evaluate the bioequivalence of two drug products,  generic clopidogrel bisulfate 75 mg film-coated tablets versus the reference Plavix® clopidogrel  bisulfate 75 mg film-coated tablets.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
"It is standard  of care in patients experiencing acute coronary syndromes.4 Clinical response to correspondence: abdel naser Zaid Department of Pharmaceutical  chemistry and Technology/Department  of Pharmacy, Faculty of Medicine and  health sciences, an-najah national  University, PO Box 7, nablus, Palestine Tel +972 9 234 5113 Fax +972 9 234 5982 email anzaid@najah.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zaid et al Running head recto: Fasting bioavailability of clopidogrel in healthy Mediterranean volunteers DOI: http://dx.doi.org/10.2147/DDDT.S78658",Non-OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
Available  from: http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_ SearchRes ults_Dissolutions.cfm?PrintAll =113.,OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
Available from: http://www.fda.gov/drugs/informationondrugs/ ucm079436.ht m 15. WHO.,Non-OADS,/arxiv_data1/oa_pdf/85/7b/dddt-9-2359.PMC4422294.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/38/ce-10-063.PMC4422295.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCore Evidence 2015:10 63–73Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  63REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S6144 1An evidence-based review of edoxaban and  its role in stroke prevention in patients with  nonvalvular atrial fibrillation T ushar Acharya Prakash Deedwania Division of Cardiology, Department  of internal Medicine, University of  California, San Francisco, Fresno,   CA, USA Correspondence: Prakash Deedwania   UCSF Fresno, Division of Cardiology  Academic Offices, 2335 E Kashian Lane,  Suite 460, Fresno CA 93701, USA   Tel +1 559 459 3943  Fax +1 559 459 5157  Email pdeedwania@fresno.ucsf.ed uAbstract:  Atrial fibrillation is the most common arrhythmia in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/9b/38/ce-10-063.PMC4422295.pdf
Available from: http://www.cleveland - clinicmeded.com/medicalpubs/pharmacy/MarApr2001/herbs_cardiac.,Non-OADS,/arxiv_data1/oa_pdf/9b/38/ce-10-063.PMC4422295.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/9b/38/ce-10-063.PMC4422295.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/38/ce-10-063.PMC4422295.pdf
"Available from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugs  AdvisoryCommittee/UCM420704.pd f. Accessed January  11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/9b/38/ce-10-063.PMC4422295.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2014.01.003Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Imaging data  were  preprocessed  and  analyzed  using NeuroElf (http://neuroelf.net)  and  Statistical  Para- metric Mapping  8.0  (SPM8;  Wellcome  Department  of Imaging Neuroscience,  London,  UK)  software  imple- mented in  MATLAB.",OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Images  were  ﬁrst  converted from DICOM  to  NIfTI  (Neuroimaging  Informat- ics Technology  Initiative)  format  using  MRIconvert (http://lcni.uoregon.edu/ ∼jolinda/MRIConvert ), robustly skull-stripped using  the  Brain  Extraction  Tool  imple- mented in  FMRIB  Software  Library  (FSL),  and  manually reoriented to  the  AC-PC  line.",OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"To  fur- ther investigate  developmental  interaction  effects,  region of interest  (ROI)  analyses  were  conducted  using  the Marsbar toolbox  for  SPM  (http://marsbar.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Supplementary  data Supplementary data  associated  with  this  article  can  be found, in  the  online  version,  at  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Frontiers  in  Human  Neuroscience  2  (19), 1–14, http://dx.doi.org/10.3389/neuro.09.019.2008.",Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"PLoS  ONE  4  (12),  e8429, http://dx.doi.org/10.1371/journal.pone.0008429.",Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Frontiers  in  Human  Neuroscience 6  (168),  1–13,  http://dx.doi.org/10.3389/fnhum.2012.00168.",Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Frontiers  in  Human  Neuroscience  4  (6),  1–9, http://dx.doi.org/10.3389/neuro.09.006.2010.",Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Social  Cognitive  and  Affec- tive  Neuroscience,  http://dx.doi.org/10.1093/scan/nst007.",Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"Journal  of  Neuroscience, http://dx.doi.org/10.1523/JNEUROSCI.4074-12.2013.Pfeifer,  J.H.,  Peake,  S.J.,  2011.",Non-OADS,/arxiv_data1/oa_pdf/e3/2c/main.PMC4422645.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/ba/03/ajg2014344a.PMC4422764.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-307329).,Non-OADS,/arxiv_data1/oa_pdf/2e/6d/gutjnl-2014-307329.PMC4422787.pdf
"In silico search using three online databases (T argetScanHuman (http://www.targetscan.org); miRBase (http://www.mirbase.org) and PicT ar(http://pictar.mdc-berlin.de)), identi ﬁed aftiphilin ( AFTPH ) with a miR-133 αbinding site at its 3 0UTR highly conserved across species ( ﬁgure 6 A).The NTR1-miR-133 α-AFTPH interaction was ﬁrst validated in NCM460-NTR1 cells transfected with as-miR-133 αand exposed to NT .",OADS,/arxiv_data1/oa_pdf/2e/6d/gutjnl-2014-307329.PMC4422787.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Polak JM, Sullivan SN, Bloom SR, et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/6d/gutjnl-2014-307329.PMC4422787.pdf
"ac.jp Submitted: 09/11/2014; Revised: 11/24/2014; Accepted: 01/09/2015http://dx.doi.org/10.1080/19336918.2015.1008332 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cancer Lett 2006; 244:143-63; PMID:16632194; http://dx.doi.org/10.1016/j.canlet.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cell Mol Life Sci2011; 68:3175-99; PMID:21818551; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cell 2002; 110:673-87; PMID:12297042; http://dx.doi.org/10.1016/S0092-8674(02)00971-6 4.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Cell Sci 2006; 119:3901-3; PMID:16988024; http://dx.doi.org/10.1242/jcs.03098 5.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Cell Sci 2009; 122:159-63; PMID:19118207; http://dx.doi.org/10.1242/jcs.018093 6.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Nat Cell Biol 2002; 4:E83-90; PMID:11944041;http://dx.doi.org/10.1038/ncb0402-e83 7.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cell Adh Migr 2013; 7:251-61; PMID:23563505; http://dx.doi.org/10.4161/cam.23840 8.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cell surface annexin II is a high afﬁnity receptor for the alternatively spliced seg- ment of tenascin-C. J Cell Biol 1994; 126:539-48; ; PMID:7518469; http://dx.doi.org/10.1083/jcb.126.2.539 9.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Mol Biol Cell 1996; 7:883-92; PMID:8816995; http://dx.doi.org/10.1091/mbc.7.6.883 10.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
"Adamsky K, Schilling J, Garwood J, Faissner A, Peles E. Glial tumor cell adhesion is mediated by binding ofthe FNIII domain of receptor protein tyrosine phos- phatase b(RPTPbeta) to tenascin C. Oncogene 2001; 20:609-18; PMID:11313993; http://dx.doi.org/10.1038/sj.onc.1204119 11.",Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
The ﬁbrino- gen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phos-phatase-zeta/ b. J Biol Chem 1997; 272:15501-9; PMID:9182584; http://dx.doi.org/10.1074/jbc.272.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Cell Biol 2001; 154:459-68; PMID:11470832; http://dx.doi.org/10.1083/jcb.200103103 13.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
"Fischer D, Chiquet-Ehrismann R, Bernasconi C, Chi- quet M. A single heparin binding region within theﬁbrinogen-like domain is functional in chick tenascin- C. J Biol Chem 1995; 270:3378-84; PMID:7531705; http://dx.doi.org/10.1074/jbc.270.27.16315 14.",Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Biol Chem 1995; 270: 4619-23; PMID:7533163; http://dx.doi.org/10.1074/ jbc.270.9.461915.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Biol Chem 2007; 282:34929-37; PMID:17901052; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Curr Drug Targets 2009; 10:645-52; PMID:19601768; http://dx.doi.org/ 10.2174/138945009788680374 17.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Biol Chem 1996; 271:24144-50; PMID:8798654; http://dx.doi.org/10.1074/jbc.271.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Oncogenesis 2013; 2:e65; PMID:23958855; http://dx.doi.org/10.1038/oncsis.2013.27 20.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cancer Metastasis Rev 2005; 24:395-402; PMID:16258727; http://dx.doi.org/10.1007/s10555-005-5131-6 22.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Int J Cancer 2003; 105:53-60; PMID:12672030; http://dx.doi.org/10.1002/ijc.11037 23.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Adv Biol Regul 2012; 52:326-39; PMID:22781746; http://dx.doi.org/10.1016/j.jbior.2012.03.004 24.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
"Yokosaki Y, Matsuura N, Higashiyama S, Murakami I, Obara M, Yamakido M, Shigeto N, Chen J, Sheppard D. Identiﬁcation of the ligand binding site for the integrin alpha9 beta1 in the third ﬁbronectin type IIIrepeat of tenascin-C. J Biol Chem 1998; 273:11423-8; PMID:9565552; http://dx.doi.org/10.1074/jbc.273.",OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Acta Histochem 2006; 108:25-35; PMID:16430945; http://dx.doi.org/10.1016/j.acthis.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Pathol 2011; 223:646-58; PMID:21341269; http://dx.doi.org/10.1002/ path.2833 27.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Carcinogenesis 2014; 35:1661-70; PMID:24743511; http://dx.doi.org/10.1093/carcin/bgu090 29.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Histochem Cytochem 2000; 48:985-98; http://dx.doi.org/ 10.1177/002215540004800712 30.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Histochem Cell Biol 1999; 111:259-64; PMID:10219625; http://dx.doi.org/ 10.1007/s004180050356 31.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Br J Cancer 2004; 90:561-5; PMID:14760364; http://dx.doi.org/10.1038/sj.bjc.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cold Spring Harb Perspect Med 2011; 1: a006478; PMID:22229119; http://dx.doi.org/10.1101/cshperspect.a006478 33.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Biol Chem 2000; 275:16891-8; PMID:10747940; http://dx.doi.org/ 10.1074/jbc.M000610200 35.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Cell Physiol 2011; 226:2617-24; PMID:21792920; http://dx.doi.org/10.1002/jcp.22614 36.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Virol 2001; 75:5405-9; PMID:11333925; http://dx.doi.org/10.1128/JVI.75.11.5405-5409.2001 102 Volume 9 Issues 1-2 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Am J Pathol 2002; 161:3-6; PMID:12107082; http://dx.doi.org/10.1016/S0002- 9440(10)64149-1 38.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Cell Biol 2008; 180:1277-89; PMID:18362184; http://dx.doi.org/10.1083/jcb.200708137 41.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Neurosci 2004; 24:238-47; PMID:14715956; http://dx.doi.org/ 10.1523/JNEUROSCI.4519-03.2004 43.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Natl Cancer Inst 2007; 99:868-80; PMID:17551147; http://dx.doi.org/10.1093/jnci/djk199 44.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Pediatr Nephrol 2002; 17:882-8; PMID:12432427; http://dx.doi.org/10.1007/s00467- 002-0950-y 45.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Biol Chem 1995; 270:23196-202; PMID:7559467; http://dx.doi.org/10.1074/jbc.270.39.23196 46.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
"Utilization of a soluble integrin-alkaline phos-phatase chimera to characterize integrin a8b1 receptor interactions with tenascin: murine a8b1 binds to the RGD site in tenascin-C fragments, but notto native tenascin-C. Biochemistry 1998; 37:5464-74; PMID:9548928; http://dx.doi.org/10.1021/bi9727489 47.",Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Oncogene 2005; 24:1525-32;PMID:15592496; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Onco- gene 2003; 22:3917-26; PMID:12813465; http://dx.doi.org/10.1038/sj.onc.1206618 51.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Mol BiolCell 2004; 15:5670-7; PMID:15483051; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Pathol 1997; 182:421-8; PMID:9306963; http://dx.doi.org/10.1002/(SICI)1096-9896(199708)182:4%3c421::AID-PATH886%3e3.0.CO;2-U 55.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Int J Cancer 1997; 73:10-5; PMID:9334802; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Hum Pathol 2012; 43:1973-81; PMID:22575259; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Pathol 1999; 189:475-80; PMID:10629546; http://dx.doi.org/ 10.1002/(SICI)1096-9896(199912)189:4%3c475:: AID-PATH462%3e3.0.CO;2-V 62.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Clin Pathol 1996; 49:521-3;PMID:8763275; http://dx.doi.org/10.1136/jcp.49.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Invest Dermatol 1997; 108:776-83; PMID:9129232; http://dx.doi.org/10.1111/1523- 1747.ep12292170 66.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Periodontal Res 1996; 31:105- 12; PMID:8708937; http://dx.doi.org/10.1111/ j.1600-0765.1996.tb00471.x 67.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Cell Cycle 2010; 9:2423- 33; PMID:20562526; http://dx.doi.org/10.4161/ cc.9.12.12048 69.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Int J Cancer 1992; 52:688-92; PMID:1385335; http://dx.doi.org/10.1002/ijc.2910520504 72.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Amer J Pathol 2003; 162:1857-67; http://dx.doi.org/10.1016/S0002-9440(10)64320-9 73.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
J Can- cer Res Clin Oncol 2006; 132:537-46;PMID:16788848; http://dx.doi.org/10.1007/s00432- 006-0106-8 74.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Arch Dermatol Res 2000;292:446-54; PMID:11000288; http://dx.doi.org/ 10.1007/s004030000152 75.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Nat Med 2009; 15:774-80; PMID:19561617; http://dx.doi.org/ 10.1038/nm.1987 92.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Clin Exp Metastasis 2012; 29:663-72; PMID:22684404; http://dx.doi.org/10.1007/s10585-012-9499-8 93.,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Proc Natl Acad Sci U S A 2011; 108:16002-7; PMID:21911392; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
Nat Med 2011; 17:867-74; PMID:21706029; http://dx.doi.org/10.1038/nm.2379 104 Volume 9 Issues 1-2 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/d4/76/kcam-09-96.PMC4422796.pdf
"deSubmitted: 09/12/2014; Revised: 12/23/2014; Accepted: 01/09/2015 http://dx.doi.org/10.1080/19336918.2015.1008331 112 Volume 9 Issues 1-2 Cell Adhesion & MigrationCell Adhesion & Migration 9:1-2, 112--124; January –April 2015; © 2015 Taylor & Francis Group, LLCREVIEW",Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell 2006; 127:679-95;PMID:17110329; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cancer cell 2013; 24:410-21; PMID:24135279; http://dx.doi.org/10.1016/j.ccr.2013.09.007 3.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Rev Cancer 2009; 9:239-52; PMID:19279573; http://dx.doi.org/10.1038/nrc26184.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Med 2011; 17:320-9; PMID:21383745; http://dx.doi.org/10.1038/nm.2328 5.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Science 2009; 326:1216-9; PMID:19965464; http://dx.doi.org/10.1126/science.11760097.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Breast Cancer Res 2009; 11:R24; PMID:19405959; http://dx.doi.org/ 10.1186/bcr2251 12.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell 1986; 47:131-9;PMID:2428505; http://dx.doi.org/10.1016/0092- 8674(86)90374-0 13.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Bio- chim Biophys Acta 2009; 1793:888-92; PMID:19162090; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cell Commun Signal 2009; 3:287-310; PMID:19838819; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J Pathol 2006;168:608-20; PMID:16436674; http://dx.doi.org/ 10.2353/ajpath.2006.050677 18.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Rev Cancer 2006; 6:281-91; PMID:16557280; http://dx.doi.org/10.1038/nrc 1839 19.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Br J Ophthalmol 1997; 81:677-82; PMID:9349157; http://dx.doi.org/10.1136/bjo.81.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cancer Lett 2006; 244:143-63; PMID:16632194; http://dx.doi.org/10.1016/j.canlet.2006.02.017 21.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell Mol Life Sci 2011; 68:3175-99; PMID:21818551; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Rev Cancer 2005; 5:591-602; PMID:16056258; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Proc Natl Acad Sci U S A 1987;84:4621-5; PMID:2440026; http://dx.doi.org/ 10.1073/pnas.84.13.4621 25.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nature 2008; 451:147-52; PMID:18185580; http://dx.doi.org/10.1038/nature 06487 27.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Mol Cancer 2014; 13:22; PMID:24495796; http://dx.doi.org/10.1186/ 1476-4598-13-22 28.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Eur J Cancer 2002; 38:2362-70; PMID:12460779;http://dx.doi.org/10.1016/S0959-8049(02)00210-1 29.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma.Differentiation 1990; 42:199-207; PMID:1692795; http://dx.doi.org/10.1111/j.1432-0436.1990.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Virchows Archiv A Pathol Anat Histopathol 1992; 421:53-6; PMID:1378984; http://dx.doi.org/10.1007/BF01607139 32.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Gynecol Oncol 2000; 79:372-8; PMID:11104607; http://dx.doi.org/10.1006/ gyno.2000.5978 33.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Eur J Cancer 1998; 34:1687-92; PMID:9893653; http://dx.doi.org/10.1016/S0959-8049(98)00215-9 34.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Br J Cancer 1998; 78:1507- 13; PMID:9836485; http://dx.doi.org/10.1038/ bjc.1998.714 35.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Med 2011; 17:867-74;PMID:21706029; http://dx.doi.org/10.1038/ nm.2379 37.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Clin Cancer Res 2004; 10:2491-8; PMID:15073129; http://dx.doi.org/10.1158/1078-0432.CCR-03-0146 38.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Protein Eng Des Sel 2006; 19:471-8; http://dx.doi.org/10.1093/protein/gzl033 40.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Lung Cancer 2009;64:28-33; PMID:18799229; http://dx.doi.org/ 10.1016/j.lungcan.2008.07.013 41.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Lung Cancer2005; 47:17-29; PMID:15603851; http://dx.doi.org/ 10.1016/j.lungcan.2004.05.016 42.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Oral Pathol Med 2003; 32:290-6; http://dx.doi.org/10.1034/j.1600-0714.2003.00019.x 44.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Biomarkers 2010; 15:39-46;PMID:19775228; http://dx.doi.org/10.3109/ 13547500903261362 45.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Laryngoscope 2000; 110:84- 92; PMID:10646721; http://dx.doi.org/10.1097/ 00005537-200001000-00016 46.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Lancet 2014; 383:816-27; PMID:24054424; http://dx.doi.org/10.1016/S0140-6736(13)60802-8 47.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Int J Cancer 1990;46:586-90; PMID:1698727; http://dx.doi.org/ 10.1002/ijc.2910460406 48.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cutan Pathol 1994; 21:424-9; PMID:7532653; http://dx.doi.org/10.1111/j.1600-0560.1994.tb00284.x 49.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cancer 2001; 92:1419-26; PMID:11745218; http://dx.doi.org/10.1002/1097- 0142(20010915)92:6%3c1419::AID-CNCR14 65%3e3.0.CO;2-J 51.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Int J Cancer 1999; 82:477-83; PMID:10404058; http://dx.doi.org/10.1002/ (SICI)1097-0215(19990812)82:4%3c477::AID- IJC2%3e3.0.CO;2-5 www.tandfonline.com 121 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Histochem Cell Biol 2012; 137:195- 204; PMID:22075565; http://dx.doi.org/10.1007/ s00418-011-0886-z 53.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Head Neck Oncol 2011; 3:25; PMID:21548989; http://dx.doi.org/10.1186/1758- 3284-3-25 54.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Int J Cancer 1997; 72:236-40; PMID:9219826;http://dx.doi.org/10.1002/(SICI)1097-0215(19970717) 72:2%3c236::AID-IJC6%3e3.0.CO;2-S 55.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Exp Dermatol 2011; 20:685-8; PMID:21649738; http://dx.doi.org/ 10.1111/j.1600-0625.2011.01314.x 57.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Can- cer Res Clin Oncol 2006; 132:537-46;PMID:16788848; http://dx.doi.org/10.1007/s00432- 006-0106-8 58.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cancer Res Clin Oncol 2009; 135:1351-8; PMID:19326143; http://dx.doi.org/10.1007/s00432-009-0576-6 59.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Stem Cells 2008; 26:2321-31; PMID:18617690; http://dx.doi.org/10.1634/ stemcells.2007-1095 63.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Struct Mol Biol 2014; 21:189-97; PMID:24440982; http://dx.doi.org/10.1038/nsmb.2756 64.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
CellAdhes Commun 1994; 1:307-17; PMID:7521758; http://dx.doi.org/10.3109/15419069409097262 65.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Arch Dermatol Res 2000; 292:446-54; PMID:11000288; http://dx.doi.org/ 10.1007/s004030000152 67.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Biol Chem 2007; 282:9172-81; PMID:17264084; http://dx.doi.org/10.1074/jbc.M608067200 69.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
FEBS Lett1994; 352:216-8; PMID:7523186; http://dx.doi.org/ 10.1016/0014-5793(94)00960-0 70.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Biol Chem 1995; 270:8650-4; PMID:7536739; http://dx.doi.org/10.1074/jbc.270.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Mol Hum Reprod 1999; 5:1066- 76; PMID:10541570; http://dx.doi.org/10.1093/ molehr/5.11.1066 72.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Biol Chem 2014; 289:17699-708; PMID:24808173; http://dx.doi.org/10.1074/jbc.M113.546622 73.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Br J Cancer 1998; 77:98-102; PMID:9459152; http://dx.doi.org/ 10.1038/bjc.1998.15 74.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Int J Cancer 1996; 69:445-7; PMID:8980244; http://dx.doi.org/10.1002/(SICI) 1097-0215(19961220)69:6%3c445::AID-IJC4%3e3.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Histopathology 2004; 45:405-11; PMID:15469480; http://dx.doi.org/10.1111/ j.1365-2559.2004.01976.x 77.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Histopathology 2003;42:280-91; PMID:12605648; http://dx.doi.org/ 10.1046/j.1365-2559.2003.01568.x 78.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Mod Pathol 2003;16:1019-27; PMID:14559985; http://dx.doi.org/ 10.1097/01.MP.0000086860.65672.73 79.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cancer cell 2007; 11:539-54; PMID:17560335; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Biochim Biophys Acta 2009; 1793:911-20; PMID:19339214; http://dx.doi.org/ 10.1016/j.bbamcr.2009.01.012 82.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Pathol 1997; 182:421-8; PMID:9306963; http://dx.doi.org/10.1002/(SICI)1096-9896(199708)182:4%3c421::AID-PATH886%3e3.0.CO;2-U 83.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Pathol 1999; 189:475-80; PMID:10629546; http://dx.doi.org/10.1002/(SICI)1096-9896(199912)189:4%3c475:: AID-PATH462%3e3.0.CO;2-V 85.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Jpn J Cancer Res 1992; 83:1073-80; PMID:1280634; http://dx.doi.org/10.1111/j.1349-7006.1992.tb02724.x 87.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell Rep 2013; 5:482-92; PMID:24139798; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Oncogene 2010; 29:6115-24; PMID:20729912; http://dx.doi.org/10.1038/onc.2010.350 94.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Int J Cancer 2004; 108:31-40; PMID:14618612; http://dx.doi.org/10.1002/ ijc.11509 95.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell 1988; 53:383-90; PMID:2452695; http://dx.doi.org/10.1016/0092-8674(88)90158-4 96.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cell Biol 2000; 150:913-20; PMID:10953015; http://dx.doi.org/10.1083/jcb.150.4.913 99.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Pathol 2011; 224:289-300;PMID:21618240; http://dx.doi.org/10.1002/path.2894 101.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Curr Biol 2010; 20:339-45; PMID:20137952; http://dx.doi.org/10.1016/j.cub.2009.12.035 102.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cell Biol 2006; 174:863-75; PMID:16966425; http://dx.doi.org/10.1083/jcb.200603013 103.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
BMC Med 2013; 11:52; PMID:23442983; http://dx.doi.org/10.1186/1741- 7015-11-52 104.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell 2009; 139:1315- 26; PMID:20064377; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Science 2011; 331:1559-64; PMID:21436443; http://dx.doi.org/10.1126/science.1203543 107.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell 2009; 139:871-90; PMID:19945376; http://dx.doi.org/10.1016/j.cell.2009.11.007 108.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J Pathol 2011;178:754-63; PMID:21281808; http://dx.doi.org/ 10.1016/j.ajpath.2010.10.015 111.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J Pathol 1998; 153:865- 73; http://dx.doi.org/10.1016/S0002-9440(10)65628-3 112.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cancer Res 2009; 69:458-65; PMID:19147558; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2610 113.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
"Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T. Involvement of tenascin-C in prolifera- tion and migration of laryngeal carcinoma cells.Virchows Arch 1999; 435:496-500; PMID:10592053; http://dx.doi.org/10.1007/ s004280050433 116.",OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Onco- gene 2003; 22:3917-26; PMID:12813465; http://dx.doi.org/10.1038/sj.onc.1206618 117.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cell Biol 2001; 154:459-68; PMID:11470832; http://dx.doi.org/10.1083/ jcb.200103103 118.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Int J Dev Biol 2011; 55:511-25; PMID:21769776; http://dx.doi.org/ 10.1387/ijdb.103243eo 119.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Mol Biol Cell 1996; 7:883-92; PMID:8816995; http://dx.doi.org/10.1091/mbc.7.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
EMBO Mol Med 2009; 1:303-14; PMID:20049734; http://dx.doi.org/10.1002/emmm.200900043 123.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Mol Biol Cell 2002; 13:3546-59; PMID:12388756; http://dx.doi.org/10.1091/mbc.E02-01-0048 124.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Pathol 2006; 210:181-91; PMID:16924594; http://dx.doi.org/10.1002/path.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J PhysiolGastrointest Liver Physiol 2011; 301:G950-5; PMID:21512158; http://dx.doi.org/10.1152/ajpgi.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Matrix Biol 2014; 34:170-8; PMID:24291458; http://dx.doi.org/10.1016/j.matbio.2013.11.002 127.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Lab Invest 2001; 81:1015-24; PMID:11454990; http://dx.doi.org/10.1038/ labinvest.3780313 128.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J Respir Cell Mol Biol 2007; 37:309-21; PMID:17496152; http://dx.doi.org/10.1165/rcmb.2006-0455OC 129.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J Physiol Lung Cell Mol Physiol 2010; 299:L785-93;PMID:20833777; http://dx.doi.org/10.1152/ ajplung.00385.2009 130.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Pathol 2007; 211:86-94; PMID:17121418; http://dx.doi.org/ 10.1002/path.2099 131.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Br J Pharmacol 2014; 171:375-88; PMID:24116743; http://dx.doi.org/10.1111/bph.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
New Engl J Med 1999;340:430-6; PMID:9971867; http://dx.doi.org/ 10.1056/NEJM199902113400604 135.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Am J Respir Crit Care Med 1998; 157:1666-80; PMID:9603153; http://dx.doi.org/10.1164/ajrccm.157.5.9707141 136.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat 1998; 393:181-5; PMID:9603523; http://dx.doi.org/10.1038/30270 137.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Med 2009; 15:774-80; PMID:19561617; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
BMC Musculoskelet Disord 2011; 12:164; PMID:21762512; http://dx.doi.org/10.1186/1471-2474-12-164 139.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Immunol 2001; 167:6431-40; PMID:11714809; http://dx.doi.org/10.4049/ jimmunol.167.11.6431 140.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Eur J Immunol 1999; 29:1435-47; PMID:10359097; http://dx.doi.org/10.1002/(SICI)1521-4141(199905)29:05% 3c1435::AID-IMMU1435%3e3.0.CO;2-N 141.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
"Garcion E, Halilagic A, Faissner A, ffrench-Constant C. Generation of an environmental niche for neural stem cell development by the extracellular matrix mol- ecule tenascin C. Development 2004; 131:3423-32;PMID:15226258; http://dx.doi.org/10.1242/dev.",OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cell Biol 1993; 123:1027-35; PMID:7693718; http://dx.doi.org/ 10.1083/jcb.123.4.1027 144.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Matrix Biol 1998; 17:47-63; PMID:9628252; http://dx.doi.org/ 10.1016/S0945-053X(98)90124-X 145.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Blood 2012; 119:5429- 37; PMID:22553313; http://dx.doi.org/10.1182/ blood-2011-11-393645 147.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Cell Sci 2013;126:5111-5; PMID:24101721; http://dx.doi.org/ 10.1242/jcs.134650 148.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Exp Hematol 2013; 41:1050- 61; PMID:24084079; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Proteome Res 2014; 13:1259-69; PMID:24422521; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
PloS one 2013; 8:e61833; PMID:23630617; http://dx.doi.org/10.1371/journal.pone.0061833 151.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Rev Cancer 2013; 13:511-8; PMID:23760023; http://dx.doi.org/10.1038/nrc3536 153.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Genes Dev 2003; 17:1253-70; PMID:12756227; http://dx.doi.org/ 10.1101/gad.1061803 154.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
EMBO J 2012; 31:254-6;PMID:22179697; http://dx.doi.org/10.1038/ emboj.2011.469 155.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Mammary Gland Biol Neoplasia 2008; 13:93-103; PMID:18228120; http://dx.doi.org/10.1007/s10911- 008-9062-z 156.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cancer Res 2004; 64:7377-85; PMID:15492259; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1234 157.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell Stem Cell 2007; 1:313-23; PMID:18371365;http://dx.doi.org/10.1016/j.stem.2007.06.002 158.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Cell 2008; 133:704-15; PMID:18485877; http://dx.doi.org/ 10.1016/j.cell.2008.03.027 159.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nature 2012; 481:85-9; http://dx.doi.org/10.1038/nature10694 160.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
J Biol Chem 2010; 285:2028-39; PMID:19887451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nature 2009; 461:109-13; PMID:19693011; http://dx.doi.org/ 10.1038/nature08268 163.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Nat Med 2009; 15:68-74; http://dx.doi.org/10.1038/nm.1908 164.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Biol Pharm Bull 2010; 33:1261-7; PMID:20686216; http://dx.doi.org/10.1248/bpb.33.1261 165.,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Mol Cell Biol2010; 30:1508-27; PMID:20086099; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
Clin Cancer Res 2008; 14:5555-64; PMID:18765548; http://dx.doi.org/10.1158/1078-0432.CCR-08-0555 124 Volume 9 Issues 1-2 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/36/11/kcam-09-112.PMC4422797.pdf
"© Stephen T Abedon *Correspondence to: Stephen T. Abedon; Email: abedon.1@osu.edu Submitted: 11/24/2014; Revised: 02/11/2015; Accepted: 02/12/2015http://dx.doi.org/10.1080/21597081.2015.1020260 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
"Hoeﬂmayr 9achieved 90% cure rates, in 1962, against bron- chitis also using a nebulizer.12A 1963 partial translation of this paper is available here: http://www.dtic.mil/cgi-bin/GetTRDoc?Location=U-2&docGetTRDoc.pdf&AD=AD0837021.Employed was a polyvalent phage lysate reportedly containing180 to 200 “different phage strains” (p. 404) G. Also present in these formulations were what are described as (p. 404)H“so- called targeted antimicrobials added to combat those bacteria which have a primary phage resistance” and which presumably should be viewed as non-phage antibacterial substances.",Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Foodborne Pathog Dis 2009; 6:807–15; PMID:19459758; http://dx.doi.org/10.1089/fpd.2008.0242 3.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Adv Virus Res 2012; 83:3–40; PMID:22748807; http://dx.doi.org/10.1016/B978-0-12-394438-2.00001-3 4.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Bacteriophage 2011; 1:66–85; PMID:22334863; http://dx.doi.org/ 10.4161/bact.1.2.15845 7.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Ann N Y Acad Sci 2014; 1323:91–100; PMID:24953233; http://dx.doi.org/ 10.1111/nyas.12468 8.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Expert Opin Ther Targets 2014; 18:851–61; PMID:24881465; http://dx.doi.org/10.1517/14728222.2014.925881] 9.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
J Aerosol Med Pulm Drug Deliv 2013; 26:317– 35; PMID:23597003; http://dx.doi.org/10.1089/ jamp.2012.1001 13.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
J Aerosol Med Pulm Drug Deliv 2014;27:315–28; PMID:24299502; http://dx.doi.org/ 10.1089/jamp.2013.1090 14.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Poult Sci 2014; 93:2788–92; PMID:25214555; http://dx.doi.org/10.3382/ps.2014- 04282 15.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Vet Microbiol 2014; 171:460–9; PMID:24315040; http://dx.doi.org/ 10.1016/j.vetmic.2013.11.001 16.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Curr Pharm Biotechnol 2010; 11:28–47; PMID:20214606; http://dx.doi.org/10.2174/138920-110790725410 17.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Adv Appl Microbiol 2011; 77:1–40;PMID:22050820; http://dx.doi.org/10.1016/B978-0- 12-387044-5.00001-7 18.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Journal of Pharmacy and Pharamcology 2011; 63:1253–64; PMID:21899540; http://dx.doi.org/10.1111/j.2042- 7158.2011.01324.x 19.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Scientiﬁca 2014; 2014:581639; PMID:25031881; http://dx.doi.org/10.1155/2014/581639 22.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Microbes Infect 2014; 16:512–7; PMID:24631574; http://dx.doi.org/10.1016/j.micinf.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Tuberculosis (Edinb) 2011; 91:71–81; PMID:20875771; http://dx.doi.org/10.1016/j.tube.2010.08.009 25.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Crit Rev Ther Drug Carrier Syst 2013; 30:277–91; PMID:23662603; http://dx.doi.org/10.1615/ CritRevTherDrugCarrierSyst.2013005684 e1020260-12 Volume 5 Issue 1 Bacteriophage,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
J Am Med Assoc 1936; 107:33–4;’ http://dx.doi.org/ 10.1001/jama.1936.92770270005010c 27.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Pharm Res 2011; 28:934–7; PMID:21063753; http://dx.doi.org/10.1007/s11095-010-0313-5 32.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Microb Biotechnol 2011; 4:643–50; PMID:21481199; http://dx.doi.org/ 10.1111/j.1751-7915.2011.00259.x 33.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Antimicrob Agents Chemother 2001; 45:649–59; PMID:11181338; http://dx.doi.org/ 10.1128/AAC.45.3.649-659.2001 38.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Med Mal Infect 2008; 38:426–30; PMID:18687542; http://dx.doi.org/10.1016/j.medmal.2008.06.023 49.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Adv Appl Microbiol 2012; 78:1–23; PMID:22305091; http://dx.doi.org/10.1016/B978-0- 12-394805-2.00001-4 50.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Future Microbiol 2013; 8:769–83; PMID:23701332; http://dx.doi.org/10.2217/fmb.13.47 51.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Clin Microbiol Infect 2014; 20:O983–O990; PMID:24920209; http://dx.doi.org/ 10.1111/1469-0691.12712 52.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
PLoS One 2013; 8:e75380;PMID:24069407; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
J Infect Dis 1-15-2010; 201:264–71; PMID:20001604; http://dx.doi.org/10.1086/649227 55.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
J Infect Dis 4-1-2010; 201:1096–104;PMID:20196657; http://dx.doi.org/10.1086/651135 56.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
PLoS One 2011; 6: e16963; PMID:21347240; http://dx.doi.org/10.1371/ journal.pone.0016963 57.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
MBio 2012; 3:e00029-12;PMID:22396480; http://dx.doi.org/10.1128/ mBio.00029-12 58.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Antimicrob Agents Chemother 2013; 57:5961–8; PMID:24041900; http://dx.doi.org/ 10.1128/AAC.01596-13 59.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
PLoS One2015; 10:e0116571; PMID:25615639; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
J Med Microbiol 2008; 57:1508–13; PMID:19018021; http://dx.doi.org/10.1099/jmm.0.2008/002873-0 61.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Antimicrob Agents Chemother 2014; 58:4005–13; PMID:24798268;http://dx.doi.org/10.1128/AAC.02388-13 63.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Meth Mol Biol 2009; 501:175–202; PMID:19066822; http://dx.doi.org/10.1007/978-1-60327-164-6_18 65.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Genet Res 1999; 74:1–11; PMID:10505404; http://dx.doi.org/10.1017/S00166- 72399003833 67.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Antimicrob Agents Chemother 2012; 56:949–54; PMID:22106213; http://dx.doi.org/10.1128/AAC.05842-11 68.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Front Microbiol 2014; 5:618; PMID:25477869; http://dx.doi.org/10.3389/fmicb.2014.00618 69.,OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Bacteriophage2014; 4:e964081; http://dx.doi.org/10.4161/ 21597073.2014.964081 70.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
PLoS One 2015; 10:e0117163; PMID:25629728; http://dx.doi.org/10.1371/journal.pone.0117163 71.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
Future Microbi- ology 2015; http://dx.doi.org/10.2217/FMB.15.28 www.tandfonline.com e1020260-13 Bacteriophage,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/kbac-05-01-1020260.PMC4422798.pdf
"TN-X is a Trimeric Protein with a Peculiar Proline-Rich Motif The hydrophobic residue-rich heptad repeats located at the N- terminus of this glycoprotein are capable of forming ahelices that serve as a structural basis for the trimerization of TN-X© Ulrich Valcourt, Lindsay B Alcaraz, Jean-Yves Exposito, Claire Lethias, and Laurent Bartholin *Correspondence to: Ulrich Valcourt; Email: ulrich.valcourt@lyon.unicancer.fr Submitted: 09/19/2014; Revised: 12/01/2014; Accepted: 12/02/2014http://dx.doi.org/10.4161/19336918.2014.994893 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),which permits unrestricted use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Genomics 1992; 12:485-91; PMID:1373119; http://dx.doi.org/ 10.1016/0888-7543(92)90438-X 3.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Immunogenetics 1992; 36:400-3; PMID:1382042; http://dx.doi.org/10.1007/BF00218048 4.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1993; 122:265-78; PMID:7686164; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Cell 1986; 47:131-9; PMID:2428505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Nature 1984; 311:267-9; PMID:6482952; http://dx.doi.org/ 10.1038/311267a0 7.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1989; 109:1765-78;PMID:2477380; http://dx.doi.org/10.1083/jcb.109.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Mol Cell Neurosci 2003;23:193-209; PMID:12812753; http://dx.doi.org/ 10.1016/S1044-7431(03)00012-5 13.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
BMC Evol Biol 2006; 6:60; PMID:16893461; http://dx.doi.org/10.1186/1471- 2148-6-60 14.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Mol Cell Neurosci 2006; 32:366-86; PMID:16831557;http://dx.doi.org/10.1016/j.mcn.2006.05.008 16.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Matrix Biol J Int Soc MatrixBiol 1996; 15:11-9; http://dx.doi.org/10.1016/S0945- 053X(96)90122-5 18.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Biol Chem 1998; 273:10602-8; PMID:9553121; http://dx.doi.org/10.1074/jbc.273.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Biol Chem 1998; 273:2073-7;PMID:9442046; http://dx.doi.org/10.1074/jbc.273.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
FEBS Lett 2006; 580:6281-5; PMID:17078949; http://dx.doi.org/10.1016/j.febslet.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Neuron 1992; 8:849-63; PMID:1375037; http://dx.doi.org/10.1016/0896- 6273(92)90199-N 22.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Biol Chem 1997; 272:22866-74; PMID:9278449; http://dx.doi.org/10.1074/jbc.272.36.22866 23.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Gene 1998; 217:1-13; PMID:9795100; http://dx.doi.org/10.1016/S0378- 1119(98)00355-2 24.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1996; 134:1499-512; PMID:8830777; http://dx.doi.org/10.1083/jcb.134.6.1499 25.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Eur J Biochem FEBS 1995; 231:83- 92; http://dx.doi.org/10.1111/j.1432-1033.1995.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1993; 120:1237-49; PMID:7679676; http://dx.doi.org/ 10.1083/jcb.120.5.1237 29.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Con- nect Tissue Res 2007; 48:93-8; PMID:17453911;http://dx.doi.org/10.1080/03008200601166160 30.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1988; 107:2757-67; PMID:2462568; http://dx.doi.org/10.1083/jcb.107.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Biochim Biophys Acta 2000; 1524:196-202; PMID:11113568; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
ActaNeuropathol (Berl) 1997; 93:431-7; http://dx.doi.org/ 10.1007/s004010050636 34.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Commun Signal 2009; 3:287-310; PMID:19838819; http://dx.doi.org/10.1007/s12079-009-0075-1 35.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
"Bristow J, Carey W, Egging D, Schalkwijk J. Tenascin- X, collagen, elastin, and the Ehlers-Danlos syndrome.Am J Med Genet C Semin Med Genet 2005; 139C:24-30; PMID:16278880; http://dx.doi.org/ 10.1002/ajmg.c.30071 36.",OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Biol Chem 2006; 281:27461-70; PMID:16861231; http://dx.doi.org/10.1074/jbc.M603147200 37.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Arch Dermatol Res 2007; 298:389-96; PMID:17033827; http://dx.doi.org/10.1007/s00403- 006-0706-9 38.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Exp Cell Res 2004;298:305-15; PMID:15242785; http://dx.doi.org/ 10.1016/j.yexcr.2004.04.030 39.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
FEBS Lett 2001; 495:44- 7; PMID:11322944; http://dx.doi.org/10.1016/S0014-5793(01)02361-4 40.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
"Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with ﬁbronectin action.Cell 1988; 53:383-90; PMID:2452695; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Clin Genet 2012; 82:1-11; PMID:22353005; http://dx.doi.org/10.1111/j.1399- 0004.2012.01858.x 42.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Nat Genet 1997; 17:104-8; PMID:9288108; http://dx.doi.org/ 10.1038/ng0997-104 43.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
N Engl J Med 2001; 345:1167-75; PMID:11642233; http://dx.doi.org/10.1056/NEJMoa002939 44.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Am J Med Genet A 2007; 143A:2215-9; PMID:17702048; http://dx.doi.org/10.1002/ajmg.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Am J Med Genet A 2005; 135:75-80; PMID:15793839; http://dx.doi.org/10.1002/ajmg.a.30671 46.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Nat Genet 2002; 30:421-5; PMID:11925569; http://dx.doi.org/10.1038/ng850 48.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Genes Cells Devoted Mol Cell Mech 2001;6:1101-11; http://dx.doi.org/10.1046/j.1365- 2443.2001.00482.x 49.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Connect Tissue Res 2011; 52:422-32; PMID:21405982; http://dx.doi.org/10.3109/03008207.2010.551616 50.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Exp Cell Res 2004; 297:49-60; PMID:15194424; http://dx.doi.org/10.1016/j.yexcr.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Hum Mol Genet 2014; 23:2339-52; PMID:24334604; http://dx.doi.org/10.1093/hmg/ ddt627 52.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Invest Dermatol 2004; 122:885-91; PMID:15102077; http://dx.doi.org/10.1111/j.0022-202X.2004.22401.x 53.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Biophys Chem 2010; 147:87-91; PMID:20089348; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Arthritis Rheum 2004; 50:2742-9; PMID:15457441; http://dx.doi.org/10.1002/art.20488 55.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Clin Invest 2001; 107:1063-9; PMID:11342567; http://dx.doi.org/10.1172/JCI12881 56.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Int J Biochem Cell Biol 2014; 53C:51-4; http://dx.doi.org/10.1016/j.biocel.2014.04.020 57.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Mol Biol 2009; 385:1277-86; PMID:19071135; http://dx.doi.org/10.1016/j.jmb.2008.11.038 58.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Cell Tissue Res 2006; 323:465-74; PMID:16331473; http://dx.doi.org/ 10.1007/s00441-005-0100-5 59.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Curr Opin Cell Biol 2002; 14:608-16; PMID:12231357; http://dx.doi.org/ 10.1016/S0955-0674(02)00361-7 60.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Eur J BiochemFEBS 1999; 263:840-8; http://dx.doi.org/10.1046/ j.1432-1327.1999.00563.x 62.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Biol Pharm Bull 2009; 32:1795-9; PMID:19801846; http://dx.doi.org/ 10.1248/bpb.32.1795 63.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Biol Chem 2000; 275:36358-68;PMID:10964924; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
JBiol Chem 2001; 276:16432-8; PMID:11278641; http://dx.doi.org/10.1074/jbc.M010210200 66.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Exp Cell Res 2004; 297:404-14; PMID:15212943; http://dx.doi.org/10.1016/j.yexcr.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Genes Cells Devoted Mol Cell Mech 2000; 5:913-27; http://dx.doi.org/10.1046/j.1365-2443.2000.00376.x 69.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Dev Cell 2009; 16:329-43; PMID:19289080; http://dx.doi.org/10.1016/j.devcel.2009.02.012 70.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Cell 2008; 134:215- 30; http://dx.doi.org/10.1016/j.cell.2008.07.001 71.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Nat Rev Mol Cell Biol 2007; 8:857-69; PMID:17895899; http://dx.doi.org/10.1038/nrm2262 72.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 2002; 157:493- 507; PMID:11970960; http://dx.doi.org/10.1083/jcb.200109100 73.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1988; 106:1659-65; PMID:2967299; http://dx.doi.org/ 10.1083/jcb.106.5.1659 74.,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1990; 110:1361-7; PMID:2139036; http://dx.doi.org/ 10.1083/jcb.110.4.1361 75.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Biol Chem 2001; 276:11347-53; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 2006; 175:111-20; PMID:17015622; http://dx.doi.org/10.1083/jcb.200606058 78.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Eur J Cell Biol 2008; 87:601-15; PMID:18342983; http://dx.doi.org/10.1016/j.ejcb.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Carcino- genesis 2011; 32:613-21; PMID:21186301; http://dx.doi.org/10.1093/carcin/bgq281 164 Volume 9 Issues 1-2 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
J Cell Biol 1993; 122:923-32;PMID:8349738; http://dx.doi.org/10.1083/jcb.122.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Cell 1998; 93:1159-70; PMID:9657149; http://dx.doi.org/10.1016/S0092-8674(00)81460-983.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Nat Rev Mol Cell Biol 2012; 13:616-30; http://dx.doi.org/10.1038/ nrm3434 84.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Mol Biol Cell 2005; 16:1987-2002; PMID:15689496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
Cell 2009; 139:871-90; PMID:19945376; http://dx.doi.org/10.1016/j.cell.2009.11.00786.,OADS,/arxiv_data1/oa_pdf/ee/7b/kcam-09-154.PMC4422802.pdf
"14,15,16Tenascin-C knockout mice have© Josephine C Adams, Ruth Chiquet-Ehrismann, and Richard P Tucker *Correspondence to: Richard P Tucker; Email: rptucker@ucdavis.edu Submitted: 06/23/2014; Revised: 08/14/2014; Accepted: 08/25/2014http://dx.doi.org/10.4161/19336918.2014.970030 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),which permits unrestricted use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Materials and Methods Identiﬁcation of novel predicted proteinsPredicted proteins from the genome of the coelacanth L. cha- lumnae were identiﬁed using the architecture search feature of Pfam (http://pfam.sanger.ac.uk/) and by tblastn and Delta Blastsearches of coelacanth sequences at the National Center for Bio-technology Information (NCBI) (http://blast.ncbi.nlm.nih.gov/ Blast.cgi) using tenascin sequences from ray-ﬁnned ﬁshes.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
"Pre- dicted proteins were identiﬁed in the genome of the elephantshark C. milii by blast analysis at the Elephant Shark Genome Project (http://esharkgenome.imcb.a-star.edu.sg/blast/) using rel-evant amino acid sequences from D. rerio (NP_571111, XP_005171845, AAI62107, CAM13370).",OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
ensembl.org/Petromyzon_marinus/Info/Index) as were the geno-mic sequences of the Japanese lamprey Lethenteron japonicum (http://jlampreygenome.imcb.a-star.edu.sg/) using tenascinamino acid sequences from D. rerio (see above) or human (NP_002151).,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
"Phylogenomic analysis Protein domains and the architecture of predicted proteins were identiﬁed using SMART (http://smart.embl-heidelberg.de/), Pfam (see above) and InterPro (http://www.ebi.ac.uk/interpro/).Some FNIII domains were aligned using ClustalW (http://www.genome.jp/tools/clustalw/) with fast pairwise alignment and otherdefault parameters to demonstrate the conserved positions of puta- tive integrin binding motifs.",OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Coiled-coils were predicted usingLOGICOIL (http://coiledcoils.chm.bris.ac.uk/LOGICOIL/).,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Cold Spring Harb Perspect Biol 2011; 3(5); PMID:21441591; http://dx.doi.org/10.1101/cshperspect.a004960 2.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Science 1992; 258:987-991; PMID:1279805;http://dx.doi.org/10.1126/science.1279805 3.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Int J Biochem Cell Biol 2009; 41:424-34; http://dx.doi.org/10.1016/j.biocel.2008.08.003 4.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Nature 2006; 439:965-8;PMID:16495997; http://dx.doi.org/10.1038/nature04 336 5.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
BMC Evol Biol 2006; 6:60; PMID:16893461; http://dx.doi.org/10.1186/1471-2148-6-60 7.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
J Cell Biol 1984; 98:1937-46; PMID:6202699; http://dx.doi.org/ 10.1083/jcb.98.6.1937 8.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Cell Mol Life Sci2011; 68:3175-99; PMID:21818551; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
"Yokosaki Y, Matsuura N, Higashiyama S, Murakami I, Obara M, Yamakido M, Shigeto N, Chen J, Sheppard D. Identiﬁcation of the ligand binding site for theintegrin alpha9 beta1 in the third ﬁbronectin type III repeat of tenascin-C. J Biol Chem 1998; 273:11423-8; PMID:9565552; http://dx.doi.org/10.1074/jbc.273.19.11423 13.",OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
J Biol Chem 1996; 271:24144-50; PMID:8798654; http://dx.doi.org/10.1074/jbc.271.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Mol Biol Cell 2004; 15:5670-7; PMID:15483051; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Oncogene 2005; 24:1525-32; PMID:15592496; http://dx.doi.org/10.1038/sj.onc.12 08342 20.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Cell Tissue Res 2008; 334:445-55; PMID:18985388; http://dx.doi.org/10.1007/s00441- 008-0715-4 21.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Eur J Biochem1999; 263:840-8; PMID:10469149; http://dx.doi.org/ 10.1046/j.1432-1327.1999.00563.x 23.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Nat Genet 2002; 30:421-5; PMID:11925569; http://dx.doi.org/10.1038/ng850 24.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
J Mol Evol 2004; 59:190-203; PMID:15486693; http://dx.doi.org/10.1007/s00239-004-2613-z 25.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Matrix Biol 2005; 24:69-77; PMID:15749003; http://dx.doi.org/10.1016/j.matbio.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
2005; 118:4199-206; PMID:16155253; http://dx.doi.org/10.1242/jcs.02547 28.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Nat Genet 2013; 45:415-21; PMID:23435085; http://dx.doi.org/10.1038/ng.2568 29.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Nature 2014; 505:174-9; PMID:24402279; http://dx.doi.org/10.1038/nature12 826 31.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Nature 2013; 496:311-6; PMID:23598338; http://dx.doi.org/10.10 38/nature12027 32.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
1998; 109(2):157-68; PMID:9729356; http://dx.doi.org/10.1016/S0165-3806(98)00076-5 33.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Int J Biochem Cell Biol 2013; 45:2392-401; PMID:23891848; http://dx.doi.org/10.1016/j.biocel.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Mol BiolEvol 2004; 21:580-6; PMID:14694077; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
2007; 5(4):e101; PMID:17407382; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
Mol Biol Evol 2009; 26:47-59; PMID:18842688; http://dx.doi.org/ 10.1093/molbev/msn222 41.,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
2009; 131:190-9;PMID:19443046; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
2011; 316(7):526-46;PMID:21809437; http://dx.doi.org/10.1002/jez.b.214 27 www.tandfonline.com 33 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/11/d5/kcam-09-22.PMC4422808.pdf
"However, transient expression of tenascin- C is observed at sites of active tissue remodeling in the adult,such as during the healing of wounds, and persistent tenascin-Cexpression is detected in pathological states such as cancer orrheumatoid arthritis (RA) (reviewed in 1-3) Tenascin-C consists of 4 dis tinct domains, which can interact with pathogenic comp onents, matrix constituents, soluble factors and cell surfa ce proteins; conferring upon© Sean P Giblin and Kim S Midwood *Correspondence to: Kim S. Midwood; Ema il: kim.midwood@k ennedy.ox.ac.uk Submitted: 10/14/2014; Revised: 11/07/2014; Accepted: 11/08/2014http://dx.doi.org/10.4161/19336918.2014.987587 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),which permits unrestricted use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Commun Signal 2009; 3:287-310; PMID:19838819; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Matrix Biol 2014; 37C:112-23; http://dx.doi.org/10.1016/j.matbio.2014.01.007 3.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Dev Biol 2011; 55:511-25; PMID:21769776; http://dx.doi.org/ 10.1387/ijdb.103243eo 10.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell Rep 2013; 5:482-92; PMID:24139798; http://dx.doi.org/10.1016/j.celrep.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nat Med 2009; 15:774-80; PMID:19561617; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Pathol 2007; 211:86-94; PMID:17121418; http://dx.doi.org/10.1002/path.2099 13.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Eur J Immunol 2006; 36:3334-45; PMID:17125141; http://dx.doi.org/ 10.1002/eji.200636271 14.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Am J Sports Med 2005; 33:1016-21; PMID:15983124; http://dx.doi.org/10.1177/0363546504271986 17.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
PloS One 2013; 8:e69549; PMID:23936043; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Hum Mol Genet 2005; 14:2779-86; PMID:16115819; http://dx.doi.org/10.1093/hmg/ddi311 19.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Genomics 1990;6:616-22; PMID:1692804; http://dx.doi.org/ 10.1016/0888-7543(90)90495-G 20.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Expression and immune function of tenascin-C.Crit Rev Immunol 2011; 31:115-45; PMID:21542790; http://dx.doi.org/10.1615/ CritRevImmunol.v31.i2.30 22.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Proc Nat Acad Sci U S A 1988; 85:2186-90; PMID:2451243; http://dx.doi.org/ 10.1073/pnas.85.7.2186 23.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nat Genet 2008; 40:1413-5; PMID:18978789;http://dx.doi.org/10.1038/ng.259 26.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nature 2014; 509:575-81; PMID:24870542; http://dx.doi.org/10.1038/nature13302 27.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nucleic Acids Res 1993; 21:163-8; PMID:7680113; http://dx.doi.org/10.1093/nar/21.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1997; 72:236-40; PMID:9219826;http://dx.doi.org/10.1002/(SICI)1097-0215 (19970717)72:2%3c236::AID-IJC6%3e3.0.CO;2-S 29.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1999; 274:17144-51; PMID:10358070; http://dx.doi.org/10.1074/jbc.274.24.17144 32.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell Mol Neurobiol 2012; 32:279-87;PMID:21968644; http://dx.doi.org/10.1007/s10571- 011-9759-1 33.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Matrix Biol 2001; 20:13-22; PMID:11246000; http://dx.doi.org/10.1016/S0945-053X(00)00136-0 34.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Gene 1991; 104:177-85; PMID:1717349; http://dx.doi.org/ 10.1016/0378-1119(91)90248-A 35.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Histochem Cytochem 1993; 41:1163-9; PMID:7687262; http://dx.doi.org/ 10.1177/41.8.7687262 36.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell 1986; 47:131-9;PMID:2428505; http://dx.doi.org/10.1016/0092- 8674(86)90374-0 37.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell 1989; 59:325-34; PMID:2478295; http://dx.doi.org/10.1016/0092-8674(89)90294-8 39.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1991; 112:355-62; PMID:1703162; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1984; 98:1926-36; PMID:6725406; http://dx.doi.org/ 10.1083/jcb.98.6.1926 42.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1988; 106:519-32; PMID:2448317; http://dx.doi.org/10.1083/jcb.106.2.519 44.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1990; 111:685-98; PMID:1696267; http://dx.doi.org/10.1083/jcb.111.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dif- ferentiation 1997; 62:71-82; PMID:9404002; http://dx.doi.org/10.1046/j.1432-0436.1997.6220071.x 50.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dev Dyn 1993; 198:123-34; PMID:7508293; http://dx.doi.org/ 10.1002/aja.100198020652.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dev Dyn 1996; 206:437-46; PMID:8853992; http://dx.doi.org/10.1002/(SICI)1097-0177(199608)206:4%3c437:: AID-AJA9%3e3.0.CO;2-J 53.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1988; 107:2341-9; PMID:2461951; http://dx.doi.org/10.1083/jcb.107.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dev Biol 1994; 161:615-25; PMID:7508872; http://dx.doi.org/10.1006/dbio.1994.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Neurosci Res 1994; 37:336-47; PMID:7513764; http://dx.doi.org/10.1002/jnr.490370306 57.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1992; 119:203-13; PMID:1382076; http://dx.doi.org/ 10.1083/jcb.119.1.203 59.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
FEBS Lett 1996; 389:304-8; PMID:8766721; http://dx.doi.org/10.1016/0014- 5793(96)00609-6 61.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell Struct Funct 2001; 26:179-87; PMID:11565810; http://dx.doi.org/10.1247/csf.26.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dev Biol 1989; 136:381- 92; PMID:2479585; http://dx.doi.org/10.1016/0012-1606(89)90264-9 63.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dev Biol 1989; 131:243-60; PMID:2462518; http://dx.doi.org/10.1016/S0012- 1606(89)80056-9 64.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Mol and Cell Neurosci 1997; 10:100-16;PMID:9361291; http://dx.doi.org/10.1006/mcne.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
66; PMID:8543661; http://dx.doi.org/10.1002/ cne.903610205 67.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Neurosci 2009; 29:9405-16; PMID:19641104; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"Garcion E, Halilagic A, Faissner A, ffrench-Constant C. Generation of an environmental niche for neuralstem cell development by the extracellular matrix mol- ecule tenascin C. Development 2004; 131:3423-32; PMID:15226258; http://dx.doi.org/10.1242/dev.01202 69. von Holst A, Egbers U, Prochiantz A, Faissner A. Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6.",OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 2007; 282:9172-81; PMID:17264084;http://dx.doi.org/10.1074/jbc.M608067200 70.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Stem Cells 2008;26:2321-31; PMID:18617690; http://dx.doi.org/ 10.1634/stemcells.2007-1095 71.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 2010; 285:37293-301; PMID:20855890; http://dx.doi.org/ 10.1074/jbc.M110.157081 72.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nature 1985; 316:146-8; PMID:2409452; http://dx.doi.org/ 10.1038/316146a0 73.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nature 1983;306:376-8; PMID:6196641; http://dx.doi.org/ 10.1038/306376a0 74.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nature 1984; 311:153-5; PMID:6206400; http://dx.doi.org/10.1038/311153a0 75.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Differentiation 1985; 30:141-51; PMID:2420673; http://dx.doi.org/10.1111/j.1432- 0436.1985.tb00525.x 76.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1992; 116:1475-86; PMID:1371773; http://dx.doi.org/10.1083/jcb.116.6.1475 78.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Neuro-sci 2004; 24:238-47; PMID:14715956; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Eur J Neurosci 1997; 9:496- 506; PMID:9104592; http://dx.doi.org/10.1111/j.1460-9568.1997.tb01627.x80.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Eur J Oral Sci 2001; 109:114-24; PMID:11347655; http://dx.doi.org/10.1034/j.1600-0722.2001.00990.x 81.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Dev Biol 1993; 156:278-92; PMID:7680630; http://dx.doi.org/ 10.1006/dbio.1993.1076 84.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell Adhes Commun 1995; 3:257-71; PMID:8846026; http://dx.doi.org/ 10.3109/15419069509081291 86.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Mol Biol Cell 1994; 5:423-37; PMID:7519904;http://dx.doi.org/10.1091/mbc.5.4.423 88.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell surface annexin II is a high afﬁnity receptor for the alternatively spliced seg- ment of tenascin-C. J Cell Biol 1994; 126:539-48;PMID:7518469; http://dx.doi.org/10.1083/jcb.126.2.539 89.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Mol Biol Cell 1996; 7:883-92; PMID:8816995; http://dx.doi.org/10.1091/mbc.7.6.883 90.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1991; 113:1159-71;PMID:1710226; http://dx.doi.org/10.1083/jcb.113.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Matrix Biol 1999; 18:75-87; PMID:10367733; http://dx.doi.org/10.1016/S0945-053X(98)00008-0 94.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Neuron Glia Biol2008; 4:271-83; PMID:19508743; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"Michele M, Faissner A. Tenascin-C stimulates contac- tin-dependent neurite outgrowth via activation ofphospholipase C. Mol and Cell Neurosci 2009; 41:397-408; PMID:19394429; http://dx.doi.org/ 10.1016/j.mcn.2009.04.004 96.",Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Mol Hum Reprod 1999; 5:1066- 76; PMID:10541570; http://dx.doi.org/10.1093/ molehr/5.11.1066 97.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1995; 270:8650-4; PMID:7536739; http://dx.doi.org/10.1074/jbc.270.15.8650 98.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cancer Lett 2006; 244:143-63;PMID:16632194; http://dx.doi.org/10.1016/j.canlet.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1992; 52:688-92; PMID:1385335; http://dx.doi.org/10.1002/ijc.2910520504 101.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1995; 63:442-9; PMID:7591246; http://dx.doi.org/ 10.1002/ijc.2910630324 103.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Br J Cancer 1993; 67:1058-64; PMID:7684238; http://dx.doi.org/10.1038/bjc.1993.194 104.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Lung Cancer 2005; 47:17-29; PMID:15603851; http://dx.doi.org/ 10.1016/j.lungcan.2004.05.016 105.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Br J Cancer 1995; 72:189-92; PMID:7541237; http://dx.doi.org/ 10.1038/bjc.1995.301 108.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Br J Surg 1995; 82:948-51; PMID:7544220; http://dx.doi.org/10.1002/bjs.1800820730 109.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Gynecol Oncol 1999; 73:415-21; PMID:10366470; http://dx.doi.org/10.1006/gyno.1999.5405 112.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Pathol Res Pract 1993;189:510-4; PMID:7690952; http://dx.doi.org/ 10.1016/S0344-0338(11)80357-2 113.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Pathol 1999; 189:475-80; PMID:10629546; http://dx.doi.org/10.1002/(SICI)1096-9896(199912)189:4%3c475:: AID-PATH462%3e3.0.CO;2-V 115.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Pathol 2004; 203:771-9; PMID:15221936; http://dx.doi.org/10.1002/path.1589 116.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Am J Pathol 1999; 154:1345-52; PMID:10329587; http://dx.doi.org/10.1016/S0002- 9440(10)65388-6 117.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Neurosurgery2002; 50:838-42; discussion 42; PMID:11904036; http://dx.doi.org/10.1097/00006123-200204000- 00028 118.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Protein Eng Des Sel 2006; 19:471-8; PMID:16928692; http://dx.doi.org/10.1093/protein/gzl033 119.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Oral Pathol Med 2007; 36:6-11;PMID:17181735; http://dx.doi.org/10.1111/j.1600- 0714.2006.00492.x 120.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Can- cer Res Clin Oncol 2006; 132:537-46; PMID:16788848; http://dx.doi.org/10.1007/s00432-006-0106-8 121.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cancer Metastasis Rev 2010; 29:595-606; PMID:20814719; http://dx.doi.org/10.1007/s10555- 010-9249-9 125.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1999; 82:477- 83; PMID:10404058; http://dx.doi.org/10.1002/(SICI)1097-0215(19990812)82:4%3c477::AID- IJC2%3e3.0.CO;2-5 126.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Clin Oral Investig 2007; 11:93-9; PMID:17111122; http://dx.doi.org/10.1007/s00784- 006-0086-8 127.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1991; 115:1127-36; PMID:1720121; http://dx.doi.org/10.1083/jcb.115.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 2007; 282:34929-37; PMID:17901052; http://dx.doi.org/10.1074/jbc.M705608200 133.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 2014; 289:17699-708;PMID:24808173; http://dx.doi.org/10.1074/jbc.M113.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Biol Pharm Bull 2010;33:1261-7; PMID:20686216; http://dx.doi.org/ 10.1248/bpb.33.1261 136.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Pathol 2006; 208:673-85; PMID:16450333; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1995; 64:65-9; PMID:7545144; http://dx.doi.org/10.1002/ijc.2910640113 139.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Colorectal Dis 2001; 16:285-91; PMID:11686525; http://dx.doi.org/ 10.1007/s003840100312 140.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Tumour Biol 2014; 35:6619-25; PMID:24696262; http://dx.doi.org/10.1007/s13277-014-1875-3 145.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int JCancer 1995; 61:443-9; PMID:7538974; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
World J Surg 2007; 31:388-94; PMID:17219282; http://dx.doi.org/10.1007/s00268-006-0328-6 147.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Surgery2007; 141:124-5; PMID:17188181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cancer Res Clin Oncol 2009; 135:1351-8; PMID:19326143; http://dx.doi.org/10.1007/s00432-009-0576-6 149.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
BMC Clin Pathol 2012; 12:14; PMID:22947174; http://dx.doi.org/10.1186/1472- 6890-12-14 151.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"Brack SS, Silacci M, Birchler M, Neri D. Tumor-tar- geting properties of novel antibodies speciﬁc to the large isoform of tenascin-C. Clin Cancer Res 2006;12:3200-8; PMID:16707621; http://dx.doi.org/ 10.1158/1078-0432.CCR-05-2804 155.",Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Br J Cancer 2010; 103:827-36; PMID:20736949; http://dx.doi.org/10.1038/sj.bjc.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cornea 1998; 17:326-32; PMID:9603390; http://dx.doi.org/10.1097/00003226-199805000-00014 157.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Bio- phys Acta 2009; 1793:888-92; PMID:19162090; http://dx.doi.org/10.1016/j.bbamcr.2008.12.012 161.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Clin Pathol 1993; 46:218-21; PMID:7681854; http://dx.doi.org/10.1136/jcp.46.3.218 163.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Neuroreport 2002; 13:1041-5; PMID:12060805; http://dx.doi.org/10.1097/ 00001756-200206120-00013164.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Arch Dermatol Res 2000; 292:446-54; PMID:11000288; http://dx.doi.org/10.1007/s004030000152 165.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1995; 270:6243-5; PMID:7534307; http://dx.doi.org/10.1074/jbc.270.11.6243 166.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1996; 66:632-5; PMID:8647625; http://dx.doi.org/10.1002/(SICI) 1097-0215(19960529)66:5%3c632::AID-IJC9%3e3.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"Bumke MA, Neri D, Elia G. Modulation of gene expression by extracellular pH variations in human ﬁbroblasts: a transcriptomic and proteomic study.Proteomics 2003; 3:675-88; PMID:12748947; http://dx.doi.org/10.1002/pmic.200300395 168.",OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nat Struct Mol Biol 2014; 21:189-97; PMID:24440982; http://dx.doi.org/10.1038/nsmb.2756 169.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Bio- chem 1989; 41:71-90; PMID:2482292; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1998; 273:10602-8; PMID:9553121; http://dx.doi.org/10.1074/jbc.273.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Nature 1984; 311:267-9; PMID:6482952; http://dx.doi.org/10.1038/311267a0 173.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1998; 273:2073-7; PMID:9442046; http://dx.doi.org/10.1074/jbc.273.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
EMBO J 2013; 32:1478-88; PMID:23584533; http://dx.doi.org/10.1038/emboj.2013.79 176.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Glycobiology 2007; 17:784-94;PMID:17369286; http://dx.doi.org/10.1093/glycob/ cwm031 178.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1986; 103:1663-70;PMID:2946699; http://dx.doi.org/10.1083/jcb.103.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
PloS One 2013; 8:e60471; PMID:23593224; http://dx.doi.org/10.1371/journal.pone.0060471 181.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Cancer 1998; 75:680-7;PMID:9495234; http://dx.doi.org/10.1002/(SICI) 1097-0215(19980302)75:5%3c680::AID-IJC4%3e3.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem2010; 285:2028-39; PMID:19887451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell 1988; 53:383-90; PMID:2452695; http://dx.doi.org/10.1016/0092-8674(88)90158-4 188.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Proc Nat Acad Sci U S A 1987; 84:2523-7; PMID:2436234; http://dx.doi.org/ 10.1073/pnas.84.8.2523 189.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"Ruggiero S, Cosgarea R, Potempa J, Potempa B, Eick S, Chiquet M. Cleavage of extracellular matrix in peri- odontitis: gingipains differentially affect cell adhesionactivities of ﬁbronectin and tenascin-C. Biochimi Bio- phys Acta 2013; 1832:517-26; PMID:23313574; http://dx.doi.org/10.1016/j.bbadis.2013.01.003 190.",OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Arterioscler Thromb Vasc Biol 2004; 24:1416-21; PMID:15178565; http://dx.doi.org/10.1161/01.ATV.0000134299.89599.53 191.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
In vivo matrix metalloproteinase-7 substrates identiﬁed in the left ventricle post-myocardial infarction using proteomics.J Proteome Res 2010; 9:2649-57; PMID:20232908; http://dx.doi.org/10.1021/pr100147r 192.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Proteomics 2010; 10:2214-23; PMID:20354994; http://dx.doi.org/10.1002/pmic.200900587 193.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell Mol Biol 2010; 43:286-95; PMID:19843707; http://dx.doi.org/10.1165/rcmb.2008-0426OC 194.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Arthritis Rheum 2008; 58:2420-31; PMID:18668564; http://dx.doi.org/10.1002/art.23654 195.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Rheu- matol Int 2012; 32:2809-17; PMID:21874326; http://dx.doi.org/10.1007/s00296-011-2067-8 196.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Matrix Biol 2010; 29:573-85; PMID:20708078; http://dx.doi.org/10.1016/j.matbio.2010.08.003 197.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Speciﬁc processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.Matrix Biol 2010; 29:31-42; PMID:19748582; http://dx.doi.org/10.1016/j.matbio.2009.08.007 198.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Physiol 2007; 211:748-58; PMID:17311283; http://dx.doi.org/10.1002/jcp.20986 199.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 2001; 154:459- 68; PMID:11470832; http://dx.doi.org/10.1083/ jcb.200103103 200.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Tissue Eng Part A 2013; 19:1972- 83; PMID:23541003; http://dx.doi.org/10.1089/ten.tea.2012.0568 201.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
PloS One 2013; 8: e62076; PMID:23637968; http://dx.doi.org/10.1371/journal.pone.0062076 202.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Immunol 2010; 184:2655-62; http://dx.doi.org/10.4049/jimmunol.0903359 204.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Matrix Biol 1998; 17:305-16; PMID:9749946; http://dx.doi.org/ 10.1016/S0945-053X(98)90083-X 205.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Invest Dermatol 2006; 126:551- 60; PMID:16374482; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Oncogene 2004;23:1656-67; PMID:15001984; http://dx.doi.org/ 10.1038/sj.onc.1207064 208.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Physiol 2006; 206:718-27; PMID:16245312; http://dx.doi.org/10.1002/jcp.20527 209.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1999;274:21840-6; PMID:10419501; http://dx.doi.org/ 10.1074/jbc.274.31.21840 210.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
FASEB J 2011; 25:3477-88; PMID:21705668; http://dx.doi.org/10.1096/fj.11-187310 211.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Am Heart Assoc 2014; 3:e000626; PMID:24614757; http://dx.doi.org/10.1161/JAHA.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1994; 127:2093-101; PMID:7528751; http://dx.doi.org/ 10.1083/jcb.127.6.2093 214.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Biol Chem 1995; 270:3429-34; PMID:7531707; http://dx.doi.org/ 10.1074/jbc.270.7.3429 215.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
DNA Cell Biol 1997; 16:559-67; PMID:9174161; http://dx.doi.org/10.1089/dna.1997.16.559 217.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter.Oncogene 1999; 18:7755-64; PMID:10618716; http://dx.doi.org/10.1038/sj.onc.1203360 220.",Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Circ Res2001; 89:131-8; PMID:11463719; http://dx.doi.org/ 10.1161/hh1401.093582 221.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Biochimi Biophys Acta 2008; 1779:145-51; PMID:18177748; http://dx.doi.org/10.1016/j.bbagrm.2007.11.012 223.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cancer Res 2009; 69:458-65; PMID:19147558; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2610 224.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
J Cell Biol 1987; 105:1387-94; PMID:3654758; http://dx.doi.org/10.1083/jcb.105.3.1387 225.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Cell Differ Dev 1990; 32:417-23;PMID:1711921; http://dx.doi.org/10.1016/0922- 3371(90)90058-5 226.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Exp Cell Res 1991; 194:297-300; PMID:1709104; http://dx.doi.org/10.1016/0014-4827(91)90368-5 227.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Differentiation 1990; 44:42-55; PMID:1701406; http://dx.doi.org/10.1111/j.1432- 0436.1990.tb00535.x 228.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
FEBS Lett 1993; 332:39-43; PMID:7691659; http://dx.doi.org/10.1016/0014- 5793(93)80479-E www.tandfonline.com 81 Cell Adhesion & Migration,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Hum Pathol 1993; 24:982-9; PMID:7504654; http://dx.doi.org/10.1016/0046- 8177(93)90112-T 236.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Br J Cancer 1998; 77:98-102; PMID:9459152; http://dx.doi.org/10.1038/bjc.1998.15 239.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Oncology 2001; 61:306-14; PMID:11721178; http://dx.doi.org/10.1159/000055338 240.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Clin Cancer Res 2007; 13:398-407; PMID:17202312; http://dx.doi.org/10.1158/1078-0432.CCR-06-0182 241.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Int J Bio-chem Cell Biol 2011; 43:441-54; PMID:21134486; http://dx.doi.org/10.1016/j.biocel.2010.11.018 242.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Exp Cell Res 1993; 206:244-54; PMID:7684694; http://dx.doi.org/ 10.1006/excr.1993.1144 243.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Br J Dermatol 2006; 155:763-70; PMID:16965426; http://dx.doi.org/10.1111/j.1365- 2133.2006.07401.x 244.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Exp Eye Res 2006; 83:1412-22;PMID:16963023; http://dx.doi.org/10.1016/j.exer.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Exp Mol Pathol 2006; 80:177-82; PMID:16259977; http://dx.doi.org/10.1016/j.yexmp.,OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Exp Dermatol2011; 20:685-8; PMID:21649738; http://dx.doi.org/ 10.1111/j.1600-0625.2011.01314.x 247.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
Histochem Cell Biol 2012; 137:195- 204; PMID:22075565; http://dx.doi.org/10.1007/ s00418-011-0886-z 248.,Non-OADS,/arxiv_data1/oa_pdf/81/d1/kcam-09-48.PMC4422809.pdf
"We brieﬂy review the expression patterns *Correspondence to: Ruth Chiquet-Ehrismann; Email: Ruth.Chiquet@fmi.ch Submitted: 10/07/2014; Revised: 12/05/2014; Accepted: 01/12/2015 http://dx.doi.org/10.1080/19336918.2015.1008333 34 Volume 9 Issues 1-2 Cell Adhesion & MigrationCell Adhesion & Migration 9:1-2, 34--47; January –April 2015; © 2015 Taylor & Francis Group, LLCREVIEW",Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
"Gene models ofTNC, tenascin-C; TNN, tenascin-W; TNR, tenascin-R; TNXB , tenascin-X were captured from the NCBI database (http://www.ncbi.nlm.nih.gov/ gene/).",OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
"The ﬁrst non-coding exons as well as about 600bp5`of the transcription start are highly conserved between human and mouse orthologs indicating the presence of conserved pro-moters, as revealed by the conservation tracks of the UCSC genome browser (http://genome.ucsc.edu/).",Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Using ConSite (http://consite.genereg.net/) to explore transcription factor bind-ing sites shared by the putative human and mouse promotersequences revealed a conserved TATA box as well as conservedSMAD binding elements.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Biochem Cell Biol 2009; 41:424- 34; PMID:18761101; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Matrix Biol 2014; 37:1-14; PMID:25064829; http://dx.doi.org/10.1016/j.matbio.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Curr Opin Cell Biol 1993; 5:869-76; PMID:7694605; http://dx.doi.org/10.1016/0955-0674(93)90037-Q 7.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Experientia 1995; 51:853-62; PMID:7556567; http://dx.doi.org/10.1007/BF01921736 8.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Biochem Cell Biol 2010; 42:1412-5; PMID:20541035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Matrix Biol 2001; 20:13-22; PMID:11246000; http://dx.doi.org/10.1016/S0945-053X(00)00136-0 11.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cancer Metastasis Rev 2010; 29:595-606; PMID:20814719; http://dx.doi.org/10.1007/s10555-010-9249-9 12.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Biochem Cell Biol 2005;37:1066-83; PMID:15743679; http://dx.doi.org/ 10.1016/j.biocel.2004.12.002 13.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Bio- chim Biophys Acta 2009; 1793:888-92; PMID:19162090; http://dx.doi.org/10.1016/j.bbamcr.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cell Mol Life Sci 2011; 68:3175-99; PMID:21818551; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Biochem Cell Biol 2012;44:1385-9; PMID:22634605; http://dx.doi.org/ 10.1016/j.biocel.2012.05.009 17.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Br J Dermatol 2010; 163:1340-5; PMID:20649799; http://dx.doi.org/10.1111/j.1365- 2133.2010.09949.x 18.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
BMC Clin Pathol 2012; 12:14; PMID:22947174; http://dx.doi.org/10.1186/1472-6890-12-14 20.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Biol Chem 1995; 270:3429-34; PMID:7531707; http://dx.doi.org/ 10.1074/jbc.270.7.3429 21.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nucleic Acids Res 1993; 21:163-8; PMID:7680113; http://dx.doi.org/10.1093/nar/21.1.163 22.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Cancer 1997; 72:236-40; PMID:9219826; http://dx.doi.org/10.1002/(SICI)1097-0215(19970717) 72:2%3c236::AID-IJC6%3e3.0.CO;2-S 23.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Matrix Biol 2000; 19:581-96; PMID:11102748; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1984; 98:1926-36; PMID:6725406; http://dx.doi.org/ 10.1083/jcb.98.6.1926 27.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cell 1986; 47:131-9; PMID:2428505; http://dx.doi.org/10.1016/0092- 8674(86)90374-0 28.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Front Physiol 2014; 5:283; PMID:25120494; http://dx.doi.org/10.3389/fphys.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Dev Biol 1988; 128:245-55; PMID:2456233; http://dx.doi.org/10.1016/0012-1606(88)90288-6 33.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1987; 105:599-608; PMID:2440899; http://dx.doi.org/10.1083/jcb.105.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Exp Cell Res 1991; 194:297-300; PMID:1709104; http://dx.doi.org/10.1016/0014- 4827(91)90368-5 36.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
FEBS Lett 1999; 445:160-4; PMID:10069392; http://dx.doi.org/10.1016/S0014-5793(99)00113-1 38.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
DNA Cell Biol 1997; 16:559-67;PMID:9174161; http://dx.doi.org/10.1089/dna.1997.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Genes Dev 1995; 9:1237-49; PMID:7758948; http://dx.doi.org/ 10.1101/gad.9.10.1237 41.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Biochem Biophys Res Commun 2009; 386:477-82; PMID:19538944; http://dx.doi.org/10.1016/j.bbrc.2009.06.059 42.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Circ Res 2001; 89:131-8; PMID:11463719; http://dx.doi.org/ 10.1161/hh1401.093582 43.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Circ Res 2004; 94:1507-14; PMID:15117820; http://dx.doi.org/10.1161/01.RES.0000130656.72424.20 44.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Am J Phys- iol Lung Cell Mol Physiol 2006; 291:L694-702; PMID:16782755; http://dx.doi.org/10.1152/ ajplung.00119.2006 45.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Development 2007; 134:2697-708; PMID:17567668; http://dx.doi.org/10.1242/dev.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Dev Biol2009; 328:392-402; PMID:19389348; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Matrix Biol 2004; 23:259-64; PMID:15296940; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Curr Opin Cell Biol 1997; 9:707-13; PMID:9330875;http://dx.doi.org/10.1016/S0955-0674(97)80125-1 52.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Scand J Med Sci Sports 2005; 15:223-30; PMID:15998339; http://dx.doi.org/10.1111/j.1600- 0838.2005.00461.x 53.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Sci 2010; 123:1511-21;PMID:20375066; http://dx.doi.org/10.1242/jcs.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
BiochimBiophys Acta 2008; 1783:1150-62; PMID:18269918; http://dx.doi.org/10.1016/j.bbamcr.2008.01.013 56.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Exp Cell Res 2006; 312:1361-70; PMID:16448650;http://dx.doi.org/10.1016/j.yexcr.2005.12.025 57.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Scand J Med Sci Sports 2009; 19:490-9; PMID:19422655; http://dx.doi.org/10.1111/j.1600-0838.2009.00928.x 58.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
FASEB J 2011; 25:3477-88; PMID:21705668; http://dx.doi.org/10.1096/fj.11- 187310 59.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Mol Cancer 2014; 13:22; PMID:24495796; http://dx.doi.org/10.1186/ 1476-4598-13-22 60.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cell 2003; 113:329-42; PMID:12732141; http://dx.doi.org/10.1016/S0092-8674(03)00278-2 61.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Am Heart Assoc 2014; 3:e000626; PMID:24614757; http://dx.doi.org/10.1161/JAHA.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Biol Chem 1999;274:21840-6; PMID:10419501; http://dx.doi.org/ 10.1074/jbc.274.31.21840 63.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1994; 127:2093-101; PMID:7528751; http://dx.doi.org/ 10.1083/jcb.127.6.2093 64.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Biochem Cell Biol 1996; 74:737-44; PMID:9164643; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Clin Invest 1995;96:1169-75; PMID:7635955; http://dx.doi.org/ 10.1172/JCI118106 66.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Reproduction 2007; 134:811-22; PMID:18042638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Scand J Immunol 2005; 61:10-7; PMID:15644118; http://dx.doi.org/10.1111/ j.0300-9475.2005.01524.x 70.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Invest Dermatol 2006; 126:551- 60; PMID:16374482; http://dx.doi.org/10.1038/sj.jid.5700090 71.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cytokine2013; 62:22-33; PMID:23481102; http://dx.doi.org/ 10.1016/j.cyto.2013.02.007 72.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
MediatorsInﬂamm 2014; 2014:561459; PMID:24876674; http://dx.doi.org/10.1155/2014/561459 73.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Dermatol Sci 2004; 35:83-92; PMID:15265520; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Biochim Biophys Acta 2008; 1782:197-228;PMID:18313409; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Oncogene 2005; 24:1525-32; PMID:15592496; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Oncogene 2004; 23:1656-67; PMID:15001984; http://dx.doi.org/ 10.1038/sj.onc.1207064 79.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Physiol 2006; 206:718-27;PMID:16245312; http://dx.doi.org/10.1002/jcp.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cardiovasc Pharmacol 2007; 49:261-8; PMID:17513943; http://dx.doi.org/10.1097/FJC.0b013e318033dfd4 81.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1993; 123:1037-45; PMID:7693719; http://dx.doi.org/10.1083/jcb.123.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Biochim Biophys Acta2008; 1779:145-51; PMID:18177748; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cancer Res 2009; 69:709-17; PMID:19147588; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3415 87.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cancer Cell; 22:709-24;PMID:23201163; http://dx.doi.org/10.1016/j.ccr.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Biochem Cell Biol 2011; 43:1550-62; PMID:21854867; http://dx.doi.org/10.1016/j.biocel.2011.08.005 91.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cancer Res 2005; 65:2353- 63; PMID:15781650; http://dx.doi.org/10.1158/ 0008-5472.CAN-04-1890 92.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
PMID:19147558; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2610 93.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nat Med 2011; 17:867-74; PMID:21706029; http://dx.doi.org/10.1038/nm.2379 94.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nature2005; 433:769-73; PMID:15685193; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045-5 96.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nat Genet 2007; 39:673-7; PMID:17401365; http://dx.doi.org/ 10.1038/ng2003 97.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nature 2008; 451:147-52; PMID:18185580; http://dx.doi.org/10.1038/nature06487 98.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Biol Chem 1996;271:31251-4; PMID:8940128; http://dx.doi.org/ 10.1074/jbc.271.49.31251 99.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
DNA Cell Biol 1998; 17:275-82;PMID:9539107; http://dx.doi.org/10.1089/dna.1998.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cytogenet Cell Genet 1998; 83:115-23; PMID:9925948; http://dx.doi.org/ 10.1159/000015146 101.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
"Putthoff P, Akyuz N, Kutsche M, Zardi L, Borgmeyer U, Schachner M. Structure of the murine tenascin-R gene and functional characterisation of the promoter.Biochem Biophys Res Commun 2003; 308:940-9; PMID:12927810; http://dx.doi.org/10.1016/S0006- 291X(03)01506-7 102.",OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1993; 120:1237-49; PMID:7679676; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Neuron 1992; 8:849-63; PMID:1375037; http://dx.doi.org/10.1016/0896-6273(92)90199-N 105.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Neurosci Res 2001; 64:70-8; PMID:11276053; http://dx.doi.org/ 10.1002/jnr.1055107.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1989; 109:1765-78; PMID:2477380; http://dx.doi.org/10.1083/jcb.109.4.1765 108.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Exp Neurol 1990; 109:98-110; PMID:2192910; http://dx.doi.org/10.1016/S0014-4886(05)80012-3 110.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Prog Neu- robiol 2000; 61:465-93; PMID:10748320; http://dx.doi.org/10.1016/S0301-0082(99)00061-1 111.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Dev Neurobiol 2008; 68:899-916; PMID:18361401; http://dx.doi.org/10.1002/dneu.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Neuropathol Appl Neurobiol 2010; 36:399-410; PMID:20202125; http://dx.doi.org/10.1111/j.1365- 2990.2010.01074.x 114.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Glia 1993; 9:163-75; PMID:8294147; http://dx.doi.org/10.1002/glia.440090302 115.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Proc Natl Acad Sci U S A 1989; 86:6582-6; PMID:2475872; http://dx.doi.org/10.1073/ pnas.86.17.6582 116.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Am J Med Genet C Semin Med Genet 2005;139C:24-30; PMID:16278880; http://dx.doi.org/ 10.1002/ajmg.c.30071 117.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Biol 1993; 122:265-78; PMID:7686164; http://dx.doi.org/10.1083/jcb.122.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
N Engl J Med 2001; 345:1167-75; PMID:11642233; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nat Genet 1997; 17:104-8; PMID:9288108; http://dx.doi.org/ 10.1038/ng0997-104 120.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Genomics 2002; 80:443-52; PMID:12376099; http://dx.doi.org/10.1006/geno.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Exp Cell Res 2008; 314:2661-73; PMID:18588874; http://dx.doi.org/10.1016/j.yexcr.2008.05.019 123.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Mol Cell Biochem 2009; 320:53-66; PMID:18679583; http://dx.doi.org/10.1007/s11010-008-9898-y 124.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Biochem Biophys Res Commun 2000; 267:626-31; PMID:10631113; http://dx.doi.org/ 10.1006/bbrc.1999.2006 125.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Am Soc Nephrol 2013; 24:1313-22; PMID:23620400; http://dx.doi.org/10.1681/ASN.2012121148 126.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Nat Genet 2002; 30:421-5; PMID:11925569; http://dx.doi.org/ 10.1038/ng850 127.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
FEBS Lett 2006; 580:6281-5; PMID:17078949; http://dx.doi.org/10.1016/j.febslet.2006.10.037 128.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Biol Chem 2006; 281:27461-70;PMID:16861231; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Exp Cell Res2004; 298:305-15; PMID:15242785; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Dev Dyn 1995; 203:491-504; PMID:7496040; http://dx.doi.org/10.1002/aja.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Eur J Biochem 1995; 231: 83-92; PMID:7543048; http://dx.doi.org/10.1111/ j.1432-1033.1995.0083f.x 132.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Am J Surg Pathol 2009; 33:1673-82; PMID:19738457; http://dx.doi.org/10.1097/ PAS.0b013e3181b6bde3 135.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Neurobiol 1998; 35:1-16; PMID:9552162; http://dx.doi.org/10.1002/(SICI)1097-4695(199804) 35:1%3c1::AID-NEU1%3e3.0.CO;2-9 136.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J CellSci 2004; 117:571-81; PMID:14709716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Mol Cell Neurosci 2003; 23:193-209; PMID:12812753; http://dx.doi.org/ 10.1016/S1044-7431(03)00012-5 138.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cancer Res 2007; 67:9169-79; PMID:17909022; http://dx.doi.org/10.1158/0008-5472.CAN-07- 0666 139.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
BMC Evol Biol 2006; 6:60;PMID:16893461; http://dx.doi.org/10.1186/1471- 2148-6-60140.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Dev Dyn 2006;235:1532-42; PMID:16534782; http://dx.doi.org/ 10.1002/dvdy.20731 141.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Cell Tissue Res 2008; 334:445-55;PMID:18985388; http://dx.doi.org/10.1007/s00441- 008-0715-4 142.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
J Cell Sci 2013; 126:5111-5; PMID:24101721; http://dx.doi.org/ 10.1242/jcs.134650 143.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Int J Cancer 2008; 122:2454-61; PMID:18306355; http://dx.doi.org/10.1002/ijc.23417 144.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
FASEB J 2010;24:778-87; PMID:19884327; http://dx.doi.org/ 10.1096/fj.09-140491 145.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Biochem Biophys Res Commun 2007; 356:935-41; PMID:17395156; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
"Congenit Anom (Kyoto) 2009; 49:77-84; PMID:19489959; http://dx.doi.org/10.1111/j.1741-4520.2009.00227.x 147. d’Amaro R, Scheidegger R, Blumer S, Pazera P, Kat- saros C, Graf D, Chiquet M. Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis.",OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
EMBO J 2012; 31:254-6; PMID:22179697; http://dx.doi.org/10.1038/emboj.2011.469 150.,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
Eur J Nucl Med Mol Imaging 2014; 41:867-77;PMID:24435772; http://dx.doi.org/10.1007/s00259- 013-2658-6 www.tandfonline.com 47 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/99/ac/kcam-09-34.PMC4422812.pdf
"orend@inserm.fr Submitted: 11/11/2014; Revised: 12/12/2014; Accepted: 12/13/2014http://dx.doi.org/10.1080/19336918.2014.1000074 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),which permits unrestricted use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cancer Cell 2009; 15:220-31; PMID:19249680; http://dx.doi.org/10.1016/j.ccr.2009.01.027 2.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cancer Lett 2006; 244:143-63;PMID:16632194; http://dx.doi.org/10.1016/j.canlet.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cell Rep 2013; 5:482-92; PMID:24139798; http://dx.doi.org/10.1016/j.celrep.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Alcohol Clin Exp Res 2008; 32:1031-9; PMID:18422837; http://dx.doi.org/10.1111/j.1530-0277.2008.00664.x 6.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Heart Lung Transplant Off Publ Int Soc Heart Transplant 2008; 27:400-7;PMID:18374876; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Cancer 1995; 61:443-9; PMID:7538974; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
"Tenascin-C is an innate broad- spectrum, HIV-1-neutralizing protein in breast m i l k .P r o cN a t lA c a dS c iUSA2 0 1 3 ;110:18220-5; PMID:24145401; http://dx.doi.org/ 10.1073/pnas.1307336110 10.",Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Colorectal Dis 2001; 16:285-91; PMID:11686525; http://dx.doi.org/ 10.1007/s003840100312 11.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
TumourBiol J Int Soc Oncodevelopmental Biol Med 2014; 35:6777-82; PMID:24722824; http://dx.doi.org/ 10.1007/s13277-014-1923-z 12.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Tumour Biol J Int Soc Oncodevelopmental Biol Med 2014; 35:6619-25; PMID:24696262; http://dx.doi.org/10.1007/s13277-014-1875-3 13.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Am J Pathol 1998;153:457-67; PMID:9708806; http://dx.doi.org/ 10.1016/S0002-9440(10)65589-7 15.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Oncogene 2000; 19:1102-13; PMID:10713697; http://dx.doi.org/10.1038/sj.onc.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Pathol 2006; 210:181-91;PMID:16924594; http://dx.doi.org/10.1002/path.2045 18.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Cell Commun Signal 2009; 3:287-310; PMID:19838819; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Dev Biol 2011; 55:511-25; PMID:21769776; http://dx.doi.org/ 10.1387/ijdb.103243eo 20.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cold Spring Harb Perspect Biol 2011; 3; a004960; PMID:21441591; http://dx.doi.org/10.1101/cshpers-pect.a004960 21.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
"Zukiel R, Nowak S, Wyszko E, Rolle K, Gawronska I, Barciszewska MZ, Barciszewski J. Suppression of human brain tumor with interference RNA speciﬁc for tenascin- C. Cancer Biol Ther 2006; 5:1002-7; PMID:16775434;http://dx.doi.org/10.4161/cbt.5.8.2886 22.",OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cancer Biol Ther 2010; 9:396-406; PMID:20118657; http://dx.doi.org/10.4161/cbt.9.5.10958 24.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Thorac Cardiovasc Surg 2004; 128:357-63; PMID:15354092; http://dx.doi.org/10.1016/j.jtcvs.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cardiovasc Res 2007; 74:335-6;PMID:17459357; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Biochem Cell Biol 2004; 36:1031-7; PMID:15094118; http://dx.doi.org/10.1016/j.biocel.2003.12.003 29.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
"Brack SS, Silacci M, Birchler M, Neri D. Tumor-tar- geting properties of novel antibodies speciﬁc to the large isoform of tenascin-C. Clin Cancer Res 2006; 12:3200-8; PMID:16707621; http://dx.doi.org/10.1158/1078-0432.CCR-05-2804 31.",Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Br J Cancer 2010; 103:827-36;PMID:20736949; http://dx.doi.org/10.1038/sj.bjc.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Leuk Res 2009; 33:1718-22; PMID:19625084; http://dx.doi.org/10.1016/j.leukres.2009.06.025 33.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Histo-chem Cell Biol 2010; 133:467-75; PMID:20237793; http://dx.doi.org/10.1007/s00418-010-0685-y 34.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Lung Cancer 2009; 64:28-33; PMID:18799229; http://dx.doi.org/10.1016/j.lungcan.2008.07.013 35.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Head Neck Oncol 2011; 3:25;PMID:21548989; http://dx.doi.org/10.1186/1758- 3284-3-25 36.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Exp Dermatol2011; 20:685-8; PMID:21649738; http://dx.doi.org/ 10.1111/j.1600-0625.2011.01314.x 37.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Clin Cancer Res 2008; 14:6515-24; PMID:18927291; http://dx.doi.org/10.1158/1078-0432.CCR-07-5041 38.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
SciTransl Med 2013; 5:201ra118; PMID:24005158; http://dx.doi.org/10.1126/scitranslmed.3006221 www.tandfonline.com 151 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Nucl Med 2013; 54:397-401;PMID:23334725; http://dx.doi.org/10.2967/ jnumed.112.111310 41.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Eur J Nucl Med Mol Imaging 2014; 41:867-77; PMID:24435772; http://dx.doi.org/ 10.1007/s00259-013-2658-6 43.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Proc Natl Acad Sci U A 1992; 89:6988-92; PMID:1379730; http://dx.doi.org/ 10.1073/pnas.89.15.6988 44.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Biol Chem 2001; 276:48644- 54; PMID:11590140; http://dx.doi.org/10.1074/ jbc.M104651200 45.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Nucleic Acids Res 2004; 32:5757-65;PMID:15509871; http://dx.doi.org/10.1093/nar/ gkh862 46.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Biomaterials 2011; 32:1130-8;PMID:21071077; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Chem Biol 2012; 19:60-71; PMID:22284355; http://dx.doi.org/ 10.1016/j.chembiol.2011.12.008 50.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Science 2006; 312:1168-71; PMID:16728630; http://dx.doi.org/10.1126/science.1125949 51.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Med Chem 2010; 53:5333-41; PMID:20568777; http://dx.doi.org/10.1021/jm100623e52.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Clin Cancer Res 2009; 15:4712-21; PMID:19584166; http://dx.doi.org/10.1158/1078- 0432.CCR-08-2635 53.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
2012; 10:9183-90; PMID:23086384; http://dx.doi.org/10.1039/ c2ob26452h 54.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
2014; 12: 9601-20; PMID:25338628; http://dx.doi.org/ 10.1039/C4OB01514B 55.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Dalton Trans 2010; 39:9055- 62; PMID:20725674; http://dx.doi.org/10.1039/ c0dt00453g 56.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Cell Biol 1988; 107:2341-9; PMID:2461951; http://dx.doi.org/10.1083/jcb.107.6.2341 57.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Faseb J 2010; 24:4535-44;PMID:20634349; http://dx.doi.org/10.1096/fj.10- 163022 58.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Brain J Neurol 2012; 135:1042-54; PMID:22418738; http://dx.doi.org/ 10.1093/brain/aws042 61.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
[Press release].http://www.immatics.com/index.php?page=57& modaction=detail&modid=403&PHPSESSID= 03b364a73eeccf59034b3463a64245f0 63.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Radiother Oncol J Eur Soc Ther Radiol Oncol 2004; 73:119-31; PMID:15542158;http://dx.doi.org/10.1016/j.radonc.2004.08.021 65.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Invest Dermatol 1994; 102:945-50; PMID:8006459; http://dx.doi.org/10.1111/1523-1747.ep12384118 66.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Radiat Oncol /C15Biol /C15Phys 2006; 66:1506-14; PMID:17069989; http://dx.doi.org/ 10.1016/j.ijrobp.2006.08.004 67.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Br J Cancer 2003; 88:1470-9; PMID:12778079; http://dx.doi.org/10.1038/sj.bjc.6600912 68.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Radiol Clin North Am 2013;51:913-25; PMID:24010913; http://dx.doi.org/ 10.1016/j.rcl.2013.05.007 71.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Semin Radiat Oncol 2012;22:40-9; PMID:22177877; http://dx.doi.org/ 10.1016/j.semradonc.2011.09.003 72.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Semin Radiat Oncol 2013; 23:75-6; PMID:23473683; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
SeminRadiat Oncol 2014; 24:54-60; PMID:24314343; http://dx.doi.org/10.1016/j.semradonc.2013.09.001 74.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Semin Radiat Oncol 2014; 24:35-42; PMID:24314340; http://dx.doi.org/10.1016/j.semradonc.2013.08.004 75.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
BMJ 2012; 345: e7765; PMID:23212681; http://dx.doi.org/10.1136/ bmj.e7765 76.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Semin Radiat Oncol 2010;20:215-6; PMID:20832012; http://dx.doi.org/ 10.1016/j.semradonc.2010.06.002 78.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Phys Med Biol 2006; 51:2813-23; PMID:16723768; http://dx.doi.org/ 10.1088/0031-9155/51/11/009 79.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Semin Radiat Oncol 2008; 18:240-3; PMID:18725110; http://dx.doi.org/10.1016/j.semradonc.2008.04.005 80.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Nat Rev Cancer 2005; 5:867-75; PMID:16327765; http://dx.doi.org/10.1038/nrc1735 81.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Clin Cancer Res Off J Am Assoc Cancer Res 2012; 18:5196-202; PMID:22730447; http://dx.doi.org/10.1158/1078-0432.CCR-11-1758 82.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Lancet Oncol 2014; 15:e170-7;PMID:24694640; http://dx.doi.org/10.1016/S1470- 2045(13)70569-2 83.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Acta Derm Venereol2001; 81:329-33; PMID:11800138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Br J Cancer 2013;109:1829-38; PMID:24002607; http://dx.doi.org/ 10.1038/bjc.2013.502 85.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cancer Res 2008; 68:7323-31; PMID:18794119; http://dx.doi.org/10.1158/0008-5472.CAN-08-0841 86.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Radiother Oncol J Eur Soc Ther Radiol Oncol 2011; 101:93-9; PMID:21885141;http://dx.doi.org/10.1016/j.radonc.2011.07.032 89.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Graefes ArchClin Exp Ophthalmol Albrecht Von Graefes Arch F €ur Klin Exp Ophthalmol 2007; 245:1347-55; PMID:17318564; http://dx.doi.org/10.1007/s00417-007-0548-y 90.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Radiat Oncol Biol Phys 2001; 50:851-5; PMID:11429211; http://dx.doi.org/10.1016/S0360-3016(01)01593-0 92.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Expression and immune function of tenascin-C. Crit Rev Immunol 2011; 31:115-45; PMID:21542790; http://dx.doi.org/10.1615/CritRevImmunol.v31.i2.3094.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Radiat Oncol Biol Phys 2010;76:242-50; PMID:20005457; http://dx.doi.org/ 10.1016/j.ijrobp.2009.07.1736 95.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Mol Cell Pharmacol 2009; 1:44-56;PMID:20336170; http://dx.doi.org/10.4255/ mcpharmacol.09.06 96.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cytokine Growth Factor Rev 2010; 21:49-59; PMID:20018551; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Oncogene 2004;23:1656-67; PMID:15001984; http://dx.doi.org/ 10.1038/sj.onc.1207064 98.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Oncogenesis 2013; 2: e65; PMID:23958855; http://dx.doi.org/10.1038/oncsis.2013.27 99.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
PloS One 2013; 8: e62076; PMID:23637968; http://dx.doi.org/ 10.1371/journal.pone.0062076 100.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Cell Mol Med 2014; 18:1491-508; PMID:24237862; http://dx.doi.org/10.1111/jcmm.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
PloS One 2010; 5: e11084; PMID:20552031; http://dx.doi.org/10.1371/journal.pone.0011084 103.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Endocr Rev 2004;25:581-611; PMID:15294883; http://dx.doi.org/ 10.1210/er.2003-0027 104.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Nat Rev Cancer 2013; 13:871-82; PMID:24263190; http://dx.doi.org/10.1038/nrc3627 105.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Clin Invest 2006;116:2610-21; PMID:17016557; http://dx.doi.org/ 10.1172/JCI24612 108.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Mol Biol Cell 2005; 16:5013-25; PMID:16030261; http://dx.doi.org/10.1091/mbc.E05-01-0065 111.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Int J Cancer J Int Cancer 2008; 123:2013-9; PMID:18688867; http://dx.doi.org/10.1002/ijc.23721 113.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Oncogene 2002; 21:878-89; PMID:11840333; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Oncogene 2006; 25:7469-81; PMID:17143291; http://dx.doi.org/ 10.1038/sj.onc.1210054 115.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Clin Oncol 2006; 24:115-22; PMID:16382120; http://dx.doi.org/10.1200/JCO.2005.03.4082 116.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Neuro Oncol 2008; 10:182-9; PMID:18287339; http://dx.doi.org/10.1215/15228517-2007-053 117.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
J Nucl Med 2008; 49:30-8; PMID:18077533; http://dx.doi.org/ 10.2967/jnumed.107.046938 118.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cancer 1994; 73:1076-82; PMID:8306250; http://dx.doi.org/ 10.1002/1097-0142(19940201)73:3 C%3c1076::AID- CNCR2820731347%3e3.0.CO;2-Z 119.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
Cancer Biother Radiopharm 2001; 16:227- 35; PMID:11471487; http://dx.doi.org/10.1089/10849780152389410 www.tandfonline.com 153 Cell Adhesion & Migration,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/kcam-09-141.PMC4422814.pdf
"© Aamna K Kaul, Eugene F Schuster, and Barbara H Jennings*Correspondence to: Barbara H Jennings; Email:bjennings@brookes.ac.uk Submitted: 11/14/2014 Revised: 12/14/2014Accepted: 12/15/2014http://dx.doi.org/10.1080/21541264.2014.1000709 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/91/ktrn-06-01-1000709.PMC4422819.pdf
"12-15,19The Inr encompasses the TSS20and its consensus© Yonathan Zehavi, Adi Kedmi, Diana Ideses, and Tamar Juven-Gershon *Correspondence to: Tamar Juven-Gershon; Email: tamar.gershon@biu.ac.il Submitted: 11/30/2014; Revised: 12/23/2014; Accepted: 01/05/2015http://dx.doi.org/10.1080/21541264.2015.1004980 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Crit Rev Biochem Mol Biol 2006; 41:105-78; PMID:16858867; http://dx.doi.org/10.1080/10409230600648736 2.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Curr Opin Cell Biol 2008; 20:253-9; PMID:18436437; http://dx.doi.org/10.1016/j.ceb.2008.03.003 3.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Dev Biol 2010; 339:225-9; PMID:19682982; http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Wiley Interdiscip Rev Dev Biol 2012;1:40-51; PMID:23801666; http://dx.doi.org/10.1002/ wdev.21 5.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Bio- chim Biophys Acta 2014; 1839:118-28; PMID: 24275614; http://dx.doi.org/10.1016/j.bbagrm.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nat Rev Genet 2007; 8:424-36; PMID:17486122; http://dx.doi.org/10.1038/nrg2026 9.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genome Res 2006; 16:1-10; PMID:16344566; http://dx.doi.org/10.1101/gr.4222606 12.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genome Biol 2006; 7:R53; PMID:16827941; http://dx.doi.org/10.1186/gb-2006- 7-7-r53 13.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
BMC Genomics 2006; 7:161; PMID:16790048; http://dx.doi.org/10.1186/1471- 2164-7-161 14.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
JBiol Chem 2014; 289:11993-2004; PMID:24634215; http://dx.doi.org/10.1074/jbc.M114.550251 16.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2005; 19:2418-23; PMID:16230532; http://dx.doi.org/10.1101/gad.342405 17.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Chromosoma2007; 116:417-29; PMID:17593382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 1998; 12:34-44; PMID:9420329; http://dx.doi.org/10.1101/gad.12.1.34 19.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genome Biol 2002; 3:RESEARCH0087; PMID:12537576; http://dx.doi.org/10.1186/gb-2002-3-12-research0087 20.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Cell 1989; 57:103-13;PMID:2467742; http://dx.doi.org/10.1016/0092- 8674(89)90176-1 21.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2010; 24:2013-8; PMID:20801935; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev2004; 18:1606-17; PMID:15231738; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell Biol2010; 30:3471-9; PMID:20457814; http://dx.doi.org/ 10.1128/MCB.00053-10 24.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 1996; 10:711-24; PMID:8598298; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 1997; 11:3020-31; PMID:9367984; http://dx.doi.org/10.1101/gad.11.22.3020 26.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell Biol 2000; 20:4754-64; PMID:10848601; http://dx.doi.org/ 10.1128/MCB.20.13.4754-4764.2000 27.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2008; 22:2823-30; PMID: 18923080; http://dx.doi.org/10.1101/gad.1698108 28.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
EMBO J 1999; 18:4835-45; PMID:10469661; http://dx.doi.org/ 10.1093/emboj/18.17.4835 29.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nat Struct Biol 1994; 1:638-53; PMID:7634103; http://dx.doi.org/10.1038/nsb0994-638 30.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nature 1993; 365:520-7; PMID:8413605; http://dx.doi.org/10.1038/365520a0 31.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nature 1993; 365:512-20; PMID:8413604; http://dx.doi.org/ 10.1038/365512a0 32.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2005; 19:794-803; PMID:15774719; http://dx.doi.org/10.1101/gad.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Dev Biol 2005; 288:405-19;PMID:16289522; http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Dev Biol 2014; 392:42-51;PMID:24836512; http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2001; 15:1021-30; PMID: 11316795; http://dx.doi.org/10.1101/gad.869101 37.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
J Cell Sci2003; 116:1847-58; PMID:12665565; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell 2005; 18:471- 81; PMID:15893730; http://dx.doi.org/10.1016/j.molcel.2005.04.005 40.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
"Genes Dev 2008;22:2353-8; PMID:18703680; http://dx.doi.org/ 10.1101/gad.1681808 41. van Werven FJ, van Bakel H, van Teeffelen HA, Alte- laar AF, Koerkamp MG, Heck AJ, Holstege FC, Timmers HT.",OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2008; 22:2359-69; PMID: 18703679; http://dx.doi.org/10.1101/gad.1682308 42.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Sci- ence 2000; 290:982-5; PMID:11062130; http://dx.doi.org/10.1126/science.290.5493.982 43.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nature 1990; 346:390-4; PMID:2197561; http://dx.doi.org/10.1038/346390a0 44.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
FEBS Lett 1992; 301:294-8; PMID:1577169; http://dx.doi.org/10.1016/0014-5793(92)80260-N 45.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Cell Biosci2011; 1:23; PMID:21711503; http://dx.doi.org/ 10.1186/2045-3701-1-23 46.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
J Biol Chem 2007; 282:14685-9; PMID:17395580; http://dx.doi.org/ 10.1074/jbc.R700012200 47.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Curr Opin Genet Dev 2010; 20:533-40;PMID:20598874; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2007; 21:2855-60; PMID:18006682; http://dx.doi.org/10.1101/gad.1623207 49.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
2007; 8:1016-8; PMID:17972900; http://dx.doi.org/ 10.1038/sj.embor.7401093 50.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Cell 1997; 91:71-83; PMID:9335336; http://dx.doi.org/10.1016/S0092- 8674(01)80010-6 51.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Curr Biol 2004; 14:593-8; PMID:15062100; http://dx.doi.org/ 10.1016/j.cub.2004.03.034 53.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nature 2007; 450:1082-5;PMID:18046332; http://dx.doi.org/10.1038/ nature06349 54.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Proc Natl Acad Sci U S A 2004; 101:13525-30; PMID:15345743; http://dx.doi.org/ 10.1073/pnas.0405536101 55.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Proc Natl Acad Sci U S A 2003; 100:14887- 91; PMID:14634207; http://dx.doi.org/10.1073/ pnas.2036440100 56.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Dev Dyn 2009; 238:2540-9; PMID:19777587; http://dx.doi.org/ 10.1002/dvdy.22083 57.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell 2008; 32:96-105; PMID:18851836; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2007; 21:2137-49; PMID:17704303; http://dx.doi.org/10.1101/gad.1583407 59.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2009; 23:2210-23; PMID:19759265; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell 2000; 6:715-22; PMID:11030350; http://dx.doi.org/10.1016/S1097-2765(00)00069-1 61.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Nucleic Acids Res 1999; 27:750-5; PMID:9889269; http://dx.doi.org/10.1093/nar/27.3.750 64.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell 2000; 6:705-13;PMID:11030349; http://dx.doi.org/10.1016/S1097- 2765(00)00068-X 67.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
J Biol Chem 2004; 279:7447-55; PMID:14570910; http://dx.doi.org/ 10.1074/jbc.M305412200 68.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell Biol 2006; 26:7492-505; PMID:17015475; http://dx.doi.org/10.1128/MCB.00349-06 69.,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Trends Biochem Sci 1999; 24:335-9; PMID:10470030; http://dx.doi.org/10.1016/S0968- 0004(99)01436-X 70.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2014; 28:2071-6; PMID:25274724; http://dx.doi.org/ 10.1101/gad.250563.114 71.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2007; 21:2936-49; PMID:17978101; http://dx.doi.org/10.1101/gad.1608807 72.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell 2013;51:480-92; PMID:23973376; http://dx.doi.org/ 10.1016/j.molcel.2013.08.009 73.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2014; 28 (19):2163-74; PMID:25223897; http://dx.doi.org/10.1101/gad.245670.114 75.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Curr Biol 2001; 11:282-7; PMID:11250159; http://dx.doi.org/10.1016/S0960-9822(01)00076-8 76.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Science 2000; 290:2312-5; PMID:11125147; http://dx.doi.org/10.1126/ science.290.5500.2312 77.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
EMBO J 2007; 26:3900-9; PMID:17703192; http://dx.doi.org/10.1038/sj.emboj.7601822 78.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Genes Dev 2008; 22:2823-30; PMID:18923080; http://dx.doi.org/10.1101/gad.1698108 79.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mol Cell 2001; 7:509-15;PMID:11463376; http://dx.doi.org/10.1016/S1097- 2765(01)00198-8 80.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Science 2001; 292:1153-5; PMID: 11352070; http://dx.doi.org/10.1126/science.1059188 81.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Mech Dev 2001; 106:203-5; PMID:11472857; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Proc Natl Acad Sci U S A 2013;110:16886-91; PMID:24082143; http://dx.doi.org/ 10.1073/pnas.1317034110 83.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Dev Cell 2013; 27:188-200; PMID:24176642; http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
Dev Dyn 2007; 236:3173-9; PMID:17948312; http://dx.doi.org/10.1002/dvdy.21350 6 Volume 6 Issue 1 Transcription,Non-OADS,/arxiv_data1/oa_pdf/cd/24/ktrn-06-01-1004980.PMC4422821.pdf
" Annals of Surgical Treatment and Research 241pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.241 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Protective effect of ischemic postconditioning against  hepatic ischemic reperfusion injury in rat liver Sam-Youl Yoon*, Chung Yun Kim1,*, Hyung Joon Han, Kun Ok Lee, Tae-Jin Song  Department of Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, 1Department of Surgery,  DamSoYu Hospital, Seoul, Korea INTRODUCTION Ischemia is defined as the diminished oxygen supply to  levels no longer sufficient to maintain physiologic cell function.",Non-OADS,/arxiv_data1/oa_pdf/ce/b3/astr-88-241.PMC4422876.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/b3/astr-88-241.PMC4422876.pdf
"246pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.246 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Laparoscopic sleeve gastrectomy in obese Korean  patients: up to 4-year follow-up in a single center Ji Yeon Park, Yong Jin Kim Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea INTRODUCTION Sleeve gastrectomy, a vertical gastrectomy that leaves a  gastric tube along the lesser curvature of the stomach, was  first described by Marceau et al.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/astr-88-246.PMC4422877.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/astr-88-246.PMC4422877.pdf
" Annals of Surgical Treatment and Research 253pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.253 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Oncologic outcomes following metastasectomy in  colorectal cancer patients developing distant metastases after initial treatment Seung Yeop Oh, Do Yoon Kim, Kwang Wook Suh Department of Surgery, Ajou University School of Medicine, Suwon, Korea INTRODUCTION Colorectal cancer can metastasize to the liver, lung, ovary,  peritoneum and other organs systemically.",Non-OADS,/arxiv_data1/oa_pdf/de/87/astr-88-253.PMC4422878.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/87/astr-88-253.PMC4422878.pdf
"260pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.260 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Comparative study between transanal tube and loop  ileostomy in low anterior resection for mid rectal cancer:  a retrospective single center trial Min-Ki Kim, Dae-Youn Won, Jin-Kwon Lee, Won-Kyung Kang, Jun-Gi Kim, Seong Taek Oh  Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, College of Medicine, Seoul, Korea INTRODUCTION Despite several development in operative methods and  instruments for colorectal patients, the incidence of anas­ tomotic leak (AL) has not decreased [1].",Non-OADS,/arxiv_data1/oa_pdf/d6/55/astr-88-260.PMC4422879.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/55/astr-88-260.PMC4422879.pdf
http://dx.doi.org/10.1177/  1553350614537561.,Non-OADS,/arxiv_data1/oa_pdf/d6/55/astr-88-260.PMC4422879.pdf
" Annals of Surgical Treatment and Research 269pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.269 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Learning curves for single incision and conventional  laparoscopic right hemicolectomy: a multidimensional analysis  Yoonah Park*, Yuen Geng Yong1,*, Seong Hyeon Yun, Kyung Uk Jung2, Jung Wook Huh, Yong Beom Cho,   Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun2 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, 1Department of  Surgery, Columbia Hospital, Kuala Lumpur, Malaysia, 2Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan  University School of Medicine, Seoul, Korea INTRODUCTION Conventional laparoscopic (CL) colectomy is widely con­ sidered to be a technically demanding procedure that has a steep learning curve.",Non-OADS,/arxiv_data1/oa_pdf/12/0a/astr-88-269.PMC4422880.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/0a/astr-88-269.PMC4422880.pdf
"276pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.276 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Noninvasive monitoring of mouse renal allograft  rejection using micro-CT Jiangang Hou1,2,*, Masayuki Fujino2,3,*, Songjie Cai2, Qiang Ding1, Xiao-Kang Li2 1Department of Urology, Huashan Hospital, Fudan University, Shanghai, China, 2Division of Transplantation Immunology, National  Research Institute for Child Health and Development, Tokyo, 3AIDS Research Center, National Institute of Infectious Diseases,  Tokyo, Japan INTRODUCTION Transplant research has depended on animal models like the  rat and the mouse for substantiation of positive results.",Non-OADS,/arxiv_data1/oa_pdf/51/fd/astr-88-276.PMC4422881.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/fd/astr-88-276.PMC4422881.pdf
" Annals of Surgical Treatment and Research 281pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.281 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Evaluation of diagnostic biomarkers for acute kidney  injury in major burn patients Dohern Kym, Yong-Suk Cho, Jaechul Yoon, Haejun Yim, Hyeong-Tae Yang Department of Surgery and Critical Care, Burn Center, Hallym University Hangang Sacred Heart Hospital, Hallym University  College of Medicine, Seoul, KoreaP < 1 (기호띄우기 ) μ α (symbol) vs. (이탤릭 ) – – < INTRODUCTION Acute kidney injury (AKI) is a common complication in burn  patients as well as critically ill patients with incidences reported  ranging from 1% to 40%, and mortality reported ranging from 50% to 100% [1-4].",Non-OADS,/arxiv_data1/oa_pdf/0b/13/astr-88-281.PMC4422882.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/13/astr-88-281.PMC4422882.pdf
" Annals of Surgical Treatment and Research 289pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.289 Annals of Surgical Treatment and ResearchCASE REPORT Giant malignant insulinoma Dimitrios Karavias, Ioannis Habeos1, Ioannis Maroulis, Christina Kalogeropoulou2, Athanasios Tsamandas3,  Ioannis Chaveles, Dionissios Karavias Department of Surgery, 1Division of Endocrinology and Diabetes, Department of Internal Medicine, Departments of 2Radiology and  3Pathology, University Hospital of Patras, Rion, Greece INTRODUCTION Insulinomas, although rare, are the most common functioning  islet tumors of the pancreas, with a reported incidence of 4  cases per 1 million patient-years [1].",Non-OADS,/arxiv_data1/oa_pdf/f4/1f/astr-88-289.PMC4422883.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/1f/astr-88-289.PMC4422883.pdf
"294pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.5.294 Annals of Surgical Treatment and ResearchCASE REPORT Large cutaneous apocrine carcinoma occurring on right  thigh aggravated after moxa treatment In Ho Choi, Sangchul Yun1 Departments of Pathology and 1Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of  Medicine, Seoul, Korea INTRODUCTION Primary cutaneous apocrine carcinoma is a rare adnexal  tumor of the skin that occurs in the area with the greatest con­ centration of apocrine glands like the axillary region, scalp and groin [1].",Non-OADS,/arxiv_data1/oa_pdf/69/6d/astr-88-294.PMC4422884.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/6d/astr-88-294.PMC4422884.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/7d/lupus-2015-000084.PMC4422903.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/b2/openhrt-2014-000185.PMC4422920.pdf
http://www.isee.nc/population/telecharpdf/4page-rpnc09.pdf (accessed 1 Aug 2014).,OADS,/arxiv_data1/oa_pdf/cd/3d/openhrt-2014-000183.PMC4422921.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/05/1e/aps201520a.PMC4422947.pdf
"191Korean J Physiol Pharmacol Vol 19: 191 －196, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.191pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: CVD, cardiovascular disease; RET, resistance  exercise training; BFR, blood flow restriction; LIRE, low intensity resistance exercise; ANS, autonomic nervous system; MVC, maxi- mum voluntary contraction.",Non-OADS,/arxiv_data1/oa_pdf/aa/0f/kjpp-19-191.PMC4422957.pdf
"197Korean J Physiol Pharmacol Vol 19: 197 －202, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.197pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: i.c.v., intracerebroventricular; PVN, paraventri- cular nucleus; HPA, hypothalamic-pituitary-adrenal; SNS, sympa-thetic nervous system; AMP, Adenosine monophosphate; ATP,  Adenosine triphosphate; STZ, Streptozotocin.",Non-OADS,/arxiv_data1/oa_pdf/41/5a/kjpp-19-197.PMC4422958.pdf
"203Korean J Physiol Pharmacol Vol 19: 203 －210, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.203pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: AMPK, AMP-activated protein kinase; p70S6K,  p70S6 kinase; eEF-2, eukaryotic elongation factor-2; EGCG, Epigal-locatechin-3-gallate; Nppa, natriuretic peptides type A; BNP, brain  natriuretic polypeptide; PE, phenylephrine.",Non-OADS,/arxiv_data1/oa_pdf/de/1c/kjpp-19-203.PMC4422959.pdf
"211Korean J Physiol Pharmacol Vol 19: 211 －218, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.211pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: COX, cyclooxygenase; ERK1/2, extracellular sig- nal-regulated kinase 1/2; iNOS, inducible nitric oxide synthase; IL1 β,  interleukin 1 β; JNK, c-Jun N-terminal kinase; LPS, lipopolysaccha- ride; MAPK, mitogen-activated protein kinase; NF- κB, nuclear fac- tor-kappa B; NO, nitric oxide; RANKL, receptor activator of nuclear  factor kappa-B ligand; TNF- α, tumor necrosis factor- α.",Non-OADS,/arxiv_data1/oa_pdf/1c/a0/kjpp-19-211.PMC4422960.pdf
"219Korean J Physiol Pharmacol Vol 19: 219 －228, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.219pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: DEK, dieckol; DPI, diphenyleneiodium; ERK, ex- tracellular signal-regulated kinase; I κBα, inhibitor of κBα; LPS,  lipopolysaccharide; NADPH oxidase, nicotinamide adenine dinuclelotide phosphate oxidase; NF- κB, nuclear factor κB; PI3K, phosphoinositide  3 kinase; ROS, reactive oxygen species; WT, Wortmannin.",Non-OADS,/arxiv_data1/oa_pdf/e8/a1/kjpp-19-219.PMC4422961.pdf
"229Korean J Physiol Pharmacol Vol 19: 229 －234, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.229pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: VCAM-1, vascular cell adhesion molecule-1;  ICAM-1, intracellular adhesion molecules-1; ROS, reactive oxygen  species; NM, nafamostat mesilate; NF-kB, nuclear factor kappa-B.",Non-OADS,/arxiv_data1/oa_pdf/69/fc/kjpp-19-229.PMC4422962.pdf
"For a certificate, please see: http://www.textcheck.",Non-OADS,/arxiv_data1/oa_pdf/69/fc/kjpp-19-229.PMC4422962.pdf
"235Korean J Physiol Pharmacol Vol 19: 235 －240, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.235pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: AR, androgen receptor; PCa, prostate cancer; LRP6,  low-density lipoprotein receptor-related protein 6; ADT, androgen  deprivation therapy; CRPC, castration-resistant prostate cancer;  ARE, androgen responsive element; ARBS, AR binding sequence; GSK-3, glycogen synthase kinase-3; APC, adenomatous polyposis  coli.",Non-OADS,/arxiv_data1/oa_pdf/bb/a1/kjpp-19-235.PMC4422963.pdf
"241Korean J Physiol Pharmacol Vol 19: 241 －247, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.241pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: ELISA, enzyme-linked immunosorbent assay;  GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MMP, matrix metalloproteinase; MTT, 3 ‐[4,5‐dimethylthiazol ‐2‐yl]‐2,5‐diphenylte- trazolium bromide; p-CA, p –coumaric acid; PIP, procollagen type I  C-peptide; qRT-PCR, quantitative reverse transcription polymerase chain reaction; SFN, stratifin; siRNA, small interfering RNA; UV,  ultraviolet.",Non-OADS,/arxiv_data1/oa_pdf/5a/d2/kjpp-19-241.PMC4422964.pdf
"249Korean J Physiol Pharmacol Vol 19: 249 －255, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.249pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: CUL3, cullin3 ; KLHL, kelch -like family member;  ER, endoplasmic reticulum; OMIM, online mendelian inheritance in man; BAPTA, 1,2- bis(o-aminophenoxy)ethane- N,N,N’,N’-tetraacetic  acid.",Non-OADS,/arxiv_data1/oa_pdf/71/21/kjpp-19-249.PMC4422965.pdf
"257Korean J Physiol Pharmacol Vol 19: 257 －262, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.257pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: HEPES, 4-(2-hydroxyethyl)-1-piperazineethane- sulfonic acid; PSS, physiological salt solution; TP receptor, throm- boxane receptor; S.E.M., standard error of means; ANOVA, analysis of variance; W/O, washout; NO, nitric oxide; Rho-kinase, Rho-asso- ciated protein kinase; COX, cyclooxygenase; PG, prostaglandin;  TXA 2, thromboxane A 2; PGF 2α, prostaglandin F 2α; PGI 2, prosta- cyclin; PGE 2, prostaglandin E 2; FP receptors, F-prostanoid recep- tors.",Non-OADS,/arxiv_data1/oa_pdf/ce/bc/kjpp-19-257.PMC4422966.pdf
"263Korean J Physiol Pharmacol Vol 19: 263 －268, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.263pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: 5-LO, 5-Lipoxygenase; LPS, Lipopolysaccharide;  TLR4, Toll-like receptor 4; ERK, extracellular signal-regulated kinase;  JNK, c-Jun N-terminal kinase; p38 MAPK, p38 mitogen-activated protein kinase; FBS, fetal bovine serum; FLAP, five lipoxygenase  activating protein; IKK, I κB kinase.",Non-OADS,/arxiv_data1/oa_pdf/7e/07/kjpp-19-263.PMC4422967.pdf
"269Korean J Physiol Pharmacol Vol 19: 269 －274, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.269pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: ALT, alanine transaminase; AMPK, AMP-activated  protein kinase; CR, calorie restriction; FFA, free fatty acids; I κBα,  inhibitor of nuclear factor- κB; mTOR, mammalian target of rapamycin;  NF-κB, nuclear factor- κB; SA-β-gal, senescence associated with  β-galactosidase; TNF- α, tumor necrosis factor- α.",Non-OADS,/arxiv_data1/oa_pdf/54/18/kjpp-19-269.PMC4422968.pdf
"275Korean J Physiol Pharmacol Vol 19: 275 －281, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.275pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: AMPA, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)  propanoic acid; MVN, medial vestibular nucleus; NMDA, N-methyl  D-asparate; NTS, nucleus tractus solitarius; pERK, phosphorylated extracellular regulated protein kinase; SAD, sinoaortic denervation;  SNP, sodium nitroprusside; VSR,  vestibulosympathetic reflex.",Non-OADS,/arxiv_data1/oa_pdf/6f/a8/kjpp-19-275.PMC4422969.pdf
"283Korean J Physiol Pharmacol Vol 19: 283 －289, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.283pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: CASP, caspase; mtDNA, mitochondrial DNA;  RCR, respiratory control ratio.",Non-OADS,/arxiv_data1/oa_pdf/8f/40/kjpp-19-283.PMC4422970.pdf
"291Korean J Physiol Pharmacol Vol 19: 291 －297, May, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.3.291pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: PDL, periodontal ligament; [Ca2+]i, intracellular  Ca2+ concentration; IL, interleukin; LPS, lipopolysaccharide; PGN,  peptidoglycan; PAMPs, pathogen-associated molecular patterns; TLR,  toll-like receptor; GCE, German cockroach extract; HDM, house dust mite; PAR, protease-activated receptor; RANKL, receptor activator  of NF-κB ligand; OPG, osteoprotegerin.",Non-OADS,/arxiv_data1/oa_pdf/67/56/kjpp-19-291.PMC4422971.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/73/ehv009.PMC4422973.pdf
the ESC EURObservational Research Pro- gramme ( http://www.eorp.org ).,Non-OADS,/arxiv_data1/oa_pdf/e6/73/ehv009.PMC4422973.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 41Adenoma Detection Rate in Patients Younger Than 50 Years  of Age: Relationship of the Adenoma Detection Rate to  Interval Cancer In Ja Park Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2015;31(2):41-42 http://dx.doi.org/10.3393/ac.2015.31.2.41 The incidence of colorectal cancer in Korea has been increasing  rapidly, and worldwide age-standardized rate of colorectal can - cer per 100,000 population was the highest in the world in 2012  [1].",Non-OADS,/arxiv_data1/oa_pdf/cb/30/ac-31-41.PMC4422983.pdf
Available from: http://ncc.re.kr/manage/ manage03_033_list.jsp .,OADS,/arxiv_data1/oa_pdf/cb/30/ac-31-41.PMC4422983.pdf
"Department of Colon and Rectal Surgery, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea Tel: +82-2-3010-3937, Fax: +82-2-474-6701  E-mail: ipark@amc.seoul.kr © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/30/ac-31-41.PMC4422983.pdf
Available from:  http://seer.cancer.gov/statfacts/html/colorect.html .,Non-OADS,/arxiv_data1/oa_pdf/cb/30/ac-31-41.PMC4422983.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 43The Wind of Change: Uncomplicated Diverticulitis  Hungdai Kim Department of Surgery, Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Seoul, KoreaEditorial Ann Coloproctol 2015;31(2):43-44 http://dx.doi.org/10.3393/ac.2015.31.2.43 Among the wide spectrum of acute diverticulitis, uncomplicated  diverticulitis (UD) is defined as a localized inflammation or  phlegmon of colonic diverticula in the absence of complications  such as abscess, perforation, fistula, obstruction, and bleeding.",Non-OADS,/arxiv_data1/oa_pdf/23/75/ac-31-43.PMC4422984.pdf
"Department of Surgery, Gastrointestinal Cancer Center, Kangbuk Samsung  Hospital, 29 Saemunan-ro, Jongno-gu, Seoul 110-746, Korea Tel: +82-2-2001-8541, Fax: +82-2-2001-2131  E-mail: hungdai.kim@samsung.com © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/75/ac-31-43.PMC4422984.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 45Different Strategies for Treating a Colovesical Fistula Moo Jun Baek  Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, KoreaEditorial Ann Coloproctol 2015;31(2):45-45 http://dx.doi.org/10.3393/ac.2015.31.2.45 A colovesical fistula (CVF) represents an abnormal communica - tion between the colon and the bladder.",Non-OADS,/arxiv_data1/oa_pdf/d6/a3/ac-31-45.PMC4422985.pdf
"Department of Surgery, Soonchunhyang University Cheonan Hospital,  Soonchunhyang University College of Medicine, 31 Suncheonhyang 6-gil,  Dongnam-gu, Cheonan 330-930, Korea Tel: +82-41-570-3633, Fax: +82-41-571-0129 E-mail: ssurge@sch.ac.kr © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/a3/ac-31-45.PMC4422985.pdf
"Taeseok Bae, Yunhyung Ha, Changkyun Kim, Jihyun Lee, Kwangil Ha, Sanghyun Shin, Y oungcheol Lee,  Yoonsik Kang Department of Surgery, Joy-Full Hospital, Seoul, KoreaOriginal Article Ann Coloproctol 2015;31(2):46-51 http://dx.doi.org/10.3393/ac.2015.31.2.46 Purpose:  This study was conducted to determine the distributions of the polyp detection rate (PDR) and the adenoma de - tection rate (ADR) according to age by analyzing the polypectomy results.",Non-OADS,/arxiv_data1/oa_pdf/eb/2b/ac-31-46.PMC4422986.pdf
"© 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/2b/ac-31-46.PMC4422986.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 52Short-term Intravenous Antibiotic Treatment in  Uncomplicated Diverticulitis Does Not Increase the Risk of  Recurrence Compared to Long-term Treatment Cosimo Riccardo Scarpa, Nicolas Christian Buchs, Antoine Poncet1, Béatrice Konrad-Mugnier,   Pascal Gervaz, Philippe Morel, Frédéric Ris Clinic for Visceral and Transplantation Surgery, Department of Surgery, University Hospital of Geneva, Geneva; 1Clinical Epidemiology,  University Hospital of Geneva, Geneva, SwitzerlandOriginal Article Ann Coloproctol 2015;31(2):52-56 http://dx.doi.org/10.3393/ac.2015.31.2.52 Purpose:  This study included all patients treated at the University Hospital of Geneva for a first episode of uncomplicated  diverticulitis.",Non-OADS,/arxiv_data1/oa_pdf/2d/d9/ac-31-52.PMC4422987.pdf
"Clinic for Visceral and Transplantation Surgery, Department of Surgery,  University Hospital of Geneva, Faculty of Medicine, University of Geneva,  Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland Tel: +41788142291, Fax: +41223723405 E-mail: cosimo.scarpa@hcuge.ch  © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/d9/ac-31-52.PMC4422987.pdf
"Schizas, Andrew B. Williams Department of Colorectal Surgery, Guy’s and St. Thomas’ NHS Trust, London, UKOriginal Article Ann Coloproctol 2015;31(2):57-62 http://dx.doi.org/10.3393/ac.2015.31.2.57 Purpose:  This research was conducted to compare the management and the outcome of patients with colovesical fistulae of  different aetiologies.",Non-OADS,/arxiv_data1/oa_pdf/25/01/ac-31-57.PMC4422988.pdf
"The objective of the study was to discuss the management and Received: February 27, 2015  •  Accepted: April 5, 2015 Correspondence to: Qamar Hafeez Kiani, FCPS Department of Colorectal Surgery, Guy’s and St. Thomas’ NHS Trust, St.  Thomas’ Hospital, Westminister Bridge Road, London (SE1 7EH), UK Current address: Department of Surgery, Shifa College of Medicine, Sector  H-8/4, Islamabad (44000), Pakistan Tel: +92-51-8463000, Fax: +92-51-4863267 E-mail: kianiqamarhafeez@hotmail.com © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/01/ac-31-57.PMC4422988.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 63Insertion of Totally Implantable Central Venous Access  Devices by Surgeons Hyeonjun An, Chun-Geun Ryu, Eun-Joo Jung, Hyun Jong Kang1, Jin Hee Paik, Jung-Hyun Y ang1,   Dae-Y ong Hwang Department of Surgery, Colorectal Cancer Center, Konkuk University Medical Center, 1Department of Surgery, Breast  Cancer Center, Konkuk  University Medical Center, Konkuk University School of Medicine, Seoul, KoreaOriginal Article Ann Coloproctol 2015;31(2):63-67 http://dx.doi.org/10.3393/ac.2015.31.2.63 Purpose:  The aim of this study is to evaluate the results for the insertion of totally implantable central venous access de - vices (TICV ADs) by surgeons.",Non-OADS,/arxiv_data1/oa_pdf/df/e3/ac-31-63.PMC4422989.pdf
"Department of Surgery, Colorectal Cancer Center, Konkuk University Medical  Center, Konkuk University School of Medicine, 120 Neungdong-ro,  Gwangjin-gu, Seoul 143-729, Korea Tel: +82-2-2030-5111, Fax: +82-2-2030-5112 E-mail: hwangcrc@kuh.ac.kr © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/e3/ac-31-63.PMC4422989.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 68Primary Extrauterine Endometrial Stromal Sarcoma in the  Sigmoid Colon Hyun-Jin Son, Joo-Heon Kim, Dong-Wook Kang, Hye-Kyung Lee, Mee-Ja Park, Seung Yun Lee Department of Pathology, Eulji University School of Medicine, Daejeon, KoreaCase Report Ann Coloproctol 2015;31(2):68-73 http://dx.doi.org/10.3393/ac.2015.31.2.68 An endometrial stromal sarcoma (ESS) is an uncommon uterine neoplasm, and its primary occurrence in the intestine as  an extrauterine ESS (EESS) is exceedingly rare.",Non-OADS,/arxiv_data1/oa_pdf/bd/76/ac-31-68.PMC4422990.pdf
"Department of Pathology, Eulji University Hospital, 95 Dunsanseo-ro,  Seo-gu, Daejeon 302-799, Korea Tel: +82-42-611-3451, Fax: +82-42-611-3459 E-mail: shjpathol@eulji.ac.kr © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/76/ac-31-68.PMC4422990.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 74Peritoneal Metastatic Goblet-Cell Carcinoid Tumor Treated  With Cytoreductive Surgery and Intraperitoneal  Chemotherapy Sang Il Y oun, Hwan Namgung, Jeong Seok Yun, Yun Jun Park, Dong-Guk Park Department of Surgery, Dankook University School of Medicine, Cheonan, KoreaCase Report Ann Coloproctol 2015;31(2):74-78 http://dx.doi.org/10.3393/ac.2015.31.2.74 We report a case of a goblet-cell carcinoid tumor of the appendix which metastasized to the peritoneum and was treated by  using cytoreductive surgery (CRS) with intraperitoneal chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/c2/c1/ac-31-74.PMC4422991.pdf
"Department of Surgery, Dankook University School of Medicine,   119 Dandae-ro, Dongnam-gu, Cheonan 330-997, Korea Tel: +82-41-550-3931, Fax: +82-41-565-6167 E-mail: dkpark@dankook.ac.kr © 2015 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/c1/ac-31-74.PMC4422991.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/ca/rjv055.PMC4423048.pdf
Editor: Rong Li./C2112015 The Authors 0006-3495/15/05/2396/12 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.03.033 2396 Biophysical Journal Volume 108 May 2015 2396–2407,Non-OADS,/arxiv_data1/oa_pdf/39/50/main.PMC4423050.pdf
Published online September 8: 2014. http://dx.doi.org/10.1681/ASN.,Non-OADS,/arxiv_data1/oa_pdf/39/50/main.PMC4423050.pdf
http://www.gascoigne.uni-hd.de .,Non-OADS,/arxiv_data1/oa_pdf/39/50/main.PMC4423050.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/be/rjv056.PMC4423054.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/07/rjv053.PMC4423060.pdf
Editor: Tobias Baumgart./C2112015 The Authors 0006-3495/15/05/2201/11 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.03.017 Biophysical Journal Volume 108 May 2015 2201–2211 2201,Non-OADS,/arxiv_data1/oa_pdf/44/fe/main.PMC4423064.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0",Non-OADS,/arxiv_data1/oa_pdf/a0/8b/cr201549a.PMC4423087.pdf
"We  identified an H3K27ac-enriched area [42] in a GC-rich  region within −2 500 to 1 500 bp upstream of the miR-149 transcriptional start site using the MethPrimer-Tools  and Databases (http://www.urogene.org/methprimer) and  the ENCODE project data on the UCSC genome browser  (http://goo.gl/6tDJ3v, Supplementary information, Figure  S4A).",OADS,/arxiv_data1/oa_pdf/32/3c/cr201551a.PMC4423088.pdf
"Subsequently, we analyzed the mouse ENCODE data  and identified a CpG sites rich region between −2 200  and −1 750 bp upstream of the mmu-miR-149 that is conserved in humans (http://goo.gl/mqQu79, Supple- mentary information, Figure S9D).",Non-OADS,/arxiv_data1/oa_pdf/32/3c/cr201551a.PMC4423088.pdf
"68Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.68 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):68-82 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  June 9, 2014/ Revised:  August 18, 2014 Accepted:  October 19, 2014 Address for correspondence: John P. John, MD Department of Psychiatry, National Institute of Mental Health a nd  Neurosciences (NIMHANS), PB No 2900 Dharmaram P.O., Hosur Road, Bangalore Karnataka 560 029, IndiaTel: +091-80-26995329/26995250, Fax: +091-80-26564492/ 26564822E-mail: jpjnimhans@gmail.com*Current affiliation of Harsha N. Halahalli is Department of Physiology, K.S.",Non-OADS,/arxiv_data1/oa_pdf/1d/a5/cpn-13-68.PMC4423152.pdf
"115Case Report http://dx.doi.org/10.9758/cpn.2015.13.1.115 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):115-117 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 23, 2014/ Revised:  December 23, 2014 Accepted:  December 31, 2014 Address for correspondence: Gulen Guler, MD Department of Child and Adolescent Psychiatry, Mersin Universit y  Medical Faculty, Ciftlikkoy Campus, Yenisehir-Mersin 33343, Tur key Tel: +90-507-5093592, Fax: +90-3242410092 E-mail: dr.gulen@hotmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Dystonia in an Adolescent on Risper idone Following the Discontinuation of  Methylphenidate: A Case Report Gulen Guler1, Veli Yildirim1, Meryem Ozlem Kutuk2, Fevziye Toros1 1Department of Child and Adolescent Psychiatry, Mersin Universit y Medical Faculty, Mersin, 2Department of Child and Adolescent  Psychiatry, Baskent University Medical Faculty, Adana, Turkey Attention-deficit/hyperactivity disorder (ADHD) is a neurodevel opmental disorder with common comorbidities that include opposi - tional defiant disorder, conduct disorder, anxiety disorder, an d affective disorders.",Non-OADS,/arxiv_data1/oa_pdf/79/93/cpn-13-115.PMC4423153.pdf
"48Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.48 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):48-52 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  September 17, 2014/ Accepted:  September 23, 2014 Address for correspondence: Alessandro Serretti, MD, PhD Department of Biomedical and NeuroMotor Sciences, University of   Bologna, Viale Carlo Pepoli 5, Bologna 40123, ItalyTel: +39-051-6584233, Fax: +39-051-521030E-mail: alessandro.serretti@unibo.it  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Dimensions of Delusions in Major Depr ession: Socio-demographic and Clinical  Correlates in an Unipolar-Bipolar Sample Leonardo Zaninotto1,2, Daniel Souery3, Raffaella Calati4, Giovanni Camardese1, Luigi Janiri1, Stuart Montgomery5,  Siegfried Kasper6, Joseph Zohar7, Diana De Ronchi2, Julien Mendlewicz8, Alessandro Serretti2 1Institute of Psychiatry and Psychology, Catholic University of the Sacred Heart, Rome, 2Department of Biomedical and NeuroMotor  Sciences, University of Bologna, Bologna, Italy, 3Laboratoire de Psychologie Medicale, Universit é Libre de Bruxelles and Psy Pluriel, Centre  Européen de Psychologie Medicale, Brussels, Belgium, 4IRCCS Centro S. Giovanni di Dio, Fatebenefratelli, Brescia, Ita ly, 5Department  of Psychiatry, Imperial College, London, United Kingdom, 6Department of Psychiatry and Psychotherapy, Medical University of Vienna,  Vienna, Austria, 7Anxiety and Obsessive Compulsive Clinic, Chaim Sheba Medical Ce nter, Tel Hashomer, Israel, 8Laboratoire de  Recherches Psychiatriques, Universit é Libre de Bruxelles, Brussels, Belgium Objective:  The present study aims at exploring associations between a con tinuous measure of distorted thought contents and  a set of demographic and clinical features in a sample of unipo lar/bipolar depressed patients.",Non-OADS,/arxiv_data1/oa_pdf/b4/7a/cpn-13-48.PMC4423154.pdf
"62Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.62 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):62-67 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  June 23, 2014/ Revised:  September 30, 2014 Accepted:  October 2, 2014 Address for correspondence: Akihiro Shiina, MD, PhD Department of Child Psychiatry, Chiba University Hospital, 1-8- 1  Inohana, Chuoh-ku, Chiba 260-8670, JapanTel: +81-43-222-7171, Fax: +81-43-226-2297E-mail: shiina-akihiro@faculty.chiba-u.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with  Schizophrenia Akihiro Shiina1,2, Nobuhisa Kanahara3, Tsuyoshi Sasaki1, Yasunori Oda4, Tasuku Hashimoto4, Tadashi  Hasegawa5, Taisuke Yoshida6, Masaomi Iyo1,4,5,7, Kenji Hashimoto8 1Department of Child Psychiatry, Chiba University Hospital, 2Division of Law and Psychiatry, Chiba University Center for For ensic Mental  Health, 3Division of Medical Treatment and Rehabilitation, Chiba Univers ity Center for Forensic Mental Health, 4Department of Psychiatry,  Graduate School of Medicine, Chiba University, 5Department of Psychiatry, Chiba University Hospital, 6Kisarazu Hospital, 7Chiba University  Center for Forensic Mental Health, 8Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan Objective: Schizophrenia is a mental disorder characterized by severe cogn itive impairment.",Non-OADS,/arxiv_data1/oa_pdf/a3/cc/cpn-13-62.PMC4423155.pdf
"Cognitive function was measured using the Japanese version of CogState (CogState Ltd.,  Connecticut, USA; http://cogstate.com) battery, which  consists of a series of computed non-verbal tests.",OADS,/arxiv_data1/oa_pdf/a3/cc/cpn-13-62.PMC4423155.pdf
"The CogState battery is a valid measurement of cogni- tive function, similar to the MATRICS (Measurement and  Treatment Research to Improve Cognition in Schizophre-nia; http://www.matricsinc.org), 46,47) which is authorized  as a standard evaluative tool for the components of cogni- tive impairment in patie nts with schizophrenia48) and oth- er diseases.49,50) Its test-retest reliability is high enough for  use in clinical evaluations,43) while it was also assessed to  have intermediate reliability and validity in a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/a3/cc/cpn-13-62.PMC4423155.pdf
"36Review http://dx.doi.org/10.9758/cpn.2015.13.1.36 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):36-47 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 27, 2014/ Revised:  December 7, 2014 Accepted:  December 8, 2014 Address for correspondence: Ganesan Venkatasubramanian,  MD, PhD Department of Psychiatry, National Institute of Mental Health a nd  Neurosciences (NIMHANS), Bangalore 560029, IndiaTel: +91-8026995256, Fax: +91-8026564830E-mail: venkat.nimhans@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Understanding Schizophrenia as a Disorder of Consciousness: Biological  Correlates and Translational Implications from Quantum Theory Perspectives Ganesan Venkatasubramanian The Schizophrenia Clinic, Department of Psychiatry and Translat ional Psychiatry Laboratory, Neurobiology Research Centre, Nati onal  Institute of Mental Health and Neurosciences, Bangalore, India From neurophenomenological perspectives, schizophrenia has been  conceptualized as “a disorder with heterogeneous manifes- tations that can be integrally understood to involve fundamenta l perturbations in consciousness ”.",Non-OADS,/arxiv_data1/oa_pdf/3e/7b/cpn-13-36.PMC4423156.pdf
"118Letter to the Editor http://dx.doi.org/10.9758/cpn.2015.13.1.118 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):118-120 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 29, 2015/ Accepted:  February 2, 2015 Address for correspondence: Kenji Hashimoto, PhD  Division of Clinical Neuroscience, Chiba University Center for  Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, JapanTel: +81-423-226-2517, Fax: +81-423-226-2561E-mail: hashimoto@faculty.chiba-u.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Combination of Nitrous Oxide with Isoflurane or Scopolamine for  Treatment-resistant Major Depression  Chun Yang, Kenji Hashimoto Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan TO THE EDITOR The N-methyl-D-aspartate (N MDA) receptor antago- nists, including ketamine, are receiving increasing atten- tion because ketamine rapidly causes a long-lasting reduc-tion in depressive symptoms in patients whose major de- pression resists conventional treatment.",Non-OADS,/arxiv_data1/oa_pdf/69/84/cpn-13-118.PMC4423157.pdf
"113Case Report http://dx.doi.org/10.9758/cpn.2015.13.1.113 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):113-114 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  July 16, 2014/ Revised:  November 19, 2014 Accepted:  November 20, 2014 Address for correspondence: Samir Kumar Praharaj, MBBS,  MD, DPM Department of Psychiatry, Kasturba Medical College, Manipal, Karnataka 576104, IndiaTel: +91-8971026304, Fax: +91-820-2571930E-mail: samirpsyche@yahoo.co.in  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Olanzapine-induced Orthostatic Hypotension Amlan Kusum Jana1, Samir Kumar Praharaj2, Nirmalya Roy1 1Department of Psychiatry, KPC Medical College and Hospital, Kol kata, West Bengal, 2Department of Psychiatry, Kasturba Medical College,  Manipal, Karnataka, India Olanzapine is an atypical antipsychotic which is efficacious in  the treatment of schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/38/03/cpn-13-113.PMC4423158.pdf
"94Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.94 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):94-102 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 25, 2015/ Revised:  March 18, 2015 Accepted:  March 24, 2015 Address for correspondence: Seunghee Won, MD, PhD Department of Psychiatry, Kyungpook National University Hospita l,  130 Dongdeok-ro, Jung-gu, Daegu 700-721, KoreaTel: +82-53-200-5747, Fax: +82-53-426-5361E-mail: wonsh864@knu.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Shared and Distinct Neurocognitive Endophenotypes of Schizophrenia and  Psychotic Bipolar Disorder Dohoon Kim, Jiwoo Kim, Taehoon Koo, Hyerim Yun, Seunghee Won Department of Psychiatry, Kyungpook National University School of Medicine, Daegu, Korea Objective: Schizophrenia and bipolar disorder are characterized by the pre sence of neurocognitive impairments on the psychosis  continuum.",Non-OADS,/arxiv_data1/oa_pdf/73/a7/cpn-13-94.PMC4423159.pdf
"83Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.83 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):83-93 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 14, 2014/ Revised:  December 2, 2014 Accepted:  December 23, 2014 Address for correspondence: Mariana Gongora, PhD Brain Mapping and Sensory Motor Integration, Institute of  Psychiatry, Federal University of Rio de Janeiro (IPUB/UFRJ), R ua  Cel.",Non-OADS,/arxiv_data1/oa_pdf/8c/27/cpn-13-83.PMC4423160.pdf
"25Review http://dx.doi.org/10.9758/cpn.2015.13.1.25 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):25-35 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 10, 2014/ Revised:  November 19, 2014 Accepted:  November 20, 2014 Address for correspondence: Ather Muneer, MD Islamic International Medical College, Riphah International  University, 274 Peshawar Road, Rawalpindi 4622, PakistanTel: +92-0515481828, Fax: +92-0515125170E-mail: muneerather2@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature  Review and an Update Ather Muneer Islamic International Medical College, Riphah International Uni versity, Rawalpindi, Pakistan Bipolar disorder is a chronic, recurrent condition with the usu al onset during adolescence or early adulthood.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/cpn-13-25.PMC4423161.pdf
"103Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.103 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):103-108 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  March 19, 2015/ Accepted:  March 24, 2015 Address for correspondence:  Hye-Jin Seo, MD Department of Psychiatry, The Catholic University of Korea,  Yeouido St. Mary ’s Hospital, 10 63-ro, Yeongdeungpo-gu, Seoul  150-713, KoreaTel: +82-2-3779-1250, Fax: +82-2-780-6577E-mail: carpe-diem80@daum.net  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Relationship between Cognitive Decline and Psychopathology in Patients  with Schizophrenia and Bipolar Disorder Moon-Doo Kim1, Hye-Jin Seo2, Hyunju Yun3, Young-Eun Jung1, Joon Hyuk Park1, Chang-In Lee1, Ji Hyun Moon4,  Seong-Chul Hong5, Bo-Hyun Yoon3, Won-Myong Bahk2 Departments of 1Psychiatry, 4Family Medicine, and 5Preventive Medicine, Jeju National University School of Medicin e, Jeju, 2Department  of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, 3Department of Psychiatry, Naju National Hospital, Naju, Korea Objective: The primary goals of the present study were to assess intellect ual function in participants with schizophrenia or  bipolar disorder (BD) and to investigate the relationships betw een cognitive decline and the severity of each type of  psychopathology.",Non-OADS,/arxiv_data1/oa_pdf/31/d7/cpn-13-103.PMC4423162.pdf
"109Case Report  http://dx.doi.org/10.9758/cpn.2015.13.1.109 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):109-112 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 8, 2014/ Revised:  November 15, 2014 Accepted:  November 19, 2014 Address for correspondence: Ippei Takeuchi, M. Pharm  Department of Psychiatry, Okehazama Hospital, Minamiyakata  3-879, Sakae-cho, Toyoake, Aichi 470-1168, Japan Tel: +81-562-97-1361, Fax: +81-562-97-8004E-mail: 134331503@ccalumni.meijo-u.ac.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Effect of Scopolamine Butylbromide on  Clozapine-induced Hypersalivation in  Schizophrenic Patients: A Case Series Ippei Takeuchi1,2, Tatsuyo Suzuki1, Taro Kishi1, Daisuke Kanamori1, Manako Hanya2, Junji Uno1, Kiyoshi Fujita1,  Hiroyuki Kamei2 1Department of Psychiatry, Okehazama Hospital, Toyoake, Aichi, 2Office of Clinical Pharmacy Practice and Health Care Management   Faculty of Pharmacy, Meijo University, Nagoya, Japan Clozapine has been demonstrated to be useful for treating refra ctory schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/6b/59/cpn-13-109.PMC4423163.pdf
"12Review http://dx.doi.org/10.9758/cpn.2015.13.1.12 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):12-24 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  July 2, 2014/ Revised:  August 23, 2014 Accepted:  September 10, 2014 Address for correspondence: Georgina Oliver, BHSc Department of Psychiatry, The Melbourne Clinic - The Professori al  Unit, 2 Sailsbury St., Richmond, Victoria 3121, AustraliaTel: +61-422-529-432, Fax: +61-3-9421-0704E-mail: georgina.oliver@unimelb.edu.au  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related  Disorders: A Systematic Review Georgina Oliver1, Olivia Dean1,2,3, David Camfield4,5,6, Scott Blair-West1, Chee Ng1, Michael Berk1,2,3,4,  Jerome Sarris1,4 1Department of Psychiatry, The Melbourne Clinic, The University of Melbourne, Melbourne, 2Innovation in Mental and Physical Health and  Clinical Treatment: Strategic Research Centre, School of Medici ne, Deakin University, Geelong, 3The Florey Institute of Neuroscience and  Mental Health, 4Centre for Human Psychopharmacology, Swinburne University, Melb ourne, 5Illawarra Health & Medical Research Institute  (IHMRI), 6School of Psychology, University of Wollongong, Wollongong, Aus tralia Objective: Obsessive compulsive and related disorders are a collection of debilitating psychiatric disorders in which the role  of glutamate dysfunction in the underpinning neurobiology is be coming well established.",Non-OADS,/arxiv_data1/oa_pdf/13/ab/cpn-13-12.PMC4423164.pdf
"53Original Article http://dx.doi.org/10.9758/cpn.2015.13.1.53 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):53-61 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  August 13, 2014/ Revised:  September 26, 2014 Accepted:  September 29, 2014 Address for correspondence: Ajeet Bhagat Singh, MD IMPACT Strategic Research Centre, School of Medicine, Deakin  University, Geelong, PO Box 9148, St. Albans Park, VIC, Austral ia Tel: +613-5248-7211, Fax: +613-5248-4767E-mail: a.singh@deakin.edu.au  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine  Transporter Genetic Variation on Antidepr essant Efficacy in Major Depression:   A Pilot Study Ajeet Bhagat Singh1, Chad A. Bousman2,3,4,5, Chee Hong Ng2, Keith Byron6, Michael Berk1,2,5,7 1IMPACT Strategic Research Centre, School of Medicine, Deakin Un iversity, Geelong, Departments of 2Psychiatry and 3General Practice,  Parkville, VIC, 4Centre for Human Psychopharmacology, Swinburne University of Te chnology, Hawthorne, VIC, 5Florey Institute of  Neuroscience and Mental Health, Parkville, VIC, 6Healthscope Pathology, Clayton, VIC, Australia, 7Centre for Youth Mental Health, Orygen  Youth Health Research Centre, Parkville, VIC, Australia Objective: Previous studies suggest child abuse and serotonergic polymorph ism influence depression susceptibility and anti- depressant efficacy.",Non-OADS,/arxiv_data1/oa_pdf/84/6e/cpn-13-53.PMC4423165.pdf
"1Review http://dx.doi.org/10.9758/cpn.2015.13.1.1 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(1):1-11 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  June 16, 2014/ Revised:  July 22, 2014 Accepted:  July 23, 2014 Address for correspondence: Olivia M. Dean, PhD IMPACT Strategic Research Centre, School of Medicine, Deakin  University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/0b/9e/cpn-13-01.PMC4423166.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)The role of CR6-interacting factor 1 in Alzheimer ’s disease J Byun et al 973 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/87/d7/cdd2014184a.PMC4423180.pdf
Detailed genotypic and phenotypic information about these miceare available (http://www.informatics.jax.org/external/ko/lexicon/2682.html).,OADS,/arxiv_data1/oa_pdf/60/be/cdd20155a.PMC4423195.pdf
Informa- tion on β1-integrin fl/flmice are also available (http://jaxmice.jax.org/strain/004605.,Non-OADS,/arxiv_data1/oa_pdf/60/be/cdd20155a.PMC4423195.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)β1–integrin –SSH1 –Coﬁlin in AD JA Woo et al 934 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/60/be/cdd20155a.PMC4423195.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dddt-9-2351.PMC4423500.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2351–2358Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2351Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8327 5Critical appraisal of bevacizumab in the treatment  of ovarian cancer Hiroyuki Y oshida Akira Yabuno Keiichi Fujiwara Department of Gynecologic  Oncology, Saitama Medical University  international Medical Center, Hidaka,   Saitama, JapanAbstract:  Bevacizumab is the first molecular-targeted agent to be used for the treatment of  ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dddt-9-2351.PMC4423500.pdf
"This review presents the latest  evidence supporting the use of BV therapy in ovarian cancer and describes potential  personalized treatment for BV therapy.Correspondence: Hiroyuki Yoshida Department of Gynecologic Oncology,  Saitama Medical University international  Medical Center, 1397-1 Yamane, Hidaka  City, Saitama 350-1298, Japan Tel +81 42 984 4637 Fax +81 42 984 4741 email hiro_y@saitama-med.ac.j p Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Y oshida et al Running head recto: Bevacizumab for the treatment of ovarian cancer DOI: http://dx.doi.org/10.2147/DDDT.S83275",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dddt-9-2351.PMC4423500.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dddt-9-2351.PMC4423500.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/4a/dddt-9-2351.PMC4423500.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 959–967OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  959Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8199 5evaluation and comparison of two commercially  available targeted next-generation sequencing  platforms to assist oncology decision making glen J Weiss1 Brandi r hoff1 robert P Whitehead1 ashish sangal1 susan a gingrich1 robert J Penny2 David W Mallery2 scott M Morris2 eric J Thompson2 David M loesch2 Vivek Khemka1 1cancer Treatment centers of  america, Western regional Medical  center, goodyear, aZ, Usa; 2Paradigm  Diagnostics, Phoenix, aZ, UsaBackground:  It is widely acknowledged that there is value in examining cancers for genomic  aberrations via next-generation sequencing (NGS).",Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
"The era of precision medicine  and consequent genomic profiling a patient’s tumor to identify a unique treatment  option is upon us.2 We and others have reported on use of next-generation sequencing  (NGS) technologies in prospective studies.3–7 The field of sequencing technologies correspondence: glen J Weiss  cancer Treatment centers of america,  Western regional Medical center,  14200 W celebrate life Way, goodyear,  aZ 85338, Usa Tel +1 623 207 3000 Fax +1 623 207 3003 email glen.weiss@ctca-hope.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Weiss et al Running head recto: Evaluation and comparison of NGS platforms DOI: http://dx.doi.org/10.2147/OTT.S81995",Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
"The F1 list is listed as current as of august 4, 2014 ( http://www.foundationone.com/genelist1.php ).",Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
Available  from http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ ucm279174.htm.,Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
"Available from: https://www.genomeweb.com/clinical-genomics/ belgiums-oncodna-sequence-1300-patients-under-breast-international- groups-auror a. Accessed February 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7a/83/ott-8-959.PMC4423502.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/9b/cia-10-813.PMC4423503.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 813–819Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  813OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7272 4Helicobacter pylori  infection in Chinese patients  with atrial fibrillation De-Zhao Wang1 Wei Chen1 song Yang2 Jun Wang3 Qun li1 Qiang Fu2 shi-Jing li3 Bu-Xing Chen1 1Department of Cardiology,   Beijing Tiantan hospital, Capital  Medical University, 2Department  of Ultrasonography, Beijing Tiantan  hospital, Capital Medical University,   3Department of Cardiology, Beijing  Mentougou District hospital, Beijing,   People’s Republic of ChinaObjective:  To explore the relationship between Helicobacter pylori  (Hp) infection and atrial  fibrillation (AF) in Chinese patients.",Non-OADS,/arxiv_data1/oa_pdf/c4/9b/cia-10-813.PMC4423503.pdf
"Some studies reported that the  structural and electrophysio  logical basis of the occurrence of AF might be the  left atrial reentrant micro ring and enlarged left atrium.1 Some researchers found  that elevated plasma high-sensitive C-reactive protein (hs-CRP) level was an  independent risk factor for AF, which indicated that chronic inflammation seemed  to play an important role in the development of AF.2 A study from the digestion  department of internal medicine (Beijing Mentougou District Hospital, Beijing  China) showed that the Helicobacter pylori  (Hp) infection rate was as high as  50% in Chinese adults, and Hp was not only an important pathogenic reason for  chronic gastritis and stomach cancer but also closely related to the occurrence of  non-gastrointestinal diseases.3Correspondences: Bu-Xing Chen;  De-Zhao Wang  Department of Cardiology, Beijing  Tiantan hospital, Capital Medical  University, no 6, Tiantan Xili, Dongcheng  District, Beijing 100050, People’s  Republic of China Tel +86 10 6709 6572; +86 10 6709 6577 email chbux@126.co m; docwdz@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Helicobacter pylori  infection and atrial fibrillation DOI: http://dx.doi.org/10.2147/CIA.S72724",Non-OADS,/arxiv_data1/oa_pdf/c4/9b/cia-10-813.PMC4423503.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c4/9b/cia-10-813.PMC4423503.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c4/9b/cia-10-813.PMC4423503.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/d4/ott-8-955.PMC4423504.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 955–957OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  955Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8396 1severe thrombocytopenia after dasatinib  treatment in a patient with philadelphia  chromosome-positive chronic myeloid leukemia runzhe Chen Fei Wang Xiaoping Zhang Chong Gao Baoan Chen Department of Hematology and  Oncology (Key Department of Jiangsu  Medicine), Zhongda Hospital, Medical  school, southeast University, Nanjing,   Jiangsu province, people’s republic  of ChinaAbstract:  Dasatinib, a second-generation tyrosine kinase inhibitor, is used for treating patients  with Philadelphia chromosome (Ph) positive leukemia, especially for those who are resistant or  intolerant to imatinib.",Non-OADS,/arxiv_data1/oa_pdf/6f/d4/ott-8-955.PMC4423504.pdf
"This is the first report of severe thrombocytopenia caused by  dasatinib, and we hope this case will help remind clinicians to pay more attention to  this side effect.Correspondence: Baoan Chen Department of Hematology and  Oncology, Zhongda Hospital, Medical  school, southeast University, Dingjiaqiao  87, Gulou District, Nanjing 210009,  Jiangsu province, people’s republic  of China Tel +86 25 8327 2006 Fax +86 25 8327 2011 email cba8888@hotmail.co mJournal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Chen et al Running head recto: Thrombocytopenia after dasatinib treatment DOI: http://dx.doi.org/10.2147/OTT.S83961",Non-OADS,/arxiv_data1/oa_pdf/6f/d4/ott-8-955.PMC4423504.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/d4/ott-8-955.PMC4423504.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/d4/ott-8-955.PMC4423504.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/8b/copd-10-843.PMC4423505.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 843–852International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  843OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8055 8Is intrathoracic tracheal collapsibility correlated  to clinical phenotypes and sex in patients  with COPD?,Non-OADS,/arxiv_data1/oa_pdf/22/8b/copd-10-843.PMC4423505.pdf
"Keywords:  airway, computed tomography, lung density, pulmonary function, lung volumes Introduction Intrathoracic tracheal collapsibility refers to an expiratory collapse of the intrathoracic  trachea due to tracheal wall weakness caused by reduction and atrophy of the pars  membranacea longitudinal and elastic fibers, with consequent anterior bulging of the   trachea posterior wall and/or impaired cartilage integrity.1–5 Various degrees of  expiratory tracheal collapse can occur, up to tracheomalacia, when the reduction of  intrathoracic tracheal cross-sectional area at computed tomography (CT) is more  than 50%.4 As well as some primary congenital syndromes such as polychondritis  and Mounier-Kuhn disease, several acquired conditions associated with intrathoracic  tracheal collapsibility have been described in adults.1–3 A substantial proportion of patients with chronic obstructive pulmonary disease  (COPD) could develop various degrees of airway collapsibility6 due to chronic  inflammation and irritant exposure, instability of the tracheal wall due to the loss of Correspondence: gianna Camiciottoli Pulmonary Pathophysiology Unit,  Department of Clinical and experimental  Medicine, University of Florence, largo  Brambilla 3, Florence 50134, Italy Tel +39 347 673 3664 email gianna.camiciottoli@unifi.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Camiciottoli et al Running head recto: Intrathoracic tracheal collapsibility, phenotypes, and sex DOI: http://dx.doi.org/10.2147/COPD.S80558",Non-OADS,/arxiv_data1/oa_pdf/22/8b/copd-10-843.PMC4423505.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/22/8b/copd-10-843.PMC4423505.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/8b/copd-10-843.PMC4423505.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/f4/ppa-9-589.PMC4423506.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 589–596Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  589OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7947 7The influence of cultural and religious orientations  on social support and its potential impact on  medication adherence ernieda hatah1 Kien Ping Lim1,2 Adliah Mohd Ali1 noraida Mohamed shah1 Farida islahudin1 1Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan Raja Muda  Abdul Aziz, 2Pharmacy Department,   Kuala Lumpur General Hospital, Jalan  Pahang, Kuala Lumpur, MalaysiaPurpose:  Social support can positively influence patients’ health outcomes through a number  of mechanisms, such as increases in patients’ adherence to medication.",Non-OADS,/arxiv_data1/oa_pdf/2b/f4/ppa-9-589.PMC4423506.pdf
"However, according to the  World Health Organization, only half of patients with chronic disease adhere to their  medications.1 This scenario was also observed in Malaysia.2 In the retrospective study correspondence: ernieda hatah Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan Raja Muda  Abdul Aziz, 50300 Kuala lumpur,  Malaysia Tel +60 3 9289 7328 Fax +60 3 2698 3271 email ernieda@ukm.edu.m y Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hatah et al Running head recto: Social support and factors for medication adherence DOI: http://dx.doi.org/10.2147/PPA.S79477",Non-OADS,/arxiv_data1/oa_pdf/2b/f4/ppa-9-589.PMC4423506.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2b/f4/ppa-9-589.PMC4423506.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/58/cia-10-803.PMC4423507.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 803–811Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  803OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8211 9Intramedullary versus extramedullary fixation  in the management of subtrochanteric femur  fractures: a meta-analysis Pengcheng liu1,2,* Xing Wu1,* hui shi1,2 run liu1 hexi shu1 JinPeng gong1 Y ong Yang1 Qi sun1 Jiezhou Wu1,2 Xiaoyang nie1 Ming Cai1 1Department of Orthopedics,   shanghai T enth People’s hospital,   T ongji University, school of Medicine,   shanghai, 2First Clinical Medical  College, nanjing Medical University,   nanjing, People’s republic of China *These authors contributed equally  to this workBackground:  Intramedullary and extramedullary fixation methods are used in the management  of subtrochanteric femur fractures.",Non-OADS,/arxiv_data1/oa_pdf/f4/58/cia-10-803.PMC4423507.pdf
"Prevention of the complications of long-time immobilization and the beginning Correspondence: Ming Cai Department of Orthopedics, shanghai  Tenth People’s hospital, no 301 Middle  Yanchang road, shanghai 200072,  People’s republic of China Tel +86 132 6222 7613 email cmdoctor@tongji.edu.c n Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Liu et al Running head recto: Intramedullary versus extramedullary fixation in subtrochanteric DOI: http://dx.doi.org/10.2147/CIA.S82119",Non-OADS,/arxiv_data1/oa_pdf/f4/58/cia-10-803.PMC4423507.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f4/58/cia-10-803.PMC4423507.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f4/58/cia-10-803.PMC4423507.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/56/ppa-9-597.PMC4423509.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 597–605Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  597OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7602 7Adherence counseling during patient contacts  in swiss community pharmacies Fabienne Boeni isabelle Arnet Kurt e hersberger Pharmaceutical care research group,   Department of Pharmaceutical  sciences, University of Basel, Basel,   switzerlandPurpose:  Numerous studies showed the effectiveness of pharmaceutical care in improving  medication adherence in primary care patients.",Non-OADS,/arxiv_data1/oa_pdf/23/56/ppa-9-597.PMC4423509.pdf
"Keywords:  pharmaceutical care, community pharmacy, medication adherence Introduction Pharmaceutical care has been defined as “…the pharmacist’s contribution to the care  of individuals in order to optimize medicines use and improve health outcomes,”1 and  the pharmacist has been designated as part of the health care team for added value  in the health care system.2–4 Pharmaceutical care activities practiced by community  pharmacies have been shown effective in improving medication adherence.5–12 Face- to-face counseling during dispensing of medication is part of pharmaceutical care.4  Counseling can include providing education to patients (eg, about therapy, their  condition), intervening in a patient’s drug therapy (eg, optimizing intake times),  and ultimately, helping improve medication adherence.13 Previous studies reported  significantly improved adherence and persistence through targeted counseling by  community pharmacists.14–16correspondence: Fabienne Boeni Pharmaceutical care research group,  Department of Pharmaceutical sciences,  University of Basel, Klingelbergstrasse 50,  ch-4056 Basel, switzerland Tel +41 61 267 15 29 Fax +41 61 267 14 26 email fabienne.boeni@unibas.c h Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Boeni et al Running head recto: Adherence counseling in Swiss community pharmacies DOI: http://dx.doi.org/10.2147/PPA.S76027",Non-OADS,/arxiv_data1/oa_pdf/23/56/ppa-9-597.PMC4423509.pdf
"Available from: http://www.fip.org/www/uploads/data - base_file.php?id =331&table_id =, 2014.",OADS,/arxiv_data1/oa_pdf/23/56/ppa-9-597.PMC4423509.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/23/56/ppa-9-597.PMC4423509.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/21/dddt-9-2399.PMC4423515.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2399–2407Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2399Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7660 2Wnt blockers inhibit the proliferation of lung  cancer stem cells Xueyan Zhang1,* Yuqing lou1,* Xiaoxuan Zheng1 huimin Wang1 Jiayuan sun1 Qianggang Dong2 Baohui han1 1Department of Pulmonary Medicine,   shanghai chest hospital, shanghai  Jiaotong University, shanghai, People’s  republic of china; 2section of cancer  stem cells, shanghai cancer institute,   shanghai Jiaotong University, shanghai,   People’s republic of china *These authors contributed equally  to this workBackground:  Previous study has confirmed that the occurrence of Wnt pathway activation  is associated with risk of non-small-cell lung cancer recurrence.",Non-OADS,/arxiv_data1/oa_pdf/f1/21/dddt-9-2399.PMC4423515.pdf
"correspondence: Baohui han Department of Pulmonary Medicine,  shanghai chest hospital, shanghai  Jiaotong University, huaihai West  road 241#, shanghai 200030,  People’s republic of china email hanbaohsh@yeah.ne t  Qianggang Dong section of cancer stem cells, shanghai  cancer institute, shanghai Jiaotong  University, Xietu road 25#, shanghai  200000, People’s republic of china email qianggang_dong@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Wnt blockers inhibit lung cancer stem cell growth DOI: http://dx.doi.org/10.2147/DDDT.S76602",Non-OADS,/arxiv_data1/oa_pdf/f1/21/dddt-9-2399.PMC4423515.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f1/21/dddt-9-2399.PMC4423515.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/21/dddt-9-2399.PMC4423515.pdf
Available at:http://www.vmnvd.gov.lv/lv/469-veselibas-aprupes-pakalpojumi/veza-savlaicigas-atklasanas-programma/626-veza-savlaicigas-atklasanas-programmas-rezultati [Accessed 2 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/a9/cf/meg-27-536.PMC4423577.pdf
Available at: http://bookshop.europa.eu/is-bin/INTERSHOP.en ﬁnity/ WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start?PublicationKey=ND3210390 .,Non-OADS,/arxiv_data1/oa_pdf/a9/cf/meg-27-536.PMC4423577.pdf
Available at: http://www.can cerscreening.nhs.uk/bowel/ifobt.pdf [Accessed 20 February 2012].Improving uptake of colorectal cancer screening Santare et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/cf/meg-27-536.PMC4423577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/1d/main.PMC4423648.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 332–339 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.017 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8c/1d/main.PMC4423648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/1d/main.PMC4423648.pdf
http://dx.doi.org/10.1080/ 15435075.2014.891220 .,Non-OADS,/arxiv_data1/oa_pdf/8c/1d/main.PMC4423648.pdf
"10, 43. http://dx.doi.org/10.1186/1746-4269-10-43 , Online First.",Non-OADS,/arxiv_data1/oa_pdf/8c/1d/main.PMC4423648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/6f/main.PMC4423649.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 249–255 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.016 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/68/6f/main.PMC4423649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/6f/main.PMC4423649.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC4423650.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 317–321 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.10.008 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC4423650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC4423650.pdf
Available: < http://en.wikipedia.org/wiki/Muzaffargarh_District# Geography_and_climate > (accessed 19.10.14).,Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC4423650.pdf
"http://dx.doi.org/10.1371/journal.-ppat.1003602 .Harwood, A.D., You, J., Lydy, M.J., 2009.",Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC4423650.pdf
< http://edis.ifas.uX.edu/IN081 > (accessed 15.01.13).,Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC4423650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/11/main.PMC4423651.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 312–316 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.10.006 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c5/11/main.PMC4423651.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/11/main.PMC4423651.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 265–273 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.007 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9d/5a/main.PMC4423652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/5a/main.PMC4423652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/5a/main.PMC4423652.pdf
< http://research.calacademy.org/research/ichthyology/ catalog/ﬁshcatmain.asp >.,Non-OADS,/arxiv_data1/oa_pdf/9d/5a/main.PMC4423652.pdf
http://dx.doi.org/10.1111/ele.12141 .,Non-OADS,/arxiv_data1/oa_pdf/9d/5a/main.PMC4423652.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/66/f3/pgp-34-303.PMC4423653.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/37/d5/pgp-34-304.PMC4423654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/93/main.PMC4423657.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 322–326 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.015 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/d0/93/main.PMC4423657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/93/main.PMC4423657.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/c3/main.PMC4423658.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 243 –248 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.001 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/29/c3/main.PMC4423658.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/c3/main.PMC4423658.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 340–350 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.005 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC4423714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC4423714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC4423714.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2015.",OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC4423714.pdf
Website: <http://faostat.fao.org >.,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC4423714.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 293 –301 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.09.016 1319-562X ª2014 King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/4c/98/main.PMC4423715.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/05/main.PMC4423716.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.019 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/05/main.PMC4423716.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4423717.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 256 –264 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.003 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4423717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4423717.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2014.",OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4423717.pdf
Available online: < http://faostat.fao.org > (accessed 17.01.14).,Non-OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4423717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/a6/main.PMC4423718.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 284–292 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.12.010 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/b2/a6/main.PMC4423718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/a6/main.PMC4423718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/main.PMC4423719.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 327–331 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.014 1319-562X ª2014 The Author.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/main.PMC4423719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/main.PMC4423719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/47/main.PMC4423720.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 351 –357 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.009 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b4/47/main.PMC4423720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/47/main.PMC4423720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/1d/main.PMC4423721.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 274–283 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.03.004 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/79/1d/main.PMC4423721.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/1d/main.PMC4423721.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 302–311 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.10.003 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/84/53/main.PMC4423722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/53/main.PMC4423722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/53/main.PMC4423722.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Bone Marrow Transplantation website (http://www.nature.com/bmt)Pre-SCT multigene MRD array in AML M Goswami et al 651 © 2015 Macmillan Publishers Limited Bone Marrow Transplantation (2015) 642 –651",Non-OADS,/arxiv_data1/oa_pdf/df/a4/bmt2014326a.PMC4424111.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"All determinations were performed in triplicates.Biological activities of O. dictamnus essential oil Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"The results are shown as mean 9SD of three independent experiments.Biological activities of O. dictamnus essential oil Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"However, further research to elucidate the exact mode of action of essential oils, as well to determine the safety of the long-term use of high doses, is required in order to expand their use in industrial practice.Biological activities of O. dictamnus essential oil Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
"Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231.Phytomedicine 2010; 17: 581 /C18.Biological activities of O. dictamnus essential oil Citation: Microbial Ecology in Health & Disease 2015, 26: 26543 - http://dx.doi.org/10.3402/mehd.v26.26543 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/MEHD-26-26543.PMC4424236.pdf
Fact Sheet 2010 Available at: http://apps.Who.Int/hpvcentre/statistics/dynamic/ico/coun- try_pdf/tur_fs.pdf?Cfıd=4107527&cftoken=2 (accessed  on October 2011).,OADS,/arxiv_data1/oa_pdf/45/78/AMS-11-21717.PMC4424238.pdf
SCOPUS (http://www.scopus.com) and Medline (http://www.ncbi.nlm.nih.gov/pubmed)  databases were searched using the following  search terms in titles and abstracts (also in combi- nation with MESH terms): (“randomized controlled trial” or randomized or placebo or cholesterol or  triglyceride or LDL or LDL-C or LDL-cholesterol or  HDL or HDL-C or HDL-cholesterol or hyperlipidemia  or hyperlipidemic or hypolipidemic or dyslipidemia or dyslipidemic) and (astaxanthin).,OADS,/arxiv_data1/oa_pdf/37/02/AMS-11-25010.PMC4424245.pdf
"Material and methods Patient selection Patients with biopsy-proven IgAN with protein- uria (1–3.5 g/day) from 2005 to 2011, who were registered in the Sun Yat-sen University First Hos- pital IgAN Database (http://igan.medidata.cn), were enrolled in this study.",Non-OADS,/arxiv_data1/oa_pdf/fe/1a/AMS-11-25015.PMC4424250.pdf
Similarity searches with obtained sequences  were performed online based on the NCBI GenBank database (http://www.ncbi.nlm.nih.gov) BLAST.,OADS,/arxiv_data1/oa_pdf/9c/7c/AMS-11-25020.PMC4424255.pdf
"Messori A, Fadda V , Gatto R, Maratea D, Trippoli S. PubMed Commons (comment), 15 February 2014, available at http://www.ncbi.nlm.nih.gov/pubmed/24273556.",Non-OADS,/arxiv_data1/oa_pdf/78/3b/AMS-11-25030.PMC4424265.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2015; 110:741–748; doi: 10.1038/ajg.2015.115; published online 14 April 2015     1   Department of Gastroenterology, County Durham and Darlington NHS Foundation Trust ,  Durham ,  UK   ;     2   Cliniques Universitaires Saint-Luc, Université Catholique de  Louvain ,  Brussels ,  Belgium   ;     3   Université Paris V-René-Descartes ,  Paris ,  France   ;     4   Klinik für Gastroenterologie und Hepatologie, Klinikum St Georg ,  Leipzig ,  Germany   ;      5   Institute of Rural Health ,  Lublin ,  Poland   ;     6   Orlickoústecká nemocnice , Ústí nad Orlicí,  Czech Republic   ;     7   University of Medicine and Pharmacy Carol Davila ,   Bucharest ,  Romania   ;     8   Shire ,  Basingstoke ,  UK   ;     9   Shire-Movetis NV ,  Turnhout ,  Belgium   ;     10   Shire ,  Wayne ,  Pennsylvania ,  USA   .",Non-OADS,/arxiv_data1/oa_pdf/fe/88/ajg2015115a.PMC4424376.pdf
"ICH  Harmonised Tripartite Guidelines for Good Clinical Practice, 1996  ;   http://www.ich.org/fi  leadmin/Public_Web_Site/ICH_Products/Guidelines/Effi   cacy/ E6/E6_R1_Guideline.pdf     Accessed 11 June 2012  .",Non-OADS,/arxiv_data1/oa_pdf/fe/88/ajg2015115a.PMC4424376.pdf
http://www.wma.net/e/policy/b3.htm   [Cited 12 August 2009].,Non-OADS,/arxiv_data1/oa_pdf/fe/88/ajg2015115a.PMC4424376.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/fe/88/ajg2015115a.PMC4424376.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2015; 110:725–732; doi: 10.1038/ajg.2015.106; published online 28 April 2015     1   Department of Internal Medicine, Long Beach VA Medical Center ,  Long Beach ,  California ,  USA   ;     2   Department of Medicine, UCI College of Medicine ,  Irvine ,   California ,  USA   ;     3   AB Clinical Trials ,  Las Vegas ,  Nevada ,  USA   ;     4   SZ Schmerzzentrum Berlin GmbH ,  Berlin ,  Germany   ;     5   PRA Health Sciences ,  Salt Lake City ,  Utah ,   USA   .",Non-OADS,/arxiv_data1/oa_pdf/53/3a/ajg2015106a.PMC4424379.pdf
Guideline for Good Clinical Practice E6(R1)     http://www.ich.org/  Accessed 11 December 2012.,Non-OADS,/arxiv_data1/oa_pdf/53/3a/ajg2015106a.PMC4424379.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/53/3a/ajg2015106a.PMC4424379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Attenuated leptin reduction with GLP-1 treatment EW Iepsen et al 841 © 2015 Macmillan Publishers Limited International Journal of Obesity (2015) 834 –841",Non-OADS,/arxiv_data1/oa_pdf/18/6f/ijo2014177a.PMC4424381.pdf
"Enormous numbers of isogenic miceare now available (http://www.findmice.org), either as breedingcolonies, as frozen embryos or sperm, or as embryonic stemcells ( Figure 1 ).",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/mi2014113a.PMC4424382.pdf
"Academic Press, (available online athttp://www.informatics.jax.org/morsebook/index.shtml1978).",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/mi2014113a.PMC4424382.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/REVIEW 486 VOLUME 8 NUMBER 3 |MAY 2015 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/mi2014113a.PMC4424382.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank A. Mowat (Glasgow University, Glasgow) for constructive comments on the manuscript before submission.",Non-OADS,/arxiv_data1/oa_pdf/bc/04/mi201487a.PMC4424383.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES 558 VOLUME 8 NUMBER 3 |MAY 2015 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/bc/04/mi201487a.PMC4424383.pdf
"At least three representative images from each intestinal piece were captured and thearea of each ILF within these determined using ImageJ (http://rsbweb.nih.gov/ij/), from which the mean ILF size per intestinal piece was determined.",OADS,/arxiv_data1/oa_pdf/ef/ef/mi201490a.PMC4424384.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank S. Jung (Weizzman Institute of Science, Rehovot, Israel) for providing the CD11c-DTR mice, N. Ghilardi (Genentech, South SanFrancisco, CA) and A. MacDonald (University of Edinburgh) for providing the IL-23p19 /C0//C0mice, and Merck Sharp & Dohme (Whitehouse Station, NJ) for providing the IL-25/C0//C0mice.",Non-OADS,/arxiv_data1/oa_pdf/ef/ef/mi201490a.PMC4424384.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES Mucosal Immunology |VOLUME 8 NUMBER 3 |MAY 2015 595",Non-OADS,/arxiv_data1/oa_pdf/ef/ef/mi201490a.PMC4424384.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2015; 110:580–587; doi: 10.1038/ajg.2015.67; published online 17 March 2015     1   Departments of Family Medicine and Urology, University of Michigan School of Medicine ,  Ann Arbor ,  Michigan ,  USA   ;     2   Ironwood Pharmaceuticals, Inc. ,   Cambridge ,  Massachusetts ,  USA   ;     3   Lieberman Inc. ,  Great Neck ,  New York ,  USA   ;     4   Division of Gastroenterology, University of Michigan School of Medicine ,   Ann Arbor ,  Michigan ,  USA   .",Non-OADS,/arxiv_data1/oa_pdf/02/32/ajg201567a.PMC4424385.pdf
http://www.census.gov/population/projections/ .,OADS,/arxiv_data1/oa_pdf/02/32/ajg201567a.PMC4424385.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/02/32/ajg201567a.PMC4424385.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank Michelle Katajew, Marion Strau b, and Kathleen Siegel for excellent technical assistance, Birgit Fehrenbacher (University Hospital Tuebingen) and Patricia Kysar (UC Davis) for performing electron microscopy, Dr Matthias Flo ¨tenmeyer (MPI Tuebingen) for assistance with scanning electron microscopy, and Dr Christoph Po ¨hlmann (Robert Bosch Hospital, Stuttgart) for providing and helping with pathogenic bacterial strains.",Non-OADS,/arxiv_data1/oa_pdf/32/d0/mi2014100a.PMC4424388.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES Mucosal Immunology |VOLUME 8 NUMBER 3 |MAY 2015 671",Non-OADS,/arxiv_data1/oa_pdf/32/d0/mi2014100a.PMC4424388.pdf
"2015;19(1):1-10 ISSN : 2233-6834 (Print)  ISSN : 2233-6842 (Online) http://dx.doi.org/10.5717/jenb.2015.19.1.1 ORIGINAL PAPER Persimmon vinegar ripening with the mountain-cultivated ginseng ingestion  reduces blood lipids and lowers inflammatory cytokines in obese adolescents Hyobin Seo1, Byung-Duk Jeon2 and Sungpil Ryu1* 1Department of Leisure Sports, Kyungpook National University, Sangju, Korea  2Department of Physical Education Leisure, Suseong College, Daegu, Korea (Received: 2015/01/06, Revised: 2015/03/02, Published online: 2 015/03/11) Hyobin Seo, Byung-Duk Jeon and Sungpil Ryu.",Non-OADS,/arxiv_data1/oa_pdf/96/51/jenb-19-1-1.PMC4424440.pdf
2009;http://www.nso.go.kr/statclass/St atClassAction.do?method=disDepth3&s_scode=E65&e_scode=E68.,OADS,/arxiv_data1/oa_pdf/96/51/jenb-19-1-1.PMC4424440.pdf
"2015;19(1):11-18 ISSN : 2233-6834 (Print)  ISSN : 2233-6842 (Online) http://dx.doi.org/10.5717/jenb.2015.19.1.11 ORIGINAL PAPER Treadmill exercise after social isolation increases the levels of NGF, BDNF, and  synapsin I to induce survival of neurons in the hippocampus, and improves depression-like behavior Young-Pyo Hong, Hyo-Chul Lee and Hyun-Tae Kim* Department of Health and Sport Science, Korea National Sport University, Seoul, Korea (Received: 2015/01/16, Revised: 2015/02/01, Published online: 2 015/02/05) Young-Pyo Hong, Hyo-Chul Lee and Hyun-Tae Kim.",Non-OADS,/arxiv_data1/oa_pdf/88/9c/jenb-19-1-11.PMC4424441.pdf
"2015;19(1):19-24 ISSN : 2233-6834 (Print)  ISSN : 2233-6842 (Online) http://dx.doi.org/10.5717/jenb.2015.19.1.19 ORIGINAL PAPER The effect of muscle power training with elastic band on blood glucose,  cytokine, and physical function in elderly women with hyperglycemia Eun Hee Jin1, Sok Park2 and Jae Moo So3* 1Department of Sports Science, Sungkyunkwan University, Suwon, Korea 2Department of Sports and Health Management, Mokwon University, Daejeon, Korea 3Department of physical education, Konkuk University, Seoul, Korea (Received: 2015/01/25, Revised: 2015/02/26, Published online: 2 015/03/02) Eun Hee Jin, Sok Park and Jae Moo So.",Non-OADS,/arxiv_data1/oa_pdf/cc/de/jenb-19-1-19.PMC4424442.pdf
"2015;19(1):25-30 ISSN : 2233-6834 (Print)  ISSN : 2233-6842 (Online) http://dx.doi.org/10.5717/jenb.2015.19.1.25 ORIGINAL PAPER Effects of potato and lotus leaf extract intake on body composition and blood  lipid concentration Keuneil Lee1, Jongkyu Kim1, Namju Lee2, Sok Park3, Hyunchul Cho1 and Yoonseok Chun1* 1Sports Wellness Center, YongIn University, Gyeonggi-do, Korea 2Department of Sports Health Medicine, Jungwon University, Chungcheongbuk-do, Korea 3Depatment of Sports and Health Management, Mokwon University, Daejeon, KoreaW (Received: 2015/02/01, Revised:2015/03/05, Published online: 20 15/03/14) Keuneil Lee, Jongkyu Kim, Namju Lee, Sok Park, Hyunchul Cho and Yoonseok Chun.",Non-OADS,/arxiv_data1/oa_pdf/65/ba/jenb-19-1-25.PMC4424443.pdf
"2015;19(1):31-38 ISSN : 2233-6834 (Print)  ISSN : 2233-6842 (Online) http://dx.doi.org/10.5717/jenb.2015.19.1.31 ORIGINAL PAPER Effects of different doses of leucine ingestion following eight weeks of resistance  exercise on protein synthesis and hypertrophy of skeletal muscle in rats Ju Hyun Gil and Chang Keun Kim* Department of Exercise physiology, Korea National Sport University, Seoul, Korea  (Received: 2015/01/27, Revised: 2015/02/27, Published online: 2 015/03/11) Ju Hyun, Gil and Chang Keun Kim.",Non-OADS,/arxiv_data1/oa_pdf/9e/2f/jenb-19-1-31.PMC4424444.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/3c/fb/JOVR-10-49.PMC4424719.pdf
"As of  December 2013, 164 variations in CYP1B1  have been  publicly reported of which 136 cases are considered to  be PCG associated (Human Genome Mutation Database;  http://www.hgmd.cf.ac.uk/ac/index.php).",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/JOVR-10-68.PMC4424722.pdf
"MYOC Several loci have been reported for POAG,  (GLC1A  to GLC1O; Human Gene Nomenclature;   http://www.genenames.org), but the causative gene  in only four have been identified.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/JOVR-10-68.PMC4424722.pdf
[80] In the National Center for Biotechnology  Information (NCBI) website (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/b1/f2/JOVR-10-68.PMC4424722.pdf
"Accepted:  2015-03-02 doi:10.4103/1673-5374.155412         http://www.nrronline.org/ Kuan CY, Sun YY (2015) Towards reperfusion-centric preclinical  stroke research: outside the box of “reperfusion injury” .",Non-OADS,/arxiv_data1/oa_pdf/5c/f6/NRR-10-534.PMC4424735.pdf
"Accepted:  2015-02-09 doi:10.4103/1673-5374.155413         http://www.nrronline.org/ Park JM, Hess DC (2015) Breaking out from the neuroprotective log- jam: combined treatment with remote ischemic conditioning and mi- nocycline in the prehospital setting.",Non-OADS,/arxiv_data1/oa_pdf/47/54/NRR-10-537.PMC4424736.pdf
"Accepted:  2015-02-13 doi:10.4103/1673-5374.155414         http://www.nrronline.org/ Caltana L, Nieto ML, Brusco A (2015) Oleanolic acid, a promising neu - roprotective agen t for cerebral ischemia.",Non-OADS,/arxiv_data1/oa_pdf/d0/d5/NRR-10-540.PMC4424737.pdf
"Accepted:  2015-02-28 doi:10.4103/1673-5374.155415          http://www.nrronline.org/ Constantino LC, Vandresen-Filho S, Tasca CI (2015) Neuroprotection  induced by NMDA preconditioning as a strategy to understand brain  tolerance mechanism.",Non-OADS,/arxiv_data1/oa_pdf/06/ae/NRR-10-542.PMC4424738.pdf
"This temporal progression  is possibly linked to the progressive decline of Wnt signals sup- porting Emx2  expression (Theil et al, 2002) and late arousal of  Fgf8 (http://developingmouse.brain-map.org/) antagonizing it (Garel et al., 2003).",Non-OADS,/arxiv_data1/oa_pdf/da/ab/NRR-10-550.PMC4424741.pdf
"Accepted:  2015-02-06 doi:10.4103/1673-5374.155418        http://www.nrronline.org/ Falcone C, Mallamaci A (2015) Tuning of neocortical astrogenesis  rates by Emx2 in neural stem cells.",Non-OADS,/arxiv_data1/oa_pdf/da/ab/NRR-10-550.PMC4424741.pdf
"Accepted:  2015-02-07 doi:10.4103/1673-5374.155420         http://www.nrronline.org/ Montecinos-Oliva C, Schüller A, Inestrosa NC (2015) Tetrahydrohy- perforin: a neuroprotective modified natural compound against Alz- heimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/70/c1/NRR-10-552.PMC4424742.pdf
Accepted:  2015-02-11 doi:10.4103/1673-5374.155419          http://www.nrronline.org/ Chandran JS (2015) Perspectives on disrupted-in-schizophrenia 1 sig- naling in neurogenesis.,Non-OADS,/arxiv_data1/oa_pdf/cb/d1/NRR-10-555.PMC4424743.pdf
"Accepted:  2015-03-03 doi:10.4103/1673-5374.155422         http://www.nrronline.org/ Zheng MMZ, Phillips AA, Elliott SL, Krassioukov A V (2015) Prazosin: a potential new management tool for iatrogenic autonomic dysreflexia  in individuals with spinal cord injury?",Non-OADS,/arxiv_data1/oa_pdf/19/23/NRR-10-557.PMC4424744.pdf
Accepted:  2015-03-15 doi:10.4103/1673-5374.155421         http://www.nrronline.org/ Di Polo A (2015) Dendrite pathology and neurodegeneration: focus  on mTOR.,Non-OADS,/arxiv_data1/oa_pdf/ac/0c/NRR-10-559.PMC4424745.pdf
Accepted:  2015-02-26 doi:10.4103/1673-5374.155423         http://www.nrronline.org/ Knerlich-Lukoschus F (2015) Chemokines and their receptors: im- portant mediators to be aware of in neuroregenerative approaches for  spinal cord injury .,OADS,/arxiv_data1/oa_pdf/08/d1/NRR-10-562.PMC4424746.pdf
"Accepted:  2015-03-08 doi:10.4103/1673-5374.155424         http://www.nrronline.org/ Goulart CO, Martinez AMB (2015) Tubular conduits, cell-based  therapy and exercise to improve peripheral nerve regeneration.",Non-OADS,/arxiv_data1/oa_pdf/6a/2d/NRR-10-565.PMC4424747.pdf
Cochrane systematic review software RevMan 5.2 software (http://handbook.cochrane.org) was used to perform the meta-analysis.,OADS,/arxiv_data1/oa_pdf/0f/47/NRR-10-583.PMC4424750.pdf
"Statistical analysis Clinical and methodological heterogeneity analysis was performed for the included studies, and then subgroup analysis (RevMan 5.2 software, http://handbook.cochrane.org) was performed.",OADS,/arxiv_data1/oa_pdf/0f/47/NRR-10-583.PMC4424750.pdf
"DATA ReTRIv AL: We searched the main databases for eligible trials including Medline (from  1966 to June 2014), Embase (from 1980 to June 2014), Cochrane Library (Issue 6, 2014), Chinese National Knowledge Infrastructure (from 1995 to June 2014), Current Controlled Trials (http:// controlled-trials.com), Clinical Trials.gov (http://clinicaltrials.gov), and Chinese Clinical Trial  Registry (http://www.chictr.org).",OADS,/arxiv_data1/oa_pdf/93/fe/NRR-10-667.PMC4424763.pdf
"com), Clinical Trials.gov (http://clinicaltrials.gov), and  Chinese Clinical Trial Registry (http://www.chictr.org) were searched by using the Mesh or text keywords of “cilostazol, phosphodiesterase 3 inhibitor, atherosclerosis, and ischemic  stroke” .",OADS,/arxiv_data1/oa_pdf/93/fe/NRR-10-667.PMC4424763.pdf
Statistical analysis We used RevMan 5.2 software (http://tech.cochrane.org/revman) to perform this meta-analysis.,OADS,/arxiv_data1/oa_pdf/93/fe/NRR-10-667.PMC4424763.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Adverse outcomes predictor ZY Chen et al 557 © 2015 Macmillan Publishers Limited European Journal of Clinical Nutrition (2015) 552 –557",Non-OADS,/arxiv_data1/oa_pdf/6d/fd/ejcn2014239a.PMC4424800.pdf
URL http://www.scb.se/ Pages/ProductTables____341406.aspx.,OADS,/arxiv_data1/oa_pdf/13/d1/ejcn2014183a.PMC4424802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Misclassi ﬁcation of elderly malnutrition NN Gavriilidou et al 571 © 2015 Macmillan Publishers Limited European Journal of Clinical Nutrition (2015) 565 –571",Non-OADS,/arxiv_data1/oa_pdf/13/d1/ejcn2014183a.PMC4424802.pdf
"Ricoveri, personale e spesa delle aziende ospedaliere (2003) http://www.agenas.it/images/agenas/monitor/pdf/Monitor_16.pdf (last access November 2013).",Non-OADS,/arxiv_data1/oa_pdf/57/bc/ejcn2014255a.PMC4424803.pdf
"EuroStat 2012: http://epp.eurostat.ec.europa.eu/portal/ page/portal/hicp/data/database (last access November 2013).20 Mertes N, Schulzki C, Goeters C, Winde G, Benzing S, Kuhn KS et al.",OADS,/arxiv_data1/oa_pdf/57/bc/ejcn2014255a.PMC4424803.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/I.v.",Non-OADS,/arxiv_data1/oa_pdf/57/bc/ejcn2014255a.PMC4424803.pdf
"Generali- zability may be further limited by restricted patient popula- tions,9,13geographic locations,9,11,15small sample sizes,11or insufficient variables.9,11–14The current study therefore aimed to develop, in a large European cohort of incidentclinical investigation http://www.kidney-international.org &2015 International Society of Nephrology Correspondence: Ju¨rgen Floege, Division of Nephrology, RWTH University of Aachen, Pauwelsstrasse 30, 52057 Aachen, Germany.E-mail: juergen.floege@rwth-aachen.de Part of this study was presented as a pre liminary communication at the Annual Meeting of the American Society of Nep hrology, Philadelphia, November 2011.",Non-OADS,/arxiv_data1/oa_pdf/73/75/ki2014419a.PMC4424813.pdf
"Two-Year All-Cause Mortality Risk ""Heat-Map"" for a European Incident Dialysis Population, Based on Selected Modifiable and Non-Modifiable Risk Markers.Supplementary material is linked to the online version of the paper athttp://www.nature.com/ki REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/73/75/ki2014419a.PMC4424813.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 1008 Kidney International (2015) 87, 996– 1008clinical investigation J Floege et al.",Non-OADS,/arxiv_data1/oa_pdf/73/75/ki2014419a.PMC4424813.pdf
"Yet, these animals stillbasic research http://www.kidney-international.org &2015 International Society of Nephrology Correspondence: Jessy J. Alexander, Division of Nephrology, Department of Medicine, Clinical and Translational Research Center, University at Buffalo School of Medicine and Biomedical Sciences, 875 Ellicott Street, 8-022A,Buffalo, New York 14203, USA.",Non-OADS,/arxiv_data1/oa_pdf/d4/fc/ki2014373a.PMC4424815.pdf
Supplementary material is linked to the online version of the paper athttp://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/fc/ki2014373a.PMC4424815.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Kidney International (2015) 87, 930– 939 939JJ Alexander et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/fc/ki2014373a.PMC4424815.pdf
"The third objective wasto validate a subset of markers that could be further used inclinics for the stratification of kidney recipients with a lowrisk of rejection.clinical investigation http://www.kidney-international.org &2015 International Society of Nephrology Correspondence: Sophie Brouard, Pavillon Jean Monnet, Ho ˆtel Dieu, CHU de Nantes, 30, Boulevard Jean Monnet, Nantes cedex 01, Nantes 44093,France.",Non-OADS,/arxiv_data1/oa_pdf/65/78/ki2014395a.PMC4424816.pdf
Supplementary material is linked to the online version of the paper athttp://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/65/78/ki2014395a.PMC4424816.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Kidney International (2015) 87, 984– 995 995D Baron et al.",Non-OADS,/arxiv_data1/oa_pdf/65/78/ki2014395a.PMC4424816.pdf
"1–3Patients with comple- ment alternative pathway dysregulation are at lifelongrisk of thrombocytopenia, hemolysis, and renal impairmentthat may also occur with extrarenal (i.e., neurological,http://www.kidney-international.org clinical trial &2015 International Society of Nephrology Correspondence: Christoph Licht, Division of Nephrology and Program in Cell Biology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.",Non-OADS,/arxiv_data1/oa_pdf/eb/89/ki2014423a.PMC4424817.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Kidney International (2015) 87, 1061– 1073 1073C Licht et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/89/ki2014423a.PMC4424817.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)Preferable sites of transgene in AdV genome M Suzuki et al 429 © 2015 Macmillan Publishers Limited Gene Therapy (2015) 421 –429",Non-OADS,/arxiv_data1/oa_pdf/f4/54/gt2014124a.PMC4424821.pdf
"Foreword Bibliography DOI http://dx.doi.org/ 10.1055/s-0034-1367634Endoscopy International Open2014; 2: E45© Georg Thieme Verlag KGStuttgart · New YorkE-ISSN 2196-9736 Corresponding author: Prof. Thierry PonchonHospices Civils de LyonHépato-Gastro-Entérologieplace d ’Arsonval Pavillon H69003 LyonFrancethierry.ponchon@chu-lyon.fr Thierry Ponchon Foreword E45THIEME Dear colleagues and friends, !",Non-OADS,/arxiv_data1/oa_pdf/a1/28/10-1055-s-0034-1367634.PMC4424871.pdf
"Recently, several cases of Open AccessJ Kawashima and others Subacute thyroiditis-like symptoms with amyloid goiterID: 14-0117; May 2015 DOI: 10.1530/EDM-14-0117 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/ad/bd/edmcr-2015-140117.PMC4424874.pdf
J Kawashima and others Subacute thyroiditis-like symptoms with amyloid goiterID: 14-0117; May 2015 DOI: 10.1530/EDM-14-0117 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/ad/bd/edmcr-2015-140117.PMC4424874.pdf
J Kawashima and others Subacute thyroiditis-like symptoms with amyloid goiterID: 14-0117; May 2015 DOI: 10.1530/EDM-14-0117 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/ad/bd/edmcr-2015-140117.PMC4424874.pdf
J Kawashima and others Subacute thyroiditis-like symptoms with amyloid goiterID: 14-0117; May 2015 DOI: 10.1530/EDM-14-0117 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/ad/bd/edmcr-2015-140117.PMC4424874.pdf
( doi:10.1189/jlb.0606402 ) Received in ﬁnal form 1 April 2015 Accepted 8 April 2015 J Kawashima and others Subacute thyroiditis-like symptoms with amyloid goiterID: 14-0117; May 2015 DOI: 10.1530/EDM-14-0117 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/ad/bd/edmcr-2015-140117.PMC4424874.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/8d/ddv053.PMC4424950.pdf
"The variants were annotated and prior- itized using an in-house pipeline VaRank (http://lbgi.fr/VaRank/, (40)(41).",OADS,/arxiv_data1/oa_pdf/07/8d/ddv053.PMC4424950.pdf
A detailed histology proto- col can be found at http://www.empress.har.mrc.ac.uk.,Non-OADS,/arxiv_data1/oa_pdf/07/8d/ddv053.PMC4424950.pdf
"Web Resources The URLs for data presented herein are as follows:1000 Genome Browser, http://browser.1000genomes.orgBDGP, http://www.fruit ﬂy.org D[4]/phenodent Diagnosing Dental Defects Database, www.phenodent.org dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP Ensembl Genome Browser, http://www.ensembl.orgEurexpress, http://www.eurexpress.org/ee/Exome Variant Server (EVS) http://evs.gs.washington.edu/EVS/ GenBank, http://www.ncbi.nlm.nih.gov/Genbank GeneHub-GEPIS, http://www.cgl.ucsf.edu/Research/genentech/genehub-gepis/genehubgepis-search.htmlGene expression in tooth, http://bite-it.helsinki.",Non-OADS,/arxiv_data1/oa_pdf/07/8d/ddv053.PMC4424950.pdf
"ﬁ GenePaint, http://www.genepaint.org HSF2.4.1, http://www.umd.be/HSF NCBI, http://www.ncbi.nlm.nih.gov/Online Mendelian Inheritance in Man (OMIM), http://www.omim.orgUCSC Genome Browser, http://genome.ucsc.edu/cgi-bin/hgGatewayUniGene, http://www.ncbi.nlm.nih.gov/unigene VaRank, http://lbgi.fr/VaRank/ EMBL-EBI Interpro, http://www.ebi.ac.uk/interpro/EMPReSS, http://www.empress.har.mrc.ac.uk References 1.",Non-OADS,/arxiv_data1/oa_pdf/07/8d/ddv053.PMC4424950.pdf
"Available at: https://cshmonographs.org/index.php/monographs/article/view/3854 (last accessed, 17 February 2015).",Non-OADS,/arxiv_data1/oa_pdf/07/8d/ddv053.PMC4424950.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/40/ddv067.PMC4424953.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 24, Number 10, 2015 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2014.0484 1150",Non-OADS,/arxiv_data1/oa_pdf/00/ff/scd.2014.0484.PMC4424969.pdf
142. http://genkyotex.com/genkyotex/ 143.,Non-OADS,/arxiv_data1/oa_pdf/00/ff/scd.2014.0484.PMC4424969.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/80/dmso-8-219.PMC4425233.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 219–226Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  219Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8047 2health-related quality of life in type  1 and   type 2 diabetic patients in a Portuguese   central public hospital eduardo Sepúlveda1,2 rui Poínhos2,3 Miguel constante4,5 José Pais-ribeiro1,2 Paula Freitas6,7 Davide carvalho6,7 1Faculty of Psychology and  educational Sciences, University of  Porto, Porto, Portugal; 2associação  de Prevenção e apoio à Diabetes,   Porto, Portugal; 3Faculty of nutrition  and Food Sciences, University of  Porto, Porto, Portugal; 4institute of  Psychiatry, King’s college london,   london, UK; 5Department of  Psychiatry, hospital Beatriz Ângelo,   loures, Portugal; 6Department  of endocrinology, Diabetes and  Metabolism, centro hospitalar São  João, Porto, Portugal; 7Faculty of  Medicine, University of Porto, Porto,   Portugal correspondence: eduardo Sepúlveda   Faculty of Psychology and educational  Sciences, University of Porto, rua  alfredo allen, s/n,  4200-135 Porto,  Portugal   email edusepulvedamoura@gmail.co mBackground:  Diabetes mellitus is a chronic metabolic disease, the prevalence of which has  registered a considerable increase, mainly in adults and elderly.",Non-OADS,/arxiv_data1/oa_pdf/37/80/dmso-8-219.PMC4425233.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/37/80/dmso-8-219.PMC4425233.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/80/dmso-8-219.PMC4425233.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/e8/dddt-9-2431.PMC4425234.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2431–2447Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2431Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8123 6Preparation and clinical evaluation of nano- transferosomes for treatment of erectile  dysfunction Maha Fadel M ali1 heba F salem2 hany F abdelmohsen3 sameh K attia4 1Pharmaceutical T echnology Unit,   Medical applications of lasers  Department, national institute  of laser enhanced science,   cairo University, cairo, egypt;   2Pharmaceutics and industrial  Pharmacy Department, 3clinical  Pharmacy Department, Faculty  of Pharmacy, Beni-suef University,   Beni-suef, egypt; 4Dermatology  and andrology Department,   Faculty  of Medicine, Minia  University,  Minia,  egyptObjective:  The goal of the present study was to formulate topical nanocarriers of the low-cost  vasodilator, papaverine hydrochloride (PH), as an alternative to the painful penile injections.",Non-OADS,/arxiv_data1/oa_pdf/8e/e8/dddt-9-2431.PMC4425234.pdf
"Alternative forms of administration of vasoactive and  vasodilatory substances are being investigated.2 Topical therapy has the potential to  become a first-line treatment for ED because it acts locally at the penile level, thus correspondence: heba F salem Pharmaceutics and industrial Pharmacy  Department, Faculty of Pharmacy,   Beni-suef University, el shahid shehata  ahmed hijaz st, Beni-suef, egypt Tel +20 10 0194 4381 email heba_salem2004@yahoo.co.u kJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ali et al Running head recto: Evaluation of nano-transferosomes for treatment of ED DOI: http://dx.doi.org/10.2147/DDDT.S81236",Non-OADS,/arxiv_data1/oa_pdf/8e/e8/dddt-9-2431.PMC4425234.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8e/e8/dddt-9-2431.PMC4425234.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/e8/dddt-9-2431.PMC4425234.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/94/copd-10-853.PMC4425235.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 853–867International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  853OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7416 2supported self-management for patients with  COPD who have recently been discharged from  hospital: a systematic review and meta-analysis Correspondence:  rachel e Jordan Public health, epidemiology and  Biostatistics, school of health and  Population sciences, Public health  Building, University of Birmingham,  edgbaston, Birmingham B15 2TT, UK Tel +44 121 414 6775 email r.e.jordan@bham.ac.u k saimma Majothi1 Kate Jolly1 nicola r heneghan2 Malcolm J Price1 richard D riley3 alice M T urner4 susan e Bayliss1 David J Moore1 sally J singh5 Peymané adab1 David a Fitzmaurice6 rachel e Jordan1 1Public health, epidemiology and  Biostatistics, school of health and  Population sciences, University  of Birmingham, Birmingham, UK;   2school of sport, exercise and  rehabilitation sciences, University  of Birmingham, Birmingham, UK;   3research Institute of Primary Care  and health sciences, Keele University,   staffordshire, UK; 4Queen elizabeth  hospital research laboratories,   Birmingham, UK; 5Centre for exercise  and rehabilitation science, University  hospitals of leicester nhs Trust,   glenfield hospital, leicester, UK;   6Primary Care Clinical sciences,   school of health and Population  sciences, University of Birmingham,   Birmingham, UKPurpose:  Although many hospitals promote self-management to chronic obstructive pulmonary  disease (COPD) patients post discharge from hospital, the clinical effectiveness of this is  unknown.",Non-OADS,/arxiv_data1/oa_pdf/3c/94/copd-10-853.PMC4425235.pdf
A recent systematic review has  shown that supported self-management interventions can be effective in reducing Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Majothi et al Running head recto: Systematic review: COPD self-management post discharge DOI: http://dx.doi.org/10.2147/COPD.S74162,Non-OADS,/arxiv_data1/oa_pdf/3c/94/copd-10-853.PMC4425235.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/3c/94/copd-10-853.PMC4425235.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3c/94/copd-10-853.PMC4425235.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/94/copd-10-853.PMC4425235.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/dddt-9-2421.PMC4425236.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2421–2429Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2421Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7965 8Pharmacokinetics of mitragynine in man satariya Trakulsrichai1,2 Korbtham sathirakul3,4 saranya auparakkitanon5 Jatupon Krongvorakul5 Jetjamnong sueajai5 nantida noumjad5 chonlaphat sukasem5 Winai Wananukul2,6 1Department of emergency Medicine,   Faculty of Medicine ramathibodi  hospital, 2ramathibodi Poison center,   Faculty of Medicine ramathibodi  hospital, 3Department of Pharmacy,   Faculty of Pharmacy, Mahidol  University, Bangkok, Thailand; 4center  for Drug research Discovery and  Development, Thammasat Univerisity,   Prathumthani, Thailand; 5Department  of Pathology, Faculty of Medicine  ramathibodi hospital, 6Department  of Medicine, Faculty of Medicine  ramathibodi hospital, Mahidol  University, Bangkok, ThailandBackground:  Kratom, known botanically as Mitragyna speciosa  (Korth.",Non-OADS,/arxiv_data1/oa_pdf/89/3e/dddt-9-2421.PMC4425236.pdf
"), also known as Ketum in  Malaysia, belongs to the Rubiaceae family, which can grow in tropical and subtropi - cal regions of Asia.1,2 It is a native tree indigenous to Southeast Asia, especially in  Thailand and Malaysia.2,3 It contains many alkaloids such as mitragynine, paynan - theine, speciogynine, and 7-hydroxymitragynine.2 Mitragynine is the most abundant  active alkaloid isolated from Kratom.2,4 Mitragynine has an antinociceptive effect,  similar to 7-hydroxymitragynine, one of alkaloids, which is a significantly more potent  analgesic than mitragynine and morphine.2,4 Kratom possesses dose-dependent phar - macological effects, with stimulant effects in lower doses and opiate-like effects in  higher doses.4 Other clinical effects include antinociceptive, antiinflammatory, antidi - arrheal, antitussive, antipyretic, euphoric, antidepressant, anxiolytic, blood pressure correspondence: Winai Wananukul ramathibodi Poison center and  Department of Medicine, Faculty  of Medicine ramathibodi hospital,  Mahidol University, 270 rama Vi road,  ratchatewi, Bangkok 10400, Thailand Tel +66 2 201 1084 Fax +66 2 201 1086 email winai.wan@mahidol.ac.t h Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Trakulsrichai et al Running head recto: Pharmacokinetics of Kratom DOI: http://dx.doi.org/10.2147/DDDT.S79658",Non-OADS,/arxiv_data1/oa_pdf/89/3e/dddt-9-2421.PMC4425236.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/89/3e/dddt-9-2421.PMC4425236.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/3e/dddt-9-2421.PMC4425236.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/b1/dddt-9-2409.PMC4425237.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2409–2419Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7779 0Ultrasound contrast agent loaded with nitric  oxide as a theranostic microdevice Dmitry grishenkov1–3 adrian gonon3,4 eddie Weitzberg5 Jon O lundberg5 Johan harmark6 Barbara cerroni7 gaio Paradossi7 Birgitta Janerot-sjoberg1–3 1Department of clinical science,   intervention, and T echnology,   Karolinska institutet, stockholm,   sweden; 2Department of Medical  engineering, KTh, royal institute  of T echnology, school of T echnology  and health, stockholm, sweden;   3Department of clinical Physiology,   Karolinska University hospital,   stockholm, sweden; 4Department  of Medicine, Karolinska institutet,   stockholm, sweden; 5Department  of Physiology and Pharmacology,   Karolinska institutet, stockholm,   sweden; 6Department of Biosciences  and nutrition, Karolinska institutet,   KTh, royal institute of T echnology,   school of T echnology and health,   stockholm, sweden; 7Department  of chemical sciences and T echnologies,  University of rome T or Vergata,  rome,  italyAbstract:  The current study describes novel multifunctional polymer-shelled microbubbles  (MBs) loaded with nitric oxide (NO) for integrated therapeutic and diagnostic applications   (ie, theranostics) of myocardial ischemia.",Non-OADS,/arxiv_data1/oa_pdf/c3/b1/dddt-9-2409.PMC4425237.pdf
"Intravenously injected ultrasound contrast agents (UCAs) correspondence:  Dmitry grishenkov Karolinska institutet, Department  of clinical science, intervention and  Technology, Division of Medical imaging  and Technology, alfred nobels alle 10,  se-141 52 stockholm, sweden Tel +46 8790 9720 email dmitry.grishenkov@ki.s eJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Grishenkov et al Running head recto: Theranostic contrast agent loaded with nitric oxide DOI: http://dx.doi.org/10.2147/DDDT.S77790",Non-OADS,/arxiv_data1/oa_pdf/c3/b1/dddt-9-2409.PMC4425237.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c3/b1/dddt-9-2409.PMC4425237.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/b1/dddt-9-2409.PMC4425237.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/79/dddt-9-2463.PMC4425238.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2463–2473Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2463Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7978 2The mechanism of ccn1-enhanced retinal  neovascularization in oxygen-induced retinopathy  through Pi3K/akt–VegF signaling pathway Yu Di1 Yiou Zhang2 hongwei Yang1 aiyuan Wang1 Xiaolong chen1 1Department of Ophthalmology,   shengjing affiliated hospital of china  Medical University, shenyang, People’s  republic of china; 2graduate school,   china Medical University, shenyang,   People’s republic of chinaBackground:  CCN1 (also called Cyr 61) is an extracellular matrix signaling molecule that has been  implicated in neovascularization through its interactions with several endothelial integrin receptors.",Non-OADS,/arxiv_data1/oa_pdf/3e/79/dddt-9-2463.PMC4425238.pdf
"Current therapies  aim at eliminating/reducing the actual causes of RNV while simultaneously normal - izing the retinal vasculature.4  It is now apparent that VEGF is a prominent factor in ROP that stimulates endothe - lial cell proliferation and tube formation and mediates ischemia-induced RNV.5–8 correspondence: Xiaolong chen Department of Ophthalmology,  Shengjing Affiliated Hospital of China  Medical University, heping district,  sanhao road 36, shenyang 110004,  People’s republic of china Tel +86 189 4025 1892 email chenxiaolongsy@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Di et al Running head recto: CCN1 enhances neovascularization via PI3K/Akt-VEGF pathway DOI: http://dx.doi.org/10.2147/DDDT.S79782",Non-OADS,/arxiv_data1/oa_pdf/3e/79/dddt-9-2463.PMC4425238.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3e/79/dddt-9-2463.PMC4425238.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/79/dddt-9-2463.PMC4425238.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/68/dddt-9-2485.PMC4425239.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2485–2499Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2485Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8203 0Body protective compound-157 enhances  alkali-burn wound healing in vivo and promotes  proliferation, migration, and angiogenesis in vitro T onglie huang1,* Kuo Zhang2,* lijuan sun3 Xiaochang Xue1 cun Zhang1 Zhen shu1 nan Mu1 Jintao gu1 Wangqian Zhang1 Yukun Wang1 Yingqi Zhang1 Wei Zhang1 1state Key laboratory of  cancer Biology, Department  of Biopharmaceutics, school of  Pharmacy, The Fourth Military  Medical University, 2national  engineering research center for  Miniaturized Detection systems,   school of life sciences, northwest  University, 3Department of  Ophthalmology, Xijing  hospital, The  Fourth Military Medical University,   Xi’an, People’s republic of china *These authors contributed equally  to this workAbstract:  Chemical burns take up a high proportion of burns admissions and can penetrate deep  into tissues.",Non-OADS,/arxiv_data1/oa_pdf/d3/68/dddt-9-2485.PMC4425239.pdf
"Many growth factors such as transforming growth  factor (TGF)- β,2 platelet-derived growth factor (PDGF),3 epidermal growth factor (EGF),4  and fibroblast growth factor (FGF),5 as well as interleukin (IL)-16 and tumor necrosis  factor (TNF),7 have been evaluated in a wide spectrum of in vivo and in vitro experiments correspondence: Yingqi Zhang;  Wei Zhang state Key laboratory of cancer Biology,  Department of Biopharmaceutics, school  of Pharmacy, The Fourth Military Medical  University, chang-le Xi street #169,  Xi’an 710032, People’s republic of china Tel/Fax +86 29 8477 4773;   +86 29 8477 3488 email zhangyqh@fmmu.edu.c n;  zhangw90@fmmu.edu.c nJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Huang et al Running head recto: Body protective compound-157 in wound healing DOI: http://dx.doi.org/10.2147/DDDT.S82030",Non-OADS,/arxiv_data1/oa_pdf/d3/68/dddt-9-2485.PMC4425239.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d3/68/dddt-9-2485.PMC4425239.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/68/dddt-9-2485.PMC4425239.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/43/dddt-9-2449.PMC4425240.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2449–2461Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2449Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7978 4structural dynamics and inhibitor searching  for Wnt-4 protein using comparative  computational studies Mirza a hammad syed sikander azam national center for Bioinformatics,   Quaid-i-azam University, islamabad,   PakistanAbstract:  Wnt-4 (wingless mouse mammary tumor virus integration site-4) protein is involved  in many crucial embryonic pathways regulating essential processes.",Non-OADS,/arxiv_data1/oa_pdf/04/43/dddt-9-2449.PMC4425240.pdf
"Since the initial  discovery of the Int-1 protein,16 only two crystal structures has been resolved.17,18 Wnt proteins are believed to be animal proteins because they are only present in  invertebrates and vertebrates.19 Wnt proteins are highly conserved in terms of their correspondence: syed sikander azam national center for Bioinformatics,  Quaid-i-azam University, islamabad  45320, Pakistan Tel +92 51 9064 4130 email ssazam@qau.edu.p k Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hammad and Azam Running head recto: Structural dynamics and inhibitor searching for Wnt-4 protein DOI: http://dx.doi.org/10.2147/DDDT.S79784",Non-OADS,/arxiv_data1/oa_pdf/04/43/dddt-9-2449.PMC4425240.pdf
"In  the course of this pathway, Wnts target nearly 125 proteins,  and this number is set to grow as research on these genes  continues ( http://www.stanford.edu/group/nusselab/cgi- bin/wnt/target_gene s).",Non-OADS,/arxiv_data1/oa_pdf/04/43/dddt-9-2449.PMC4425240.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/04/43/dddt-9-2449.PMC4425240.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/43/dddt-9-2449.PMC4425240.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/6b/dddt-9-2475.PMC4425241.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2475–2484Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2475Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7271 6Enhanced anti-inflammatory potential of   cinnamate-zinc layered hydroxide in   lipopolysaccharide-stimulated ra W 264.7   macrophages Malik adewoyin1 sumaiyah Megat nabil  Mohsin2 Palanisamy arulselvan1 Mohd Zobir hussein2 sharida Fakurazi1,3 1Laboratory of Vaccines and  immunotherapeutics, institute  of Bioscience, 2Materials synthesis  and characterization laboratory,   Institute of Advanced T echnology,   3Faculty of Medicine and Health  sciences, Pharmacology Unit,   Universiti Putra Malaysia, selangor,   MalaysiaBackground:  Cinnamic acid (CA) is a phytochemical originally derived from Cinnamomum  cassia , a plant with numerous pharmacological properties.",Non-OADS,/arxiv_data1/oa_pdf/be/6b/dddt-9-2475.PMC4425241.pdf
"The major components of  innate immunity are phagocytes (macrophages, neutrophils, and dendritic cells),  complement system protein, and natural killer cells.5,6 Although the first immune cells correspondence: sharida Fakurazi Faculty of Medicine and Health  Sciences, and Laboratory of Vaccines  and immunotherapeutics, institute  of Bioscience, Universiti Putra Malaysia,  43400 UPM serdang, selangor, Malaysia Tel +603 8947 2331 Fax +603 8942 2341 email sharida@upm.edu.m y;   sharida.fakurazi@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Adewoyin et al Running head recto: Anti-inflammatory potential of cinnamate-zinc layered hydroxide DOI: http://dx.doi.org/10.2147/DDDT.S72716",Non-OADS,/arxiv_data1/oa_pdf/be/6b/dddt-9-2475.PMC4425241.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/be/6b/dddt-9-2475.PMC4425241.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/6b/dddt-9-2475.PMC4425241.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 339–346Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  339HyPotHEsisopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S7658 7Applying Expectancy theory to residency training:  proposing opportunities to understand resident  motivation and enhance residency training Ehyal shweiki1 Niels D Martin2 Alec C Beekley1 Jay s Jenoff1 George J Koenig1 Kris R Kaulback1 Gary A Lindenbaum1 Pankaj H Patel1 Matthew M Rosen1 Michael s Weinstein1 Muhammad H Zubair2 Murray J Cohen1 1Department of surgery, thomas  Jefferson University Hospital,  Philadelphia, PA, UsA; 2Department of  surgery, Perelman school of Medicine  at the University of Pennsylvania,  Philadelphia, PA, UsA Correspondence: Ehyal shweiki   Department of surgery, thomas Jefferson  University Hospital, 1100 Walnut street,  MoB suite 702, Philadelphia,   PA 19107, UsA   tel +1 215 955 2165   Fax +1 215 923 7957   Email ehyal.shweiki@jefferson.ed uAbstract:  Medical resident education in the United States has been a matter of national pri - ority for decades, exemplified initially through the Liaison Committee for Graduate Medical  Education and then superseded by the Accreditation Council for Graduate Medical Education.",Non-OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
"Available from: http://acgme.org/acgmeweb/Portals/0/   PFAssets/ProgramRequirements/ab_ACGMEglossary.pd f. Accessed  February 8, 2012.",OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
Available from:  http://www.absurgery.or g. Accessed.,Non-OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
Available from: http://www.flsprogram.org/ index/fls-program-description /.,OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/d1/amep-6-339.PMC4425242.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 821–825Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  821OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7799 0Opinions of high school students in central elazig  about elderliness A Ferdane Oguzoncul¹ Murat Aygen² Yasemin Acik¹ s erhan Deveci¹ B Canan Demirbag³ edibe Pirincci¹ ¹Department of Public health,   Faculty of Medicine, Fırat University,   elazig, T urkey; ²Faculty of economics  and Administrative Sciences, Fırat  University, Elazig, T urkey; ³Department  of Public health, school of n ursing,   Faculty of health sciences, Karadeniz  T echnical University, Trabzon, T urkeyMethods:  Students attending five different types of high schools in central Elazig (a city in  Turkey) during the 2009–2010 school year constitute the study population.",Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
"Life expectancy at birth is 75 years or  older in 37 world nations.6Correspondence: A Ferdane Oguzoncul Fırat Universitesi Tip Fakultesi, Halk  sagligi Anabilim Dali, Kat:3 23119  elazig, Turkey Tel +90 0424 237 0000 ext 4685 email aferdane@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Oguzoncul et al Running head recto: High school students’ opinions on elderliness DOI: http://dx.doi.org/10.2147/CIA.S77990",Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
Available from: http://www.un.org/esa/population/publications/ worldageing19502050 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
Available from:  http://www.bsm.gov.tr/makale/20011.asp?sayi =2001.,OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
"Avail - able from: http://sbu.saglik.gov.tr/Ekutuphane/kitaplar/si y. Accessed  April 27, 2010.",Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
Available from:  http://www.phdernegi.org/kongre_dokumanlar/iii.uphk_ozet_kitabi.,Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
Avail - able from http://www.tuyev.org.tr/haberler/index.php?haber_id=6.,Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
Available from http://www.tuyev.org.tr/haberler/index.php?haber_id =5.,Non-OADS,/arxiv_data1/oa_pdf/1e/8a/cia-10-821.PMC4425243.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/ea/cmar-7-093.PMC4425244.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 93–103Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  93ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S7616 3long-term survival in advanced melanoma  patients using repeated therapies: successive  immunomodulation improving the odds?,Non-OADS,/arxiv_data1/oa_pdf/b2/ea/cmar-7-093.PMC4425244.pdf
"The manner in which the data was presented varied between different study reports.1,23–39 adapted and reproduced with permission from australian Melanoma  Research Foundation data  2014 http://www.melanomaresearch.com.a u. Abbreviations:  CR, complete response; PR, partial response; sD, s table disease; DTIC, dacarbazine; ns, not specified; B-raf, B-raf mutant pathway inhibitors vemurafenib  and dabrafenib; inhib, inhibitor; il2, interleukin-2; CTla-4, anti-cytotoxic lymphocyte antigen-4 inhibitory antibodies ipilimumab and Yervoy; VMCl, vaccinia melanoma cell  lysate vaccine; TIL, autologous tumor infiltrating lymphocytes; MEK, mitogen-activated protein kinase inhibitors; MEK/1,  1 mg dose; MeK/2,  2 mg dose; PD-1, programmed  death receptor inhibitors; PDl-1, programmed death-1 receptor ligand inhibitory monoclonal antibody; m, months.",Non-OADS,/arxiv_data1/oa_pdf/b2/ea/cmar-7-093.PMC4425244.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/b2/ea/cmar-7-093.PMC4425244.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/ea/cmar-7-093.PMC4425244.pdf
"Schmutz Department of Water, Atmosphere and Environment,Institute of Hydrobiology and Aquatic Ecosystem Management, BOKU, University of Natural Resources and Life Sciences, Max Emanuel-Strasse 17, 1180 Vienna, Austriae-mail: clemens.trautwein@boku.ac.atURL: http://www.wau.boku.ac.at/ihg.htmlAquat Sci (2012) 74:329–341 DOI 10.1007/s00027-011-0224-5 Aquatic Sciences 123",Non-OADS,/arxiv_data1/oa_pdf/3d/56/27_2011_Article_224.PMC4425263.pdf
"(2007 ) with the readily available software tool for the European Fish Index (EFI, http://fame.boku.ac.at/ ).",Non-OADS,/arxiv_data1/oa_pdf/3d/56/27_2011_Article_224.PMC4425263.pdf
We used the EFT calculation tool included in the EFI software package to predict EFTbased on seven environmental descriptors for each sam- pling site ( http://fame.boku.ac.at ).,OADS,/arxiv_data1/oa_pdf/3d/56/27_2011_Article_224.PMC4425263.pdf
Available at http://www.spatialecology.com/htools .,Non-OADS,/arxiv_data1/oa_pdf/3d/56/27_2011_Article_224.PMC4425263.pdf
Available at: http://fame.boku.,Non-OADS,/arxiv_data1/oa_pdf/3d/56/27_2011_Article_224.PMC4425263.pdf
"http://www.mayo.edu/hsr/ techrpt/61.pdf (cited on 12/03/2010) Van Sickle J, Baker J, Herlihy A, Bayley P, Gregory S, Haggerty P, Ashkenas L, Li J (2004) Projecting the biological condition ofstreams under alternative scenarios of human land use.",Non-OADS,/arxiv_data1/oa_pdf/3d/56/27_2011_Article_224.PMC4425263.pdf
Available at: http://www.tfl.gov.uk/roadusers/cycling/11598.,Non-OADS,/arxiv_data1/oa_pdf/22/c8/10.1177_1468794112468472.PMC4425295.pdf
Manuals are available at: http://www.actconsortium.org/publications.php/12/ prime-trainer-and-learner-manuals.,Non-OADS,/arxiv_data1/oa_pdf/69/ab/10.1177_1356389014551484.PMC4425297.pdf
URL (consulted 5 April 2012): http://pdf.usaid.gov/ pdf_docs/Pnabq044.pdf Cartwright N (2011) A philosopher’s view of the long road from RCTs to effectiveness.,Non-OADS,/arxiv_data1/oa_pdf/69/ab/10.1177_1356389014551484.PMC4425297.pdf
"URL: http://www.mrc.ac.uk/documents/pdf/complex-interventions-guidance/ Oakley A, Strange V, Bonell C, et al.",OADS,/arxiv_data1/oa_pdf/69/ab/10.1177_1356389014551484.PMC4425297.pdf
URL: http://www.un.org/ sg/globalstrategy.shtml,Non-OADS,/arxiv_data1/oa_pdf/69/ab/10.1177_1356389014551484.PMC4425297.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/ijn-10-3183.PMC4425311.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3183–3191International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3183RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8252 7epigenetic mechanisms in cancer: push and pull  between kneaded erasers and fate writers Ammad Ahmad Farooqi1 Jen-Yang Tang2–4 Ruei-Nian Li5 Muhammad Ismail1 Yung-Ting Chang6 Chih-w en Shu7 Shyng-Shiou F Yuan8,9 Jing-Ru Liu5 Qaisar Mansoor1 Chih-Jen Huang2,3,* Hsueh-w ei Chang5,9–11,* 1Institute of Biomedical and Genetic  engineering (IBGe), KRL Hospital,   Islamabad, Pakistan, 2Department of  Radiation Oncology, Faculty of Medicine,   College of Medicine, 3Department of  Radiation Oncology, Kaohsiung Medical  University Hospital, 4Department of  Radiation Oncology, Kaohsiung Municipal  Ta-T ung Hospital, 5Department of  Biomedical Science and environmental  Biology, Kaohsiung Medical University,   Kaohsiung, Taiwan; 6Doctor Degree  Program in Marine Biotechnology, National  Sun Yat-sen University/Academia Sinica,   7Department of Medical education and  Research, Kaohsiung veterans General  Hospital, 8Translational Research Center,   9Cancer Center, Kaohsiung Medical  University Hospital, 10Institute of Medical  Science and Technology, National Sun  Yat-sen University, 11Research Center of  environmental Medicine, Kaohsiung Medical  University, Kaohsiung, Taiwan *These authors contributed equally to this  workAbstract:  Research concerning the epigenome over the years has systematically and sequentially  shown substantial development and we have moved from global inhibition of modifications  of the epigenome toward identification and targeted therapy against tumor-specific epigenetic  mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/ijn-10-3183.PMC4425311.pdf
edu.tw Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Farooqi et al Running head recto: Epigenetic mechanisms in cancer DOI: http://dx.doi.org/10.2147/IJN.S82527,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/ijn-10-3183.PMC4425311.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2f/2c/ijn-10-3183.PMC4425311.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/2c/ijn-10-3183.PMC4425311.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/tcrm-11-683.PMC4425312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 683–689Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  683Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7923 2serous macular detachment, yellow macular  deposits, and prominent middle limiting membrane  in multiple myeloma Berna Dogan1 Muhammet Kazim erol1 Devrim T oslak1 Deniz T urgut Coban1 Mehmet Bulut1 ayse Cengiz1 Esin Sogutlu Sarı2 1antalya Training and Research  Hospital, eye Clinic, antalya, T urkey;   2Balıkesir University Medicine Faculty,   Eye Clinic, Balıkesir, T urkeyAbstract:  Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may  be associated with ocular complications.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/tcrm-11-683.PMC4425312.pdf
"The characteristic signs of myeloma include bone pain, hypercalcemia,  anemia, renal failure, and hyperviscosity syndrome.1 The retinal findings in hyperviscosity syndrome are common retinal hemorrhages,  microaneurysms, venous dilatation and tortuosity, and white-centered hemorrhages.2  Serous macular detachment has been reported in a few cases in patients with multiple  myeloma.3–5 Ho et al first reported serous macular detachment with or without subreti - nal precipitates or fundus signs of serum hyperviscosity in one patient with multiple  myeloma, one patient with Waldenstrom’s macroglobulinemia, and one patient with  benign polyclonal gammopathy.3 Rusu et al reported observation of associated serous  detachment in four patients, three with multiple myeloma, and one with light-chain  deposition disease.5 Here, we describe a rare case that presented as sudden vision loss and was diag - nosed as multiple myeloma in which hyperviscosity retinopathy, serous macular  detachment, yellow macular deposits, prominent middle limiting membrane (MLM),  and Roth spots (white-centered hemorrhages) at the outer plexiform layer were  evaluated by spectral-domain optical coherence tomography (SD-OCT), enhanced  depth imaging OCT (EDI-OCT), fundus fluorescein angiography (FFA), and fundus  autofluorescence.Correspondence: Berna Dogan antalya Training and Research Hospital,  Eye Clinic, Varlık Mh., Kazım Karabekir  Caddesi, 07100 Sog ˘uksu /Muratpaşa/ antalya, Turkey Tel +90 24 2249 4400 email bernadoga3@hotmail.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Dogan et al Running head recto: A patient with multiple myeloma presenting with visual loss DOI: http://dx.doi.org/10.2147/TCRM.S79232",Non-OADS,/arxiv_data1/oa_pdf/a1/59/tcrm-11-683.PMC4425312.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a1/59/tcrm-11-683.PMC4425312.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/tcrm-11-683.PMC4425312.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1103–1109Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1103Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6841 7The clinical utility of lurasidone in schizophrenia:  patient considerations Correspondence: Philip D Harvey Department of Psychiatry and Behavioral  Sciences, University of Miami, Miller  School of Medicine, 1120 Nw  14th Street, Miami, FL 33136, USA Fax +1 305 243 1619 email philipdharvey1@cs.co m Philip D Harvey 1Department of Psychiatry and  Behavioral Sciences, University of  Miami, Miller School of Medicine,   Miami, FL, USA; 2Bruce w Carter vA  Medical Center, Miami, FL, USAAbstract:  Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia  in a number of countries including the United Kingdom, other European countries, the United  States, and Canada.",Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
Relevant information regarding Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Harvey Running head recto: Lurasidone in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S68417,Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
Available from: http://www.latuda.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
"Available from: https://www.sunovionprofile.com/sp/ latuda-bp/metabolic-parameters.htm l. Accessed March 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/86/7e/ndt-11-1103.PMC4425313.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijn-10-3269.PMC4425314.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3269–3274International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3269OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7446 9The ability of streptomycin-loaded chitosan- coated magnetic nanocomposites to possess  antimicrobial and antituberculosis activities Mohamed ezzat el Zowalaty1,2 samer hassan hussein al ali3,4 Mohamed I husseiny2,5 Benjamin M geilich6,7 Thomas J Webster7,8 Mohd Zobir hussein9 1laboratory of Vaccines and  Immunotherapeutics, Institute of  Bioscience, Universiti Putra Malaysia,   selangor Darul ehsan, Malaysia;   2Department of Microbiology and  Immunology, Faculty of Pharmacy,   Zagazig University, Zagazig, egypt;   3laboratory of Molecular Biomedicine,   Universiti Putra Malaysia, selangor  Darul ehsan, Malaysia; 4Faculty of  Pharmacy, Isra University, amman,   Jordan; 5Beckman research Institute  of city of hope, Duarte, ca, Usa;   6Department of Bioengineering,   7Department of chemical engineering,   Northeastern University, Boston,   Ma, Usa; 8center of excellence for  advanced Materials research, King  abdulaziz University, Jeddah, Kingdom  of saudi arabia; 9Materials synthesis  and characterization laboratory,   Institute of advanced T echnology;   Universiti Putra Malaysia, selangor  Darul ehsan, MalaysiaAbstract:  magnetic nanoparticles (mNPs) were synthesized by the coprecipitation of Fe2+ and Fe3+  iron salts in alkali media.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijn-10-3269.PMC4425314.pdf
"Keywords:  iron oxide nanoparticles, chitosan, streptomycin, Mycobacterium tuberculosis ,  antimicrobial activity Introduction Nanomaterials are compounds of interest in numerous fields, including physics and  chemistry, because the reduced dimension of a solid material (such as a particle, grain,  tube, etc) leads to novel, unexpected physical and chemical properties that differ from  that of the corresponding bulk material.1 The foundation of these unexpected properties  is due to the large surface-to-volume ratio of these nanoparticles, compared to their  micron equivalents.2 Iron oxide nanoparticles (for example, magnetite or Fe3O4) are an  example of an ultra-small nanomaterial, which are beginning to revolutionize science.3  In addition, iron oxide nanoparticles are promising candidates for drug delivery,4 contrast  enhancers in magnetic resonance imaging (mRI) medical diagnostics,5 and are promis - ing antimicrobial agents to combat bacteria resistant to conventional antibiotics.6 Infections caused by antibiotic resistant microorganisms are increasing globally,  reaching epidemic proportions.7 Antimicrobial resistance to various classes of antibiotics  is on the rise, with the emergence of multiple drug resistance among different micro - organisms raising great concern in clinical settings.8,9 The escalating rate of microbial  resistance to several different classes of antimicrobial agents raises significant global correspondence: Mohamed ezzat el  Zowalaty laboratory of Vaccines and  Immunotherapeutics, Institute of  Bioscience, Universiti Putra Malaysia,  serdang, 43400 UPM, selangor Darul  ehsan, Malaysia email elzow001@gmail.co m  Mohd Zobir hussein  Materials synthesis and characterization  laboratory, Institute of advanced  Technology, Universiti Putra Malaysia,  serdang, 43400 UPM, selangor, Malaysia  Tel +603 8946 6801 Fax +603 8943 5380 email mzobir@upm.edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: El Zowalaty et al Running head recto: Potential antituberculosis activity of streptomycin nanocomposites DOI: http://dx.doi.org/10.2147/IJN.S74469",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijn-10-3269.PMC4425314.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijn-10-3269.PMC4425314.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijn-10-3269.PMC4425314.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/96/ijn-10-3269.PMC4425314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/e5/ijn-10-3275.PMC4425315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3275–3289International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3275OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8079 5Inducing cell cycle arrest and apoptosis  by dimercaptosuccinic acid modified Fe3O4  magnetic nanoparticles combined with nontoxic  concentration of bortezomib and gambogic  acid in rPMI-8226 cells Wei Zhang1,* lixing Qiao2,* Xinchao Wang3,* ravichandran senthilkumar1 Fei Wang1 Baoan chen1,4 1Medical school, southeast University,   Nanjing, People’s republic of china;  2Department of Pediatrics, Zhongda  hospital, Medical school, southeast  University, Nanjing, People’s republic  of china; 3Department of Thyroid and  Breast, the Fourth central hospital,   Tianjin, People’s republic of china;  4Department of hematology and  Oncology, Zhongda hospital, Medical  school, southeast University, Nanjing,   People’s republic of china *These authors contributed equally  to this workAbstract:  The purpose of this study was to determine the potential benefits of combination  therapy using dimercaptosuccinic acid modified iron oxide (DMSA-Fe3O4) magnetic nanoparticles  (MNPs) combined with nontoxic concentration of bortezomib (BTZ) and gambogic acid (GA) on  multiple myeloma (MM) RPMI-8226 cells and possible underlying mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/cd/e5/ijn-10-3275.PMC4425315.pdf
"It has been demonstrated that  the synergetic drug combinations of BTZ with adriamycin and dexamethasone5,6 correspondence: Baoan chen Department of hematology and  Oncology, Zhongda hospital, Medical  school, southeast University,   87 DingjiaQiao road, Nanjing 210009,  People’s republic of china Tel +86 25 8327 2006 Fax +86 25 8327 2011 email  cba8888@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: BTZ-GA/DMSA-Fe3O4 MNPs to treat MM RPMI-8226 cells DOI: http://dx.doi.org/10.2147/IJN.S80795",Non-OADS,/arxiv_data1/oa_pdf/cd/e5/ijn-10-3275.PMC4425315.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cd/e5/ijn-10-3275.PMC4425315.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/e5/ijn-10-3275.PMC4425315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/dc/ppa-9-609.PMC4425316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 609–617Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  609Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S8255 5development of a patient decision aid for type 2   diabetes mellitus for patients not achieving  glycemic control on metformin alone Alicia C Shillington1 Nananda Col2 Robert A Bailey3 Mark A Jewell1 1ePI-Q, Inc., oak Brook, Il, USA;   2Shared decision-making Resources,   georgetown, M e, USA; 3Janssen  Scientific Affairs, llC, Raritan,   NJ, USAPurpose:  To describe the process used to develop an evidence-based patient decision aid  (PDA) that facilitates shared decision-making for treatment intensification in inadequately  controlled type 2 diabetes mellitus (T2DM) consistent with International Patient Decision  Aids Standards.",Non-OADS,/arxiv_data1/oa_pdf/e4/dc/ppa-9-609.PMC4425316.pdf
"Patient’s inadequate, incomplete, or incorrect knowledge of the benefits and risks Correspondence: Alicia C Shillington ePI-Q, Inc., 1315 West 22nd Street, Suite  410, oak Brook, Il 60523, USA tel +1 630 605 2393 Fax +1 630 570 5506 email  alicia.shillington@epi-q.com  Journal name: Patient Preference and Adherence Article Designation: Methodology Y ear: 2015 Volume: 9 Running head verso: Shillington et al Running head recto: PDA for T2DM DOI: http://dx.doi.org/10.2147/PPA.S82555 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/e4/dc/ppa-9-609.PMC4425316.pdf
Or use: http://youtu.be/p24Oa_27td 4Video abstract,Non-OADS,/arxiv_data1/oa_pdf/e4/dc/ppa-9-609.PMC4425316.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e4/dc/ppa-9-609.PMC4425316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/7c/ijn-10-3171.PMC4425317.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3171–3181International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3171OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8043 4Formation of curcumin nanoparticles via solution- enhanced dispersion by supercritical cO2 Zheng Zhao1,3 Maobin Xie2 Yi li2 aizheng chen4 gang li5 Jing Zhang2 huawen hu2 Xinyu Wang1,3 shipu li1,3 1state Key lab of advanced  Technology for Materials synthesis  and Processing, Wuhan University of  Technology, Wuhan, People’s republic  of china; 2Institute of Textiles and  clothing, The hong Kong Polytechnic  University, hong Kong; 3Biomedical  Materials and engineering research  center of hubei Province, Wuhan  University of T echnology, Wuhan,   People’s republic of china; 4college  of chemical engineering, huaqiao  University, Xiamen, People’s republic  of china; 5National engineering  laboratory for Modern silk, college  of T extile and clothing engineering,   soochow University, suzhou, People’s  republic of chinaAbstract:  In order to enhance the bioavailability of poorly water-soluble curcumin, solution- enhanced dispersion by supercritical carbon dioxide (CO2) (SEDS) was employed to prepare  curcumin nanoparticles for the first time.",Non-OADS,/arxiv_data1/oa_pdf/18/7c/ijn-10-3171.PMC4425317.pdf
"Decreasing the particle size of these drugs can correspondence: Yi li Institute of Textiles and clothing, The  hong Kong Polytechnic University,  11 Yuk choi road, hung hom,  hong Kong Tel +852 2766 6479 Fax +852 2773 1432 email tcliyi@polyu.edu.h k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhao et al Running head recto: Formation of curcumin nanoparticles by the SEDS process DOI: http://dx.doi.org/10.2147/IJN.S80434",Non-OADS,/arxiv_data1/oa_pdf/18/7c/ijn-10-3171.PMC4425317.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/18/7c/ijn-10-3171.PMC4425317.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/7c/ijn-10-3171.PMC4425317.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijn-10-3203.PMC4425318.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3203–3215International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3203OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7924 1greener synthesis of electrospun collagen/ hydroxyapatite composite ﬁbers with an excellent  microstructure for bone tissue engineering Yuanyuan Zhou1,2 hongchang Yao1 Jianshe Wang1 Dalu Wang1 Qian liu1 Zhongjun li1 1college of chemistry and Molecular  engineering, Zhengzhou University,   Zhengzhou, People’s Republic of  china; 2Institute of enviromental and  Municipal engineering, North china  University of Water resources and  electric Power, Zhengzhou, People’s  Republic of ChinaAbstract:  In bone tissue engineering, collagen/hydroxyapatite (HAP) fibrous composite  obtained via electrospinning method has been demonstrated to support the cells’ adhesion and  bone regeneration.",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijn-10-3203.PMC4425318.pdf
"The unique  characteristics of natural bones are the spatial orientation between the inorganic crys - tals and collagen macromolecules at the nanolevel,3 where nanocrystals (about 50 nm  length) of biological HAP are aligned parallel to the collagen fibrils, which is believed  to be the source of the mechanical strength of bones.4 Therefore, to a large extent such  a collagen/HAP fibrous composite with a similar composition and microstructure to  natural bone has been regarded as a prospective candidate for bone tissue engineering  and attracted much attention in recent years.correspondence: Zhongjun li college of chemistry and Molecular  engineering, Zhengzhou University,  Zhengzhou 450001, People’s Republic  of china Tel +86 371 6778 3123 Fax +86 371 6778 3123 email lizhongjun@zzu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhou et al Running head recto: Green collagen/HAP fibers for bone tissue engineering DOI: http://dx.doi.org/10.2147/IJN.S79241",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijn-10-3203.PMC4425318.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijn-10-3203.PMC4425318.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/e5/ijn-10-3203.PMC4425318.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/a3/oajsm-6-129.PMC4425319.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 129–136Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  129OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8063 7effects of training and anthropometric   factors on marathon and  100 km   ultramarathon race performance giovanni Tanda1 Beat Knechtle2,3 1Polytechnic School, University  of genoa, genoa, italy;  2gesundheitszentrum St gallen,   St gallen,  3institute of Primary  care, University of Zurich, Zurich,   Switzerland correspondence: Beat Knechtle   gesundheitszentrum St gallen   26, Vadianstrasse, 9001 St gallen   Switzerland   Tel +41 71 226 8282   Fax +41 71 226 8272   email beat.knechtle@hispeed.c hBackground:  Marathon (42 km) and  100 km ultramarathon races are increasing in popularity.",Non-OADS,/arxiv_data1/oa_pdf/67/a3/oajsm-6-129.PMC4425319.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/67/a3/oajsm-6-129.PMC4425319.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/a3/oajsm-6-129.PMC4425319.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/69/ijn-10-3291.PMC4425320.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3291–3302International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3291OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7881 4hydroxypropyl- β-cyclodextrin functionalized  calcium carbonate microparticles as a potential  carrier for enhancing oral delivery of water- insoluble drugs lihua Zhang1 Wufu Zhu2 Qisi lin1 Jin han1 liqun Jiang1 Yanzhuo Zhang1,3 1Jiangsu Key laboratory of New  Drug research and clinical Pharmacy,   Xuzhou Medical college, Xuzhou,   People’s republic of china; 2school  of Pharmacy, Jiangxi science and  T echnology Normal University,   Nanchang, People’s republic of china;   3Department of Pharmaceutics, school  of Pharmacy, Xuzhou Medical college,   Xuzhou, People’s republic of chinaAbstract:  The objective of the present study was to demonstrate that a novel hydroxypropyl- β-cyclodextrin functionalized calcium carbonate (HP- β-CD/CC) based amorphous solid disper - sion (ASD) can be used to increase the solubility and oral bioavailability of water-insoluble  drugs.",Non-OADS,/arxiv_data1/oa_pdf/1f/69/ijn-10-3291.PMC4425320.pdf
"Keywords:  nanopore, solid dispersion, solubility, dissolution rate, bioavailability Introduction It is estimated that more than two-thirds of the compounds currently emerging from  the drug discovery pipeline have a solubility ,100 μg/mL and thus, according to the  definition of the United States Pharmacopeia, they may be considered poorly soluble or  insoluble in aqueous media.1,2 The poor aqueous solubility of an active pharmaceutical  ingredient (API) presents a major challenge for the drug development industry when  developing dosage forms for API belonging to biopharmaceutical classification system  (BCS) classes II (poor solubility and high permeability) and IV (poor solubility and poor  permeability).3–5 Water-insoluble drugs exhibit low oral bioavailability and are inef - fective therapeutically due to their low dissolution profile in physiological fluids.6,7 In recent years, there has been considerable interest in developing mesoporous inor - ganic materials as prospective oral drug carriers to improve the aqueous solubility and correspondence: Yanzhuo Zhang Department of Pharmaceutics, school of  Pharmacy, Xuzhou Medical college, PO  Box 62, 209 Tongshan road, Quanshan  District, Xuzhou, Jiangsu Province  221004, People’s republic of china   Tel +86 516 8326 2139   Fax +86 516 8326 2139   email yanzhuozhang@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: Functionalized calcium carbonate based amorphous solid dispersion DOI: http://dx.doi.org/10.2147/IJN.S78814",Non-OADS,/arxiv_data1/oa_pdf/1f/69/ijn-10-3291.PMC4425320.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/69/ijn-10-3291.PMC4425320.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/69/ijn-10-3291.PMC4425320.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/cc/ijn-10-3245.PMC4425321.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3245–3267International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3245RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7748 0Targeted delivery of brain-derived neurotrophic  factor for the treatment of blindness and deafness Igor Khalin1 Renad Alyautdin2 Ganna Kocherga3 Muhamad Abu Bakar1 1Faculty of Medicine and Defence  Health, National Defence University  of Malaysia, Kuala Lumpur, Malaysia;   2Scientific Centre for expertise of  Medical Application Products, Moscow,   Russia; 3Ophthalmic Microsurgery  Department, International Medical  Center Oftalmika, Kharkiv, UkraineAbstract:  Neurodegenerative causes of blindness and deafness possess a major challenge in  their clinical management as proper treatment guidelines have not yet been found.",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/ijn-10-3245.PMC4425321.pdf
"Eventually, the main approaches of BDNF delivery to the posterior segment Correspondence: Igor Khalin Faculty of Medicine and Defence Health,  National Defence University of Malaysia,  Sungai Besi Camp, Kuala Lumpur 57000,  Malaysia Tel +60 11 1115 2725 email khalins@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Khalin et al Running head recto: BDNF as a therapeutic strategy for blindness and deafness DOI: http://dx.doi.org/10.2147/IJN.S77480",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/ijn-10-3245.PMC4425321.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs300/en /.,Non-OADS,/arxiv_data1/oa_pdf/d4/cc/ijn-10-3245.PMC4425321.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d4/cc/ijn-10-3245.PMC4425321.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/cc/ijn-10-3245.PMC4425321.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/b4/ijn-10-3217.PMC4425322.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3217–3229International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3217OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8206 1Oxidative stress by layered double hydroxide  nanoparticles via an sFK-JNK and p38-NF- κB  signaling pathway mediates induction of interleukin-6  and interleukin-8 in human lung epithelial cells soo-Jin choi hee-Jeong Paek Jin Yu Department of Food science and  T echnology, seoul Women’s University,   seoul, republic of KoreaAbstract:  Anionic nanoclays are layered double hydroxide nanoparticles (LDH-NPs) that have  been shown to exhibit toxicity by inducing reactive oxidative species and a proinflammatory  mediator in human lung epithelial A549 cells.",Non-OADS,/arxiv_data1/oa_pdf/db/b4/ijn-10-3217.PMC4425322.pdf
"Keywords:  layered double hydroxide, mitogen-activated protein kinases, Src family kinases,  nuclear factor kappa B, oxidative stress, inflammatory cytokine Introduction Nanotechnology and engineered nanoparticles have been extensively applied in  diverse industrial fields, including manufacturing, processing, materials, and consumer  products.1,2 Although nanomaterials provide many benefits related to their small size,  large surface area, and high reactivity, there is growing concern about their possible  adverse effects on human health.3,4 Further, the toxic effects of nanoparticles may be  closely associated with their size-related properties.5,6 Of the various types of nanopar - ticles, inorganic layered double hydroxide nanoparticles (LDH-NPs), also known as  anionic nanoclays, have attracted much attention as heat retention additives in plastic  films, flame retardants, stabilizing agents for polymers, precursors of catalytic and  magnetic materials, and drug delivery carriers in biology and medicine.7,8 LDH-NPs  have the potential for widespread use due to their lamellar structures, which allow  intercalation of anionic molecules between layers, enabling their controlled release  and protecting them from surrounding environmental conditions.9correspondence: soo-Jin choi seoul Women’s University, 621  hwarang-ro, Nowon-gu, seoul 139-774,  republic of Korea Tel +82 2 9705 634 Fax +82 2 9705 977 email sjchoi@swu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Choi et al Running head recto: Toxicity mechanism of layered double hydroxides in lung epithelial cells DOI: http://dx.doi.org/10.2147/IJN.S82061",Non-OADS,/arxiv_data1/oa_pdf/db/b4/ijn-10-3217.PMC4425322.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/db/b4/ijn-10-3217.PMC4425322.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/b4/ijn-10-3217.PMC4425322.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/39/ott-8-985.PMC4425323.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 985–990OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  985ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7883 6Impact of beta-blockers on prostate cancer  mortality: a meta-analysis of 16,825 patients Hua Lu1,2 Xingjie Liu2 Fengfu Guo2 Shanfeng Tan2 Guangjian Wang2 Hongjun Liu2 Jianming Wang2 Xiangfei He2 Yanshuai Mo2 Benkang Shi1 1Department of Urology, Qilu  Hospital of Shandong University,   Shandong, People’s Republic of  China; 2Department of Urology, Linyi  People’s Hospital, Shandong, People’s  Republic of ChinaIntroduction:  Increasing evidence suggests that beta-blocker use might be associated with  reduced mortality in prostate cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8f/39/ott-8-985.PMC4425323.pdf
"Beta-blockers were also found to increase the anti-angiogenic effects Correspondence: Hua Lu Department of Urology, Qilu Hospital  of Shandong University, No 107 Jinan  culture road, District of Lixia, Shandong,  250012, People’s Republic of China Tel +86 539 822 6999 Fax +86 539 822 6999 Email luhua1116@163.co m;   luhua1111@yeah.ne t Benkang Shi Department of Urology, Qilu Hospital  of Shandong University, No 107, Jinan  culture road, District of Lixia, Shandong,  250012, People’s Republic of China Tel +86 531 8216 9114 Fax +86 531 8216 9114 Email 13969006388@163.co m Journal name: OncoTargets and Therapy Article Designation: ORIGINAL RESEARCH  Y ear: 2015 Volume: 8 Running head verso: Lu et al Running head recto: Impact of beta-blockers on prostate cancer mortality DOI: http://dx.doi.org/10.2147/OTT.S78836",Non-OADS,/arxiv_data1/oa_pdf/8f/39/ott-8-985.PMC4425323.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8f/39/ott-8-985.PMC4425323.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/39/ott-8-985.PMC4425323.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/0e/tcrm-11-705.PMC4425324.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 705–712Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  705Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6465 7Practical use of sevelamer in chronic kidney disease  patients on dialysis in People’s Republic of China Correspondence: Bin Fu Second Affiliated Hospital to Tianjin  University of Traditional Chinese  Medicine, 861 ZhenLi Street, Tianjin,  300150, People’s Republic of China Tel +86 22 6033 5393 email fubin_nephrology@163.co m Lin Meng1,2 Bin Fu1 1Department of Nephrology,   Second Affiliated Hospital to Tianjin  University of Traditional Chinese  Medicine, Tianjin, People’s Republic  of China; 2Tianjin University of  Traditional Chinese Medicine, Tianjin,   People’s Republic of China Abstract:  Hyperphosphatemia is a common complication of dialysis patients.",Non-OADS,/arxiv_data1/oa_pdf/2b/0e/tcrm-11-705.PMC4425324.pdf
"Overview of sevelamer Sevelamer is a high molecular weight (1,016 Da) cationic hydrogel polymer/resin that  prevents absorption of dietary phosphate by binding it in the gastrointestinal (GI) tract.2,3  Sevelamer has sustained a clinically preferred safety profile over other calcium-based Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Meng and Fu Running head recto: Use of sevelamer in People’s Republic of China DOI: http://dx.doi.org/10.2147/TCRM.S64657",Non-OADS,/arxiv_data1/oa_pdf/2b/0e/tcrm-11-705.PMC4425324.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/2b/0e/tcrm-11-705.PMC4425324.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/0e/tcrm-11-705.PMC4425324.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/57/ndt-11-1145.PMC4425325.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1145–1148Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1145Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8313 7Depressive disorders co-existing with addison– Biermer anemia – case report Correspondence: Mark Jean Just piekary Medical Centre, Department  of General and endocronological surgery,  Municipal Hospital in piekary slaskie,  11 szpitalna street, piekary slaskie,  41-940, poland email marek.just@wp.p lMark Jean Just1 Mariusz Kozakiewicz2 1Department of General and  endocronological surgery, piekary  Medical Centre, piekary slaskie,   2Department of Food Chemistry  Collegium Medicum in Bydgoszcz,   Nicolaus Copernicus University,   T oruń, PolandBackground:  Anemia is a disease that can co-exist with depression, other mental disorders,  or somatic diseases.",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ndt-11-1145.PMC4425325.pdf
"Treatment of depression and conversion symptoms should combine  pharmaco- and psychotherapy.6 For severe depression, treatment with anti-depressive  drugs alone may be insufficient, requiring additional inclusion of atypical neuroleptics.7  It is worth noting that in people suffering from depression and with a positive his - tory of somatic diseases, such as Addison–Biermer anemia or endocrine diseases, the  neuroleptic malignant syndrome (NMS) is more likely to occur following neuroleptic  treatment, than in people without somatic diseases.Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Just and Kozakiewicz Running head recto: Depressive disorders co-existing with anemia DOI: http://dx.doi.org/10.2147/NDT.S83137",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ndt-11-1145.PMC4425325.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e2/57/ndt-11-1145.PMC4425325.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/57/ndt-11-1145.PMC4425325.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 669–681Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  669ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8162 3association of diabetes-related distress,  depression, medication adherence, and health- related quality of life with glycated hemoglobin,  blood pressure, and lipids in adult patients with  type 2 diabetes: a cross-sectional study  Correspondence: Boon-how Chew Department of Family Medicine, Faculty  of Medicine and health sciences,  Universiti Putra Malaysia, 43400 serdang,  selangor, Malaysia Tel +60 3 8947 2520  Fax +60 3 8947 2328  email chewboonhow@gmail.co m Boon-how Chew1 Mohd-sidik sherina2 noor-hasliza hassan3 1Department of Family Medicine,   2Department of Psychiatry, Faculty  of Medicine and health sciences,   Universiti Putra Malaysia, serdang;   3Klinik Kesihatan Dengkil, Jalan  Dengkil, MalaysiaAbstract:  This study examined the associations of diabetes-related distress (DRD), depressive  symptoms, health-related quality of life (HRQoL), and medication adherence with glycemia,  blood pressure (BP), and lipid biomarkers in adults with type 2 diabetes mellitus (T2D).",Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
"Keywords:  distress, depression, medication adherence, quality of life, type 2 diabetes mellitus,  glycated hemoglobin, blood pressure, lipids Introduction It is widely known that patients living with type 2 diabetes (T2D) carry a high burden  of psychosocial problems1 and psychological disorders.2–4 Worrying about the future,  the possibility of complications, and feelings of guilt or anxiety when “off-track” with  diabetes management are reported to be sources of significant distress.5,6  Emotional distress in people with diabetes mellitus mainly comprises diabetes- related distress (DRD) and depression.7 Among adults with T2D, DRD and depression Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Chew et al Running head recto: DRD, DS, MA, HRQoL, and biomarkers of risk DOI: http://dx.doi.org/10.2147/TCRM.S81623 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
Or use: http://youtu.be/Nyq75N30tY UVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
"Available from: http://www.moh.gov.my/ attachments/3878.pd f. Accessed April 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/6d/tcrm-11-669.PMC4425326.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/07/ijn-10-3163.PMC4425327.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3163–3170International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3163ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7596 2Delivery as nanoparticles reduces imatinib  mesylate-induced cardiotoxicity and improves  anticancer activity Gregory Marslin1 Ann Mary Revina2,3 Vinoth Kumar Megraj  Khandelwal4 Krishnamoorthy Balakumar5 Jose Prakash6 Gregory Franklin1,* Caroline J Sheeba2,3,7,* 1AgroBioPlant Group, Centre for  the Research and Technology of  Agro-Environment and Biological  Sciences (CITAB), University of  Minho, Braga, Portugal; 2Life and  Health Sciences Research Institute  (ICVS), School of Health Sciences,   University of Minho, Braga, Portugal;   3ICVS/3B’s – PT Government  Associate Laboratory, Braga/ Guimarães, Portugal; 4Department  of Translational Pharmacology,   Consorzio Mario Negri Sud, Santa  Maria Imbaro, Italy; 5Department  of Pharmaceutics, PSG College  of Pharmacy, Coimbatore, Tamil Nadu,   India; 6Department of Pharmaceutics,   Vels University, Chennai, Tamil Nadu,   India; 7Regenerative Medicine Program,  Department of Biomedical Sciences  and Medicine, University of Algarve,  Faro, Portugal *These authors contributed equally  to this workAbstract:  Clinical effectiveness of imatinib mesylate in cancer treatment is compromised by  its off-target cardiotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/9b/07/ijn-10-3163.PMC4425327.pdf
"However, KIT and PDGFR are also expressed in normal cells, where they perform Correspondence: Gregory Franklin AgroBioPlant Group, Centre for  the Research and Technology of  Agro-Environment and Biological  Sciences (CITAB), University of Minho,  4710-057 Braga, Portugal Tel +351 2 5360 4865 Fax +351 2 5360 4809 Email franklin@bio.uminho.p t Journal name: International Journal of Nanomedicine Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 10 Running head verso: Marslin et al Running head recto: Nanoparticle delivery of imatinib DOI: http://dx.doi.org/10.2147/IJN.S75962",Non-OADS,/arxiv_data1/oa_pdf/9b/07/ijn-10-3163.PMC4425327.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9b/07/ijn-10-3163.PMC4425327.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/07/ijn-10-3163.PMC4425327.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/3c/ijwh-7-459.PMC4425328.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 459–476International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  459RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6947 2Outcomes for women admitted to a mother  and baby unit: a systematic review Rebecca Gillham1 Anja Wittkowski1,2 1School of Psychological Sciences,   University of Manchester, 2Manchester  Mental Health and Social Care Trust,   Manchester, UKAbstract:  Mother and baby units (MBUs) provide inpatient psychiatric care for mothers and  their infants up to a year after childbirth.",Non-OADS,/arxiv_data1/oa_pdf/55/3c/ijwh-7-459.PMC4425328.pdf
"To date, no reviews have evaluated its psychological outcomes,  despite the important clinical treatment these units provide for mothers in crisis.Correspondence: Anja Wittkowski School of Psychological Sciences,  University of Manchester, 2nd floor,  Zochonis Building, Brunswick Street,  Manchester M13 9PL, UK Tel +44 161 306 0400 Fax +44 161 306 0401 email anja.wittkowski@manchester.ac.u k Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Gillham and Wittkowski Running head recto: Review of outcomes for women admitted to an MBU DOI: http://dx.doi.org/10.2147/IJWH.S69472",Non-OADS,/arxiv_data1/oa_pdf/55/3c/ijwh-7-459.PMC4425328.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/55/3c/ijwh-7-459.PMC4425328.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/3c/ijwh-7-459.PMC4425328.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/02/ndt-11-1137.PMC4425329.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1137–1143Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1137OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8253 2evaluating depressive symptoms in mania: a  naturalistic study of patients with bipolar disorder allan h Y oung1  Jonas eberhard1,2 1institute of Psychiatry, King’s college  london, london, UK; 2corporate  Medical affairs, h. lundbeck a/s,   copenhagen, DenmarkObjective:  This study aimed to evaluate patients with bipolar I disorder (BD-I) who have  mania with depressive symptoms and who meet the new “with mixed features” specifier of the  Diagnostic and Statistical Manual of Mental Disorders , fifth edition (DSM-5).",Non-OADS,/arxiv_data1/oa_pdf/66/02/ndt-11-1137.PMC4425329.pdf
"Keywords:  bipolar disorder, mania with depressive symptoms, mixed features, DSM-5 Introduction Bipolar I disorder (BD-I) is a chronic disease that has a lifetime prevalence of  approximately 1% and is characterized by periods of mania, depression, or combina - tions of both (mixed states).1–3 Manic episodes with depressive symptoms are generally  more severe and are associated with a poorer prognosis, than pure manic episodes.4,5  However, although these types of mixed episodes are common – occurring in at least  30% of patients with BD5–7 – they are not easily or consistently identified by clinicians.4,5  Reaching a correct diagnosis through the systematic search for depressive symptoms  during a manic episode is likely to be important for optimizing patient outcomes.4 Recently, the Diagnostic and Statistical Manual of Mental Disorders , fifth edition  (DSM-5) provided a new “with mixed features” specifier for hypomanic, manic, or  depressive episodes.8 At least three of six depressive symptoms must be present to  allocate the specifier to a manic or hypomanic episode.8 To accompany this, a short, correspondence: allan h Young institute of Psychiatry, Psychology and  Neurosciences, PO72 De crespigny Park,  Denmark hill, london se5 8aF, UK Tel +44 207 848 0088 Fax +44 207 848 0298 email allan.young@kcl.ac.u k Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Y oung and Eberhard Running head recto: Evaluating depressive symptoms in mania (bipolar disorder) DOI: http://dx.doi.org/10.2147/NDT.S82532",Non-OADS,/arxiv_data1/oa_pdf/66/02/ndt-11-1137.PMC4425329.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/66/02/ndt-11-1137.PMC4425329.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/02/ndt-11-1137.PMC4425329.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/2b/imcrj-8-097.PMC4425330.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 97–98International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  97Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6565 5opana® eR induced thrombotic  thrombocytopenic purpura Nabil Kotbi Bernadine Han Duncan Cheng anna e odom Department of p sychiatry,    Weill Cornell Medical College,    New Y ork-p resbyterian Hospital,    White plains, NY, Usa Correspondence: anna e odom   21 Bloomingdale Road,   White plains, NY 10605, Usa   tel +1 646 734 3697   Fax +1 914 682 6958   email anna.odom.phd@gmail.co mAbstract:  We present the case of a patient who developed thrombotic thrombocytopenic  purpura  (TTP) following intravenous injection of Opana® ER.",Non-OADS,/arxiv_data1/oa_pdf/47/2b/imcrj-8-097.PMC4425330.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/47/2b/imcrj-8-097.PMC4425330.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/2b/imcrj-8-097.PMC4425330.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/f0/opth-9-751.PMC4425331.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 751–755Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  751Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7880 3T ube shunt coverage with gamma-irradiated  cornea allograft (Visiongraft) Feyzahan ekici Marlene r Moster Victor Cvintal Wanda D hu Michael Waisbourd glaucoma research Center, Wills eye  hospital, Philadelphia, P a, UsaPurpose:  To investigate the clinical outcomes of tube shunt coverage using sterile  gamma-irradiated cornea allograft.",Non-OADS,/arxiv_data1/oa_pdf/0f/f0/opth-9-751.PMC4425331.pdf
"By avoiding the risk of bacterial, fungal, and virus transmission it offers more  safety when compared to fresh corneas.15 In recent pilot studies, gamma-irradiated  sterile cornea allograft has been reported effective and safe as a coverage material for  glaucoma tube shunt surgery in a limited number of patients.16,17Correspondence: Feyzahan ekici glaucoma research Center, Wills eye  hospital, 840 Walnut street, suite 1140,  Philadelphia, Pa 19107, Usa Tel +1 215 928 3200 Fax +1 215 928 0166 email feyzahan@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ekici et al Running head recto: Gamma-irradiated cornea allograft for tube shunt coverage DOI: http://dx.doi.org/10.2147/OPTH.S78803",Non-OADS,/arxiv_data1/oa_pdf/0f/f0/opth-9-751.PMC4425331.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0f/f0/opth-9-751.PMC4425331.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/f0/opth-9-751.PMC4425331.pdf
"Available from: http://www.tbionline.org/accreditation- licensure.ph p. Accessed 3 April, 2014.",Non-OADS,/arxiv_data1/oa_pdf/0f/f0/opth-9-751.PMC4425331.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/c3/jpr-8-203.PMC4425332.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 203–215Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  203ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7817 7Priority interventions to improve the  management of chronic non-cancer pain in  primary care: a participatory research of the  accORD program lyne lalonde1–4 Manon choinière3,5 elisabeth Martin3 lise lévesque3 Éveline hudon2,3,6 Danielle Bélanger2 sylvie Perreault1,7 anaïs lacasse8 Marie-claude laliberté1,9 1Faculty of Pharmacy, Université de  Montréal, Montreal, Qc , canada; 2Équipe  de recherche en soins de première ligne,   centre de santé et de services sociaux  de laval, laval, Qc , canada; 3centre  de recherche, centre hospitalier de  l’Université de Montréal (cRchUM),   Montreal, Qc , canada; 4sanofi aventis  endowment chair in ambulatory  Pharmaceutical care, Faculty of Pharmacy,   Université de Montréal and centre de  santé et de services sociaux de laval, Qc ,   canada; 5Department of anesthesiology,   Faculty of Medicine, Université de Montréal,   Montreal, Qc , canada; 6Department of  Family Medicine and emergency, Faculty of  Medicine, Université de Montréal, Montreal,   Qc, canada; 7sanofi aventis endowment  chair in Drug Utilization, Faculty of  Pharmacy, Université de Montréal,   Montreal, Qc , canada; 8Département des  sciences de la santé, Université du Québec  en abitibi-Témiscamingue, Rouyn-n oranda,   Qc, canada; 9abbVie corporation,   st-laurent, Qc , canada correspondence: lyne lalonde   centre de recherche, centre   hospitalier de l’Université de Montréal,   Tour st-antoine, Room s03.436,   850 rue st-Denis, Montreal,   Qc h2X 0a9, canada   Tel +1 514 890 8000 ext 15491   Fax +1 514 412 7038   email lyne.lalonde@umontreal.c aPurpose:  There is evidence that the management of chronic non-cancer pain (CNCP) in pri - mary care is far from being optimal.",Non-OADS,/arxiv_data1/oa_pdf/08/c3/jpr-8-203.PMC4425332.pdf
"Available  from: http://www.enniscentre.com/wp-content/uploads/2012/04/ Prejudice-again-chronic-pain.pd f. Accessed September 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/08/c3/jpr-8-203.PMC4425332.pdf
Available  from: http://www.cfhi-fcass.ca/Migrated/PDF/ResearchReports/  CommissionedResearch/teamwork-synthesis-report_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/c3/jpr-8-203.PMC4425332.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/08/c3/jpr-8-203.PMC4425332.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/c3/jpr-8-203.PMC4425332.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/54/ijn-10-3193.PMC4425333.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3193–3201International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3193OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7580 2Integration of nondegradable polystyrene and  degradable gelatin in a core–sheath nanofibrous  patch for pelvic reconstruction liangpeng ge1–5,* Qingtao li2,3,* Junzi Jiang2,3 Xiaoyan Y ou1 Zuohua liu1 Wen Zhong6 Y ong huang1 Malcolm MQ Xing2,3 1chongqing academy of animal  sciences, chongqing, People’s republic  of china; 2Department of Mechanical  and Manufacturing engineering,   Biochemistry and Medical genetics,   University of Manitoba, Winnipeg, MB,   canada; 3Manitoba Institute of child  health, Winnipeg, MB, canada; 4Key  laboratory of Pig Industry sciences,   Ministry of agriculture,chongqing,   People’s republic of china;   5chongqing Key laboratory of Pig  Industry sciences, chongqing, People’s  republic of china; 6Department of  Textile sciences, Faculty of human  ecology, University of Manitoba,   Winnipeg, MB, canada *These authors contributed equally  to this workAbstract:  Pelvic organ prolapse (POP) is a serious health issue affecting many adult women.",Non-OADS,/arxiv_data1/oa_pdf/31/54/ijn-10-3193.PMC4425333.pdf
"Their structural and functional proteins are similar to the native mammalian extracellular correspondence: Malcolm MQ Xing Department of Mechanical and  Manufacturing engineering,  Biochemistry and Medical genetics,  University of Manitoba, 75a chancellors  circle, University of Manitoba, MB r3T  2N2, canada email m alcolm.xing@umanitoba.c a  Yong huang chongqing academy of animal  sciences, No.770, changzhou road,  rongchang, chongqing, 402460,  People’s republic of china   email 329439047@qq.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ge et al Running head recto: Nondegradable polystyrene/degradable gelatin in pelvic reconstruction DOI: http://dx.doi.org/10.2147/IJN.S75802",Non-OADS,/arxiv_data1/oa_pdf/31/54/ijn-10-3193.PMC4425333.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/54/ijn-10-3193.PMC4425333.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/54/ijn-10-3193.PMC4425333.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/6e/prbm-8-115.PMC4425334.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 115–131Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  115Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S5860 1A selective review of glutamate pharmacological  therapy in obsessive–compulsive and related  disorders Marco A Grados1 elizabeth B Atkins2 Gabriela i Kovacikova3 erin Mcvicar4 1Division of Child and Adolescent  Psychiatry, Johns Hopkins University  School of Medicine, Baltimore,   MD, 2Department of Psychology,   Smith College, Northampton, MA,   3Department of Psychology, wellesley  College, wellesley, MA,  4Susquehanna  University, Selinsgrove, PA, USA Correspondence: Marco A Grados   Division of Child and Adolescent  Psychiatry, Johns Hopkins University  School of Medicine,  1800 Orleans St –   12th floor, Baltimore, MD,  21287, USA   Tel +1 443 287 2291  Fax +1 410 955 8691  email mjgrados@jhmi.ed uAbstract:  Glutamate, an excitatory central nervous system neurotransmitter, is emerging as a  potential alternative pharmacological treatment when compared to gamma-aminobutyric acid  (GABA)-, dopamine-, and serotonin-modulating treatments for neuropsychiatric conditions.",Non-OADS,/arxiv_data1/oa_pdf/5d/6e/prbm-8-115.PMC4425334.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/5d/6e/prbm-8-115.PMC4425334.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5d/6e/prbm-8-115.PMC4425334.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/42/idr-8-083.PMC4425335.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 83–88Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  83ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S8034 1Discrepancy in MALDI-TOF MS identification   of uncommon gram-negative bacteria from   lower respiratory secretions in patients   with cystic fibrosis atqah abdulWahab1,2 saad J Taj-aldeen3 emad Bashir Ibrahim3 eman Talaq4 Marawan abu-Madi4 Rashmi Fotedar5 1Department of Pediatrics, hamad  Medical corporation, Doha, Qatar;   2Department of Pediatrics, Weill  cornell Medical college, Doha,  Qatar;  3Microbiology Division,  Department of laboratory  Medicine and Pathology, hamad  Medical corporation, Doha, Qatar;   4Department of health sciences,  college of arts and sciences,  Qatar University, Doha, Qatar;   5Biotechnology center, Ministry of  environment, Doha, Qatar correspondence: atqah abdulWahab   Department of Pediatrics, hamad   Medical corporation, PO Box  3050,   Doha, Qatar   Mobile +974 55 544 911   Tel +974 44 392 834   Fax +974 44 439 571   email atqah2015@gmail.co mIntroduction:  Early identification of microbial organisms from respiratory secretions of  patients with cystic fibrosis (CF) is important to guide therapeutic decisions.",Non-OADS,/arxiv_data1/oa_pdf/37/42/idr-8-083.PMC4425335.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/37/42/idr-8-083.PMC4425335.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/42/idr-8-083.PMC4425335.pdf
Available from https://www.cysticfibrosis.org.uk/media/82034/ CD_Laboratory_Standards_Sep_1 0. pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/42/idr-8-083.PMC4425335.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/f9/ott-8-969.PMC4425336.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 969–975OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  969Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7909 9GSTM1  null genotype and gastric cancer risk in  the chinese population: an updated meta-analysis  and review Xi-liang Zhang Y ong-hui cui Department of gastroenterology,   The First People’s hospital of  shangqiu city, shangqiu, henan,   People’s republic of chinaAbstract:  Although a number of studies have been conducted on the association between  the GSTM1  null genotype and gastric cancer in People’s Republic of China, this association  remains elusive and controversial.",Non-OADS,/arxiv_data1/oa_pdf/ef/f9/ott-8-969.PMC4425336.pdf
"The most common genotype of GSTM1  gene is a homozygous deletion  (null genotype), which has been suggested to be associated with the loss of enzyme  activity and increased vulnerability to cytogenetic damage that resulted in the increased correspondence: Xi-liang Zhang Department of gastroenterology,  The First People’s hospital of shangqiu  city, no 292, Kai Xuannan rd,  shangqiu, henan, 476100, People's  republic of china Tel +86 370 325 5209 Fax +86 370 325 5209 email xiliangzhangmed@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang and Cui Running head recto: GSTM1  null genotype and gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S79099",Non-OADS,/arxiv_data1/oa_pdf/ef/f9/ott-8-969.PMC4425336.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ef/f9/ott-8-969.PMC4425336.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/f9/ott-8-969.PMC4425336.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 691–703Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  691Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5429 8Optimal management of constipation associated  with irritable bowel syndrome Manuele Furnari1 Nicola de Bortoli2 irene Martinucci2 Giorgia Bodini1 Matteo Revelli3 elisa Marabotto1 Alessandro Moscatelli1 Lorenzo Del Nero1 edoardo Savarino4 edoardo G Giannini1 vincenzo Savarino1 1Division of Gastroenterology,   Department of internal Medicine,   University of Genoa, Genoa, italy;   2Division of Gastroenterology,   Department of Translational Research  and New Technology in Medicine  and Surgery, University of Pisa, Pisa,   italy; 3Department of Radiology,   San Bartolomeo Hospital, Sarzana,   italy; 4Division of Gastroenterology,   Department of Surgery, Oncology,   and Gastroenterology, University  of Padua, Padua, italyAbstract:  Irritable bowel syndrome (IBS) is a common chronic functional disorder of the  gastrointestinal tract, meanly characterized by recurrent abdominal pain or discomfort and altered  bowel habit.",Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
"It must be acknowledge that these classes are inclined to Correspondence: Manuele Furnari Division of Gastroenterology,  Department of internal Medicine,  University of Genoa, viale Benedetto Xv,  6, 16132 Genoa, italy Tel +39 010 353 8956 Fax +39 010 353 8956 email manuele.furnari@unige.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Furnari et al Running head recto: Management of IBS-C DOI: http://dx.doi.org/10.2147/TCRM.S54298",Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
"Available from: http://www.fda.gov/downloads/ Drugs/Guidances/UCM205269.pd f. Accessed March 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
Available from:  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm317505.ht m  84.,Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/d2/tcrm-11-691.PMC4425337.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/2a/ndt-11-1131.PMC4425338.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1131–1136Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1131OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8321 6in patients suffering from idiopathic central serous  chorioretinopathy, anxiety scores are higher than  in healthy controls, but do not vary according to  sex or repeated central serous chorioretinopathy Nooshin Bazzazi1 Mohammad ahmadpanah2 siamak akbarzadeh1 Mohammad ali seif rabiei3 edith holsboer-Trachsler4 serge Brand4,5 1Department of Ophthalmology,   Faculty of Medicine, hamadan  University of Medical sciences,   hamadan, iran; 2research center for  Behavioral Disorders and  substance  abuse, hamadan University of Medical  sciences; hamadan, iran; 3Department  of social Medicine, Faculty of  Medicine, hamadan University  of Medical sciences, hamadan, iran;   4Psychiatric clinics of the University  of Basel, center for affective,   stress and sleep Disorders,  Basel,   switzerland; 5Department of sport  and health science, sport science  section, University of Basel, Basel,   switzerlandIntroduction:  Idiopathic central serous chorioretinopathy (CSCR) is a relatively common  ophthalmic disorder characterized by the development of a serous detachment of the sensory  retina.",Non-OADS,/arxiv_data1/oa_pdf/7e/2a/ndt-11-1131.PMC4425338.pdf
"Symptomatic patients may experience sudden onset  of dim and blurred vision, micropsia, metamorphopsia, decreased color vision, and  central scotoma.5 Although the condition is normally unilateral, bilateral involvement  have been reported in about 40% of cases.1,2 Further, CSCR typically occurs more  frequently in young males than in females.3 Thus, males show a significantly higher  mean annual incidence of CSCR than females, and the peak mean annual incidence  occurs in men between 35 and 39 years.6 In most cases, CSCR is self-limiting and  resolves spontaneously in 2–3 months, though usually without a complete recovery of  visual function.3 Furthermore, some patients may suffer from persistent or recurrent correspondence: serge Brand Psychiatric clinics of the University of  Basel, center for affective, stress and  sleep Disorders, Wilhelm Klein-strasse  27, 4012 Basel, switzerland Tel +41 61 32 55 114 Fax +41 61 32 55 513 email serge.brand@upkbs.c hJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Bazzazi et al Running head recto: Anxiety and central serous chorioretinopathy DOI: http://dx.doi.org/10.2147/NDT.S83216",Non-OADS,/arxiv_data1/oa_pdf/7e/2a/ndt-11-1131.PMC4425338.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7e/2a/ndt-11-1131.PMC4425338.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/2a/ndt-11-1131.PMC4425338.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 619–625Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  619Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S8055 2Improving access to shared decision-making  for hispanics/latinos with inadequately controlled  type 2 diabetes mellitus Jaime A davidson1 Aracely Rosales2 Alicia C Shillington3 Robert A Bailey4 Chris Kabir3 guillermo e Umpierrez5 1touchstone diabetes Center,   University of texas Southwestern  Medical Center, dallas, tX,   USA; 2Rosales Communications,   Philadelphia, PA, USA; 3ePI-Q, Inc.,   oakbrook, Il, USA; 4health economics  and outcomes Research, Janssen  Scientific Affairs, llC, Raritan, NJ,   USA; 5division of endocrinology  and Metabolism, emory University,   Atlanta, georgia, gA, USAPurpose:  To describe the cultural and linguistic adaptation and Spanish translation of an  English-language patient decision aid (PDA) for use in supporting shared decision-making in  Hispanics/Latinos with type 2 diabetes mellitus (T2DM), a group at a high risk for complications.",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
"It is being adopted by provider organizations to improve Correspondence: Alicia C Shillington ePI-Q, Inc., 1315 West 22nd Street,  Suite 410, oak Brook, Il 60523, USA tel +1 63 0605 2393 Fax +1 63 0570 5506 email alicia.shillington@epi-q.co m Journal name: Patient Preference and Adherence Article Designation: Methodology Y ear: 2015 Volume: 9 Running head verso: Davidson et al Running head recto: Patient decision aid for Latinos/Hispanics with type 2 diabetes DOI: http://dx.doi.org/10.2147/PPA.S80552",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
Excerpts that were tested in cognitive interviews con - ducted by phone in Spanish with ten Hispanics/Latinos  with T2DM are available here http://www.dovepress.com/ get_supplementary_file.php?f=80552.pd f. Interviewees were randomly selected through a nationally represented panel  of respondents (Harris Interactive) who spoke Spanish and  were included based upon the following criteria confirmed in  the interview: 1) age of 18 years or older; 2) currently being  treated with metformin for T2DM; 3) fluent in Spanish; and  4) were notified by their health care provider that they require  additional medication to help control their blood sugar.,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
Available from: http://www.census.gov/ prod/2000pubs/p20-534.pd f 3.,OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
Available from: http://www.informedmedicaldecisions.org/ what-is-shared-decision-making /.,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
"Available from: https://decisionaid.ohri.ca/docs/ develop/ODSF.pd f. Accessed October 15, 2014.",OADS,/arxiv_data1/oa_pdf/c1/fc/ppa-9-619.PMC4425339.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/44/ott-8-977.PMC4425340.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 977–984OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  977Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8237 8sirT1 expression is associated with poor  prognosis of lung adenocarcinoma chong li1,2,* lingling Wang3,* liang Zheng4 Xianghong Zhan4 Bin Xu1,2 Jingting Jiang1,2 changping Wu1,2 1Department of Tumor Biological  Treatment, the Third affiliated  hospital, soochow University,   changzhou, 2cancer immunotherapy  engineering research center  of Jiangsu Province, changzhou,   3Department of Medical education,   Jinling hospital, Medical school  of nanjing University, nanjing,   4Department of Thoracic surgery, the  Third affiliated hospital, soochow  University, changzhou, Jiangsu,   People’s republic of china *These authors contributed equally  to this workAbstract:  Several studies have reported that the overexpression of Sirtuin 1 (SIRT1) was  associated with poor prognosis in various human cancers.",Non-OADS,/arxiv_data1/oa_pdf/78/44/ott-8-977.PMC4425340.pdf
"It was reported  that SIRT1 could bind and deacetylate p53, resulting in repressing p53-mediated  transactivation.12 On the other hand, SIRT1 might also act as a tumor suppressor by  repressing several oncogenes or oncoproteins such as Survivin.13 Wang et al13 reported  that SIRT1 negatively regulated Survivin expression, leading to reduced tumor cell correspondence: changping Wu Department of Oncology, The Third  Affiliated Hospital of Soochow University,  185 Juqian road, changzhou, Jiangsu  213003, People’s republic of china Tel +86 51 968870009 Fax +86 51 986621235  email wcpjjt@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Li et al Running head recto: SIRT1 expression in lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S82378",Non-OADS,/arxiv_data1/oa_pdf/78/44/ott-8-977.PMC4425340.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/78/44/ott-8-977.PMC4425340.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/44/ott-8-977.PMC4425340.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/14/mder-8-201.PMC4425341.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 201–206Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  201ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S7799 5improving patient safety after rigid   bronchoscopy in adults: laryngeal mask   airway versus face mask – a pilot study Fulvio nisi1 antonio galzerano1 gaetano cicchitto2 Francesco Puma3 Vito aldo Peduto1 1Department of  anesthesiology,  intensive care and Pain Therapy  centre,  2Department of Pneumology  and Respiratory Medicine,  3Department of Thoracic surgery,  aO santa Maria della Misericordia,  Perugia, italy correspondence: Fulvio nisi   Department of anesthesiology, intensive  care and Pain Therapy centre, aO santa  Maria della Misericordia, via g Dottori,   06126 Perugia, italy   Tel +39 392 598 1 221  Email fulvio.nisi@gmail.co mBackground:  There are still no clear guidelines in the literature on per procedural broncho - scopic management for anesthesiologists, and few relevant datasets are available.",Non-OADS,/arxiv_data1/oa_pdf/ca/14/mder-8-201.PMC4425341.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/ca/14/mder-8-201.PMC4425341.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/11/ppa-9-607.PMC4425342.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/16/11/ppa-9-607.PMC4425342.pdf
"On page 495, author affiliations and correspondence sections  “The First Affiliated College of Medicine, Zhejiang University”  should be “The First Affiliated Hospital, College of Medicine,  Zhejiang University”.Journal name: Patient Preference and Adherence Article Designation: Corrigendum Y ear: 2015 Volume: 9 Running head verso: Liu et al Running head recto: Electronic health records and improved nursing management DOI: http://dx.doi.org/10.2147/PPA.S85715",Non-OADS,/arxiv_data1/oa_pdf/16/11/ppa-9-607.PMC4425342.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/e5/opth-9-757.PMC4425343.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 757–764Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  757Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8035 5The metabolic syndrome and severity of diabetic  retinopathy John J Chen1,2,* lucas J Wendel1,3,* emily s Birkholz1 John g Vallone4 anne l Coleman5,6 Fei Yu7 Vinit B Mahajan1,3,8 1Department of Ophthalmology and  Visual sciences, University of iowa,   iowa City, ia, Usa; 2Mayo Clinic,   rochester, M n, Usa; 3Vitreoretinal  service, University of iowa, iowa City,   ia, Usa; 4Department of Pathology,   University of southern California,   5Department of Ophthalmology,   6Department of epidemiology, school  of Public health, 7Department of  Biostatistics, University of California,   los angeles, C a, Usa; 8Omics  laboratory, University of iowa,   iowa  City, ia, Usa *These authors contributed equally  to this workBackground:  While metabolic syndrome has been strongly implicated as a risk factor for  macrovascular diseases, such as stroke and cardiovascular disease, its relationship with  microvascular diseases, including diabetic retinopathy, has been less defined.",Non-OADS,/arxiv_data1/oa_pdf/14/e5/opth-9-757.PMC4425343.pdf
"Diabetes duration,  higher average blood glucose, insulin therapy, hypertension, male sex, obesity, and  albuminuria have all been identified as independent risk factors for the develop - ment of retinopathy.5,7,8 However, other studies that refute many of these risk factors  exist.7,10 The metabolic syndrome refers to the co-occurrence of elevated plasma glucose,  excess abdominal adiposity, elevated blood pressure, and dyslipidemia.11 The clustering  of these risk factors is believed to act synergistically to cause various vascular Correspondence: Vinit B Mahajan Vitreoretinal service, Department  of Ophthalmology and Visual sciences,  University of iowa, 200 hawkins Drive,  iowa City, ia 52242, Usa Tel +1 319 356 3185 Fax +1 319 356 0363 email vinit-mahajan@uiowa.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chen et al Running head recto: Metabolic syndrome and diabetic retinopathy DOI: http://dx.doi.org/10.2147/OPTH.S80355",Non-OADS,/arxiv_data1/oa_pdf/14/e5/opth-9-757.PMC4425343.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/14/e5/opth-9-757.PMC4425343.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/e5/opth-9-757.PMC4425343.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/f2/gfv013.PMC4425480.pdf
The routine use of BIS can help to re ﬁne evaluation of the hydration status of ESRD and PD patients.SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford- journals.org.,Non-OADS,/arxiv_data1/oa_pdf/ed/f2/gfv013.PMC4425480.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/73/main.PMC4425620.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.12.004 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/8e/73/main.PMC4425620.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2,5 7e68",Non-OADS,/arxiv_data1/oa_pdf/8e/73/main.PMC4425620.pdf
http://dx.doi.org/10.1002/stem.1907 .,Non-OADS,/arxiv_data1/oa_pdf/8e/73/main.PMC4425620.pdf
http://www.cdc.gov/nchs/fastats/ adhd.htm .,OADS,/arxiv_data1/oa_pdf/71/74/40263_2015_Article_241.PMC4425805.pdf
http://www.nimh.nih.gov/health/ publications/attention-deﬁcit-hyperactivity-disorder/adhd_booklet_ CL508_144426.pdf .,Non-OADS,/arxiv_data1/oa_pdf/71/74/40263_2015_Article_241.PMC4425805.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 28169 - http://dx.doi.org/10.3402/mehd.v26.28169 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7b/18/MEHD-26-28169.PMC4425810.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 28168 - http://dx.doi.org/10.3402/mehd.v26.28168 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Presentation at the 1st International Symposium on the Microbiome in Health and Disease with a Special Focus on Autism Time Speaker Presentation Title 8:00/C18:15 Richard Frye, MD, PhD Introduction to the Symposium 8:15/C18:30 John Rodakis, BS An Autistic Child’s Response to Antibiotics: An N of One Case 8:30/C19:30 Carl Cerneglia, PhD Microbiome and the Environment 9:45/C110:45 Emma Allen-Vercoe, PhD The Human Gut Microbiota: Forgotten Organ, Important Ally 10:45/C111:45 Tore Midtvedt, PhD The Gut and the Brain: A Scandinavian way of Approaching Autism 11:45/C112:45 William Parker, PhD The (Potential) Role of Fauna and Flora Disruption in the Human Body as Constituents to the Development of Autism 1:30/C12:30 Jim Adams, PhD and Rosa Krajmalnik-Brown, PhD Gut Bacteria in Children with Autism 2:30/C13:30 Derrick MacFabe, MD Gut Bacterial Metabolites as Possible Environmental Triggers of Autism Spectrum Disorder 3:45/C14:45 Richard Frye, MD, PhD The Influence of Microbiome Metabolites on Mitochondrial Function in Children with Autism Spectrum Disorder 4:45/C15:45 Susan Swedo, MD PANDAS/PANS and the MicrobiomeRichard E. Frye and John Slattery 2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 28168 - http://dx.doi.org/10.3402/mehd.v26.28168",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol Health Dis 2015; 26: 26914, doi: http://dx.doi.org/10.3402/mehd.v26.26914 14.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol Health Dis 2015;26: 26309, doi: http://dx.doi.org/10.3402/mehd.v26.26309 16.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol Health Dis 2015; 26: 26253,doi: http://dx.doi.org/10.3402/mehd.v26.2625317.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol HealthDis 2015; 26: 27458, doi: http://dx.doi.org/10.3402/mehd.v26.27458 18.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol Health Dis 2015; 26: 26382,doi: http://dx.doi.org/10.3402/mehd.v26.26382 19.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol Health Dis 2015; 26: 26555, doi: http://dx.doi.org/10.3402/mehd.v26.26555 20.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"Microb Ecol Health Dis 2015; 26: 26878, doi: http://dx.doi.org/10.3402/mehd.v26.26878Introduction Citation: Microbial Ecology in Health & Disease 2015, 26: 28168 - http://dx.doi.org/10.3402/mehd.v26.28168 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/MEHD-26-28168.PMC4425811.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Endocrine pancreatic dys- function in the form of diabetes mellitus has also been linked to several mitochondrial diseases (81, 82) andresearch has suggested that insulin resistance, the basicGastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Propionic acid is also produced by adding high fructose corn syrup substrate to propio- nibacteria cultures, which are then inoculated into foods.Inulin propionate has recently been suggested as a weightGastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"1 of (40) for behavioral videos of propionic acidrodent model of ASD, link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747729/figure/F0001/].",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"This is important as each turn ofGastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Interestingly, the finding that the main high affinity blood /C1brain barrier transporter of propionic acid can be competi-tively inhibited by hydroxybutyrate (231) gives a potentialmechanism where ketogenic diets may work throughGastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"10 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Glob Adv Health Med 2013; 2: 52 /C166.Gastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Microb Ecol Health Dis 2012; 23: 19260, doi:http://dx.doi.org/10.3402/mehd.v23i0.19260 41.",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"12 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Mitochondrial DNA rearrangements withGastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"14 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Microb Ecol Health Dis 2012;23: 18984, doi: http://dx.doi.org/10.3402/mehd.v23i0.18984 152.",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Effects of a propionic acid- based preservative on storage characteristics, nutritive value,Gastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"16 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"Br J Surg 2001; 88: 393 /C19.Gastrointestinal and mitochondrial dysfunction in autism Citation: Microbial Ecology in Health & Disease 2015, 26: 27458 - http://dx.doi.org/10.3402/mehd.v26.27458 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/ae/MEHD-26-27458.PMC4425813.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"However, many children with ASD, especially thosethat are medically complex, demonstrate wide variability in ASD symptoms over time with waxing andwaning in theAutism and the enteric microbiome Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Autism Research Institute survey of parent ratings of treatment efﬁcacy % Worse % No change % Better Number of reports Antifungals: Diflucan 5 34 62 1,214 Antifungals: Nystatin 5 43 52 1,969Candida diet 3 39 58 1,141Autism and the enteric microbiome Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Children with ASD should be diagnosed carefully,Autism and the enteric microbiome Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"and determine its role inAutism and the enteric microbiome Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"10 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Microb Ecol Health Dis 2014; 25: 24145, doi:http://dx.doi.org/10.3402/mehd.v25.24145 9.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Microb Ecol Health Dis 2012; 23: 19260, doi:http://dx.doi.org/10.3402/mehd.v23i0.19260 13.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Microb Ecol Health Dis 2015; 26: 26914, doi: http://dx.doi.org/10.3402/mehd.v26.26914 15.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Anaerobe 2011;17: 367 /C18.Autism and the enteric microbiome Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Microb Ecol Health Dis 2015; 26: 27458, doi: http://dx.doi.org/10.3402/mehd.v26.27458 33.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Microb Ecol Health Dis 2015; 26:26253, doi: http://dx.doi.org/10.3402/mehd.v26.26253 34.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Microb Ecol Health Dis 2015; 26: 26309, doi: http://dx.doi.org/10.3402/mehd.v26.26309 43.",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"12 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"J Insect Physiol2014; 67: 64 /C19.Autism and the enteric microbiome Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"14 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26878 - http://dx.doi.org/10.3402/mehd.v26.26878",Non-OADS,/arxiv_data1/oa_pdf/9c/94/MEHD-26-26878.PMC4425814.pdf
"Methods: After the rs-fMRI data preprocessing using DP ARSF A  (http://www.restfmri.net) based on Matlab-2012a: (1) DC and EC maps were calculated and compared between the remitting MS  and healthy control (HC) (n= 34), respectively; (2) DC and EC  maps were also compared in paired relapsing(rapid-onset) MS and remitting MS (n=11); (3) in remitting MS group, linear regres-sion analysis was conducted for evaluating the relationship between clinical metric and voxel-wise centrality and rest-state  functional connectivity of the obtained abnormal regions.",OADS,/arxiv_data1/oa_pdf/de/57/10.1177_1352458514563659.PMC4425815.pdf
"The R-fMRI data preprocessing and pro- cessing was performed using DP ARSF A (http://www.restfmri.net)  based on Matlab 2012a; the spatial patterns of DMN was con-structed by seed-based (posterior cingulate cortex) correlation analysis, then 6 principal components of DMN was selected for  more GCA.",OADS,/arxiv_data1/oa_pdf/de/57/10.1177_1352458514563659.PMC4425815.pdf
Reprints and permissions:   http://www.sagepub.co.uk/  journalsPermissions.nav 678 http://msj.sagepub.comMULTIPLE SCLEROSIS MSJJOURNAL Introduction Neuromyelitis optica (NMO) is an immune-mediated disorder of the central nervous system (CNS) in which the optic nerves and the spinal cord are preferentially involved.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"http://msj.sagepub.com 679development of spectral domain OCT (SD-OCT)  allows enhanced resolution (2 µm), shorter acquisi-tion times, three-dimensional scans, and video imag-ing.",OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"Multiple Sclerosis Journal 21(6) 680 http://msj.sagepub.cominclude deposition of IgG and activated complement,  loss of AQP4 expression, astrocytopathy, neutrophil accumulation and demyelination with axon loss.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"http://msj.sagepub.com 681patients with or without clinical ON.19 Interestingly,  another study reported that NMOSD eyes without a  history of ON had prolonged P100 latencies on VEP compared to normal controls; however, the absolute latencies were still within the normal range.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"Multiple Sclerosis Journal 21(6) 682 http://msj.sagepub.comsporadically correlated with the overall Expanded  Disability Status Scale (EDSS).46 Although this may  not be surprising in light of the limited amount of visual function captured in the EDSS, the weaker cor - relation between RNFL thickness and EDSS in NMOSD as compared to MS may be the product of both distinct pathophysiology and involvement of a more limited spectrum of the CNS neuroaxis.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"http://msj.sagepub.com 683MS have shown good correlation between RNFL  measures and both white and gray matter atrophy17,70  and brain parenchymal fraction.71 Another recent  study in a cohort of CIS and early RRMS patients with short disease duration (3.2 years) and mild levels of disability (median EDSS 1.5) indicated that in early stages of relapsing forms of the disease, OCT-derived retinal measures reflect white matter damage, with variability in gray matter being an age-related effect.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"Multiple Sclerosis Journal 21(6) 684 http://msj.sagepub.comof neuroprotection or regeneration, and stratification  of patients based on different patterns of damage.",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"http://msj.sagepub.com 685University of Düsseldorf, Germany: Orhan Aktas University of Goettingen, Germany: Jens WuerfelUniversity of Southern Denmark, Denmark:  Nasrin Asgari Walton Center, Liverpool, UK: Anu JacobYale University School of Medicine, Department of  Neurology, New Haven, CT, USA: Kevin O’Connor Funding This work was supported by the German Ministry for Education and Research (Competence Network Multiple Sclerosis) (to FP).",Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
Multiple Sclerosis Journal 21(6) 686 http://msj.sagepub.com 24.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
http://msj.sagepub.com 687patterns of retinal damage in neuromyelitis optica and  multiple sclerosis.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
Multiple Sclerosis Journal 21(6) 688 http://msj.sagepub.com 76.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/10.1177_1352458514567216.PMC4425816.pdf
"686Journals of Gerontology: BIOLOGICAL SCIENCES , 2015, 686–693 doi:10.1093/gerona/glu161 Original Article Advance Access publication September 9, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/f2/glu161.PMC4425849.pdf
"Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.Nicotine & Tobacco Research , 2015, 746–749 doi:10.1093/ntr/ntv019 Brief report Advance Access publication January 29, 2015 746This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or  transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/5e/ntv019.PMC4425935.pdf
"Rockville, MD: US  Department of Health and Human Services; 2004. http://www.surgeonge- neral.gov/library/smokingconsequences/ .",Non-OADS,/arxiv_data1/oa_pdf/0c/5e/ntv019.PMC4425935.pdf
Conﬂict of interests All authors have completed the Uniﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf(available on request from the corresponding author) and declare: JJ and HP have received grants from National Program on Key Research Project of New Drug Innovation (2008ZX09312-016).,Non-OADS,/arxiv_data1/oa_pdf/d0/e7/13318_2014_Article_197.PMC4426132.pdf
http://www.goldcopd.org/uploads/users/ﬁles/GOLD_ Report_2013_Feb19.pdf .,OADS,/arxiv_data1/oa_pdf/d0/e7/13318_2014_Article_197.PMC4426132.pdf
"At the time we submitted this manuscript, the data  could be obtained from Web links provided by the original authors: The blogs data set was available at http://websites  .psychology.uwa.edu.au/labs/cogscience/Publications/ LskyetalPsychSciClimate.xls, and the panel data set was available at http://websites.psychology.uwa.edu.au/labs/cogscience/documents/PLOSONE2013Data.csv.",OADS,/arxiv_data1/oa_pdf/c9/f1/10.1177_0956797614566469.PMC4426137.pdf
"Retrieved from http://www.theguardian.com/environment/blog/2012/jul/27/   climate-sceptics-conspiracy-theorists Cumming, G. (2014).",Non-OADS,/arxiv_data1/oa_pdf/c9/f1/10.1177_0956797614566469.PMC4426137.pdf
"Retrieved from http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0075637 Lewandowsky, S., Oberauer, K., & Gignac, G. E. (2013).",Non-OADS,/arxiv_data1/oa_pdf/c9/f1/10.1177_0956797614566469.PMC4426137.pdf
Retrieved from http://www.telegraph.co.uk/ news/earth/environment/climatechange/9503044/Climate-change-deniers-are-either-extreme-free-marketeers-or-conspiracy-theorists.html R Development Core Team.,Non-OADS,/arxiv_data1/oa_pdf/c9/f1/10.1177_0956797614566469.PMC4426137.pdf
"Retrieved from http://www.R-project.org/ Ullman, J.",Non-OADS,/arxiv_data1/oa_pdf/c9/f1/10.1177_0956797614566469.PMC4426137.pdf
"Although as of June 2013, 15 states had current or anticipated ADAP cost-containment measures, including 3 states with waiting lists (http://www.nastad.org/ docs/ADAP_Watch/ADAP-Watch-June-2013.html), the imp- lementation of the Affordable Care Act (ACA) might increase access to medications for more persons through Medicaid expansion.45Ensuring that providers have access to case man- agement referrals may allow them to feel more comfortable prescribing ART to unstably housed persons, who according to studies can be adherent with proper support.46 In multivariable analysis, we found Hispanic providers were less likely to cite structural barriers as reasons to delay ART.",Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
"pewhispanic.org/2013/08/29/mapping-the-latino-population-by- state-county-and -city/, http://kff.org/hivaid s/fact-shee t/aids-drug- assistance-programs/), this finding may reflect geographic differences across states rather than differences in how structural barriers are perceiv ed by Hispanic providers com- pared to non-Hispanic providers, although we did not collect data that would allow us to fully assess this.",Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
http://aidsinfo.nih.gov/contentfiles/adultandado- lescentgl001226.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
http://aidsinfo.nih.gov/contentfiles/adultandado- lescentgl003371.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
http://aidsinfo.nih.gov/ContentFiles/AdultandA- dolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
"Published July 14, 2009. http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.html.",Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distin- guishing-public-health-research-nonresearch.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/32/10.1177_2325957414557267.PMC4426141.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.Dear Editor, Nowadays, essential oils are used in different prod - ucts such as food as natural antioxidants, antibacterial  and flavoring compounds (1).",Non-OADS,/arxiv_data1/oa_pdf/58/cc/jjm-08-03-20128.PMC4426161.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d3/d4/jjm-08-03-20783.PMC4426162.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/98/36/jjm-08-03-21444.PMC4426187.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Correspondence:  James J. Galligan, MD, Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan  State University, 293 Farm Lane, Giltner Hall 108, East Lansing, Michigan 48824, USA.",Non-OADS,/arxiv_data1/oa_pdf/38/b0/nihms686554.PMC4426191.pdf
"REVIEW ARTICLEBrain Tumor Res Treat  2015 ;3(1):1-7  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.1 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/e7/btrt-3-1.PMC4426272.pdf
"Convenient housekeeping genes (HKGs) ORIGINAL ARTICLEBrain Tumor Res Treat  2015 ;3(1):24-29  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.24 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/61/btrt-3-24.PMC4426273.pdf
"Since  then there was no evidence of disease and she was having reg - ular check-ups on outpatient clinic basis.CASE REPORTBrain Tumor Res Treat  2015 ;3(1):30-33  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.30 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/d1/btrt-3-30.PMC4426274.pdf
"On this CASE REPORTBrain Tumor Res Treat  2015 ;3(1):34-38  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.34 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/aa/btrt-3-34.PMC4426275.pdf
"The MRI showed dark signal in - tensity on T2-weighted images and peripheral high signal in -CASE REPORTBrain Tumor Res Treat  2015 ;3(1):39-43  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.39 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/ad/btrt-3-39.PMC4426276.pdf
"The radiological follow-up was performed CASE REPORTBrain Tumor Res Treat  2015 ;3(1):44-47  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.44 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/20/btrt-3-44.PMC4426277.pdf
"The score of the liver disease was 10 points and  Child-Pugh class was C. He took brain computed tomography CASE REPORTBrain Tumor Res Treat  2015 ;3(1):48-51  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.48 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/ad/btrt-3-48.PMC4426278.pdf
"The histopath - ological examination showed a nodular architecture with nod -CASE REPORTBrain Tumor Res Treat  2015 ;3(1):52-55  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.52 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/7c/btrt-3-52.PMC4426279.pdf
"5).CASE REPORTBrain Tumor Res Treat  2015 ;3(1):56-59  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.56 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/e9/btrt-3-56.PMC4426280.pdf
"CASE REPORTBrain Tumor Res Treat  2015 ;3(1):60-63  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.60 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/21/btrt-3-60.PMC4426281.pdf
"Orthopedics 2008;31:281.LETTER TO THE EDITORBrain Tumor Res Treat  2015 ;3(1):64-64  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.64 Received December 23, 2014 Revised February 4, 2015 Accepted February 4, 2015 Correspondence Mohamed Amin Ghobadifar  Zoonoses Research Center, Medicine School, Jahrom University of Medical  Sciences, Motahari Avenue, Jahrom 139, IranTel: +98-936-620-8078, Fax: +98-713-635-40-94E-mail: amin_m505@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/a9/btrt-3-64.PMC4426282.pdf
"The  most recent WHO central nervous system (CNS) tumor clas - sification system was published in 2007 and continues to inte -REVIEW ARTICLEBrain Tumor Res Treat  2015 ;3(1):8-23  /  pISSN 2288-2405  /  eISSN 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.1.8 This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/3c/btrt-3-8.PMC4426283.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/3c/btrt-3-8.PMC4426283.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR).,Non-OADS,/arxiv_data1/oa_pdf/3a/5c/bmjresp-2015-000086.PMC4426285.pdf
Longitude Prize 2014 —Antibiotics 2014. http://www.longitudeprize.,Non-OADS,/arxiv_data1/oa_pdf/3a/5c/bmjresp-2015-000086.PMC4426285.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"Based on WC, the postprandial TC/HDL-c and TG/HDL-c ratios were significantly higher than the fasting ratios (Table 3).Comparative study on metabolic control in type 2 diabetic patients Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"#and##: significantly different from male patients at#pB0.05,##pB0.01.Comparative study on metabolic control in type 2 diabetic patients Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"6 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"Mutual association between apolipoproteins ratio and lipid ratios during fasting and postprandial states.Comparative study on metabolic control in type 2 diabetic patients Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"8 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"The burden of mortality attributable to diabetes:Comparative study on metabolic control in type 2 diabetic patients Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"10 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 27400 - http://dx.doi.org/10.3402/ljm.v10.27400",Non-OADS,/arxiv_data1/oa_pdf/af/7b/LJM-10-27400.PMC4426286.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 21, Numbers 9 and 10, 2015DOI: 10.1089/ten.tea.2014.0477 1507",Non-OADS,/arxiv_data1/oa_pdf/b6/14/ten.tea.2014.0477.PMC4426298.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF INTERFERON & CYTOKINE RESEARCH Volume 35, Number 5, 2015Mary Ann Liebert, Inc.DOI: 10.1089/jir.2014.0225 340",Non-OADS,/arxiv_data1/oa_pdf/d9/e1/jir.2014.0225.PMC4426323.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bd/19/hepatmon-15-04-25142.PMC4426333.pdf
"National Oceanic and Atmospheric Administration (2012), Rapid Refresh (RR), Earth system research laboratory, http://rapidrefresh.noaa.gov/.National Weather Service (NWS) (2010), National Weather Service Manual 10-1401, Department of Commerce, NOAA, http://www.nws.noaa.gov/directives/sym/pd01014001curr.pdf.",OADS,/arxiv_data1/oa_pdf/a0/99/jgrd0118-11611.PMC4426335.pdf
"University of Wyoming (2012), Atmospheric Sounding, University of Wyoming, College of Engineering, Department of Atmospheric Science,http://weather.uwyo.edu/upperair/sounding.html.",Non-OADS,/arxiv_data1/oa_pdf/a0/99/jgrd0118-11611.PMC4426335.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/86/d0/hepatmon-15-04-25539.PMC4426354.pdf
"In urology, the percentage distribution of patients  by physician specialty by those aged 65 years and older and  enrolled in Medicare is 46.2%, whereas the corresponding New horizons in geriatric urology Hyung Jee Kim Department of Urology, Dankook University College of Medicine, Cheonan, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:335-336. http://dx.doi.org/10.4111/kju.2015.56.5.335 pISSN 2005-6737  •  eISSN 2005-6745Editorial Corresponding Author:  Hyung Jee Kim Department of Urology, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 330-997, Korea TEL: +82-41-550-6630, FAX: +82-41-550-7053, E-mail: killtumor@dankook.ac.kr ⓒ The Korean Urological Association, 2015 percentage is 26.6% in neurology [6].",Non-OADS,/arxiv_data1/oa_pdf/20/e1/kju-56-335.PMC4426503.pdf
"orgKim http://dx.doi.org/10.4111/kju.2015.56.5.335 Urology  will provide opportunities to broaden both basic and  clinical research in the field of geriatric urology, especially  urinary incontinence and urinary tract infection in the  elderly.",Non-OADS,/arxiv_data1/oa_pdf/20/e1/kju-56-335.PMC4426503.pdf
Available from: http://sgis.kostat.go.kr/publicsmodel.,OADS,/arxiv_data1/oa_pdf/20/e1/kju-56-335.PMC4426503.pdf
"Keywords:  Diagnosis; Magnetic resonance imaging; Pathology; Prostatic neoplasms; Urology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:337-345. http://dx.doi.org/10.4111/kju.2015.56.5.337 pISSN 2005-6737  •  eISSN 2005-6745Review Article Received:  11 March, 2015   •  Accepted:  6 April, 2015 Corresponding Author:  Nathan Lawrentschuk Olivia Newton-John Cancer Research Institute, Austin Hospital, 145 Studley Road PO Box 5555, Heidelberg, Victoria 3084, Australia TEL: +613-9496-5000, FAX: +613-9458-4779, E-mail: lawrentschuk@gmail.com ⓒ The Korean Urological Association, 2015 at 50% [1].",Non-OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
"orgKatelaris et al http://dx.doi.org/10.4111/kju.2015.56.5.337 but rather overtreatment, which carries an economic burden  and risks of urinary incontinence, erectile dysfunction, and  urethral stricture [4,5] .",Non-OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
orgKatelaris et al http://dx.doi.org/10.4111/kju.2015.56.5.337 assist in the risk stratification of patients on the basis of  tumor aggressiveness [14].,OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
orgKatelaris et al http://dx.doi.org/10.4111/kju.2015.56.5.337 compared with the histopathology results from the radical  prostatectomy specimens.,OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
orgKatelaris et al http://dx.doi.org/10.4111/kju.2015.56.5.337 CONFLICTS OF INTEREST The authors have nothing to disclose.,Non-OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
http://dx.doi.org/10.1002/ jmri.24801.,OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
http://dx.doi.org/10.1007/ s00345-014-1370-x.,Non-OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
http://dx.doi.org/10.1007/s00345-014-1448-5.,Non-OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
http://dx.doi.org/10.1016/j.urolonc.2015.01.023.,OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
http://dx.doi.org/10.1016/j.juro.2015.01.088.,OADS,/arxiv_data1/oa_pdf/f4/3e/kju-56-337.PMC4426504.pdf
"Keywords:  Biopsy; Infection; Prostate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Korean J Urol 2015;56:346-350. http://dx.doi.org/10.4111/kju.2015.56.5.346 pISSN 2005-6737  •  eISSN 2005-6745Review Article Received:  2 January, 2015   •  Accepted:  10 March, 2015 Corresponding Author:  Seung-Ju Lee Department of Urology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea TEL: +82-31-249-7470, FAX: +82-31-253-0949, E-mail: lee.seungju@gmail.com ⓒ The Korean Urological Association, 2015 as  we l l  [9,12-14 ].",Non-OADS,/arxiv_data1/oa_pdf/11/05/kju-56-346.PMC4426505.pdf
orgLee http://dx.doi.org/10.4111/kju.2015.56.5.346 swab culture results showed a notable decrease in the  incidence of infectious complications after TRUS-Bx caused  by fluoroquinolone-resistant organisms as well as a decrease  in the overall cost of care [31].,Non-OADS,/arxiv_data1/oa_pdf/11/05/kju-56-346.PMC4426505.pdf
Avail - able from: https://www.auanet.org/resources/white-paper-on- the-incidence-prevention-and-treatment-of-complications- related-to-prostate-needle-biopsy.cfm.,Non-OADS,/arxiv_data1/oa_pdf/11/05/kju-56-346.PMC4426505.pdf
orgLee http://dx.doi.org/10.4111/kju.2015.56.5.346 24.,Non-OADS,/arxiv_data1/oa_pdf/11/05/kju-56-346.PMC4426505.pdf
"Keywords:  Cystic kidney diseases; Follow-up studies; Growth This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received:  1 December, 2014   •  Accepted:  26 January, 2015 Corresponding Author:  Hongzoo Park Department of Urology, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon 200-722, Korea TEL: +82-33-258-9478, FAX: +82-33-258-2455, E-mail: amcmd@kangwon.ac.kr ⓒ The Korean Urological Association, 2015family history of renal cystic disease or evidence of chronic  kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/a2/f6/kju-56-351.PMC4426506.pdf
orgKorean J Urol 2015;56:351-356. http://dx.doi.org/10.4111/kju.2015.56.5.351 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/a2/f6/kju-56-351.PMC4426506.pdf
"orgPark and Kim http://dx.doi.org/10.4111/kju.2015.56.5.351 (abdominal pain or hematuria) owing to increasing size (6–8  cm) or a complication like infection, hemorrhage, or rupture  [6] .",Non-OADS,/arxiv_data1/oa_pdf/a2/f6/kju-56-351.PMC4426506.pdf
orgPark and Kim http://dx.doi.org/10.4111/kju.2015.56.5.351 patients were dropped from follow-up.,Non-OADS,/arxiv_data1/oa_pdf/a2/f6/kju-56-351.PMC4426506.pdf
orgPark and Kim http://dx.doi.org/10.4111/kju.2015.56.5.351 REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/a2/f6/kju-56-351.PMC4426506.pdf
"Keywords:  Lymph node excision; Treatment outcome; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received:  4 March, 2015   •  Accepted:  1 April, 2015 Corresponding Author:  Ozgur Ugurlu Department of Urology, Private Akay Hastanesi, Akay caddesi, Büklüm sokak No:4, Kavaklıdere, Ankara 06540, Turkey TEL: +90-532-6172029, FAX: +90-312-4165149, E-mail: ugurluozgur@hotmail.com ⓒ The Korean Urological Association, 2015invasive bladder cancer is radical cystectomy (RC) and  bilateral lymph node dissection (LND).",Non-OADS,/arxiv_data1/oa_pdf/6a/46/kju-56-357.PMC4426507.pdf
orgKorean J Urol 2015;56:357-364. http://dx.doi.org/10.4111/kju.2015.56.5.357 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/6a/46/kju-56-357.PMC4426507.pdf
orgUgurlu et al http://dx.doi.org/10.4111/kju.2015.56.5.357 improves survival and the accuracy of cancer staging  [1-5] .,Non-OADS,/arxiv_data1/oa_pdf/6a/46/kju-56-357.PMC4426507.pdf
orgUgurlu et al http://dx.doi.org/10.4111/kju.2015.56.5.357 5-year OS (Fig.,OADS,/arxiv_data1/oa_pdf/6a/46/kju-56-357.PMC4426507.pdf
orgUgurlu et al http://dx.doi.org/10.4111/kju.2015.56.5.357 metastasis in their study was 6.8%; Steven and Poulsen [16]  reported a rate of 6%.,OADS,/arxiv_data1/oa_pdf/6a/46/kju-56-357.PMC4426507.pdf
orgUgurlu et al http://dx.doi.org/10.4111/kju.2015.56.5.357 25.,OADS,/arxiv_data1/oa_pdf/6a/46/kju-56-357.PMC4426507.pdf
"Keywords:  Lasers; Prostate; Prostatic hyperplasia; Thulium This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - New Technology/Lasers in Urology Received:  1 December, 2014   •  Accepted:  7 April, 2015 Corresponding Author:  Stefano Carlo Maria Picozzi Department of Urology, IRCCS Policlinico San Donato, Via Morandi 30, San Donato Milanese, Milan 20097, Italy TEL: +390252774329, FAX: +393336116639, E-mail: stepico@tin.it ⓒ The Korean Urological Association, 2015benign prostatic hypertrophy (BPH) between 30 and 80 mL  [1].",Non-OADS,/arxiv_data1/oa_pdf/1f/0d/kju-56-365.PMC4426508.pdf
orgKorean J Urol 2015;56:365-369. http://dx.doi.org/10.4111/kju.2015.56.5.365 pISSN 2005-6737  •  eISSN 2005-6745,OADS,/arxiv_data1/oa_pdf/1f/0d/kju-56-365.PMC4426508.pdf
orgCarmignani et al http://dx.doi.org/10.4111/kju.2015.56.5.365 5].,OADS,/arxiv_data1/oa_pdf/1f/0d/kju-56-365.PMC4426508.pdf
orgCarmignani et al http://dx.doi.org/10.4111/kju.2015.56.5.365 been developed in the transurethral treatment of BOO  in an effort to decrease the existing morbidity of TURP.,OADS,/arxiv_data1/oa_pdf/1f/0d/kju-56-365.PMC4426508.pdf
"Keywords:  Morbidity; Pain; Questionnaires; Stents; Ureter This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received:  16 February, 2015   •  Accepted:  18 March, 2015 Corresponding Author:  Dominik Abt Department of Urology, St. Gallen Cantonal Hospital, Rorschacherstrasse 95, 9007 St. Gallen, Switzerland TEL: +41-714941418, FAX: +41-714942891, E-mail: dominik01.abt@kssg.ch ⓒ The Korean Urological Association, 2015associated with a well-defined side effect profile.",Non-OADS,/arxiv_data1/oa_pdf/f0/b2/kju-56-370.PMC4426509.pdf
orgKorean J Urol 2015;56:370-378. http://dx.doi.org/10.4111/kju.2015.56.5.370 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/f0/b2/kju-56-370.PMC4426509.pdf
"orgAbt et al http://dx.doi.org/10.4111/kju.2015.56.5.370 loop of the stent was completely ipsilateral, group B had  loops crossing the perpendicular line, and group C consisted  of patients with completely contralateral intravesical stent  loops (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f0/b2/kju-56-370.PMC4426509.pdf
"orgAbt et al http://dx.doi.org/10.4111/kju.2015.56.5.370 •	Despite 	many	advances	in	stent	composition, 	construction 	 geometry, and design, the ideal stent has yet to be  designed [21-23].•	Drug-eluting 	stents	seem	to	have	a	very	limited	effect	 [24] and do not play a role in clinical routine.",Non-OADS,/arxiv_data1/oa_pdf/f0/b2/kju-56-370.PMC4426509.pdf
orgAbt et al http://dx.doi.org/10.4111/kju.2015.56.5.370 often radiating to the genitalia.,OADS,/arxiv_data1/oa_pdf/f0/b2/kju-56-370.PMC4426509.pdf
orgAbt et al http://dx.doi.org/10.4111/kju.2015.56.5.370 Urol 2010;183:1037-42.,OADS,/arxiv_data1/oa_pdf/f0/b2/kju-56-370.PMC4426509.pdf
"Keywords:  Lithotripsy; Treatment outcome; Urolithiasis This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received:  23 February, 2015   •  Accepted:  4 April, 2015 Corresponding Author:  Chi-Fai NG  The S.H.",Non-OADS,/arxiv_data1/oa_pdf/08/0e/kju-56-379.PMC4426510.pdf
orgKorean J Urol 2015;56:379-385. http://dx.doi.org/10.4111/kju.2015.56.5.379 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/08/0e/kju-56-379.PMC4426510.pdf
"orgNg et al http://dx.doi.org/10.4111/kju.2015.56.5.379 (CT) to assess urinary calculi has provided information  on some stone parameters, such as mean stone density  (MSD) and stone volume (SV), that could be used to predict  treatment outcomes after SWL [1,2].",OADS,/arxiv_data1/oa_pdf/08/0e/kju-56-379.PMC4426510.pdf
orgNg et al http://dx.doi.org/10.4111/kju.2015.56.5.379 for analysis were involved in this study [14] .,OADS,/arxiv_data1/oa_pdf/08/0e/kju-56-379.PMC4426510.pdf
"orgNg et al http://dx.doi.org/10.4111/kju.2015.56.5.379 have been better for the imaging measurements to have  been performed by more than one blinded staff member,  and this might have helped to minimize error in the  measurement.",OADS,/arxiv_data1/oa_pdf/08/0e/kju-56-379.PMC4426510.pdf
"Keywords:  Body mass index; Lower urinary tract symptoms; Metabolic syndrome X; Physiological sexual dysfuntion; Waist-hip ratio This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Sexual Dysfunction/Infertility Received:  28 January, 2015   •  Accepted:  23 February, 2015 Corresponding Author:  So Shin Kye Department of Family Medicine, National Police Hospital, Songi-ro 123, Songpa-gu, Seoul 138-708, Korea TEL: +82-2-3400-1395, FAX: +82-2-3400-1164, E-mail: soskye@nph.go.kr *These authors contributed equally to this study and should be considered co-first authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/c5/kju-56-386.PMC4426511.pdf
orgKorean J Urol 2015;56:386-392. http://dx.doi.org/10.4111/kju.2015.56.5.386 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/ce/c5/kju-56-386.PMC4426511.pdf
orgPark et al http://dx.doi.org/10.4111/kju.2015.56.5.386 2.,OADS,/arxiv_data1/oa_pdf/ce/c5/kju-56-386.PMC4426511.pdf
orgPark et al http://dx.doi.org/10.4111/kju.2015.56.5.386 1.004–1.045).,OADS,/arxiv_data1/oa_pdf/ce/c5/kju-56-386.PMC4426511.pdf
orgPark et al http://dx.doi.org/10.4111/kju.2015.56.5.386 symptoms and sexual function according to several clinical  parameters [11].,OADS,/arxiv_data1/oa_pdf/ce/c5/kju-56-386.PMC4426511.pdf
"Keywords:  Age factors; Stress urinary incontinence; Urodynamics This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Geriatric Urology Received:  9 January, 2015  •  Accepted:  25 February, 2015 Corresponding Author:  Myung Ki Kim Department of Urology, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju 561-756, Korea TEL: +82-63-250-2574, FAX: +82-63-250-1564, E-mail: mkkim@jbnu.ac.kr ⓒ The Korean Urological Association, 2015In the Korean EPIC study, the overall prevalence of  LUTS was 61.4% (53.7% of  men, 68.9% of  women) and the  prevalence increased with age.",Non-OADS,/arxiv_data1/oa_pdf/6b/27/kju-56-393.PMC4426512.pdf
orgKorean J Urol 2015;56:393-397. http://dx.doi.org/10.4111/kju.2015.56.5.393 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/6b/27/kju-56-393.PMC4426512.pdf
"orgShin et al http://dx.doi.org/10.4111/kju.2015.56.5.393 detrusor contractility, and urethral sphincter function with  increasing age [1,4-7] .",OADS,/arxiv_data1/oa_pdf/6b/27/kju-56-393.PMC4426512.pdf
orgShin et al http://dx.doi.org/10.4111/kju.2015.56.5.393 outcome of the most recent study for age-associated change  in urodynamic parameters in a large group of women.,OADS,/arxiv_data1/oa_pdf/6b/27/kju-56-393.PMC4426512.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/27/kju-56-393.PMC4426512.pdf
"Keywords:  Child; Endoscopy; Urodynamics; Vesico-ureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Pediatric Urology Received:  31 December, 2014   •  Accepted:  25 February, 2015 Corresponding Author:  Sang Won Han Department of Urology and Urological Science Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-2316, FAX: +82-2-312-2538, E-mail: swhan@yuhs.ac ⓒ The Korean Urological Association, 2015renal damage, patients with VUR must take prophylactic  antibiotics, manage constipation, or be periodically checked  for urinary tract infection (UTI).",Non-OADS,/arxiv_data1/oa_pdf/d7/e5/kju-56-398.PMC4426513.pdf
orgKorean J Urol 2015;56:398-404. http://dx.doi.org/10.4111/kju.2015.56.5.398 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/d7/e5/kju-56-398.PMC4426513.pdf
orgJung et al http://dx.doi.org/10.4111/kju.2015.56.5.398 group and 3.19±0.80 in the failure group (p=0.012).,OADS,/arxiv_data1/oa_pdf/d7/e5/kju-56-398.PMC4426513.pdf
orgJung et al http://dx.doi.org/10.4111/kju.2015.56.5.398 ET was 68.4%.,OADS,/arxiv_data1/oa_pdf/d7/e5/kju-56-398.PMC4426513.pdf
orgJung et al http://dx.doi.org/10.4111/kju.2015.56.5.398 our experience and analysis of factors affecting success rate.,OADS,/arxiv_data1/oa_pdf/d7/e5/kju-56-398.PMC4426513.pdf
"Keywords:  Stents; Ureter; Urolithiasis This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case Report Received:  27 February, 2015   •  Accepted:  30 March, 2015 Corresponding Author:  Min Su Kim Department of Urology, Seoul Medical Center, 156 Sinnae-ro, Jungnang-gu, Seoul 131-795, Korea TEL: +82-2-2276-7851, FAX: +82-2-2276-7903, E-mail: cau1004@naver.com ⓒ The Korean Urological Association, 2015CASE REPORT A 53-year-old man with gout and chronic renal disease  was admitted to the hospital because of right flank pain,  nausea, vomiting, and fever.",Non-OADS,/arxiv_data1/oa_pdf/f4/e5/kju-56-405.PMC4426514.pdf
orgKorean J Urol 2015;56:405-408. http://dx.doi.org/10.4111/kju.2015.56.5.405 pISSN 2005-6737  •  eISSN 2005-6745,Non-OADS,/arxiv_data1/oa_pdf/f4/e5/kju-56-405.PMC4426514.pdf
orgKim et al http://dx.doi.org/10.4111/kju.2015.56.5.405 B  AFig.,OADS,/arxiv_data1/oa_pdf/f4/e5/kju-56-405.PMC4426514.pdf
orgKim et al http://dx.doi.org/10.4111/kju.2015.56.5.405 occurs more often in cases with no hydronephrosis.,Non-OADS,/arxiv_data1/oa_pdf/f4/e5/kju-56-405.PMC4426514.pdf
"SUPPLEMENTARY MATERIAL Scan this QR code to see the supplementary material,  or visit http://kjurology.org/src/sm/kju-56-405-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f4/e5/kju-56-405.PMC4426514.pdf
"Global Database on Body Mass  Index, 2006: Accessed May 30, 2014, at http://apps.who.int/ bmi/index.",OADS,/arxiv_data1/oa_pdf/9b/99/NAJMS-7-151.PMC4426518.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp47Editorial Vertical facetal instability: Is it the point of genesis of  spinal spondylotic disease?,Non-OADS,/arxiv_data1/oa_pdf/78/1a/JCVJS-6-47.PMC4426519.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp49Editorial Can foramen magnum decompression surgery become  historical?,Non-OADS,/arxiv_data1/oa_pdf/cf/a2/JCVJS-6-49.PMC4426520.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp51Original Article Posterior atlantoaxial ‘facetal’ instability associated  with cervical spondylotic disease Atul Goel Department of Neurosurgery, King Edward VII Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Parel, Mumbai, Maharashtra,  India Corresponding author: Prof. Atul Goel, Department of Neurosurgery, King Edward VII Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Parel,  Mumbai - 400 012, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/6b/57/JCVJS-6-51.PMC4426521.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/57/JCVJS-6-51.PMC4426521.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/6b/57/JCVJS-6-51.PMC4426521.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp56Original Article Stabilization of metastatic lesions affecting the second  cervical vertebra Joseph F .,Non-OADS,/arxiv_data1/oa_pdf/20/c9/JCVJS-6-56.PMC4426522.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp60Original Article The impact of steroids, methotrexate, and biologics  on clinical and radiographic outcomes in patients with rheumatoid arthritis undergoing fusions at the craniovertebral junction Ryan Khanna, Brian J. Dlouhy1, Zachary A. Smith, Sandi K. Lam2, Tyler R. Koski,  Nader S. Dahdaleh Departments of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, 1Neurological Surgery, University  of Iowa, Carver School of Medicine, Iowa City, Iowa, 2Division of Pediatric Neurosurgery, Texas Children’s Hospital, Houston, Texas, United States Corresponding author: Dr. Nader S. Dahdaleh, Department of Neurologic Surgery, Northwestern University, 676 N. St. Clair, Suite 2210, Chicago, Illinois-60611,  United States.",Non-OADS,/arxiv_data1/oa_pdf/be/e9/JCVJS-6-60.PMC4426523.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp65Original Article Simple facet joint repair with dynamic pedicular  system: Technical note and case series Ali Fahir Ozer, Tuncer Suzer, Mehdi Sasani1, Tunc Oktenoglu1, Phillip Cezayirli2,  Hosein Jafari Marandi3, Deniz Ufuk Erbulut4 Koc University Medical School, Neurosurgery Department, 1American Hospital, Neurosurgery Department, 4Koc University, Mechanical Engineer - ing Department, Istanbul, Turkey, 2Albert Einstein College of Medicine/Montefiore Medical Center, Neurosurgery Residency, New York, USA, 3Iran  University of Medical Science, Hazrat Rasoul Medical Complex, Spine Surgery Division, Tehran, Iran Corresponding author: Prof. Ali Fahir Ozer, Department of Neurosurgery, Koc University School of Medicine, Rumelifeneri Yolu Sarıyer, Istanbul - 34450, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/90/1a/JCVJS-6-65.PMC4426524.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp69Original Article The impact of L5 dorsal root ganglion degeneration and  Adamkiewicz artery vasospasm on descending colon dilatation following spinal subarachnoid hemorrhage:  An experimental study; first report Cengiz Ozturk1, Ayhan Kanat2, Mehmet Dumlu Aydin3, Coskun Yolas4, Mehmet Esref Kabalar5,  Betul Gundogdu6, Aslihan Duman7, Ilyas Ferit Kanat8, Cemal Gundogdu6 4Departments of Neurosurgery, and 5Pathology, 1Erzurum Regional Research and Education Hospital Family Physician, Erzurum, 2Department of  Neurosurgery, Medical Faculty, Recep Tayyip Erdogan University, Rize, 3Departments of Neurosurgery, and 6Pathology, Medical Faculty, Ataturk  University, Erzurum, 7Department of Pathology, Giresun University, Medical Faculty, Giresun, 8Department of Internal Medicine, Atatürk Training  and Research Hospital, Ankara, Turkey Corresponding author: Dr. Ayhan Kanat, Department of Neurosurgery, Medical Faculty, Recep Tayyip Erdogan University, Merkez - 53100 Rize, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/07/e6/JCVJS-6-69.PMC4426525.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/07/e6/JCVJS-6-69.PMC4426525.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp76Case Report Trigeminal neuralgia secondary to basilar impression:  A case report Maurus Marques de Almeida Holanda, Normando Guedes Pereira Neto1,  Gustavo de Moura Peixoto1, Rayan Haquim Pinheiro Santos1 Neurosurgeon, Associate Professor of Neurology, Department of Internal Medicine, Federal University of Paraíba (UFPB), João Pessoa, Paraiba,  1Medical Students, Federal University of Paraíba (UFPB), João Pessoa, Paraiba, Brazil Corresponding author: Dr. Maurus Marques de Almeida Holanda, Rua Borja Peregrino, 191, João Pessoa, Paraíba, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/88/04/JCVJS-6-76.PMC4426526.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp79Case Report Dystrophic thoracic spine dislocation associated with  type-1 neurofibromatosis: Case report and rationale for treatment David Meneses-Quintero1, Fernando Alvarado-Gómez1, Gabriel Alcalá-Cerra1,2,3 1Department of Spine Surgery, Instituto de Ortopedia Infantil Roosevelt, Bogotá, 2Department of Neurologic Research, Health Sciences and Neurosciences  (CISNEURO) Research Group, Cartagena de Indias, Cartagena, 3Department of Neurosurgery, Universidad de Cartagena, Cartagena, Colombia Corresponding author: Dr. Gabriel Alcalá-Cerra, Health Sciences and Neurosciences (CISNEURO) Research Group/Grupo de Investigación en Ciencias de la Saludy  Neurociencias (CISNEURO).",Non-OADS,/arxiv_data1/oa_pdf/71/c8/JCVJS-6-79.PMC4426527.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/71/c8/JCVJS-6-79.PMC4426527.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp89Case Report Intractable vomiting caused by vertebral artery  compressing the medulla: A case report Lauren Gorton, Ahmed M. Ashour, Jonathon Lebovitz, Angela Di Cosola, Saleem I. Abdulrauf Department of Neurological Surgery, Saint Louis University, Saint Louis, Missouri, United States of America Corresponding author:   Saleem I. Abdulrauf, Chairman, Department of Neurological Surgery, Saint Louis University, Saint Louis, Missouri, USA.",Non-OADS,/arxiv_data1/oa_pdf/0f/b8/JCVJS-6-89.PMC4426530.pdf
Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp92Case Report Cervical myelopathy due to single level disc herniation  presenting as intramedullary mass lesion: What to do first?,Non-OADS,/arxiv_data1/oa_pdf/73/3b/JCVJS-6-92.PMC4426531.pdf
"Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp97Letter to Editor Intervertebral disc  calcification in childhood:  Case report and review  of relevant literature Sir, Idiopathic IDC of childhood is a rare benign self-limited  condition.",Non-OADS,/arxiv_data1/oa_pdf/51/7c/JCVJS-6-97.PMC4426532.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/16/bb/jcbfm2014188a.PMC4426739.pdf
"Infarct size, whichis devoid of red staining, was determined on the digital images usingImageJ software (open source ImageJ software available at http://rsb.info.",OADS,/arxiv_data1/oa_pdf/29/af/jcbfm2014208a.PMC4426753.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/29/af/jcbfm2014208a.PMC4426753.pdf
The promoter sequences for BDNF (Accession num-ber 8188) and eNOS (Accession number 26552) were retrieved from the  “Transcriptional Regulatory Element Database” website (http://rulai.cshl.,OADS,/arxiv_data1/oa_pdf/e0/bd/mt2014163a.PMC4426795.pdf
edu/cgi-bin/TRED/tred.cgi?process=home) and the transcription start sites  were retrieved from the “DBTSS: Database of Transcriptional Start Sites”  website (http://dbtss.hgc.jp/index.html?nmid=DBTSS:NM_000603) and  the “Human (Homo sapiens) Genome Browser Gateway” website (http:// genome-euro.ucsc.edu/cgi-bin/hgGateway).,OADS,/arxiv_data1/oa_pdf/e0/bd/mt2014163a.PMC4426795.pdf
"To identify  the family or individual transcription factors that potentially bind to the  identified sequences, genomic regions from UCSC ENCODE genome  browser 34,49 were compared against a comprehensive library of known  motifs consisting of motif matrices from the JASPAR database (http://jas-par.genereg.net/).",OADS,/arxiv_data1/oa_pdf/e0/bd/mt2014163a.PMC4426795.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 42 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/e0/bd/mt2014163a.PMC4426795.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 52 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/c5/95/mt2014178a.PMC4426801.pdf
"1683 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/8a/btu853.PMC4426829.pdf
"3 Example An example dataset, based on data published in ( Enerly et al., 2011 ) and formatted for ENViz, can be downloaded from http://www.agilent.com/labs/research/compbio/enviz/data.html.",OADS,/arxiv_data1/oa_pdf/db/8a/btu853.PMC4426829.pdf
Availability and implementation : R code to implement this method is available at http://www.bio- stat.wisc.edu/ kendzior/MADGiC/.,OADS,/arxiv_data1/oa_pdf/94/3c/btu858.PMC4426832.pdf
"1526 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/3c/btu858.PMC4426832.pdf
project (http://cancergenome.nih.gov/) and the Cancer Genome Project (http://www.sanger.ac.uk/research/projects/cancergenome/).,Non-OADS,/arxiv_data1/oa_pdf/94/3c/btu858.PMC4426832.pdf
2 Methods 2.1 TCGA somatic mutation data The TCGA somatic mutation datasets consist of exome somatic mutation calls between tumor tissue samples and normal samples(from either matched tissue or blood) of cancer patients and arefreely available for download from the TCGA data download portal(available at https://tcga-data.nci.nih.gov/tcga/).,OADS,/arxiv_data1/oa_pdf/94/3c/btu858.PMC4426832.pdf
Information about TCGA and the investigators and institutions who consti- tute the TCGA research network can be found at http://cancergenome.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/btu858.PMC4426832.pdf
"1614 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/27/btu863.PMC4426834.pdf
"Thewidely used TRANSFAC database (http://www.gene-regulation.com/pub/databases.html) only reports information for a handful ofTFs included in this analysis, and the number of known targetsamong the selected 1000 genes is usually very low (one or two atmaximum), precluding a systematic enrichment analysis.",Non-OADS,/arxiv_data1/oa_pdf/b3/27/btu863.PMC4426834.pdf
URL: http://bioconductor.org/packages/release/bioc/html/FGNet.html Contact: jrivas@usal.es Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/fa/d0/btu864.PMC4426835.pdf
"1686 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/d0/btu864.PMC4426835.pdf
"We apply our framework to PINs of yeast and human, identifying seven biological process and two cellular component GO terms to be topologically orthologous for the two organisms.Availability and implementation: http://bio-nets.doc.ic.ac.uk/goCCA.zip Contact: natasha@imperial.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/35/b1/btv026.PMC4426845.pdf
"1632 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/b1/btv026.PMC4426845.pdf
"2.2.2 Gene ontology (GO) annotations We obtain GO term annotations for the human and yeast proteinsfrom the NCBI FTP Server (ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/gene2go.gz) (downloaded on June 11, 2013) ( Maglott et al.",OADS,/arxiv_data1/oa_pdf/35/b1/btv026.PMC4426845.pdf
We use the full GO hierarchy (http://www.geneontology.org/ontology/obo_format_1_2/) and infer par-ent GO annotations from ‘is-a’ relationships.,Non-OADS,/arxiv_data1/oa_pdf/35/b1/btv026.PMC4426845.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/f0/rru108.PMC4426910.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"6 May 2011. http://www.mext.go.jp/ component/english/__icsFiles/a ﬁeldﬁle/2011/05/10/ 1304797_0506.pdf (8 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"http://www.mhlw.go.jp/english/topics/2011eq/workers/ tepco/lhc/pr_140604.html (31 August 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"http://www.icrp.org/docs/icrp%20 statement%20on%20tissue%20reactions.pdf (25 February 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"http://www.mhlw.go.jp/ ﬁle/04- Houdouhappyou-11303000-Roudoukijunkyokuanzeneiseibu-Roudoueiseika/0000047451.pdf (11 June 2014, date last accessed) (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
http://www.nsr.go.jp/archive/mext/ b_menu/shingi/housha/toushin/__icsFiles/a ﬁeldﬁle/2011/ 03/07/1302851_1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"http://www.nsr.go.jp/activity/bousai/ iodine_tablet/index.html (13 November 2013, date last accessed) (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"Exposure dose distribution of the workers at Fukushima Daiichi Nuclear Power Plant http://www.mhlw.go.jp/english/ topics/2011eq/workers/irpw/index.html (16 February 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/54/2a/rru110.PMC4426911.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/25/rru120.PMC4426914.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/fa/rru122.PMC4426916.pdf
"http://rsb.info.nih.gov/ij/1997-2009 (28 February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/17/fa/rru122.PMC4426916.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/4e/rru123.PMC4426917.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/5d/rru125.PMC4426919.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/b1/rru126.PMC4426920.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/rru128.PMC4426922.pdf
Analyzed genes were functionally annotated according tothe gene ontology (GO) consortium ( http://www.geneontology.,OADS,/arxiv_data1/oa_pdf/e5/9c/rru128.PMC4426922.pdf
Analyzed genes were functionally classi ﬁed based on DAVID bioinformatics ( http://david.abcc.ncifcrf.gov ) by uploading target476 C.S.,OADS,/arxiv_data1/oa_pdf/e5/9c/rru128.PMC4426922.pdf
Raw and normalized DNA microarray data has been submitted to the Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/ geo/) with the following accession number: GSE61759.,OADS,/arxiv_data1/oa_pdf/e5/9c/rru128.PMC4426922.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/5c/rrv001.PMC4426925.pdf
Statistical analysis Statistical analysis was performed by Student t-test or paired t-test using R Project software ( http://www.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/5d/5c/rrv001.PMC4426925.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any mediu m, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"http://www.mext.go.jp/component/english/ __icsFiles/a ﬁeldﬁle/2011/05/10/1304797_0506.pdf (8 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"http://www.iaea.org/newscenter/focus/fukushima/japan- report2/ (18 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"http://www.nsr.go.jp/activity/bousai/iodine_ tablet/index.html (13 November 2013, date last accessed) (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
http://www.niph.,Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
http://www.iaea.,Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"Seismic damage information as of 22nd August (236th release) http://www.meti.go.jp/press/2011/08/20110822002/ 20110822002-1.pdf (12 January 2013, date last accessed) (in Japanese).",OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
http://www.pref.fukushima.,Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"http://www.mhlw.go.jp/ english/topics/2011eq/workers/irpw/index.html (10 February 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
http://www.iaea.org/newscenter/focus/actionplan/reports/ enhancetransparency2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"Communication with the Public in a Nuclear or Radio- logical Emergency http://www-pub.iaea.org/MTCD/Publications/ PDF/EPR-Communcation_web.pdf (25 March 2013, date last accessed).428 T.",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
http://www.ndawg.org/images/stories/ndawgdocuments/Reports/ CommunicationsWorkshopReportFeb09.pdf .,Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"Guidelines for Remediation Strategies to Reduce the Radiological Consequences of Environmental Contamination.http://www-pub.iaea.org/MTCD/Publications/PDF/trs475_web.pdf(25 March 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
"Manual for ﬁrst responders to a radiological emergency reported by IAEA http://www-pub.iaea.org/MTCD/publications/ PDF/epr_Firstresponder_web.pdf (18 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/08/c6/rrv013.PMC4426935.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/5d/ahmt-6-081.PMC4427063.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2015:6 81–89Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  81OriginAl reseArcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S7691 6Adolescents with personality disorders   suffer from severe psychiatric stigma: evidence   from a sample of 131 patients Kirsten catthoor1,3 Dine J Feenstra2 Joost Hutsebaut2 Didier schrijvers3 Bernard sabbe3 1Department of Psychiatry,   Psychiatrisch Ziekenhuis stuivenberg,   ZnA Antwerpen, Antwerp, Belgium;   2Viersprong institute for studies on  Personality Disorders, Halsteren, the  netherlands; 3collaborative Antwerp  Psychiatric research institute,   University of Antwerp, Wilrijk,   Belgium correspondence: Kirsten catthoor   cAPri, campus Drie eiken,  Universiteitsplein 1, 2610 Wilrijk, Belgium   Tel +32 478 353 957   email kirstencatthoor@yahoo.co mBackground:  The aim of the study is to assess the severity of psychiatric stigma in a sample  of personality disordered adolescents in order to evaluate whether differences in stigma can  be found in adolescents with different types and severity of personality disorders (PDs).",Non-OADS,/arxiv_data1/oa_pdf/1a/5d/ahmt-6-081.PMC4427063.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/1a/5d/ahmt-6-081.PMC4427063.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/5d/ahmt-6-081.PMC4427063.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/e2/lra-8-007.PMC4427064.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 7–10Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  7CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/LRA.S8169 6Ultrasound-guided epidural anesthesia for a  parturient with severe malformations of the  skeletal system undergoing cesarean delivery:   a case report LinLi Luo* Juan Ni* Lan Wu Dong Luo Department of Anesthesiology, West  China second Hospital, sichuan  University, Chengdu, sichuan,    people’s Republic of China *these authors contributed equally to  this work and should be considered  co-first authors Correspondence: Dong Luo   Department of Anaesthesiology,  West China second Hospital, sichuan  University, Number 20, section 3 Renmin  Nan Road, Chengdu, sichuan 610041,  people’s Republic of China   tel +86 28 8550 3753 (office)   Fax +86 28 8550 3752   email l uodong8706@163.co mAbstract:  Anesthetic management of patients with preexisting diseases is challenging and  individualized approaches need to be determined based on patients’ complications.",Non-OADS,/arxiv_data1/oa_pdf/60/e2/lra-8-007.PMC4427064.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/60/e2/lra-8-007.PMC4427064.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/e2/lra-8-007.PMC4427064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 485–491International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  485OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7887 4Knowledge and attitudes of latin american  gynecologists regarding unplanned pregnancy  and use of combined oral contraceptives luis Bahamondes1 Josefina lira-Plascencia2 ricardo Martin3 Victor Marin4 Maria Y Makuch1 1Department of Obstetrics and  gynecology, school of Medical  sciences, University of campinas  (UnIcaMP), campinas, Brazil;   2Instituto nacional de Perinatología,   México, DF , México; 3Hospital  Universitario, Fundación santa Fe de  Bogotá, Bogotá, colombia; 4Hospital  central, Petróleos Mexicanos, México,   DF , MéxicoBackground:  Unintended pregnancy is a public health problem and unmet medical need  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
"Also, in 2008, a worldwide estimate showed that four  out of ten pregnancies were unintended, with a higher proportion in South American correspondence: luis Bahamondes Department of Obstetrics and  gynecology, school of Medicine,  University of campinas, caixa Postal  6181, 13084-971 campinas, sP, Brazil Tel +55 19 3289 5207 Fax +55 19 3289 2440 email bahamond@caism.unicamp.b r Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Bahamondes et al Running head recto: Latin American gynecologists and combined oral contraceptives DOI: http://dx.doi.org/10.2147/IJWH.S78874",Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
Available from: http://www.earth- policy.org/data_highlights/2012/highlights2 6.,Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
"Available from: http://www.guttmacher.org/pubs/ fb_IAW .htm l. Accessed October 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
Available from: http://www.who.int/ reproductivehealth /publications/family_planning/9789241563888/e n/.,Non-OADS,/arxiv_data1/oa_pdf/ad/42/ijwh-7-485.PMC4427065.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/98/cmar-7-105.PMC4427066.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 105–119Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  105Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S8131 0expanding role of lenalidomide in hematologic  malignancies Nilanjan Ghosh Michael R Grunwald Omotayo Fasan Manisha Bhutani Levine Cancer institute, Carolinas  HealthCare System, Charlotte,   NC, USA Correspondence: Nilanjan Ghosh   Department of Hematologic Oncology  and Blood Disorders, Levine Cancer  institute,  1021 Morehead Medical Drive,  Suite 5300, Charlotte, NC  28204, USA   Tel +1 980 442 4363  Fax +1 980 442 5241  email n ilanjan.ghosh@carolinashealthcare.",Non-OADS,/arxiv_data1/oa_pdf/e3/98/cmar-7-105.PMC4427066.pdf
Or use: http://youtu.be/s8P_L-QLjk s,Non-OADS,/arxiv_data1/oa_pdf/e3/98/cmar-7-105.PMC4427066.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/e3/98/cmar-7-105.PMC4427066.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/98/cmar-7-105.PMC4427066.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 235–247ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  235ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8255 6Cost-effectiveness of ranibizumab versus  aflibercept in the treatment of visual impairment  due to diabetic macular edema: a UK healthcare  perspective stephane a Régnier1 William Malcolm2 Jennifer haig3 Weiguang Xue4 1novartis Pharma ag, Basel,  switzerland; 2novartis  Pharmaceuticals UK ltd, Frimley  Business Park, UK; 3Optum,  Burlington, On , Canada; 4Optum,  Uxbridge, UK Correspondence: stephane a Régnier   novartis Pharma ag novartis Campus,  Fabrikstrasse 6, Ch-4056, Basel,  switzerland   Tel +41 61 535 5607   Email stephane.regnier@novartis.co mBackground:  Ranibizumab and aflibercept are alternative anti-vascular endothelial growth  factor agents approved for the treatment of visual impairment (VI) due to diabetic macular  edema (DME).",Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
"Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Assessment_Report_-_ Variation/ human/002392/WC500172846.pd f. Accessed October 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Available from: http://www.nice.org.uk/guidance/ ta294.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000715/ WC500043546.pd f. Accessed March 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/002392/WC500135815.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Available from: https://www.gov.uk/government/publications/nhs- reference-costs-financial-year-2011-to-201 2.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
"Available from: http://www.nice.org.uk/ nicemedia/live/13037/52883/52883.pd f. Accessed October 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Available from: http://www.info.doh.gov.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Available from: http://www.pssru.ac.uk/ project-pages/unit-costs/2011 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Available from: http://www.pssru.ac.uk/project-pages/ unit-costs/2003 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
"Available from: http://www.kingsfund.org.uk/publications/paying-pric e.  Accessed October 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/ceor-7-235.PMC4427067.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/15/oajsm-6-137.PMC4427068.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 137–147Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  137OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7462 2effectiveness of a tailored neck training program  on neck strength, movement, and fatigue   in under-19 male rugby players: a randomized  controlled pilot study Matthew D Barrett1 T erence F Mcloughlin2 Kieran r gallagher1 Don gatherer3 Michael Tr Parratt1 Jonathan r Perera1 Tim Wr Briggs1 1royal national Orthopaedic  hospital, Stanmore, Middlesex,  United Kingdom;  2royal liverpool  University hospital, liverpool,  Mersey Deanery, United Kingdom;   3The gatherer Partnership, Aylesbury,  United Kingdom correspondence: Matthew David Barrett   royal national Orthopaedic hospital,  Brockley hill, Stanmore, Middlesex,  hA74lP, United Kingdom   email mbarrett24@gmail.co mPurpose:  To investigate the effect of a tailored neck muscle conditioning program on neck  muscle strength, neck muscle fatigue, and range of neck movement in  16–18-year-old male  rugby players.",Non-OADS,/arxiv_data1/oa_pdf/7d/15/oajsm-6-137.PMC4427068.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/7d/15/oajsm-6-137.PMC4427068.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/15/oajsm-6-137.PMC4427068.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/9a/ijn-10-3303.PMC4427069.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3303–3314International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3303OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7930 6effective small interfering rNa delivery in vitro  via a new stearylated cationic peptide Baoling chen1,2 ran Pan1,2 Diana askhatova1 P chen1,2 1Department of chemical  engineering, 2Waterloo Institute  for Nanotechnology, University  of Waterloo, Waterloo, ON, canadaAbstract:  A crucial bottleneck in RNA interference-based gene therapy is the lack of safe  and efficient delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/e3/9a/ijn-10-3303.PMC4427069.pdf
"Carrier-based strategies have been explored as a simple  and fast means to protect the siRNA and maximize its therapeutic effects.correspondence: P chen Department of chemical engineering,  University of Waterloo, 200 University  avenue West, Waterloo, ON N2l 3g1,  canada Tel +1 519 888 4567 ext 35586 Fax +1 519 888 4347 email p4chen@uwaterloo.c a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Small interfering RNA delivery in vitro via a stearylated cationic peptide DOI: http://dx.doi.org/10.2147/IJN.S79306",Non-OADS,/arxiv_data1/oa_pdf/e3/9a/ijn-10-3303.PMC4427069.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/9a/ijn-10-3303.PMC4427069.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/9a/ijn-10-3303.PMC4427069.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/ef/dmso-8-227.PMC4427070.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 227–239Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  227Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8233 8interaction between leucine and  phosphodiesterase  5 inhibition in modulating  insulin sensitivity and lipid metabolism lizhi Fu1 Fenfen li1 antje Bruckbauer2 Qiang cao1 Xin cui1 rui Wu1 hang Shi1 Bingzhong Xue1 Michael B Zemel2 1Department of Biology, center for  Obesity reversal, georgia State  University, atlanta, ga, 2nuSirt  Biopharma inc., nashville, Tn , USa correspondence: Michael B Zemel   nuSirt Biopharma inc.,  11020 Solway  School road, Suite  109, Knoxville,   Tn 37931, USa   Tel +1 865 206 6154  email mzemel@nusirt.co mPurpose:  Leucine activates SIRT1/AMP-activated protein kinase (AMPK) signaling and mark - edly potentiates the effects of other sirtuin and AMPK activators on insulin signaling and lipid  metabolism.",Non-OADS,/arxiv_data1/oa_pdf/3b/ef/dmso-8-227.PMC4427070.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/3b/ef/dmso-8-227.PMC4427070.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/ef/dmso-8-227.PMC4427070.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/e5/ndt-11-1149.PMC4427071.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1149–1155Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1149Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6747 0Profile of agomelatine and its potential   in the treatment of generalized anxiety disorder Michelle Nigri Levitan1 Marcelo Papelbaum1,2 Antonio Egidio Nardi1 1Laboratory of Panic and Respiration,   Institute of Psychiatry of the  Federal University of Rio de Janeiro,   2State Institute of Diabetes and  Endocrinology of Rio de Janeiro,   Rio de Janeiro, BrazilBackground:  Although many generalized anxiety disorder (GAD) patients respond to the  available pharmacological treatments, nearly half of them do not present the expected results.",Non-OADS,/arxiv_data1/oa_pdf/54/e5/ndt-11-1149.PMC4427071.pdf
"This feature could be interesting, especially considering the latency of efficacy for the Correspondence: Michelle Nigri Levitan Avenida Ataulfo de Paiva 204/707, Leblon,  Rio de Janeiro, 22440-033 Brazil   Tel +55 21 2137 6436 Fax +55 21 2135 6436 email milevitan@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Levitan et al Running head recto: Agomelatine in the treatment of generalized anxiety disorder  DOI: http://dx.doi.org/10.2147/NDT.S67470",Non-OADS,/arxiv_data1/oa_pdf/54/e5/ndt-11-1149.PMC4427071.pdf
Available online: http://emc.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/54/e5/ndt-11-1149.PMC4427071.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/54/e5/ndt-11-1149.PMC4427071.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/e5/ndt-11-1149.PMC4427071.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/34/copd-10-869.PMC4427072.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 869–871International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  869Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S8356 4Pleural plaques in smoking-associated fibrosis  and pulmonary asbestosis rahul G Sangani1 Andrew J Ghio2 John e Parker1 1Department of Pulmonary and  Critical Care Medicine, West Virginia  University, Morgantown, WV, USA;   2Environmental Public Health Division,   National Health and Environmental  Effects Research Laboratory, US  environmental Protection Agency,   Chapel Hill, NC, USADear editor  Bledsoe et al presents an interesting study examining the disparities between radiologic  and pathologic diagnoses of asbestosis in cases referred for consultation in pulmonary  malignancy.1 The authors conclude that the clinical diagnosis of asbestosis cannot be  reliably distinguished from interstitial fibrosis in heavy smokers.",Non-OADS,/arxiv_data1/oa_pdf/80/34/copd-10-869.PMC4427072.pdf
"2011;6:191–198.Correspondence: rahul G Sangani Department of Pulmonary and Critical  Care Medicine, West Virginia University,  Robert C Byrd Health Science Center,   1 Medical Center Drive, Morgantown,  WV 26505, USA tel +1 304 293 4661 Fax +1 304 293 3724 email rgsangani@hsc.wvu.ed u Journal name: International Journal of COPD Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Sangani et al Running head recto: Pleural plaques in smoking-associated fibrosis DOI: http://dx.doi.org/10.2147/COPD.S83564",Non-OADS,/arxiv_data1/oa_pdf/80/34/copd-10-869.PMC4427072.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/80/34/copd-10-869.PMC4427072.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/34/copd-10-869.PMC4427072.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 99–102International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  99Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8335 1an unusual case of prostate tuberculosis:   a case report ahmad Jasem abdulsalam1 Mohammad adel  abdulsalam2 1Faculty of Medicine, Health science  Center, Jabriya, Kuwait;  2Mubarak al  Kabeer Hospital, Jabriya, Kuwait Correspondence: ahmad Jasem  abdulsalam   Faculty of Medicine, Health science  Center, po Box  24923, safat  13110,  Jabriya, Kuwait   tel +965 9792 3190  email a7medo@gmail.co mIntroduction:  Tuberculosis of the prostate is a rare complication of miliary tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
Avail - able from: http://emedicine.medscape.com/article/221777-overview .,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
Available from:  http://emedicine.medscape.com/article/450651-overview#aw2aab6b 4.,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
Available from http://www.cdc.gov/tb /.,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/imcrj-8-099.PMC4427073.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/fc/opth-9-765.PMC4427074.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 765–772Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  765Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S8050 3effect of alcaftadine 0.25% on ocular itch  associated with seasonal or perennial allergic  conjunctivitis: a pooled analysis of two multicenter  randomized clinical trials Joseph B Ciolino1 eugene B Mclaurin2 nicholas P Marsico3 stacey l ackerman4 Julia M Williams5 linda Villanueva5 David a hollander5 1Department of Ophthalmology,   Massachusetts eye and ear infirmary,   harvard Medical school, Boston, M a,   Usa; 2T otal eye Care, P .a., Memphis,   Tn, Usa; 3east West eye institute,   los angeles, C a, Usa; 4Philadelphia  eye associates, Philadelphia, P a, Usa;   5allergan, inc., irvine, C a, UsaPurpose:  Seasonal and perennial allergic conjunctivitis represent the majority of cases of  ocular allergy.",Non-OADS,/arxiv_data1/oa_pdf/03/fc/opth-9-765.PMC4427074.pdf
"Allergic conjunctivitis encompasses a group of disorders  that include seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis Correspondence: Joseph B Ciolino Department of Ophthalmology,  Massachusetts Eye and Ear Infirmary,  harvard Medical school, 243 Charles  street, Boston, Ma 02114, Usa Tel +1 617 573 5575 Fax +1 617 573 4324 email j oseph_ciolino@meei.harvard.ed uJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ciolino et al Running head recto: Alcaftadine in seasonal or perennial allergic conjunctivitis DOI: http://dx.doi.org/ 10.2147/OPTH.S80503",Non-OADS,/arxiv_data1/oa_pdf/03/fc/opth-9-765.PMC4427074.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/03/fc/opth-9-765.PMC4427074.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/fc/opth-9-765.PMC4427074.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 209–216Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  209Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S8033 7impact of an educational intervention on provider  knowledge, attitudes, and comfort level regarding  counseling women ages 40–49 about breast  cancer screening T eresa J Bryan1,2 carlos a estrada1,2 analia castiglioni3 erin D snyder1,2 1University of alabama at Birmingham,   Birmingham, al, Usa; 2Birmingham  Veterans administration Medical  center, Birmingham, al, Usa;   3University of central Florida college  of Medicine, Orlando, Fl, Usa correspondence: Teresa J Bryan   Department of Medicine, University of  Alabama at Birmingham, Faculty Office  Towers, room 720, 510 20th street  south, Birmingham, al 35294, Usa   Tel +1 205 934 3007   Fax +1 205 975 7797   email tb500@uab.ed uBackground:  Mammography screening for women under the age of 50 is controversial.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Available  from: http://seer.cancer.gov/csr/1975_2010 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Available from: http://globocan.iarc.fr/pages/fact_sheets_popula - tion.asp x. Accessed March 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/137339/1/978924150793 6_eng.pdf?ua= 1.,OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/107980/1/E93419.pdf?ua= 1.,OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Available  from: http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ ID=297 7.,Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Available from: http://www.prevention.va.gov/ docs/V ANCP_BreastCancerFact.pd f. Accessed December 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Available  from: http://www.va.gov/QUALITYOFCARE/initiatives/compare/ prevention-breast-cancer-screening.as p. Accessed December 24,  2014.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Available from:  http://www.cancer.gov/bcrisktool /.,Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Available from: http://www.prevention.va.gov/docs/V ANCP_BreastCan - cerFact.pd f. Accessed December 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Available  from: http://www.cancer.gov/cancertopics/pdq/screening/breast/patien t.  Accessed March 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Physician resources:1 life saved (per 2000 screened x 10 years)Assess patient risk/ preferenceEvery 2 years Every 2 years until 75 years of age40–49 years of age Benefit Explaining overdiagnosis ResourcesHarms50–59 years of age 60+ years of age http://www.prevention.va.gov/ScreeningforBreastCance r.asp3 http://www.cancer.gov/bcrisktool /4 http://www.prevention.va.gov/docs/VANCP_BreastCancerFact.pd f5 http://www.cancer.gov/cancertopics/pdq/screening/breast/patien t6,Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/22/jmdh-8-209.PMC4427075.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/35/amep-6-347.PMC4427076.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 347–352Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  347PErsPEctivEsopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S8293 7Limitations of the biopsychosocial model in  psychiatry tony B Benning Maple ridge Mental Health centre,   Maple ridge, Bc , canada correspondence: tony B Benning   Maple ridge Mental Health centre,   #500 22470 Dewdney trunk road,   Maple ridge, Bc, v2X 5Z6, canada   tel +1 60 4476 7165   Fax +1 60 4476 7199   Email t onybbenning@hotmail.co mAbstract:  A commitment to an integrative, non-reductionist clinical and theoretical perspec - tive in medicine that honors the importance of all relevant domains of knowledge, not just “the  biological,” is clearly evident in Engel’ s original writings on the biopsychosocial model.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/amep-6-347.PMC4427076.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/f0/35/amep-6-347.PMC4427076.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/35/amep-6-347.PMC4427076.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/9f/ccid-8-231.PMC4427077.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 231–238Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  231OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S8046 7acne treatment patterns, expectations,   and satisfaction among adult females   of different races/ethnicities Marta I rendon1 David a rodriguez2 ariane K Kawata3 arnold n Degboe4 T eresa K Wilcox3 Caroline T Burk5 selena r Daniels4 Wendy e roberts6 1rendon Center for Dermatology  and aesthetic Medicine, Boca raton,  Fl, Usa;  2Dermatology associates  and research, Coral gables, F l,  Usa;  3evidera, Bethesda, MD, Usa;   4allergan Inc., Irvine, Ca, Usa;   5health Outcomes Consultant, laguna  Beach, Ca, Usa;  6generational and  Cosmetic Dermatology, rancho  Mirage, Ca, Usa Correspondence: Marta I rendon   rendon Center for Dermatology and  aesthetic Medicine,  880 north West   13th street, suite  3C, Boca raton,   Fl 33486, Usa   Tel +1 561 529 4667  Fax +1 561 750 9873  email martarendon@yahoo.co mBackground:  Limited data are available on acne treatment patterns, expectations, and satisfac - tion in the adult female subpopulation, particularly among different racial and ethnic groups.",Non-OADS,/arxiv_data1/oa_pdf/a0/9f/ccid-8-231.PMC4427077.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/a0/9f/ccid-8-231.PMC4427077.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/9f/ccid-8-231.PMC4427077.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/6c/cia-10-827.PMC4427078.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 827–828Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  827Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S8360 0response to “Oral health in the elderly patient   and its impact on general well-being:  a nonsystematic review” paper Małgorzata Muc-Wierzgoń teresa Kokot ewa Nowakowska-Zajdel Adam Błażelonis edyta Fatyga Department of Internal Medicine,   Silesian Medical University, Bytom,   PolandDear editor Gil-Montoya et al has recently published an interesting article in Clinical Interven - tions in Aging entitled: “Oral health in the elderly patient and its impact on general  well-being: a nonsystematic review”.1 Authors presented a non-systematic review of  the published data regarding the oral health status of the elderly and its main repercus - sions, including its impact on general health and nutrition.",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/cia-10-827.PMC4427078.pdf
"Disclosure The authors report no conflicts of interest in this work.Correspondence: Małgorzata Muc- Wierzgoń  Department of Internal Medicine, Silesian  Medical University, st Żeromskiego 7,  41-902 Bytom, Poland tel/fax +48 32 281 2122 email mwierzgon@sum.edu.p l Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Muc-Wierzgo ń et al Running head recto: Response to “Oral health in the elderly patient and its impact on general well-being DOI: http://dx.doi.org/10.2147/CIA.S83600",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/cia-10-827.PMC4427078.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/cia-10-827.PMC4427078.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f9/6c/cia-10-827.PMC4427078.pdf
"Avail - able from: http://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/ ToothLoss/ToothLossSeniors65andOlder.ht m. Accessed March 26,   2015.",Non-OADS,/arxiv_data1/oa_pdf/f9/6c/cia-10-827.PMC4427078.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/a9/ijnrd-8-041.PMC4427079.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 41–51International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  41ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S7874 9Decade-long trends (1999–2009) in the  characteristics, management, and hospital  outcomes of patients hospitalized with acute  myocardial infarction with prior diabetes   and chronic kidney disease Mayra Tisminetzky1 David D McManus1,2 alon Dor2 Ruben Miozzo3,4 Jorge Yarzebski1 Joel M gore2 Robert J goldberg1,2 1Department of Quantitative health  sciences,  2Division of cardiovascular  Medicine, Department of Medicine,   University of Massachusetts Medical  school, Worcester, M a, 3Department  of Psychiatry, Johns hopkins  school of Medicine, Baltimore, MD,   4Department of Psychiatry, University  of Massachusetts Medical school,   Worcester, M a, Usa correspondence: Robert J goldberg   Division of epidemiology of chronic  Diseases and Vulnerable Populations,  Department of Quantitative health  sciences, University of Massachusetts  Medical school,  368 Plantation street,  Worcester, Ma  01605, Usa   Tel +1 508 856 3991  Fax +1 508 856 8993  email r obert.",Non-OADS,/arxiv_data1/oa_pdf/bf/a9/ijnrd-8-041.PMC4427079.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/bf/a9/ijnrd-8-041.PMC4427079.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/a9/ijnrd-8-041.PMC4427079.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 773–781Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  773Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S7706 7Global reported endophthalmitis risk following  intravitreal injections of anti-veGF: a literature  review and analysis Douglas K Sigford1 Shivani Reddy1 Christine Mollineaux2 Shlomit Schaal1 1Department of Ophthalmology  and visual Sciences, University  of Louisville, Louisville, 2Department  of Ophthalmology and visual Science,   University of Kentucky, Lexington,   KY, USAPurpose:  To report on endophthalmitis occurrence and associated risk factors following the  intravitreal injection of anti-VEGF agents based on a review of published literature.",Non-OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
"It is US  Food and Drug administration-approved for use in exAMD, diabetic macular edema, and  macular edema associated with retinal vein occlusion, and is supplied directly to practices Correspondence: Shlomit Schaal Department of Ophthalmology and visual  Sciences, University of Louisville, 301 east  Muhammad Ali Boulevard, Louisville, KY  40202, USA Tel +1 502 751 4379 Fax +1 502 852 2737 email s.schaal@louisville.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Sigford et al Running head recto: Endophthalmitis risk after intravitreal anti-VEGF injections DOI: http://dx.doi.org/10.2147/OPTH.S77067",Non-OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
"Available  from: http://www.cdc.gov/HAI/outbreaks/currentsituatio n. Accessed  July 30, 2013.",OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
"Avail - able from: http://ophthalmologyrounds.ca/modules/ contentManager / upload/document/alwaysOnLine/ScientificUpdate_en.pd f. Accessed  January 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/09/opth-9-773.PMC4427080.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 477–483International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  477OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8062 4cervical cancer screening and treatment  of cervical intraepithelial neoplasia in female sex  workers using “screen and treat” approach smita Joshi1 Vinay Kulkarni2 Trupti Darak2 Uma Mahajan1 Y ogesh srivastava3 sanjay gupta3 sumitra Krishnan1 Mahesh Mandolkar2 alok chandra Bharti3 1Hirabai cowasji Jehangir Medical  research Institute (HcJM rI), Jehangir  Hospital Premises, Pune, Maharashtra,   India; 2Prayas Health group, amrita  clinic, Pune, India; 3Institute for  cytology and Preventive Oncology,   Indian council of Medical research,   new Delhi, IndiaObjective:  Female sex workers (FSWs) are at an increased risk of human immunodeficiency  virus (HIV) as well as human papillomavirus (HPV) infections and thus have an increased risk  of cervical intraepithelial neoplasia (CIN) and cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
"The overall prevalence of correspondence: smita Joshi Hirabai cowasji Jehangir Medical  research Institute (HcJMrI), Jehangir  Hospital Premises, 32 sassoon road,  Pune 411001, Maharashtra, India Tel +91 98 8113 2506 email smitanjoshi@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Joshi et al Running head recto: Screening and treatment of cervical intraepithelial neoplasia DOI: http://dx.doi.org/10.2147/IJWH.S80624 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Or use: http://youtu.be/Gd_DtfTYad MVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/2249815 4.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/1099580 5.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
"Available from:  http://naco.gov.in/upload/Surveillance/Reports&Publication/HIV SentinelSurveillanceIndiaCountryReport,2008-09.pd f. Accessed  March 31, 2014.",OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
"Available from:  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid =3143430& tool=pmcentrez&rendertype =abstrac t. Accessed September 18, 2013.",OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2262866 1.,OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
"Available from: http://www.naco.gov.in/upload/STI RTI  services/National_Guidelines_on_PMC_of_RTI_Including_STI 1.pd f.  Accessed April 7, 2014.",OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/1465580 9.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Avail - able from: http://www.ncbi.nlm.nih.gov/pubmed/1840467 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/1746603 5.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/2459777 9.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.who.int/ vaccine_safety /committee/reports/wer8829.pdf?ua =1.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/ijwh-7-477.PMC4427081.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/e0/dddt-9-2501.PMC4427082.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2501–2514Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2501Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7840 2Preparation and characterization of genipin-cross- linked silk fibroin/chitosan sustained-release  microspheres shuguang Zeng1,* Manwen Ye1,2,* Junqi Qiu1 Wei Fang1 Mingdeng rong1 Zehong guo1 Wenfen gao1 1Department of Oral and Maxillofacial  surgery, guangdong Provincial  stomatological hospital, southern  Medical University, 2Department of  stomatology, guangdong Women and  children hospital, guangzhou Medical  University, guangzhou, guangdong,   People’s Republic of China *These authors contributed equally  to this workAbstract:  We report the effects of distinct concentrations of genipin and silk fibroin  (SF):chitosan (CS) ratios on the formation of SF–CS composite microspheres.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/dddt-9-2501.PMC4427082.pdf
"One of the materials that can be used for this purpose is silk fibroin (SF), correspondence: shuguang Zeng Department of Oral and Maxillofacial  surgery, guangdong Provincial  stomatological hospital, southern  Medical University, Jiangnan Da Dao  #366, guangzhou 510280, People’s  Republic of China Tel +86 20 8440 3311 Fax +86 20 8443 3177 email sunrisezdoctor@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zeng et al Running head recto: Genipin-cross-linked silk fibroin/chitosan microspheres DOI: http://dx.doi.org/10.2147/DDDT.S78402",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/dddt-9-2501.PMC4427082.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9d/e0/dddt-9-2501.PMC4427082.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/e0/dddt-9-2501.PMC4427082.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/a2/ijgm-8-165.PMC4427083.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 165–173International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  165RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S8187 8evaluation of the impact of rehospitalization   in the management of hepatic encephalopathy Sammy Saab Department of Medicine, University  of California, Los Angeles,   Los Angeles, CA, USA Correspondence: Sammy Saab   Departments of Medicine and Surgery,  University of California, Los Angeles,   200 UCLA Medical Plaza, Suite 214,   Los Angeles, CA 90095, USA   Tel +1 310 206 6705   Fax +1 310 206 4197   email ss aab@mednet.ucla.ed uBackground:  Overt hepatic encephalopathy (HE), which is associated with neuropsychiatric  symptoms and neuromuscular dysfunction in patients with liver cirrhosis, is often managed in  the hospital setting.",Non-OADS,/arxiv_data1/oa_pdf/b3/a2/ijgm-8-165.PMC4427083.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b3/a2/ijgm-8-165.PMC4427083.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/a2/ijgm-8-165.PMC4427083.pdf
"http://medent.usyd.edu.au/fact/ticks.htm  (accessed  February  17,  2015 ).",Non-OADS,/arxiv_data1/oa_pdf/b0/6b/cop-0006-0120.PMC4427139.pdf
"http://www.allergy.org.au/patients/insect -allergy -bites -and-stings/tick -allergy  (accessed  February 10, 2015) .",Non-OADS,/arxiv_data1/oa_pdf/b0/6b/cop-0006-0120.PMC4427139.pdf
"http://www.health.gov .au/lyme -disease  (accessed February 18,  2015 ).",Non-OADS,/arxiv_data1/oa_pdf/b0/6b/cop-0006-0120.PMC4427139.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 639–648Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  639OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8161 2Determinants of medication adherence among  adults with type 2 diabetes mellitus in three  Malaysian public health clinics: a cross-sectional study Boon-how chew1 noor-hasliza hassan2 Mohd-sidik sherina3 1Department of Family Medicine,   Faculty of Medicine and health  sciences, Universiti Putra Malaysia,   2Klinik Kesihatan Dengkil, Ministry  of health, 3Department of Psychiatry,   Faculty of Medicine and health  sciences, Universiti Putra Malaysia,   serdang, MalaysiaAbstract:  Medication adherence (MA) in adults with type 2 diabetes mellitus (T2D) is  associated with improved disease control (glycated hemoglobin, blood pressure, and lipid profile),  lower rates of death and diabetes-related complications, increased quality of life, and decreased  health care resource utilization.",Non-OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
"The data also  show that for every 25% increase in MA, a patient’s HbA1c is reduced by 0.34%.7 However, adherence to medical therapy in general and adherence to medica - tion in particular have posed significant challenges to both health care systems and correspondence: Boon-how chew Department of Family Medicine, Faculty  of Medicine and health sciences,  Universiti Putra Malaysia, 43400 serdang,  selangor, Malaysia Tel +60 3 8947 2520 Fax +60 3 8947 2328 email chewboonhow@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chew et al Running head recto: Medication adherence in Malaysian patients with T2D DOI: http://dx.doi.org/10.2147/PPA.S81612 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
Or use: http://youtu.be/bX2VwEbMBA 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
Available from: http://apps.who.int/ iris/handle/10665/6604 0.,OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
"Available from: http://www.moh.gov.my/ attachments/3878.pd f. Accessed April 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f0/e8/ppa-9-639.PMC4427255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/be/tcrm-11-739.PMC4427256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 739–749Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  739Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7176 2The role of empagliflozin in the management  of type 2 diabetes by patient profile Maka S Hedrington Stephen N Davis Department of Medicine, University  of Maryland School of Medicine,   Baltimore, MD, USAAbstract:  Current recommendations for the management of type 2 diabetes mellitus (T2DM)  include patient-centered approach, ie, targeting glycemic control based on patient and disease  characteristics.",Non-OADS,/arxiv_data1/oa_pdf/ea/be/tcrm-11-739.PMC4427256.pdf
"Injectable treatment  options for T2DM include insulin and insulin analogs, amylin mimetics with slowing of  gastric emptying time and inhibition of glucagon production, and glucagon-like peptide-1  (GLP-1) receptor agonists that increase insulin release and inhibit glucagon secretion.1,2Correspondence: Stephen N Davis Department of Medicine, University  of Maryland School of Medicine,  22 South Greene Street, Room N3w42,  Baltimore, MD 21201, USA Tel +1 410 328 2488 Fax +1 410 328 8688 email sdavis@medicine.umaryland.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Hedrington and Davis Running head recto: Empagliflozin in the management of type 2 diabetes DOI: http://dx.doi.org/10.2147/TCRM.S71762",Non-OADS,/arxiv_data1/oa_pdf/ea/be/tcrm-11-739.PMC4427256.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/ea/be/tcrm-11-739.PMC4427256.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ea/be/tcrm-11-739.PMC4427256.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/be/tcrm-11-739.PMC4427256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/bd/tcrm-11-731.PMC4427257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 731–738Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  731Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8182 5Recurrent respiratory papillomatosis: current  and future perspectives Marco Carifi1 Domenico Napolitano1 Morando Morandi1 Danilo Dall’Olio2 1Department of Otolaryngology,   Azienda Ospedaliera di Rilievo  Nazionale A Cardarelli, Naples,   2Department of Otolaryngology,   Ospedale Maggiore CA Pizzardi,   Bologna, italyAbstract:  Although recurrent respiratory papillomatosis is a benign disease of the upper  aerodigestive tract caused by infection with human papillomavirus, the disease process is unpre - dictable, ranging from mild disease and spontaneous remission to an aggressive disease with  pulmonary spread and requirement for frequent surgical debulking procedures.",Non-OADS,/arxiv_data1/oa_pdf/ba/bd/tcrm-11-731.PMC4427257.pdf
"In adults, HPV infection might occur  following oral sex.14,15 However, the simple presence of HPV in the upper airway tract  does not necessarily cause infection of the mucosa; immunodeficiency and associated Correspondence: Marco Carifi Department of Otolaryngology, Azienda  Ospedaliera di Rilievo Nazionale A  Cardarelli, via Antonio Cardarelli 9,  Naples 80131, italy email marco.carifi@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Carifi et al Running head recto: Recurrent respiratory papillomatosis DOI: http://dx.doi.org/10.2147/TCRM.S81825",Non-OADS,/arxiv_data1/oa_pdf/ba/bd/tcrm-11-731.PMC4427257.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ba/bd/tcrm-11-731.PMC4427257.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/bd/tcrm-11-731.PMC4427257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/a5/rru-7-065.PMC4427258.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 65–79Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  65Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S6344 7immunotherapy for bladder cancer Oliver Fuge1 Nikhil vasdev1 Paula Allchorne2 James SA Green2 1Department of Urology, Lister  Hospital, Stevenage, UK; 2Department  of Urology, Bartshealth NHS Trust,   whipps Cross Rd, London, UK Correspondence: James SA Green   Department of Urology, Barts Health  NHS Trust (whipps Cross), whipps  Cross Rd, London e11 1NR, UK   email James.Green@bartshealth.nhs.u kAbstract:  It is nearly  40 years since Bacillus Calmette–Guérin (BCG) was first used as an  immunotherapy to treat superficial bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/21/a5/rru-7-065.PMC4427258.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/21/a5/rru-7-065.PMC4427258.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/a5/rru-7-065.PMC4427258.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/25/opth-9-795.PMC4427259.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 795–799Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  795Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7794 8indications and results in anophthalmic socket  reconstruction using dermis-fat graft Orapan aryasit   Passorn Preechawai Department of Ophthalmology,   Faculty of Medicine, Prince of songkla  University, hat Yai, songkhla, ThailandObjectives:  To present the indications for a dermis-fat graft in anophthalmic socket reconstruc - tion and evaluate the results of this procedure.",Non-OADS,/arxiv_data1/oa_pdf/c3/25/opth-9-795.PMC4427259.pdf
"The dermis-fat graft has been used as an orbital implant in primary enucleation,  secondary implants, and tissue augmentation in a contracted socket.3,6–9 In developed  countries, most surgeons prefer to use a porous polyethylene implant.10,11 On the  other hand, in Thailand, surgeons use both nonporous and porous orbital implants in Correspondence: Orapan aryasit Department of Ophthalmology, Faculty  of Medicine, Prince of songkla University,  Kanjanavanit road, hat Yai, songkhla  90110, Thailand email all_or_none22781@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Aryasit and Preechawai Running head recto: Anophthalmic socket reconstruction using dermis-fat graft DOI: http://dx.doi.org/10.2147/OPTH.S77948",Non-OADS,/arxiv_data1/oa_pdf/c3/25/opth-9-795.PMC4427259.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c3/25/opth-9-795.PMC4427259.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/25/opth-9-795.PMC4427259.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/35/opth-9-783.PMC4427260.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 783–784Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  783Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S8319 7Systematic review of the association between  Alzheimer’s disease and chronic glaucoma Sarah F Janssen1 Nomdo M Jansonius2 Femke Bouwman3 Frank D Verbraak1,4 Arthur A Bergen5 1Department of Ophthalmology,   VU Medical Center, Amsterdam;   2Department of Ophthalmology,   University of Groningen, University  Medical Center Groningen,   Groningen; 3Alzheimer Center, VU  Medical Center, 4Department of  Ophthalmology, 5Department of  Clinical Genetics, Academic Medical  Center, Amsterdam, the NetherlandsDear editor We read with great interest the paper by Tsilis et al entitled “Systematic review of the  association between Alzheimer’s disease and chronic glaucoma” published recently in  this journal.1 The potential overlap in the pathobiological background of Alzheimer’s  disease (AD) and primary open angle glaucoma (POAG) is currently a topic of intense  discussion and could provide further insight into both of these complex diseases.",Non-OADS,/arxiv_data1/oa_pdf/d9/35/opth-9-783.PMC4427260.pdf
"2013;37:   31–67.Correspondence: SF Janssen Department of Ophthalmology,  VU Medical Center Amsterdam,  De Boelelaan 1117, 1081 HV   Amsterdam, the Netherlands tel +312 0444 1099 email sf.janssen@vumc.n lJournal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2015 Volume: 9 Running head verso: Janssen et al Running head recto: Relationship between Alzheimer’s disease and chronic glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S83197",Non-OADS,/arxiv_data1/oa_pdf/d9/35/opth-9-783.PMC4427260.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d9/35/opth-9-783.PMC4427260.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/35/opth-9-783.PMC4427260.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/ae/opth-9-785.PMC4427261.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 785–793Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  785Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7891 8Patient satisfaction with glaucoma therapy:  reality or myth?,Non-OADS,/arxiv_data1/oa_pdf/7b/ae/opth-9-785.PMC4427261.pdf
"However, studies Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lemij et al Running head recto: Patient satisfaction with glaucoma therapy DOI: http://dx.doi.org/10.2147/OPTH.S78918",Non-OADS,/arxiv_data1/oa_pdf/7b/ae/opth-9-785.PMC4427261.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7b/ae/opth-9-785.PMC4427261.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/ae/opth-9-785.PMC4427261.pdf
Available from: http://ieaweb.org/good- epidemiological-practice-gep / 19.,Non-OADS,/arxiv_data1/oa_pdf/7b/ae/opth-9-785.PMC4427261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 627–638Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  627OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7849 5information and decision-making needs among  people with affective disorders – results   of an online survey sarah liebherz lisa Tlach Martin härter Jörg Dirmaier Department of Medical Psychology,   University Medical center hamburg- eppendorf, hamburg, germanyBackground:  Patient decision aids are one possibility for enabling and encouraging patients  to participate in medical decisions.",Non-OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
"SDM is defined as an interactional process  in which the patient and the physician aim to reach a decision together that is based  on shared information and the best available evidence.3 In the course of this process, correspondence: sarah liebherz Department of Medical Psychology,  University Medical center hamburg- eppendorf, Martinistraße 52, W26,  D-20246 hamburg, germany Tel +49 40 7410 57969 Fax +49 40 7410 54940 email s.liebherz@uke.d e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Liebherz et al Running head recto: Decision-making needs and affective disorders DOI: http://dx.doi.org/10.2147/PPA.S78495",Non-OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
Available from: http://decisionaid.ohri.ca/ AZsumm.php?ID=105 8.,OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
"Available from: http://www.awmf.org/uploads/tx_ szleitlinien/038-019l_S3_Bipolare_Stoerungen_2012-09.pd f. Accessed  March 26, 2015.",OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
"Available from: http://www.awmf.org/uploads/tx_szleitlinien/ nvl-005k_S3_Unipolare_Depression_Kurzfassung_2012-01_01.pd f.  Accessed March 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7c/8e/ppa-9-627.PMC4427262.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/ed/tacg-8-109.PMC4427263.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 109–121The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  109Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S4959 0The genetic landscape of X-linked adreno- leukodystrophy: inheritance, mutations, modifier  genes, and diagnosis Christoph wiesinger1 Florian S eichler2 Johannes Berger1 1Department of Pathobiology of the  Nervous System, Center for Brain  Research, Medical University of  vienna, vienna, Austria;  2Department  for Neurology, Massachusetts General  Hospital, Harvard Medical School,  Boston, MA, USA Correspondence: Johannes Berger   Department of Pathobiology of the  Nervous System, Center for Brain  Research, Medical University of vienna,  Spitalgasse  4, A-1090 vienna, Austria   Tel +43 1 40160 34301   Fax +43 1 40160 934093   email johannes.berger@meduniwien.ac.a tAbstract:  X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1  gene  encoding a peroxisomal ABC transporter.",Non-OADS,/arxiv_data1/oa_pdf/61/ed/tacg-8-109.PMC4427263.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/61/ed/tacg-8-109.PMC4427263.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/ed/tacg-8-109.PMC4427263.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 801–811Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  801Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7978 5A novel intravitreal fluocinolone acetonide  implant (iluvien®) in the treatment of patients  with chronic diabetic macular edema that  is insufficiently responsive to other medical  treatment options: a case series Vera K schmit-eilenberger augenklinik städtisches Klinikum,   Karlsruhe, Baden-Württemberg,   germanyBackground:  Iluvien® is a novel, nonbiodegradable, sustained-release drug delivery system  (0.2 µg/d fluocinolone acetonide [FAc]) indicated in Europe for the treatment of vision  impairment associated with chronic diabetic macular edema (DME), considered insufficiently  responsive to available therapies.",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
"It could be shown that 20.1% of patients with type 1 diabetes, Correspondence: Vera K schmit- eilenberger augenklinik städtisches Klinikum,  Moltkestraße 90, D-76133 Karlsruhe,  Baden-Württemberg, germany Tel +49 721 974 2001 Fax +49 721 974 2009 email dr.schmit-eilenberger@email.d eJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Schmit-Eilenberger Running head recto: FAc implant in insufficiently responsive DME: a case series DOI: http://dx.doi.org/10.2147/OPTH.S79785",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
Available from: https://www.medicines.org.uk/emc/ medicine/2763 6.,Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
"Available from: http://www.aaojournal.org/cms/ attachment/ 2005446053/2023774732/mmc1.pd f. Accessed August 22,  2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/opth-9-801.PMC4427264.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/b2/prbm-8-133.PMC4427265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 133–141Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  133Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S6119 2white coat hypertension: improving the   patient–health care practitioner relationship Briana Cobos Kelly Haskard-Zolnierek Krista Howard Department of Psychology, Texas  State University, San Marcos, TX, USA Correspondence: Kelly Haskard- Zolnierek   Texas State University, Department   of Psychology,  601 University Drive,   San Marcos, TX  78666, USA   Tel +1 512 245 8710  Fax +1 512 245 3153  email kh36@txstate.ed uAbstract:  White coat hypertension is characterized by the variability of a patient’ s blood pres - sure measurements between the physician’ s office and the patient’ s home environment.",Non-OADS,/arxiv_data1/oa_pdf/60/b2/prbm-8-133.PMC4427265.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/60/b2/prbm-8-133.PMC4427265.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/60/b2/prbm-8-133.PMC4427265.pdf
"Available from: http://www.dermnetnz.org/hair-nails-sweat/ ectodermal-dysplasia.html (accessed October 10, 2014).",Non-OADS,/arxiv_data1/oa_pdf/70/29/ccr30003-0280.PMC4427368.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/9f/ott-8-1009.PMC4427449.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1009–1015OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1009Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8214 4ABCB1  c3435T polymorphism is associated  with leukemia susceptibility: evidence   from a meta-analysis limin Ma1 linhai ruan1 hongchao liu2 haiping Yang1 Yanming Feng2 1Department of hematology, The  First affiliated hospital, 2Medical  college, henan University of science  and T echnology, luoyang, People’s  republic of chinaIntroduction and objective:  Many studies have been conducted on the association between  the adenosine triphosphate-binding cassette, subfamily B, member 1 ( ABCB1 ) gene C3435T  polymorphism and leukemia risk, however, the previously published findings remain controver - sial.",Non-OADS,/arxiv_data1/oa_pdf/32/9f/ott-8-1009.PMC4427449.pdf
"Keywords:  adenosine triphosphate-binding cassette, subfamily B, member 1 gene, multidrug- resistance gene, meta-analysis Introduction Leukemia is a group of malignant diseases of the hematopoietic system, with an esti - mated 54,270 new cases and 24,450 deaths expected in the USA in 2015.1 Although  the incidence of leukemia increases gradually, with age the most prominent risk fac - tor, the etiology and mechanisms underlying the pathogenesis of leukemia are not yet  fully understood.2 Epidemiological studies have found that advanced age, radiation,  smoking, and exposure to chemical carcinogens are risk factors which contribute to  the genesis of leukemia.3–5 However, only a small proportion of people exposed to  these risk factors develop leukemia, suggesting that host genetic factors might play an  important role.6 Recent genome-wide association studies have identified the presence correspondence: linhai ruan Department of hematology, The First  Affiliated Hospital, Henan University  of science and Technology, 24 Jinghua  road, luoyang 471003, henan,  People’s republic of china Tel/fax +86 379 6483 0481 email linhairuan@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ma et al Running head recto: Association of ABCB1  C3435T polymorphism with leukemia DOI: http://dx.doi.org/10.2147/OTT.S82144",Non-OADS,/arxiv_data1/oa_pdf/32/9f/ott-8-1009.PMC4427449.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/32/9f/ott-8-1009.PMC4427449.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/9f/ott-8-1009.PMC4427449.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 999–1007OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  999Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6466 4Personalized treatment strategies for non-small- cell lung cancer in Chinese patients: the role  of crizotinib Fei-Yu Niu1,2 Yi-Long wu2 1Graduate School, Southern Medical  University, Guangzhou, People’s  Republic of China; 2Guangdong Lung  Cancer institute, Guangdong General  Hospital, Guangdong Academy of  Medical Sciences, Guangzhou, People’s  Republic of ChinaAbstract:  Anaplastic lymphoma kinase ( ALK) rearrangement is an oncogene targeted with  approved drugs second to epidermal growth factor receptor  (EGFR ) in lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
"It was only based on results of PROFILE Correspondence: Yi-Long wu Guangdong Lung Cancer institute,  Guangdong General Hospital, Guangdong  Academy of Medical Sciences, 106  Zhongshan 2nd Road, Guangzhou  510080, People’s Republic of China Tel +86 20 8387 7855 Fax +86 20 8382 7712 email syylwu@live.c n Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Niu and Wu Running head recto: Crizotinib in Chinese patients DOI: http://dx.doi.org/10.2147/OTT.S64664",Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
Available from: http://clinicaltrial.gov/ct2/show/ NCT0163900 1.,Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
Available  from: http://clinicaltrial.gov/ct2/show/NCT0204210 5.,Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/2d/ott-8-999.PMC4427450.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/29/opth-9-821.PMC4427451.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 821–824Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  821Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S8148 3an atypical presentation of sinus mucopyocele  in a pediatric cystic fibrosis patient elan Horesh andrew a Colin roy Casiano sara t Wester Bascom palmer eye Institute,   University of Miami Miller school  of Medicine, Miami, FL, UsaAbstract:  This case report details an association of chronic allergic conjunctivitis and respiratory  tract colonization in a cystic fibrosis (CF) patient due to an ethmoidal mucocele infected with  Escherichia coli .",Non-OADS,/arxiv_data1/oa_pdf/1c/29/opth-9-821.PMC4427451.pdf
"In addition, patients Correspondence: sara Wester Bascom palmer eye Institute, University  of Miami Miller school of Medicine,  900 NW 17th street, Miami, FL  33136, Usa tel +1 305 326 6086 email swester2@med.miami.ed u Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Horesh et al Running head recto: Sinus mucocele and allergic conjunctivitis in CF patient DOI: http://dx.doi.org/10.2147/OPTH.S81483",Non-OADS,/arxiv_data1/oa_pdf/1c/29/opth-9-821.PMC4427451.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1c/29/opth-9-821.PMC4427451.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/29/opth-9-821.PMC4427451.pdf
"Available from: http://www.uptodate.com/contents/allergic- conjunctivitis?source =search_resul t. Accessed March 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1c/29/opth-9-821.PMC4427451.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/a8/ott-8-991.PMC4427452.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 991–997OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  991Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8314 0an analysis of brachytherapy with computed  tomography-guided permanent implantation  of iodine-125 seeds for recurrent nonkeratin  nasopharyngeal carcinoma Xinying shen1,2 Y ong li2 Yanfang Zhang2 Jian Kong2 Yanhao li1 1Department of interventional  radiology, nanfang hospital, southern  Medical University, guangzhou,   2Department of interventional  radiology, shenzhen People’s hospital,   The second clinical Medical college  of Jinan University, shenzhen,   People’s  republic of chinaBackground:  125I seed implantation is a new method in treatment of nasopharyngeal carcinoma  (NPC), and it is worthwhile to evaluate its feasibility.",Non-OADS,/arxiv_data1/oa_pdf/ec/a8/ott-8-991.PMC4427452.pdf
"In southern China, 2% of NPC is  type I, 3% type II, and 95% type III.3 Because of their anatomic situation at the base of  skull, most nasopharyngeal carcinomas spread early to cervical nodes and are difficult correspondence: Yanhao li Department of interventional radiology,  nanfang hospital, southern Medical  University, 1838 guangzhou avenue  north, guangzhou, guangdong 510515,  People’s republic of china Tel +86 20 6164 2082 email yanhaoli@yahoo.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Shen et al Running head recto: 125I seed brachytherapy for recurrent nonkeratin NPC DOI: http://dx.doi.org/10.2147/OTT.S83140",Non-OADS,/arxiv_data1/oa_pdf/ec/a8/ott-8-991.PMC4427452.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ec/a8/ott-8-991.PMC4427452.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/a8/ott-8-991.PMC4427452.pdf
Geneva: World Health Organization; 2014. http://www.who.int/countries/sdn/en/ [accessed 10 January 2014].,Non-OADS,/arxiv_data1/oa_pdf/5b/55/ihu063.PMC4427533.pdf
Sudan J Med Sci; 2009. http://www.sudjms.net/ issues/5-3/html/7%29Why%20do%20people%20prefer%20traditional %20bonesetters%20in%20Sudan.htm [accessed 20 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/5b/55/ihu063.PMC4427533.pdf
Inauguration of Free Ambulance Call Services; 2009. http://www.ashorooq.net/index.php?option=com_content&view=article&id=1405:2009-07-01-17-36-17&catid=77:2009-04-08-05-57-59&Itemid=1201 [in Arabic] [accessed 20 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/5b/55/ihu063.PMC4427533.pdf
http://www.unhcr.org/52 fa062a9.html [accessed 11 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
2013; http://hdr.undp.org/en/content/human-development-report-2013[accessed 14 February 2014].4 WHO.,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
Ge neva: World Health Organization; 2014. http://www.who.int/gho/publications/world_health_statistics/2014/ en/[accessed 10 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
Writenet; 2009. http://www.unhcr.org/refworld/pdﬁd/4a9797572.pdf [accessed 30 January 2013].,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
Geneva: IPSOS & International Committee of the Red Cross; 2010. https://www.icrc.org/eng/assets/ﬁles/other/ icrc_002_1008.pdf [accessed 10 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
https://aidworkersecurity.org/ incidents/report/country [accessed 16 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
Aid Worker Security Report 2013. https://aidworkersecurity.org/ sites/default/ﬁles/AidWorkerSecurityReport_2013_web.pdf [accessed 16 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/cf/4d/ihu086.PMC4427534.pdf
Over 970 Kenyan-basedHCWs have completed an eight-modular online training free of charge ( http://www.marps-africa.org ) since its creation in 2011.,Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
"The online version ( http://www.marps-africa.org )o f the second edition is frequently used in Kenya and over 970 HCWs, including over 420 government HCWs, have completed it, either through self-training or facilitated learning (E. Sanders, per- sonal communication).",Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
"New WHO guidelines on the Prevention, Diagnosis, Treatment and Care of Key Populations , 5and an online curriculum for health- care providers developed by the Global Forum on MSM and HIV (MSMGF) and Johns Hopkins University ( http://www.msmgf.org/ promotinghealth [accessed 17 December 2014]) were both released in advance of the AIDS conference in July 2014, Mel- bourne, Australia.",Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
"Technical guidance on clinical care for MSM and a comprehensive training curriculum for HCWs working with MSM patients has re- cently been made available ( http://www.msmgf.org/promoting health ) and an introductory manual on Health Care Provision for MSM, Sex Workers, and People Who Inject Drugs has been devel- oped in South Africa in 2013.53Front-line HCWs in sSA would bene ﬁt from an accessible and basic introductory training manual that is tailored speci ﬁcally to their region.",Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
"Given that the online training programme is regularly used, with over 970 Kenyan HCWs graduating since 2011, and is actively promoted by the National STI and AIDS Control Pro- gramme (NASCOP) in Kenya ( http://nascop.or.ke/ ), an update of training materials would be bene ﬁcial.",Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
"Acknowledgements: We thank the International AIDS Vaccine Initiative (IAVI) for ﬁnancially supporting the establishment of http://www.marps- africa.org ; and Mary-Anne Barckhoff, an IAVI consultant, for designingand maintaining the website.",Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
http://projectreporter.nih.gov/project_info_description.cfm?aid=8661 309&icde=22764832 [accessed 17 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/db/49/ihu101.PMC4427535.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/da/copd-10-873.PMC4427594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 873–879International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  873OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8043 9The association between combined non-cystic  fibrosis bronchiectasis and lung cancer in patients  with chronic obstructive lung disease Yeon Wook Kim1 Kwang-Nam Jin2 Eun Y oung Heo3 Sung Soo Park3 Hee Soon Chung3 Deog Kyeom Kim3 1Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, seoul national  University College of Medicine, Seoul,   republic of Korea; 2Department  of Radiology, Seoul National  University College of Medicine,   seoul Metropolitan government- seoul national University Boramae  Medical Center, seoul, republic of  Korea; 3Division of Pulmonary and  Critical Care Medicine, Department  of Internal Medicine, seoul national  University College of Medicine, Seoul  Metropolitan government- seoul  national University Boramae Medical  Center, seoul, republic of KoreaBackground:  Whereas the epidemiological association between lung cancer and chronic  obstructive pulmonary disease (COPD), a chronic inflammatory respiratory disease, is well  known, limited studies have examined the association between lung cancer and non-cystic fibrosis  bronchiectasis, a representative chronic airway inflammatory disease.",Non-OADS,/arxiv_data1/oa_pdf/2c/da/copd-10-873.PMC4427594.pdf
"Inflammation-mediated pathways might involve immune and non- immune systems, producing chemical mediators such as eicosanoids, cytokines, growth  factors, and reactive oxygen species.6 Therefore, chronic inflammation is likely to play a Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kim et al Running head recto: Bronchiectasis and risk of lung cancer in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S80439 Correspondence: Deog Kyeom Kim Division of Pulmonary and Critical  Care Medicine, Department of Internal  Medicine, seoul national University  College of Medicine, Seoul Metropolitan  government-seoul national University  Boramae Medical Center, 20 Boramaero- 5-Gil, Dongjak-Gu, Seoul 156-707,  republic of Korea Tel +82 2 8702 228 Fax +82 2 8312 826 email kimdkmd@snu.ac.k r",Non-OADS,/arxiv_data1/oa_pdf/2c/da/copd-10-873.PMC4427594.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2c/da/copd-10-873.PMC4427594.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/da/copd-10-873.PMC4427594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/6c/dddt-9-2545.PMC4427595.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2545–2551Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2545Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8234 7sonodynamic effect of hematoporphyrin  monomethyl ether on ligature-induced  periodontitis in rats Deshu Zhuang1 Jialong han1 liangjia Bi1 Yueping Wang1 Yanru hao2 Qi Zhou3 Wenwu cao3,4 1Department of stomatology, The  Fourth affiliated hospital, harbin  Medical University, harbin, People’s  republic of china; 2Department  of stomatology, The First affiliated  hospital, harbin Medical University,   harbin, People’s republic of china;   3condensed Matter science and  Technology institute, harbin institute  of Technology, harbin, People’s  republic of china; 4Department of  Mathematics and Materials research  institute, The Pennsylvania state  University, University Park, P a, UsaObjectives:  The aim of this study was to perform a histological evaluation of sonodynamic  therapy (SDT) of hematoporphyrin monomethyl ether (HMME) on artificially induced peri - odontal disease in rats.",Non-OADS,/arxiv_data1/oa_pdf/94/6c/dddt-9-2545.PMC4427595.pdf
"Although systemic or local application of antibiotics therapy  can reduce pathogenic bacteria and their endotoxins inside the periodontal pockets, the  effect is not completely satisfactory, because many bacteria may gain resistance during  this antimicrobial process.4 Scaling and root planing has been widely used in clinical correspondence: liangjia Bi Department of stomatology, The Fourth  Affiliated Hospital, Harbin Medical  University, PO Box 31, Yinhang street,  nangang District, harbin 150001,  People’s republic of china Tel/fax +86 451 8257 6566 email stevenchuang88@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhuang et al Running head recto: Sonodynamic effects on periodontitis in rats DOI: http://dx.doi.org/10.2147/DDDT.S82347",Non-OADS,/arxiv_data1/oa_pdf/94/6c/dddt-9-2545.PMC4427595.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/94/6c/dddt-9-2545.PMC4427595.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/6c/dddt-9-2545.PMC4427595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 829–837Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  829OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7951 1“I am active”: effects of a program to promote  active aging neyda Ma Mendoza- ruvalcaba1 elva Dolores Arias-Merino2 1health sciences Department,   University of guadalajara, University  Center of T onala guadalajara, Jalisco,   Mexico; 2Public health Department,   University of guadalajara, University  Center of health sciences,   guadalajara, Jalisco, MexicoBackground:  Active aging involves a general lifestyle strategy that allows preservation of  both physical and mental health during the aging process.",Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
mx Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mendoza-Ruvalcaba and Arias-Merino Running head recto: A program to promote active aging DOI: http://dx.doi.org/10.2147/CIA.S79511,Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Available from:  http://www.activeageingaustralia.com.a u. Accessed October 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Available  from: http://www.epa.gov/research/aging/bhc/index.ht m. Accessed  October 20, 2014.",OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Available from: http://www.icaa.cc/index.as p. Accessed October 22,  2014.",Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Available from: http://www.age-platform.eu/age-policy-work/ solidarity-between-generations/lastest-news/1231-2012-european- year-on-active-ageing-and-intergenerational-solidarit y. Accessed  October 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
"Available from: http://apps.who.int/bmi/ index.jsp?introPage =intro_3.htm l. Accessed October 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
Available from: http://rlrw.bnu.edu.cn/NewsImage/2012410114358.,Non-OADS,/arxiv_data1/oa_pdf/31/50/cia-10-829.PMC4427596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/8b/cia-10-839.PMC4427597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 839–847Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  839OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6927 0Association between functional performance  and executive cognitive functions in an elderly  population including patients with low  ankle–brachial index naomi Vidal  Ferreira1 Paulo Jannuzzi Cunha2 Danielle Irigoyen da Costa3 Fernando dos santos1 Fernando Oliveira Costa1 Fernanda Consolim- Colombo4 Maria Cláudia Irigoyen1 1heart Institute, Medical school,   Universidade de são Paulo, são Paulo,   sP , Brazil; 2neuroimaging in Psychiatry  laboratory, Department of Psychiatry,   Medical school, Universidade de  são Paulo, são Paulo, sP , Brazil;   3rio grande do sul Cardiology  Institute, Fundação Universitária de  Cardiologia, Porto Alegre, rs, Brazil;   4Medical school, Universidade nove  de Julho, são Paulo, sP , BrazilIntroduction:  Peripheral arterial disease, as measured by the ankle–brachial index (ABI),  is prevalent among the elderly, and is associated with functional performance, assessed  by the 6-minute walk test (6MWT).",Non-OADS,/arxiv_data1/oa_pdf/7e/8b/cia-10-839.PMC4427597.pdf
"Keywords:  cognition, vascular disease, 6-minute walk test Introduction Lower extremity peripheral arterial disease (PAD), a cardiovascular disease (CVD)  resulting from atherosclerotic processes affecting the lower limbs,1 is prevalent among  the elderly.2 Low ankle–brachial index (ABI), the most utilized criterion for detecting  PAD,3 may lead to pain on exertion, skeletal muscle atrophy and weakness,4 resulting Correspondence: naomi Vidal  Ferreira Av Dr eneas de Carvalho Aguiar, 44,  Cerqueira Cesar, são Paulo, sP, CeP  05403-000, Brazil email naomivferreira@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ferreira et al Running head recto: Functional performance and executive cognitive functions DOI: http://dx.doi.org/10.2147/CIA.S69270",Non-OADS,/arxiv_data1/oa_pdf/7e/8b/cia-10-839.PMC4427597.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7e/8b/cia-10-839.PMC4427597.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7e/8b/cia-10-839.PMC4427597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/2e/ccid-8-239.PMC4427598.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 239–248Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  239OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7987 1Antioxidant, anti-inflammatory, anti-apoptotic, and  skin regenerative properties of an Aloe vera -based  extract of Nerium oleander  leaves (nae-8®) Kathleen F Benson1 robert a newman2,3 gitte s Jensen1 1nIs labs, Klamath Falls, Oregon,  Usa; 2University of Texas MD  anderson Cancer Center, houston,  TX, Usa; 3nerium Biotechnology, Inc,  san antonio, TX, Usa Correspondence: robert a newman   112 Whale rock lane   surry, Me 04684, UK   Tel +1 207 667 5214   email newmanscientificconsulting@gmail.",Non-OADS,/arxiv_data1/oa_pdf/8d/2e/ccid-8-239.PMC4427598.pdf
Or use: http://youtu.be/dm6cmxFGzz Y,Non-OADS,/arxiv_data1/oa_pdf/8d/2e/ccid-8-239.PMC4427598.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8d/2e/ccid-8-239.PMC4427598.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/2e/ccid-8-239.PMC4427598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/04/ijn-10-3337.PMC4427599.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3337–3350International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3337OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7770 6Electrospun nanofibrous SF/P(LLA-CL) membrane:  a potential substratum for endothelial  keratoplasty Junzhao Chen1,* Chenxi Yan1,* Mengyu Zhu1,* Qinke Yao1 Chunyi Shao1 Wenjuan lu1 Jing Wang2 Xiumei Mo2 Ping Gu1 Yao Fu1 Xianqun Fan1 1Department of Ophthalmology,   Ninth People’s Hospital, Shanghai Jiao  T ong University School of Medicine,   2Biomaterials and Tissue engineering  Laboratory, College of Chemistry  and Chemical Engineering and  Biotechnology, Donghua University,   Shanghai, People’s Republic of China *These authors contributed equally  to this workBackground:  Cornea transplant technology has progressed markedly in recent decades,  allowing surgeons to replace diseased corneal endothelium by a thin lamellar structure.",Non-OADS,/arxiv_data1/oa_pdf/b8/04/ijn-10-3337.PMC4427599.pdf
